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ABSTRACT  
 
The cosmetic industry is constantly in search of ingredients from natural sources because of 
their multifunctional properties, competitive effectiveness, and lower toxicity effects. 
Otherwise, mushrooms have been an important part of our diet for years due to their rich 
nutritional and abundant content in biomolecules; however, their cosmeceutical and 
nutricosmetic potential have not been fully exploited. This study aimed at optimizing the 
extraction of bioactive compounds from Ganoderma lucidum and Agaricus blazei by Response 
Surface Methodology (RSM) and comparing conventional extraction techniques with more 
sustainable methods. Further studies regarding their nutritional and chemical composition (e.g., 
sugars, organic acids, tocopherols, and fatty acids), were conducted. Also, extracts obtained 
from those mushrooms, but also from Agaricus bisporus, Pleurotus ostreatus and Lentinula 
edodes extracts, using the Soxhlet extraction system, were analysed in terms of anti-
inflammatory, anti-tyrosinase, antioxidant, and antimicrobial activities followed by their 
characterization in terms of phenolic acids and related compounds, ergosterol, and 
triterpenoids. Furthermore, the obtained extracts were incorporated in a base cosmetic cream 
to ascertain bioactive properties sustainment. Moreover, to evaluate the individual 
cosmeceutical contribution of p-hydroxybenzoic acid, p-coumaric acid, protocatechuic acid, 
cinnamic acid and ergosterol, their anti-inflammatory, anti-tyrosinase, and antimicrobial 
activities were studied, followed by incorporation of these compounds in a base cosmetic 
cream. Because of the possibility of the extracts and the individual compounds to lose their 
potency over time either due to oxidation or degradation, microparticles were prepared using 
the atomization/coagulation technique. The microparticles were characterized in terms of 
morphology, particle size distribution, and encapsulation efficiency. This is followed by 
incorporation of the produced microparticles into a base cosmetic cream and comparison of 
their performance with the free forms (formulations containing free extracts/individual 
compounds). The most promising extracts and their corresponding formulations were 
submitted to in vitro safety evaluation using the MTT and LDH assays in keratinocyte (HaCaT) 
and fibroblast (HFF-1) cell lines. Moreover, they were submitted to ex vivo skin permeation 
studies using a Franz diffusion apparatus with pig ear skin as permeation membrane to 
determine topical bioavailability of the bioactive compounds present in the extracts.  
The optimization study on bioactive compounds recovery from G. lucidum and A. blazei using 
RSM showed that the values predicted by the models were in close agreement with 
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experimental observations. Furthermore, it was concluded that the extraction yield of bioactive 
compounds from the studied mushrooms was highly dependent on the extraction variables 
(time, temperature, solvent proportion, solid-liquid ratio, and power). A. blazei and G. ludidum 
also showed high nutritional contribution. α-Tocopherol, oxalic acid and twenty-one fatty acids 
(mainly PUFA) were quantified in A. blazei. G. lucidum showed a similar fatty acids’ profile 
(PUFA˃SFA˃MUFA) and with the presence of α-tocopherol and δ-tocopherol. 
Comparatively, A. blazei revealed lower fat content, but higher energy contribution. The cell 
viability effect of the extract prepared from A. blazei on Caco-2 and HT29-MTX cells was 
found to be maintained in a concentration-dependent manner.  
The ethanolic extracts obtained from the studied mushrooms showed antioxidant, anti-
inflammatory, anti-tyrosinase and antimicrobial activities, and after incorporation into the base 
cosmetic cream, the final cosmeceutical formulations preserved some of these bioactivities. G. 
lucidum extract was found to be a rich source of triterpenoids mainly due to the high 
contribution of ganoderic acid A, C2, and H, while phenolic acids (p-hydroxybenzoic acid, p-
coumaric acid and protocatechuic acid), the related compound cinnamic acid, and ergosterol 
were identified in A. bisporus, P. ostreatus, L. edodes and A. blazei extracts. Each one of these 
compounds also showed anti-inflammatory, anti-tyrosinase and antimicrobial activities. 
Furthermore, microparticles were successfully used to encapsulate extract/individual 
compounds with high encapsulation efficiency and yield. After incorporation of the free 
extracts/individual compounds and the produced microparticles into the base cosmetic cream, 
the encapsulated forms allowed for a controlled release leading to bioactivity preservation 
when compared with the free forms.  
Because they presented the most interesting cosmeceutical potential, P. ostreatus and G. 
lucidum extracts were submitted to toxicological studies, revealing no toxicity in keratinocytes 
and fibroblast cell lines, which is indicative of their potential safety to be used as cosmeceutical 
ingredients. Protocatechuic acid and syringic acid were the only compounds permeating from 
the G. lucidum extract, while very low detection was observed for compounds present in the P. 
ostreatus extract. Similar results were also obtained for the formulation prepared using both 
extracts. The results showed that tritepenoids in G. lucidum might be natural permeation 
enhancers and these results pointed out for the suitability of using these mushroom extracts as 
skin care ingredients. Overall, the results showed that skin care products can be formulated 
using mushroom extracts and that these extracts have the potential to be utilised at large scale 
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use. Hence, integration of wastes generated by the mushroom processing industry, which can 
serve as raw materials for the obtainment of bioactive extracts, can be intensified. 
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RESUMEN 
 
La industria cosmética está constantemente en busca de ingredientes de origen natural debido 
a sus propiedades multifuncionales, su eficacia competitiva, y su menor toxicidad. Por otra 
parte, los hongos han sido una parte importante de nuestra dieta durante años debido a su 
riqueza nutricional y su abundante contenido en biomoléculas; sin embargo, su potencial 
cosmecéutico y nutricosmético no ha sido plenamente explotado. Este estudio tuvo como 
objetivo la optimización, utilizando la metodología de superficie de respuesta (RSM), de la 
extracción de compuestos bioactivos a partir de Ganoderma lucidum y Agaricus blazei y la 
comparación de técnicas de extracción convencionales con métodos más sostenibles. Se 
llevaron a cabo estudios adicionales relacionados con su composición química y valor 
nutricional (por ejemplo, azúcares, ácidos orgánicos, tocoferoles, y ácidos grasos). Además, 
extractos obtenidos, utilizando el sistema de extracción de Soxhlet, a partir de esos hongos 
junto con otros procedentes de Agaricus bisporus, Pleurotus ostreatus y extractos de Lentinula 
edodes, se analizaron en términos de actividad anti-inflamatoria, anti-tirosinasa, antioxidante, 
y antimicrobiana seguido de su caracterización en términos de ácidos fenólicos y compuestos 
relacionados, ergosterol, y triterpenoides. Además, los extractos obtenidos fueron incorporados 
en una crema cosmética base para evaluar propiedades bioactivas de soporte. Además, para 
evaluar la contribución individual como cosmecéuticos del ácido p-hidroxibenzoico, ácido p-
cumárico, ácido protocatéquico, ácido cinámico y ergosterol, fueron estudiadas sus 
propiedades anti-inflamatorias, anti-tirosinasa, y actividades antimicrobianas, seguido de la 
incorporación de estos compuestos en una crema cosmética base. Debido a la posibilidad de 
que los extractos y los compuestos individuales puedan perder su potencia con el tiempo, ya 
sea debido a la oxidación o la degradación, se prepararon en forma de micropartículas usando 
la técnica de atomización/coagulación. Las micropartículas se caracterizaron en términos de 
morfología, distribución de tamaño de partícula, y la eficiencia de encapsulación. A 
continuación, dichas micropartículas se incorporaron en una crema cosmético de base y se 
comparó su comportamiento frente a las formas libres (formulaciones que contienen extractos 
libres/compuestos individuales). Los extractos más prometedores y sus correspondientes 
formulaciones fueron sometidos a test de evaluación in vitro de su seguridad utilizando los 
ensayos de MTT y LDH en líneas celulares de queratinocitos humanos (HaCaT) y fibroblastos 
(HFF-1). Además, los extractos fueron sometidos a estudios ex vivo de permeabilidad de la piel 
utilizando una celda de Franz provista con una membrana natural obtenida a partir de la piel 
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de oreja de cerdo para determinar la biodisponibilidad tópica de los compuestos bioactivos 
presentes en los extractos. 
El estudio de optimización en la recuperación de compuestos bioactivos de Ganoderma 
lucidum y A. blazei mediante RSM mostró que los valores predichos por los modelos estaban 
muy de acuerdo con las observaciones experimentales. Además, se concluyó que el 
rendimiento de extracción de compuestos bioactivos a partir de los hongos estudiados era 
altamente dependiente de las variables de extracción (tiempo, temperatura, proporción de 
disolvente, la relación sólido-líquido, y potencia). A. blazei y G. ludidum también mostraron 
un elevado valor nutricional. Se cuantificaron a-tocoferol, ácido oxálico y veintiún ácidos 
grasos (principalmente PUFA) en A. blazei. G. lucidum, por su parte, mostró un perfil de ácidos 
grasos similares (PUFA˃SFA˃MUFA) y con la presencia de α-tocoferol y δ-tocoferol. 
Comparativamente, A. blazei reveló un menor contenido de grasa, pero mayor aporte de 
energía. Se observó que el efecto sobre la viabilidad celular del extracto preparado a partir de 
A. blazei en líneas celulares Caco-2 y HT29-MTX se mantenía de una manera concentración-
dependiente. 
Los extractos etanólicos obtenidos a partir de los hongos estudiados mostraron actividad 
antioxidante, anti-inflamatoria, anti-tirosinasa y antimicrobiana, y después de la incorporación 
en la crema cosmético base, las formulaciones cosmecéuticas finales conservaron algunas de 
estas bioactividades. El extracto de G. lucidum se encontró que era una fuente rica de 
triterpenoides debido principalmente a la alta contribución de ácidos ganodéricos A, C2, y H, 
mientras que los ácidos fenólicos (ácido p-hidroxibenzoico, p-cumárico, ácido protocatéquico 
y ácido cinámico) y ergosterol se identificaron en A. bisporus, P. ostreatus, L. edodes y 
extractos de A. blazei. Cada uno de estos compuestos también mostraron efectos anti-
inflamatorios, anti-tirosinasa y actividades antimicrobianas. Además, se utilizaron con éxito 
micropartículas para encapsular los extractos/compuestos individuales con alta eficiencia de 
encapsulación y rendimiento. Después de la incorporación en la crema cosmética base de los 
extractos/compuestos individuales libres y las micropartículas producidas a partir de ellos, las 
formas encapsuladas permitieron una liberación controlada que conduce a una mayor 
preservación de la bioactividad cuando se compara con las formas libres. 
Debido a que presentaban el potencial cosmecéutico más interesante, los extractos de P. 
ostreatus y G. lucidum fueron sometidos a estudios toxicológicos, que revelaron ausencia de 
toxicidad en líneas celulares de queratinocitos y fibroblastos, lo cual es indicativo de su 
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potencial seguridad para ser utilizados como ingredientes cosmecéuticos. Los ácidos 
protocatequico y siríngico fueron los únicos compuestos que permeaban a partir del extracto 
de G. lucidum, mientras que se observó una muy baja permeación para los compuestos 
presentes en el extracto de P. ostreatus. También se obtuvieron resultados similares para la 
formulación preparada usando ambos extractos. Los resultados mostraron que los 
triterpenoides presentes en G. lucidum podrían ser potenciadores de la permeabilidad natural, 
lo que corrobora la idoneidad del uso de estos extractos de hongos como ingredientes para el 
cuidado de la piel. En general, los resultados mostraron que los productos para el cuidado de 
la piel se pueden formular usando extractos de hongos y que estos extractos tienen el potencial 
de ser utilizados a gran escala. Por lo tanto, la integración de los residuos generados por la 
industria de transformación de hongos, que pueden servir como materia prima para la obtención 
de extractos bioactivos, puede intensificarse. 
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CHAPTER 1: Background  
 
1.1. Skin biology, skin ageing, and common skin disorders 
 
The skin is the largest organ in the human body accounting for about 15% of total body weight. 
It acts as a barrier between the external environment providing protection against foreign 
bodies (Kamble, Sadarani, Majumdar & Bhullar, 2017). The skin structure is divided into three 
functional layers: epidermis (the outermost layer); dermis (structural support and mechanical 
barrier) and hypodermis (deepest layer) (Mota, Rijo, Molpeceres, & Reis, 2017), as shown in 
Figure 1. The epidermis is divided into Stratum corneum (SC), Stratum granulosum (SG), 
Stratum spinosum (SS) and Stratum basale (SB), from the exterior to the interior with the cells 
comprising 95% of keratinocytes and 5% of other cells (Langerhans cells, melanocytes and 
Merkel cells) (Mota et al., 2017).  
 
Figure 1. Structure of the skin showing the three functional layers (Kamble et al., 2017). 
 
Keratinocytes cells continue to undergo differentiation (i.e. keratinization), forming the dead 
superficial layer referred to as the "cornified layer", which is considered to be the first line of 
defence against an environmental threat (Hirobe, 2014). The major proteins found in 
keratinocytes are keratin and filaggrin, which together with ceramides and fatty acids, regulate 
the barrier function of the skin and prevent water loss (Juráňová, Franková, & Ulrichová, 
2017). The dermis is the layer of the skin that offers support and mechanical barrier, being 
mainly comprised by fibroblasts, dendritic, mast cells, blood and lymphatic vessels, sensory 
nerve endings, hair follicles, sweat and sebaceous glands. This layer contains structural 
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components such as collagen, elastin and extracellular fibres that maintain the tensile strength 
and elasticity of the skin. The fibroblasts are the principal cell type within the dermis and are 
primarily responsible for production, deposition, and remodelling of the extracellular matrix 
(ECM) components thereby contributing significantly to the wound healing process of the skin 
(Li, Zhao, Hao, Han, & Fu, 2017). The hypodermis is the deepest layer of the skin also known 
as the subcutaneous layer, composed of areolar and adipose tissues that anchor the skin to the 
underlying structures (muscles or bones). This layer serves as energy storage in the form of fat 
(triglycerides and cholesterol), as well as assuring thermoregulatory functions (Mota et al., 
2017).  
Bioactive compounds can effectively scavenge free radicals when they are applied topically to 
protect the skin if they reach deeper cutaneous layers. Despite the skin possessing a strong 
barrier, there are several routes in which the active ingredient can penetrate and permeate the 
skin (Costa & Santos, 2017). The absorption of bioactive ingredient into the skin takes place 
by dissolution and molecular diffusion through the skin membrane, via three different 
penetration pathways namely, intracellular pathway, intercellular pathway and appendageal 
pathway (through  sweat gland and hair follicles) as shown in Figure 2 (Bolzinger, Briançon, 
Pelletier, & Chevalier, 2012). Bioactive ingredients from various natural sources are becoming 
the major focus of recent developments in skin care products and it is important that these 
ingredients penetrate the stratum corneum and reach other skin layers. Penetration through the 
intercellular pathway occurs through the intercellular spaces and this penetration method 
predominates over the other two penetration pathways. The contribution of the appendageal 
route is negligible considering only 0.1% of the total surface area of human skin is covered by 
sweat glands and hair follicles (Lane, 2013). 
 
Figure 2. Different penetration pathways (Bolzinger et al. 2012). 
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Studies have shown that skin diseases account for nearly 34% of all the diseases encountered 
worldwide with skin ageing being the most prominent problem that tends to worsen over time 
(Xie et al., 2018). The aetiology of skin diseases varies from environmental factors such as UV 
radiation, pollution, pathogens, genetic factors and autoimmune disorders (Działo et al., 2016). 
Some of the most common skin diseases will be discussed below. 
Skin ageing: The extracellular matrix (ECM) of the skin is the structural support network made 
up of diverse proteins, sugars, and other components. These structural components include 
collagen, elastin, fibronectin, laminin, tenascin, hyaluronic acid and collectively, they are 
responsible for maintaining the tensile strength, cell adhesion, cell migration and wound 
healing of the skin (Kular, Basu, & Sharma, 2014). The breakdown of the ECM is carried out 
by a group of calcium-dependent zinc-containing endopeptidases called "matrix 
metalloproteinases (MMPs)". The activities of these enzymes result in enzymatic degradation 
and reduced de novo synthesis of collagen and elastin, while also causing changes in hyaluronic 
acid content, resulting in skin laxity and ageing (Taofiq, González-Paramás, Martins, Barreiro, 
& Ferreira, 2016). The mechanism behind the ageing process can either be intrinsic or extrinsic, 
with the intrinsic mechanism being a natural or cellular based process in the skin and other 
organs as a consequence of physiological changes that occur over time (Lorencini, Brohem, 
Dieamant, Zanchin, & Maibach, 2014). The skin is equipped with intrinsic enzymatic 
antioxidants, such as superoxide dismutase (SOD), catalase and glutathione peroxidase (GP), 
which collectively neutralize free radicals and repair oxidative damage. Continuous oxidative 
and repair processes in the body generate free radicals that often cause low activity of these 
antioxidants thereby promoting the ageing process (Taofiq, González-paramás, Barreiro, & 
Ferreira, 2017). UV radiation from sun exposure is the major environmental insult to skin and 
this tends to trigger the extrinsic ageing mechanism that results in the generation of free radical 
species (Kammeyer & Luiten, 2015). Subsequently, the free radicals induce activator protein-
1 (AP-1), a transcription factor that promotes collagen breakdown by up-regulating the MMPs. 
Overexpression of these MMPs leads to elevated levels of degraded collagen and a photoaged 
skin (Taofiq et al., 2016). Another similar extrinsic pathway responsible for an ageing skin is 
the downregulation of transforming growth factor (TGF-β), a cytokine that promotes pro-
collagen production by UV radiation, thus causing low levels of collagen synthesis (Figure 3) 
(Taofiq et al., 2016). With increasing age, collagen synthesis becomes lower and MMPs 
activities becomes higher resulting in skin wrinkling and loss of elasticity (Hui, Pin-ru, Shen, 
& Xiang-dong, 2010). 
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Figure 3. An overview of the skin ageing process (UV: ultraviolet radiation; AP-1: activator factor protein; ROS: 
reactive oxygen species; MMPs: matrix metalloproteinases; NF-κB: nuclear factor κB; TGF-β: transforming 
growth factor β). 
 
Atopic dermatitis: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized 
by eczematous lesions, intense itch, swollen and severely dry skin, making the skin susceptible 
to cutaneous infections (Akdis, Akdis, Trautmann, & Blaser, 2000). Uncontrolled production 
of inflammatory mediators has been known to cause several cell damages and initiate the 
inflammation process, with many therapeutic trials already performed to find potent treatments 
to suppress AD (Choi et al., 2011). Some glucocorticoids and other steroids have been utilised 
as anti-AD treatment. Nevertheless, prolonged use at high doses of these treatments has been 
reported to cause a variety of side effects, motivating the desire to find new promising 
alternatives of natural origin (Choi et al., 2011; Taofiq, Martins, Barreiro, & Ferreira, 2016).  
Hyperpigmentation: Hyperpigmentation is a common skin problem in middle-aged and elderly 
people. It is caused by overproduction of melanin, the pigment that is responsible for the colour 
of hair and skin either because of excessive exposure to UV light or as a manifestation of an 
ageing skin (Ali, Choudhary, Naaz, & S Ali, 2015). Tyrosinase is the key enzyme in melanin 
production and over-activity of this enzyme leads to uncontrolled production of melanin, 
causing hyperpigmentation of the skin. Hyperpigmentation disorders manifest either in the 
form of brown spots, melasma, freckles or solar lentigines (Fisk, Agbai, Lev-Tov, & Sivamani, 
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2014). Formulations containing ingredients such as hydroquinone, kojic acid, and retinoids 
have been utilised in the past to suppress the severity of hyperpigmentation, however, long 
term exposure to them have been reported to present cytotoxic, irritating and mutagenic effects 
on the skin (Chaowattanapanit, Silpa-archa, Kohli, Lim, & Hamzavi, 2017). Hence the need to 
find safe and effective alternatives from bio-based sources.  
Skin cancer: Skin cancers are the most dangerous skin diseases, and are often manifested as 
basal cell carcinoma, squamous cell carcinoma and malignant melanoma suggesting that the 
cells affected in each case are the basal cells, the squamous cells and the melanocytes, 
respectively (Działo et al., 2016). Studies have shown an increase in the reported cases of skin 
cancer, and if untreated they can spread to nearby areas, colonizing bones, other connective 
tissues, lymph nodes and other parts of the body (Epstein, 2009). One of the most common risk 
factors responsible for skin cancer development is the overexposure to UV light. Other causes 
include immunosuppression, exposure to certain chemicals, ageing and genetically inherited 
skin disorders (Chen, Hu, & Wang, 2012). 
Acne vulgaris: Acne vulgaris, occurs during adolescence due to the over stimulation of 
sebaceous glands, which causes an increased secretion of sebum (Choi et al., 2011). Another 
common cause is colonization of the skin with the bacterium Propionibacterium acnes and 
inflammation (Działo et al., 2016). Staphylococcus aureus, Staphylococcus epidermidis and P. 
acnes are the most common bacterial species that colonize the skin in acne patients. An 
investigation into the prevalence of skin colonization by these bacteria in acne patients showed 
the presence of strains resistant to one or more commonly used anti-acne antibiotics (Agrawal, 
Adholeya, Barrow, & Deshmukh, 2018). New therapy includes the use of topical formulations 
with bioactive extracts, or individual compounds, having a broad antimicrobial spectrum, 
antioxidant and anti-inflammatory properties (Tamrakar et al., 2017). 
Wound healing: Would healing includes a series of complex biological processes involving 
interaction between several inflammatory mediators, platelets, extracellular matrix molecules, 
fibroblasts, and other inflammatory cells (Yahaya, Cordier, Steenkamp, & Steenkamp, 2018). 
The proliferation and cellular differentiation of fibroblasts, stimulated by growth factors 
released by platelets and monocytes, are the most important key factors during wound healing. 
Even though conventional wound treatment has been practiced across the world, natural 
extracts, which possess important biological properties, mainly those related with anti-
inflammatory and antioxidative stress activities, can act as alternatives (Pitz et al., 2016).  
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1.2. Cosmetics, Cosmeceuticals and Nutricosmetics  
 
1.2.1. Cosmetics 
 
A “cosmetic product” is any substance with soft action that is either rubbed or sprinkled on the 
various parts of the human body (epidermis, hair, nails, lips, external genitals, the teeth or 
mucous membranes of the oral cavity) with the sole aim to clean, beautify, increase the 
attractiveness, protect and keep them in good condition (Luque de Castro, 2011). The world’s 
cosmetic industry is worth tens of billions of US dollars and is in a constant search for new and 
improved natural products to serve as suitable raw-materials, able to compete with the artificial 
synthetic counterparts or add new bioactivities (Hyde, Bahkali, & Moslem, 2010; Ramli, 2015). 
While there are several cosmetic products available on the market, they can be categorized into 
5 groups as follows:  
Skin care products: These are products designed to cleanse, sooth, restore, reinforce and protect 
the skin, thereby improving the appearance and feel of skin. This skin care category of cosmetic 
products corresponds to the largest market, accounting for about 30% of all cosmetics sold. It 
is difficult to subcategorize these products accordingly, but they include cleansers, exfoliants, 
conditioners, sunscreens and anti-ageing products (Surber & Kottner, 2017). According to the 
“Euromonitor International” anti-ageing skincare covers over 22% of the global skincare 
market, and their worth is expected to reach US$ 216 billion by 2021 (Agrawal et al., 2018). 
Hair care products: These cosmetic products are intended to be placed on the hair and scalp 
with the sole purpose of cleansing, promoting attractiveness and changing hair appearance. 
They account for about 25% of all cosmetics sold in the market and generally include products 
like tints, bleaches, lotions, conditioners, styling products, powders, shampoos, brilliantines 
and lacquers (Guerra-Tapia & Gonzalez-Guerra, 2014).  
Colour cosmetics: The colour category of cosmetics accounts for about 20% of all commercial 
cosmetics and are the most regulated cosmetic category. They are products intended to be 
applied on the skin to confer changes in colour and appearance. It includes products for the 
face like foundations, lipsticks, blushes, eye shadow, eyeliner, and mascara. These cosmetic 
products contain mixtures of multiple colouring ingredients, either from natural sources or of 
synthetic origin. The synthetic colorants are quite common due to their low cost and higher 
stability in formulations when compared to their natural counterparts (Chen et al., 2019). 
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Perfume and fragrances: This category account for about 10% of commercial cosmetics. They 
are products intended to change natural body odour. These products have been utilised since 
ancient times and the proportion of women’s to men’s fragrances is approximately two to one 
in most European countries, with France having the highest contribution in annual fragrance 
sales in Europe (Lenochová et al., 2012). 
Personal care products: They account for up to 15% of total cosmetics sold in the market. They 
include oral care products such as toothpaste, mouthwash and teeth whitening products as well 
as products as diverse as deodorant, hand soap, facial cleanser, body wash, pomade, perfumes, 
shaving cream, and toilet paper. It is important to note that these categories of cosmetic are 
complementary and have been able to satisfy user’s needs over the years (Surber & Kottner, 
2017).  
 
 
Figure 4. The emergence of new trends in the food, pharmaceutical, and cosmetic industries. 
As the global cosmetic market continues to grow steadily, there is a continuous demand for 
product diversification resulting in the emergence of products with different claims and 
functional properties. Because of the rising consciousness and awareness among consumers 
about the origin, safety and environmental implications of some of the ingredients used in 
cosmetic formulations, there is an increasing demand for the use of green and more sustainable 
raw materials during product formulation (Luque de Castro, 2011). Over the years, the 
Cosmetic Nutrition
Pharmaceutical
Cosmeceutical
Nutraceutical
Nutricosmetic
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pharmaceutical, cosmetics, and food industries have converged, giving rise to new categories 
such as cosmeceuticals, nutraceuticals, and nutricosmetics (Figure 4). 
 
1.2.2. Cosmeceuticals  
 
Cosmeceuticals are products in the interphase between cosmetics and pharmaceuticals. They 
consist of products in the forms of creams, ointments or lotions with biologically active 
compounds, which are applied topically on the skin with a medical drug-like benefit (Sharma, 
2011). The term “cosmeceutical” was first coined by Raymond Reed, a founding member of 
the United States Society of Cosmetic Chemists, but not until 1971 when the term was 
popularized by Dr. Albert Kligman, when he developed a formula to improve the appearance 
of UV damaged and wrinkled skin using retinoic acid (Amer & Maged, 2009). In the United 
States and Europe, cosmeceuticals are commercialized as cosmetics, although in Japan this 
category is termed as "quasi-drugs", "controlled cosmetics" in Thailand and "cosmetic-type 
drugs" in Hong Kong. The regulations of cosmeceuticals have not been harmonized between 
the USA, Europe, Asia, and other countries (Ramos-e-Silva, Celem, Ramos-e-Silva, & Fucci-
da-Costa, 2013). These products are known to contain ingredients that influence the biological 
function of the skin by supplying the needed nutrients for healthy skin, while improving the 
appearance, the radiance, texture and anti-ageing activity (Hyde et al., 2010). The application 
of natural ingredients such as phytonutrients, microbial metabolites, dairy products (Haruta-
Ono et al., 2012; Keller et al., 2014), minerals and animal protein components (Rodrigues, 
Pimentel, & Oliveira, 2015) for skin care is very popular today. The Asia Pacific is the largest 
cosmeceutical market and is also expected to witness the highest growth, while North America, 
Europe, Latin America, and the Middle East are growing at a modest rate with the development 
of novel and innovative products in these markets (Brandt, Cazzaniga, & Hann, 2011). There 
are more than 400 cosmeceutical manufacturers, in the U.S. market with the most well-known 
being Procter & Gamble, Johnson & Johnson, L’Oréal, Estée Lauder and Avon and Allergan, 
among others (Brandt, Cazzaniga, & Hann, 2011; Lohani et al., 2014). 
Plant-derived compounds have been used extensively for cosmeceutical applications and more 
recently, attention has been directed to the waste and residue produced during their processing, 
resulting in some of their derived bio-products, which may have the potential to be applied as 
cosmetic ingredients (Barbulova, Colucci, & Apone, 2015). Bio-products of plant species, such 
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as citrus, tomato, and olives, contain compounds like limonene, lycopene, unsaturated fatty 
acids and phenolic compounds that have shown biological properties, such as antioxidant, anti-
inflammatory and anti-tyrosinase activity. Rodrigues et al. (2015) reported that different bio-
products of the olive oil processing industry (leaves, stones, wastewater and pomace) displayed 
high antioxidant activity and contained minerals and fatty acids, with functional roles 
compatible with cosmetic ingredients. Hydroxy acids, such as glycolic, hydroxybutanoic, 
malic, citric, salicylic and lactic acids, isolated from several natural sources have been 
highlighted in the skin care sector for anti-wrinkling benefits, radical-scavenging effects, and 
treatment of several hyperpigmentation disorders (Tang & Yang, 2018). Their safety is 
constantly evaluated, and among them, glycolic and salicylic acids are becoming very popular 
in skin care products (Kornhauser, Coelho, & Hearing, 2012). 
Also, in the context of cosmetic ingredients,  Wang, Chen, Huynh, & Chang (2015) reviewed 
the bioactive properties of marine algae. The authors highlighted the presence of alginate and 
mycosporine-like amino acids (MAAs) imparting anti-oxidative properties and the ability to 
act as reactive oxygen species (ROS) scavengers. Some algae extracts were also reported to 
inhibit activator protein (AP-1) and nuclear factor kappa B (NF-κB), both transcription factors 
associated with the expression of enzymes, like matrix metalloproteinase and inducible nitric 
oxide synthase responsible for collagen degradation, and to increase the release of 
inflammatory mediators causing skin wrinkling and inflammation, respectively. The authors 
also mentioned the potential of fucoxanthin (carotenoid), phlorotannins and phloroglucinol 
(phenol derivative), to inhibit the tyrosinase enzyme and prevent melanin biosynthesis. These 
multiple properties displayed by marine algae and their bioactive components have 
demonstrated that they can be exploited as new and powerful cosmeceutical ingredients.  
Animal processing for human consumption also generates a handful of residues and raw 
materials, such as collagen, elastin and keratin, ingredients that are slowly finding their way 
into the cosmetic industry. Collagen is often recovered from the hides, skin, and bones of cows 
and pigs, while elastin can be recovered from the ligaments of cow, pork, fish and chicken. 
They are both important components of the extracellular matrix, being responsible for both 
skin elasticity and flexibility maintenance (Theocharis, Skandalis, Gialeli, & Karamanos, 
2016). Keratin, on the other hand, can be recovered from poultry feathers and porcine hairs. In 
combination, elastin and collagen offer the mechanical resistance necessary for an intact skin 
(Ferraro, Anton, & Santé-Lhoutellier, 2016).  
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Marine animals, such as starfish, sponges, and jellyfish, are other raw material sources with 
growing importance in the cosmetic industry due to their richness in phenolics and carotenoids 
(Lee et al., 2015). The mentioned authors conducted comprehensive studies to evaluate the 
antioxidant, anti-collagenase, anti-elastase and anti-hyaluronidase activity of stalked sea squirt 
(Styela clava Herdman) extract. The results revealed that the obtained extract inhibited 
collagenase, elastase and hyaluronidase enzymes, highlighting its potential to be utilised as an 
ingredient to maintain the flexibility and elasticity of the skin, as well as preserve the moisture 
content and tension of the skin. The compounds responsible for the shown activity were not 
identified or isolated. Earthworm (Lumbricus terrestris L.) has also been reported to show 
cosmeceutical significance even though very few studies have been reported so far (Azmi, 
Hashim, Hashim, Halimoon, & Majid, 2014). These authors described elastase, tyrosinase and 
collagenase inhibitory activities, suggesting that the extract contains useful anti-wrinkling and 
depigmenting ingredients. All these interesting reports have shown that extracts and 
compounds obtained from diverse natural sources have high potential to be used as cosmetic 
ingredients and thus should be investigated for this purpose. Very few studies have been carried 
out to determine the mechanism of action of the relevant extracts, as well as to identify the 
individual bioactive metabolites responsible for the ascribed bioactivities. 
 
1.2.3. Nutricosmetics 
 
Nutricosmetics are the newest trend in skin care and involve combining food, cosmetic and 
pharmaceuticals being still unknown to some dermatologists and consumers. This involves the 
consumption of dietary and nutritional supplements to produce a visual appearance benefit and 
improve the health of the skin (Luque de Castro, 2011). The focused primary action areas are 
skin, hair, and wellbeing. Healthy skin is a manifestation of overall health and as such can be 
influenced by the consumption of bioactive substances (Royer, Prado, García-Pérez, Diouf, & 
Stevanovic, 2013). This is regarded as the “inside out” approach because ingestion of bioactive 
ingredients and topical application of cosmeceuticals can synergistically combine together to 
maintain a positive skin appearance (Draelos, 2010). Many micronutrients can provide these 
effects (e.g. vitamin C has an antioxidant potential and tends to reduce free radical generation 
when the skin is exposed to UV radiation) (Royer et al., 2013). Following these trends, 
cosmetic industries are now putting more efforts to develop nutricosmetics with high contents 
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of several ingredients, such as collagen, hyaluronic acid, elastin and ceramide, known to 
maintain skin structure and function (Haruta-Ono et al., 2012). These authors reported that oral 
ingestion of dietary products improved the water-holding capacity of the skin and the barrier 
function. Hong, Jung, Noh, & Suh, (2014) also reported the beneficial effect of green tea 
ingestion due to the presence of numerous phenolic compounds responsible for significant 
inhibition of enzymes such as collagenase, elastase, and tyrosinase, thereby maintaining the 
structural stability, elasticity and blocking melanogenesis, respectively. Nutricosmetic 
formulations containing vitamin C, in the form of L-ascorbic acid, vitamin E and carotenoids 
such as astaxanthin, lutein, and lycopene all act as antioxidants and tend to quench free radicals 
(Draelos, 2010). To the best of our knowledge, the nutricosmetics area is still without enough 
scientific references as most available data are based on assumptions and some of the 
manifestations can be over-ambitious. Studies to confirm these claims are difficult to conduct 
as each control will be devoid of one essential nutrient or the other to be able to observe the 
progressive effects of deficiency of some of these bioactive ingredients on the skin and general 
health.  
 
1.3. Mushrooms: mycological classifications, bioactive and chemical compositions 
 
Mushrooms belong to the kingdom Fungi and are often referred to as the “Forgotten Kingdom” 
or the “unnoticeable Kingdom” but in fact, they have inhabited different ecological niches and 
carried out important ecosystem roles (de Mattos-Shipley et al., 2016). Basidiomycota together 
with Ascomycota are the two phyla to which most mushrooms belong, but in what concern 
their utilisation as food and medicine, the basidiomycetes are the most common (Landi et al., 
2017). Mushrooms have been an important part of our diet, consumed for years because of 
their attractive nutritional composition being an excellent source of nutrients, low in calories 
and fats and free of cholesterol. They are also an important source of proteins, vitamins, fibre 
and minerals as well as presenting multiple functional properties (Heleno et al., 2013; Money, 
2016; Oliveira et al., 2014; Taofiq et al., 2015). The consumption of mushrooms dates back to 
ancient times where they are referred to as “divine food” (de Mattos-Shipley et al., 2016). 
Generally, based on the different usages, mushrooms can be classified as edible species such 
as Pleurotus ostreatus (Jacq. ex Fr.) P. Kumm., Lentinula edodes (Berk.) Pegler, Agaricus 
bisporus (J.E. Lange) Imbach, Flammulina velutipes (Curtis) Singer and Auricularia auricular 
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(Bull.) J.Schröt., and medicinal species such as Ganoderma lucidum (Curtis) P. Karst., 
Cordyceps sinensis (Berk.) Sacc., Agaricus blazei Murrill (ABM) and Poria Cocos F.A. Wolf, 
among others. Knowledge about the bioactive composition and nutritional value of different 
mushrooms is extensive and already present for several years. In fact, they are considered as 
functional foods because of the presence of a wide range of bioactive metabolites, e.g. phenolic 
compounds, terpenoids, polysaccharides, lectins, steroids, glycoproteins and several lipid 
components (Barreira, Oliveira, & Ferreira, 2014; Ferreira et al., 2015; Oliveira et al., 2014; 
Reis, Martins, Vasconcelos, Morales, & Ferreira, 2017).  
 
1.3.1. Mycological characteristics of some selected mushroom species 
 
Agaricus bisporus is well known for its taste and aroma and is one of the most widely cultivated 
mushrooms in the world, produced on the scale of millions of tons yearly (de Mattos-Shipley 
et al., 2016). They are popularly referred to as white mushrooms, button mushrooms and 
portobello mushrooms (Leiva, Saenz-Díez, Martínez, Jiménez, & Blanco, 2015). It is an edible 
mushroom belonging to the phylum Basidiomycota, a litter-decomposing saprotroph that 
grows in a wide range of environment, native to North America, Asia and Europe (de Mattos-
Shipley et al., 2016). It typically bears a white cap (Figure 5) with dark brown gills, but the 
earliest forms growing wild had brownish cap and gills. The cultivation of this mushroom for 
commercial purposes dates back to the 16th century, and continues, nowadays, to grow 
significantly providing food with a high nutritional value in an environmentally sustainable 
way because of the use of organic waste and other low-value substrates (Leiva et al., 2015). 
 
 
Figure 5. Selected mushroom species studied in the present work. 
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Agaricus blazei is a medicinal mushroom, identical to Agaricus brasiliensis and Agaricus 
subrufescens, popularly referred to as ‘Cogumelo do Sol’ in Brazil, ‘Himematsutake’ in Japan, 
and ‘Ji Song Rong’ in China. It is rich in polysaccharides, phenolic acids, and ergosterol (Yue 
et al., 2012). A. blazei was first cultivated and consumed in the Atlantic states of the United 
States in the late 19th century, however, it was later discovered in Brazil, and called the 
‘‘Piedade mushroom’’ by Takatoshi Furumoto, who then sent it to Japan in 1965 to study their 
medicinal properties (Wisitrassameewong et al., 2012). Since then, A. blazei have become one 
of the most important mushroom exports from Brazil. In recent years, its extracts have become 
increasingly popular because of its long history of applications in treatments of diseases, 
mainly due to its immunomodulatory, anti-inflammatory, antitumor, antioxidant and antiviral 
properties (Lima, Gris, & Karnikowski, 2016; Zhai, Wang, & Han, 2015).  
Ganoderma lucidum is a large, dark, woody, Basidiomycota mushroom popularly referred to 
as reishi in Japan and lingzhi in China (Ferreira et al., 2015). It has been utilised as a functional 
food, and in traditional medicines in Korea and other Asian countries to promote longevity and 
better health (de Mattos-Shipley et al., 2016). It could be parasitic, living on hardwoods 
(especially oaks) or saprobic, living on the deadwood of hardwoods (Heleno et al., 2012). Some 
pharmacological and nutraceutical properties have been related to its capacity to act as immune 
suppressors, hypocholesterolemic agents or as coadjutant treatments in diseases such as cancer, 
hypertension, insomnia, anorexia, dizziness and chronic hepatitis (Baby, Johnson, & Govindan, 
2015; Zhao et al., 2016). These beneficial health properties are attributed to a wide variety of 
bioactive components such as polysaccharides, polyphenols, triterpenes, sterols, and proteins 
(Bishop et al., 2015; Heleno et al., 2012). 
Lentinula edodes popularly referred to as shiitake, is one of the most cultivated edible 
mushrooms in the world, being second only to A. bisporus (Hearst et al., 2009). Medicinal use 
of the shiitake mushroom, dates to the Ming dynasty (1368-1644), where reports refer that 
shiitake increased human vigour and energy, and it was used to suppress aches, pains, and 
fatigue associated with ageing (Sasaki, Linhares, Nozawa, Montalván, & Paccola-Meirelles, 
2001). Research interest on this mushroom has increased due to its content in functional 
bioactive compounds (Hearst et al., 2009). Its polysaccharide content seems to be one of the 
most interesting biomolecule’s fractions being reported to contribute to immunomodulatory, 
antimicrobial and antitumor activities (Villares, Mateo-Vivaracho, & Guillamón, 2012, Wu, 
Choi, Li, Yang, & Shin, 2016).  
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Pleurotus ostreatus commonly known as oyster mushroom, is an important edible mushroom 
widely cultivated all over the world. P. ostreatus was initially named as Agaricus ostreatus but 
later placed in the Pleurotus genus by the German mycologist Paul Kummer. It is a saprotroph 
which acts as a primary decomposer on wood growing in a wide range of temperatures, and 
utilising various lignocelluloses (Hearst et al., 2009). P. ostreatus is typically found growing 
out from trees in shelf-like clusters, widely distributed in North America, Asia, Britain, Ireland, 
and most mainland Europe. Commercial cultivation of P. ostreatus, unlike A. bisporus, 
commenced in the 19th century and ever since, its cultivation has rapidly become a worldwide 
phenomenon (de Mattos-Shipley et al., 2016). It has well-reported health-promoting benefits 
and is becoming very popular throughout the world as a good source of dietary fibre and other 
valuable nutrients (Alam et al., 2010).   
 
1.3.2. Bioactive compounds present in mushroom extracts  
 
There is an increasing interest in mushrooms because of their biologically active compounds, 
which presents medicinal and health-promoting benefits. Some of these secondary metabolites 
will be discussed below.  
1.3.2.1. Polyphenols and related compounds  
Phenolic compounds are a major class of secondary metabolites, with structural diversity, 
found in plant and fungi  (Vieira da Silva, Barreira, & Oliveira, 2016). They are not needed for 
growth or reproduction but are secreted for protection against UV, competitive warfare against 
other plants, insects, viruses and bacteria. They are also responsible for plant smell, colour, and 
flavour (Heleno, Martins, Queiroz, & Ferreira, 2015). According to their carbon chain, 
phenolic compounds can be divided into 16 major classes namely: simple phenols (C6), 
benzoquinones (C6), hydroxybenzoic acids (C6-C1), acetophenones (C6-C2), phenylacetic acids 
(C6-C2), hydroxycinnamic acids (C6-C3), phenylpropenes (C6-C3), coumarins (C6-C3), 
chromones (C6-C3), naphthoquinones (C6-C4), xanthones (C6-C1-C6), stilbenes  (C6-C2-C6), 
anthraquinones (C6-C2-C6), flavonoids (C6-C3-C6), lignans (C6-C3)2 and ellagitannins (C6-C3)n 
(Vieira da Silva et al., 2016). 
Phenolic acids are derived from the shikimate pathway (Figure 6) involving several enzymatic 
steps responsible for converting intermediates of the pentose phosphate pathway and glycolysis 
to form three crucial aromatic amino acids (phenylalanine, tyrosine, and tryptophan) (Dias, 
Sousa, Alves, & Ferreira, 2016; Heleno, Martins, et al., 2015). They have a benzene ring, a 
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carboxylic group and one or more hydroxyl and/or methoxy groups and are divided into two 
groups: i) hydroxybenzoic acids; ii) hydroxycinnamic acids. 
 
 Figure 6. Schematic representation of the hydroxycinnamic acids synthesis. 
 
The hydroxycinnamic acids group, the largest class (Figure 7), has nine carbon atoms (C6–C3); 
examples include caffeic, ferulic, p-coumaric and sinapic acids; (ii) the hydroxybenzoic acids 
group have seven carbon atoms (C6–C1); it includes gallic, p-hydroxybenzoic, protocatechuic, 
vanillic and syringic acids (Figure 7) (Pereira, Valentão, Pereira, & Andrade, 2009). Some of 
these phenolic acids can also be found in form of derivatives, such as amides (combination 
with amino acids or peptides) and esters (combination with hydroxyl acids or glycosides). 
These forms have also been reported to present interesting biological properties (Pei, Ou, 
Huang, & Ou, 2016; Pragasam & Rasool, 2013), but very few data are available to support 
their application as cosmeceutical ingredients. They exhibit multiple physiological functions, 
such as antioxidant, anti-inflammatory, anti-microbial, anti-collagenase, anti-melanogenic and 
anti-cancer (Amirullah, Zainal Abidin, & Abdullah, 2018; Carocho & Ferreira, 2013b; Ferreira, 
Barros, & Abreu, 2009; Moro et al., 2012) properties that are the basis behind their increased 
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use as cosmeceutical and nutricosmetic ingredients. The pharmacological potential displayed 
by these phenolic acids and derivatives has been largely attributed to the presence of multiple 
hydroxyl groups in their chemical structure, making them suitable free radical scavengers 
(Zhang & Tsao, 2016). Extensive work has been done on the role of these compounds in disease 
prevention and their fate in vivo after metabolism (Heleno, Martins, et al., 2015). However, 
their utilisation as skin care ingredient is gradually gaining attention.  
 
 
Figure 7. Common phenolic compounds found in mushrooms. 
 
1.3.2.2. Polysaccharides  
Polysaccharides are the major class of bioactive compounds found in mushroom and they are 
present either as glucan polysaccharides or as polysaccharide-protein complexes (Milhorini et 
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al., 2018). They generally differ in their primary structure, type of linkage, the degree of 
branching and molecular weight. They occur mostly as glucans (Figure 8), linked by β-(1-3), 
(1-6) and α-(1-3) glycosidic bonds. Some common polysaccharides found in mushrooms 
include pleuran (P. ostreatus), lentinan (L. edodes), glucomannan (A. blazei), β-D-glucan 
(Agaricus brasiliensis, Collybia dryophila), α-1,6, α-1,4-glucan (A. blazei), heteroglycan 
(Lentinus squarrosulus, Pleurotus florida, Volvariella volvace), (1-3), (1-6)-β-D-glucan (G. 
lucidum), coriolan (Coriolus versicolour), agaritine (A. bisporus), calocyban (Calocybe 
indica), α-fucoglucomannan (Inonotus obliquus), ganoderan (G. lucidium), β-pachyman 
(Wolfiporia extensa), schizophyllan (Schizophyllum commune), acidic glucuronoxylomannan 
(Tremella fuciformis) (Rathore, Prasad, & Sharma, 2017; Singdevsachan et al., 2016). These 
compounds are either intracellular as reserve material or extracellular as structural components 
of the fungal cell wall, playing vital roles in immunomodulatory and anticancer activities.  
 
Figure 8. The molecular structure of β-D-glucan (1→3), (1→6). 
 
They generally act as immuno-enhancers stimulating inflammatory cells such as lymphocytes, 
macrophages, hematopoietic stem cells, T cells, dendritic cells (DCs) and natural killer (NK) 
cells, that are important in the innate and adaptive immune system (Meng, Liang, & Luo, 2016).  
1.3.2.3. Terpenoids, triterpenes and steroidal compounds 
Terpenes are a group of organic compounds in plants, animals and macrofungi consisting of 
five carbon isoprene unit (C5H8)n as their building block, where n represents the number of 
units involved. They are classified as monoterpenes: 2 isoprene units, 10 carbon atoms, 
sesquiterpenes: 3 isoprene units, 15 carbon atoms, diterpenes: 4 isoprene units, 20 carbon 
atoms, triterpenes: 6 isoprene units, 30 carbon atoms, tetraterpenes: 8 isoprene units, 40 carbon 
atoms (Taofiq, Martins, et al., 2016). Some common terpenoids and their derivatives (Figure 
9) found in mushrooms include pleurospiroketal (Pleurotus cornucopiae), enokipodin J, 2,5-
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cuparadiene-1,4-dione, flammulinolide, enokipodin (F. velutipes), eryngiolide A (Pleurotus 
eryngii), erinacine A (Hericium erinaceum), tricholomalide A-C (Tricholoma sp.) and 
ganoderic acid, elfvingic acid A, ganoderenic acid (G. lucidum) (Rathore, Prasad, & Sharma, 
2017). These compounds have well recognized medicinal properties namely cytotoxic, 
antioxidant, anti-inflammatory and antimicrobial properties and are considered suitable in 
maintaining the overall wellbeing of the body (Ma, Chen, Dong, & Lu, 2013; Van Nguyen et 
al., 2015). The fruiting body of mushrooms, either in their fresh or processed forms, are also 
rich in sterols, mainly ergosterol, a form that can be converted into vitamin D2 by UV-radiation. 
This conversion occurs due to series of ring rearrangement forming previtamin D and, lastly, 
the active form of Vitamin D2 (Slawinska et al., 2016). Among others, vitamin D has an impact 
on bone and muscle health, cancer, cardiovascular diseases, liver function, atopic dermatitis, 
obesity, depression, and diabetes. The amount of vitamin D varies among mushroom species, 
and within the same species. Among them, mushrooms belonging to the genera Agaricus, 
Lentiula and Pleurotus have been reported to contain interesting amounts of vitamin D after 
exposure to UV (Edward et al., 2015; Jasinghe & Perera, 2006; Slawinska et al., 2016). 
Ergosterol has been reported to play several biological functions such as cytotoxic, antioxidant, 
anti-inflammatory and immunomodulatory functions (Duarte, Ferreira1, Martins, Viveiros, & 
Amaral, 2007; Shimizu et al., 2016).  
 
 Figure 9. Common terpenoids and steroidal compounds in mushroom. 
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1.3.2.4. Other bioactive metabolites 
While the above-mentioned bioactive compounds are the most abundant, other compounds 
have also been identified in different mushroom extracts. Bioactive metabolites such as organic 
acids, fatty acids, succinic and maleic derivatives, adenosine, cordycepin, and glycopeptides 
(Figure 10) have been reported to display important beneficial health properties (Imamura et 
al., 2015; Tuli, Sharma, Sandhu, & Kashyap, 2013). Lectins are glycoproteins reported to show 
physiological activity in the gastrointestinal tract (GIT) by enhancing nutrient absorption, 
inhibiting enzymes, and modulating the immune system to defend against foreign pathogens 
(Rathore et al., 2017). Cordycepin, an adenosine analog, initially extracted from the fungus 
Cordyceps militaris and Cordyceps sinensis can be utilised for several preliminary studies. This 
compound has been reported to suppress lung infections, display hypoglycaemic activity, act 
as an antidepressant and suppress the severity of inflammation (Choi, Kim, & Lee, 2014; Jeong 
et al., 2010; Rathore et al., 2017).  
 
 Figure 10. Other bioactive metabolites found in mushrooms. 
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1.4. The case of mushroom extracts and their individual metabolites as cosmeceutical 
ingredients  
 
Mushroom extract and their individual metabolites are slowly gaining attention as 
cosmeceutical ingredients because of the numerous beneficial effect they exert to the skin (Wu, 
Choi, Li, Yang, & Shin, 2016).  The compounds that they contain show excellent antioxidant, 
anti-ageing, anti-inflammatory and moisturizing effects, which make them ideal ingredients in 
the development of cosmeceutical and nutricosmetic formulations (Ferreira et al., 2015; Hyde 
et al., 2010; Taofiq et al., 2015). Despite this, only a small percentage of mushroom species 
and their individual metabolites have been explored for cosmeceutical purposes. A detailed 
description of species that have been fully explored scientifically with their active ingredient 
identified; types of bioactive properties associated with the mushroom extracts and their 
metabolites in relation to skin care; pharmacological activity of mushroom extracts and the 
bioactive compounds for skin care; mushroom ingredients that have successfully penetrated 
the stratum corneum with specific biochemical mechanism of action and proven safety in 
epidermal and dermal cells; and future trends and challenges in their use as cosmeceutical and 
nutricosmetic ingredients will be discussed below. 
 
1.4.1. Anti-tyrosinase activity of mushroom extracts and their associated metabolites  
 
Melanin is a natural pigment produced by specialized cells called melanocyte, responsible for 
the skin colour. Tyrosinase is the rate-limiting enzyme in melanin biosynthesis pathway, where 
it converts tyrosine to dihydroxyphenylalanine (DOPA) and then oxidizes it to dopaquinone 
(Meng, 2012). Subsequently, dopaquinone is converted to dopachrome through auto-oxidation, 
and finally to eumelanin (brown-black pigment) in the presence of dopachrome tautomerase 
(Figure 11). Alternatively, dopaquinone can also be converted to cysteinyl DOPA in the 
presence of cysteine or glutathione to form pheomelanin (yellow-red pigment). The synthesis 
of melanin is regulated by several signal transducers responsible for regulating the expression 
of tyrosinase and tyrosinase-related protein (TRP1 and TRP2), which in turn promotes the 
expression of microphthalmia-associated transcription factor (MITF) a melanocyte-specific 
transcription factor that is responsible for differentiation of melanocytes (Jang et al., 2017). 
Hence, most tyrosinase inhibiting compounds tend to target down-regulation of MITF 
Background 
 
 
 
21 
expression, inhibiting the whole process of melanogenesis (Działo et al., 2016). Melanin 
biosynthesis is initiated by several hormonal and chemical mediators and the most common is 
the cAMP-mediated pathway. The cAMP is known to increase the expression of MITF via 
activation of the cAMP-dependent protein kinase A (PKA) and the cAMP-response element 
binding protein (CREB) transcription factor (Park, Jin, Kim, Kim, & Lee, 2011). The complex 
process of melanogenesis is regulated by MITF through binding to the promoter region of TRP-
1, and TRP-2 thereby causing increase expression of tyrosinase enzyme responsible for 
melanin biosynthesis (Meng, 2012). Hence, compounds that tend to cause inhibition of MITF 
expression will be an inhibitor to the whole process of melanogenesis. Hyperpigmentation 
disorders, the result of increase melanin biosynthesis are unfavourable abnormalities usually 
characterized by darker skin appearance, light to dark brown spots, irregular grey patches on 
the face, neck, and trunk, and pale brown to dark brown spots on the skin, motivating 
researchers to find new ingredients or combinations of ingredients; among them the ones of 
natural origin can be effective solutions (Ali, Choudhary, Naaz, & S Ali, 2015).  
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Figure 11. The melanin biosynthesis pathway. 
 
The mechanism of depigmentation involves the inhibition of one or more steps in the 
melanogenic pathway or melanosome transfer resulting in lower melanin release and finally 
combating melanogenesis (Ali et al., 2015). Studies conducted have shown that bioactive 
compounds obtained from natural sources have the potential to suppress melanin synthesis and 
correct hyperpigmentation (Agrawal et al., 2018; Hapsari, Elya, & Amin, 2012; Maack & 
Pegard, 2016; Sanjeewa, Kim, Son, & Jeon, 2016). The most widely found compounds in 
formulations used to correct hyperpigmentation include hydroquinone, mequinol, retinoic acid, 
azelaic acid and arbutin/deoxyarbutin among others (Ali et al., 2015). The mechanism behind 
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their hyperpigmentation correcting effect include tyrosinase enzyme inhibition, melanosome 
transfer inhibition, increased epidermal turnover, antioxidation, melanosome maturation 
inhibition, inhibition of UV-induced plasmin activity in keratinocytes and direct destruction of 
melanin (Chaowattanapanit et al., 2017). Some of the above-mentioned compounds used to 
treat hyperpigmentation over the years have raised safety concerns, namely the reported 
carcinogenic potential, exogenous ochronotic effect, cell irritants and exudation of offensive 
fish odour from the skin (Tse, 2010). Others consider the use of corticosteroids and kojic acid 
that, nevertheless their high effectiveness, have been reported to cause a local or systemic 
negative effect upon long term exposure (Ali et al., 2015). Because of the negative effect 
associated with the above depigmenting agents, the search for alternative natural products rich 
in bioactive molecules with the ability to treat these disorders, such as the ones obtained from 
plants, mushrooms, rhizomes or marine algae, have become important fields of research. 
Several compounds especially phenolics such as arbutin, resveratrol, ellagic acid, and gentisic 
acid have been isolated from plants and reported to inhibit one or more steps in the melanogenic 
pathway (Ali et al., 2015). These phytochemicals do not only combat melanogenesis but also 
play additional functions such as acting as moisturizers, provide support and stability to the 
skin and have anti-ageing effect, thereby preserving the skin health (Działo et al., 2016; 
Svobodová, Psotová, & Walterová, 2003). Studies reporting the anti-tyrosinase inhibitory 
activity of mushroom extracts and individual bioactive metabolites are described in Table 1.  
Pleurotus species are among the most exploited mushroom species presenting an anti-
tyrosinase potential. Meng et al. (2011) reported that treatment of B16 melanoma cells with 
various fractions of P. citrinopileatus were able to inhibit tyrosinase activity up to 40% without 
any cytotoxic effect on the cells, while acetonic, methanolic, and hot water extracts prepared 
from the fruiting bodies of P. ferulae (0.125–1.0 mg/mL), were reported by Alam et al. (2012) 
to inhibit tyrosinase activity up to 60.10%. Similar tyrosinase activity was reported for P. 
nebrodensis with the most potent inhibition obtained for its methanolic extract (up to 50%) 
(Nuhu, Ki, & Tae, 2011). P. ostreatus being one of the most extensively studied mushroom 
has also shown anti-tyrosinase activity; ethanolic and aqueous extracts (EC50 1.13 and 2.35 
mg/mL respectively) (Hapsari et al., 2012). However, none of these studies have been able to 
identify the most important compounds contributing to these tyrosinase inhibition activities or 
further determine the mechanism behind the anti-tyrosinase activity of these extracts. Extract 
from Inonotus obliquus presented tyrosinase repression, predominantly due to the contribution 
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of betulin (5.13 µM) and trametenolic acid (7.25 µM) displaying an activity that is comparable 
to kojic acid (6.43 µM) (Yan et al., 2014). 
A potent suppressive impact on tyrosinase was also shown by Miyake et al. (2010). The authors 
reported that 2-amino-3H-phenoxazin-3-one (APO), a phenoxazinone isolated from extracts of 
A. bisporus showed melanin inhibitory activity.  After exposure of murine B16 melanoma cells 
to the isolated compound, cell viability was not suppressed, while melanin accumulation was 
significantly inhibited up to 80%. To determine the mechanism behind inhibition of the 
melanogenesis process, MITF expression was monitored in a dose-dependent manner with 
APO showing a significant decrease in its expression without affecting TRP-2 and TRP-1 
proteins. Hu et al., (2017) studied the tyrosinase inhibition effects of a triterpene rich extract 
obtained from Poria cocos, and poricoic acid A (PAA) isolated from its fruiting body, in B16F1 
melanoma cells. PAA had the best inhibitory effect up to 45.24% when its concentration 
reached 166.67 µg/mL. Different volatile constituents were obtained from Tricholoma 
magnivelare (Peck) Redhead, and their tyrosinase inhibitory activities in B16-F10 mouse 
melanoma cells were as follows α-pinene (40%), 3,5-dichloro-4-methoxybenzaldehyde (37%) 
and methyl cinnamate (24.2%) (Satooka, Cerda, Kim, Wood, & Kubo, 2017). However, the 
authors found enhanced cytotoxicity in the first two tested compounds making methyl 
cinnamate a novel potential melanogenesis inhibitor. 
The search for tyrosinase inhibiting compounds have been conducted in different mushroom 
species, however, phenolic compounds have been well reported as being the most important 
contributors to this phenomenon (Yoon, Atom, Lee, Lee, & Lee, 2011). In what concerns p-
coumaric acid as a tyrosinase inhibitor, interesting studies have been reported when compared 
to other phenolic acids (An, Koh, & Boo, 2010; Jun et al., 2012).  Seo et al., (2011) reported 
the effects of a formulation containing p-coumaric acid on UV induced erythema and 
hyperpigmentation in human skin. The formulation was applied on volunteers twice daily for 
seven days. Afterward, the site of application was monitored, and the result showed that there 
was suppression of erythema formation up to 77% and subsequent skin pigmentation was also 
reduced. Recent studies reported that phenolic acids such as caffeic acid (IC50, 43.09 ± 2.3 µM) 
and ferulic acid (IC50, 51.85 ± 1.7 µM) (Chaiprasongsuk, Onkoksoong, Pluemsamran, 
Limsaengurai, & Panich, 2016; Thangboonjit, Limsaeng-u-rai, & Panich, 2014) exhibit 
melanin biosynthesis inhibition.  
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Cinnamic acid is one of the most common phenolic acid derivatives found in mushrooms. 
Because of their relative hydrophilicity, which hinders its absorption on the skin. Ullah et al. 
(2019) synthesized fifteen amide derivatives and evaluated their tyrosinase inhibition potential 
in B16F10 melanoma cells. At 25 µM, the cell viability was maintained, and four of the 
compounds were able to exhibit strong inhibition of tyrosinase, which was found to be three-
fold greater than kojic acid. Also, four synthesized nicotinic acid derivatives, namely, 
nicotinamide, methyl nicotinate, nicotinic acid hydroxamate (NAH), and N-methyl nicotinic 
acid hydroxamate (NAH-M), were studied by Lin et al. (2012). The tyrosinase inhibitory 
activity was found to follow the following order: NAH > NAH-M > methyl nicotinate > 
nicotinamide. These results showed that nicotinamides, the water-soluble amide of nicotinic 
acid, a component of the two most important coenzymes (nicotinamide adenine dinucleotide 
(NAD) and nicotinamide adenine dinucleotide phosphate (NADP)) can be used in cosmetic 
products to suppress melanogenesis coupled with their potential as antioxidant and anti-
inflammatory agents (Otte, Borelli, & Korting, 2005). 
Chlorogenic acid (CGA) is another interesting phenolic acid with an anti-tyrosinase capacity. 
B16 melanoma cells exposed to chlorogenic acid were found to sustain their cell viability up 
to 80%  and at 500 µM, tyrosinase activity was reduced significantly (Li, Habasi, Xie, & Aisa, 
2014). In the work conducted by Kwak et al. (2015), two hybrid compounds, ascorbyl-3-p-
coumarate, and ascorbyl-2-p-coumarate (A-3-p-C and A-2-p-C) were generated from p-
coumaric acid and ascorbic acid. Both compounds were found not to reduce cell viability of 
murine melanoma B16/F10 cells and at 100 µM, they decreased melanin content up to 65 and 
59% for A-3-p-C and A-2-p-C respectively. It is interesting to note that these bioactive 
compounds, when utilised in cosmetic formulations, do not only combat melanogenesis, but 
can also cause skin cell revival, stimulate collagen and elastin synthesis and slow down the 
ageing process. These additional functions tend to further provide support and stability to the 
skin. One major drawback in the use of these compounds especially the phenolic compounds 
is their sensitivity to oxidation thus contributing to their instability in cosmetic formulations. 
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Table 1. Previous studies on the anti-tyrosinase activity of different mushroom species and their individual metabolites 
Mushroom species Pharmaceutical form Effects Reference 
A. bisporus 2-Amino-3H-
phenoxazin-3-one 
At 0.5 µM, 1 µM and 2 µM, melanin production was inhibited by 80%, 54.1% and 39.4%, respectively. (Miyake et al., 2010) 
Agaricus brasiliensis Fr. Methanolic extract Methanolic extract at 10 mg/mL inhibited tyrosinase activity up to 49.82±0.51% relative to 48.95±0.35% 
for kojic acid. 
(H. Huang et al., 2014) 
Coriolus versicolour (L.: Fr.) 
Quél. 
Ethanolic extract At 10 mg/mL, tyrosinase activity was inhibited up to 26.3±8.3%. (K. M. Park, Kwon, & 
Lee, 2015) 
Ganoderma lucidum (Curtis ) 
P. Karst. 
Ethanolic extract At 1 mg/mL, the extract inhibited tyrosinase activity up to 80%.  (C. C. Chien et al. 2008) 
Grifola frondosa (Dicks.) 
Gray 
Mycelia extract (GF-
M), Exopolysaccharide 
(EPS) 
At 100 µg/mL, EPS and GFM inhibited melanogenesis by 25 and 17% respectively. (S. W. Kim et al.  2007) 
Inonotus mikadoi (Lloyd) 
Gilb. & Ryvarden 
Extracts At 10 mg/mL, it showed tyrosinase inhibitory activity up to 46.0 ± 7.5%. (K. M. Park et al., 2015) 
Inonotus obliquus (Ach. Ex. 
Pers.) Pilát 
Extracts At 10 !g/mL, petroleum ether and n-butanol extract showed tyrosinase inhibitory activity with IC50 value 
of 3.81 and 6.32 !g/mL respectively. (Yan et al., 2014) 
Betulin and 
trametenolic acid 
Betulin tyrosinase activity showed an IC50 of 5.13 !M, trametenolic acid 7.25 !M while kojic acid (6.43 !M) was used as a control. (Yan et al., 2014) 
Lentinus lepideus (Fr.) 
Redhead & Ginns 
Extracts Acetonic, methanolic, and hot water extracts at 0.125–1.0 mg/mL inhibited tyrosinase enzyme by 9.71–
58.84, 11.23–56.22 and6.97–51.52% respectively. 
(K. N. Yoon et al., 2011) 
Metarhizium anisopliae 
(Metschn.) Sorokīn 
2-Hydroxytyrosol (2-
HT) 
2-HT inhibited tyrosinase activity with an IC50 value of 13.0 mmol/L compared to 14.8 mmol/L for kojic 
acid. 
(R. Uchida, Ishikawa, & 
Tomoda, 2014) 
Pleurotus citrinopileatus 
Singer 
Extracts At 100 µg/mL, n-butanol soluble, n-hexane soluble and ethyl acetate soluble extract caused 41.0, 27.4 and 
28.8% tyrosinase inhibition respectively. 
(T. X. Meng et al., 2011) 
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Pleurotus ferulae (Lanzi) X.L. 
Mao 
Extracts At 0.125–1.0 mg/mL, acetonic, methanolic, and hot water extracts inhibited tyrosinase enzyme by 19.81–
60.10%, 13.12–59.87% and 15.92–55.07% respectively. 
(Alam et al., 2012) 
Pleurotus nebrodensis 
(Inzenga) Quél. 
Extracts At 0.125-1.0 mg/mL, acetonic, methanolic and hot water extracts showed 2.57-55.76, 11.54-51.54 and 
6.52-50.96% tyrosinase inhibition activity respectively. 
(Nuhu et al., 2011) 
Pleurotus ostreatus (Jacq. ex 
Fr.) P. Kumm. 
Extracts At 0.125-1.0 mg/mL, acetone, methanol, and hot water extracts inhibited tyrosinase activity by 11.37-
52.05%, 11.36-59.56%, and 9.60-49.60% respectively. 
(Alam et al., 2010) 
Extracts Ethanolic and aqueous extracts inhibited tyrosinase activity with an EC50 value of 1.125 mg/mL and 2.350 
mg/mL respectively. 
(Hapsari et al., 2012) 
Poria cocos  F.A. Wolf Poricoic acid A At 166.67 µg/mL, tyrosinase activity was inhibited up to 45.24%, with no reduction in cell viability of 
B16F1 melanoma cells. 
(S. Hu et al., 2017) 
Rugiboletus extremiorientalis 
(Lj.N. Vassiljeva) 
Methanolic extract The tyrosinase inhibition was inhibited up to 50% at 0.17 mg KAE/g DW. (Kaewnarin, 
Suwannarach, Kumla, & 
Lumyong, 2016) 
Russula emetica (Schaeff.) 
Pers. 
Methanolic extract The tyrosinase inhibition was inhibited up to 50% at 0.066 KAE/g DW. (Kaewnarin et al., 2016) 
Tricholoma magnivelare 
(Peck) Redhead 
Methyl cinnamate Tyrosinase was inhibited up to 24.2% in B16-F10 mouse melanoma cells without presenting cytotoxicity. (Satooka et al., 2017) 
Bioactive compounds  Type Bioactive Effects Reference 
Ascorbyl-3-p-coumarate (A-3-
p-C), Ascorbyl-2-p-coumarate 
(A-2-p-C) 
Synthesized  A-3-p-C and A-2-p-C at 1.0 mM were found to be nontoxic to murine melanoma B16/F10 cells and at 100 
µM, both hybrid compounds decreased melanin content by 65 and 59%, respectively. 
(Kwak et al., 2015) 
Caffeic acid Commercial At 43.09 ± 2.3 µM, UVA-mediated increased melanogenesis in G361 melanoma cells was suppressed. (Thangboonjit et al., 
2014) 
Commercial The test compound inhibited UVA-induced melanin content, as well as tyrosinase activity in B16F10 
mouse melanoma cells presenting IC30 (µM), values of 17.54±4.8 and 24.1±6.2 respectively. 
(Chaiprasongsuk, et al 
2016) 
Chlorogenic acid Commercial At 100 µM, cell viability of B16 melanoma cells were maintained and at 500 µM after 48-h exposure to B16 
melanoma cells, melanin levels were suppressed. 
(H. R. Li et al., 2014) 
Background 
 
 
 
28 
Cinnamic amides Synthesized At 25 µM, four cinnamic amide derivatives maintained B16F10 melanoma cell viability and significantly 
inhibited tyrosinase activity. 
(Ullah et al., 2019) 
2-chlorcinnamic and 2,4-
dichlorocinnamic acid 
Synthesized Tyrosinase was inhibited up to 50% at 0.765 mM and 0.295 mM, for 2-chlorcinnamic acid and 2,4-
dichlorocinnamic acid respectively. 
(Y. H. Hu et al., 2014) 
Ferulic acid 
 
Commercial At 51.85 ± 1.7 µM, UVA-mediated increased melanogenesis in G361 melanoma cells was suppressed. (Thangboonjit et al., 
2014) 
Commercial At 30 µM, ferulic acid was not able to suppress UVA-induced melanin content and tyrosinase activity in 
B16F10 mouse melanoma cells. 
(Chaiprasongsuk et al., 
2016) 
Gallic acid  
 
Commercial Gallic acid at 12.5-100 µM was able to maintain cell viability of B16 melanoma cells, suppressed melanin 
content and tyrosinase activity with IC50 values of 18.3 µM and 24.8 µM respectively. 
(Kumar et al., 2013) 
Commercial At 200 µM maintained cell viability of B16F10 melanoma cells and reduces melanin synthesis via down-
regulation of MITF, CREB, tyrosinase and TRP-1 expression. 
(Su et al., 2013) 
Gallic acid  Commercial At 200 µM inhibited tyrosinase activity up to 85% and suppress melanin content in B16 melanoma cells. (Y.-J. Kim, 2007) 
Hispolon Commercial Test compound at 2 µM was able to suppress the expression of tyrosinase and MITF and subsequent 
reduction in melanin production up to 58.9-61.7%. 
(Y. S. Chen, Lee, Lin, & 
Liu, 2014) 
p-Coumaric acid Commercial At 10 µg/mL showed a higher tyrosinase activity inhibition than arbutin, but comparable to kojic acid. (An et al., 2010) 
Commercial Reduced MITF and tyrosinase mRNA expression by 73 and 82%, respectively. (Jun et al., 2012) 
Commercial  Inhibited hyperpigmentation up to 77% in human skin. (Seo et al., 2011) 
Commercial  At 22.86±2.1 µM, UVA-mediated increased melanogenesis in G361 melanoma cells was suppressed. (Thangboonjit et al., 
2014) 
p-Coumaric acid, methyl p-
coumarate 
Synthesized Inhibited tyrosinase activity with an IC50 of 3 mM compared to methyl p-coumarate IC50 30 mM. (Song, An, Kim, Koh, & 
Boo, 2011) 
Vanillin and vanillin 
derivatives 
Synthesized Cell viability in fibroblast (L929) and keratinocyte (HaCaT) cell lines were maintained in a dose-
dependent manner. Compound A, B, and C displayed tyrosinase inhibin with IC50, 21.60 µM, 16.13 µM 
and 30.85 µM comparable to kojic acid 16.69 µM. 
(Ashraf, Rafiq, Seo, 
Babar, & Zaidi, 2015) 
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1.4.2. Anti-inflammatory activity of mushroom extracts and their associated 
metabolites  
 
Inflammation is one of the most important biological responses to remove harmful toxins or 
pathogens from the body (Bellik et al., 2013). Macrophages are large specialized cells that are 
the first line of defense against invading pathogens (cellular debris, microbes, and cancer cells), 
by engulfing and digesting in a process called phagocytosis (Francisco et al., 2013). They play 
important roles in non-specific host defense mechanism and help to initiate other defense 
mechanisms. Beyond stimulating the immune system, macrophages play a crucial role in the 
inflammatory response through the release of a variety of factors. During inflammation, 
macrophages, monocytes and other inflammatory cells secrete excess inflammatory mediators, 
among them nitric oxide (NO). Production of these mediators in inflammatory cells increases 
following exposure to immune stimulants including bacterial endotoxin lipopolysaccharide 
(LPS) or viral proteins (Hseu et al., 2005). This bacteria component initiates several signal 
transduction pathways that are central to the pathogenesis of inflammation (Jeong et al., 2010). 
NO is a short-lived free radical and a signaling molecule produced from L-arginine by the 
inducible nitric oxide synthase (iNOS) enzyme (Castro et al., 2014; Hämäläinen, Nieminen, 
Vuorela, Heinonen, & Moilanen, 2007). NO, known to induce vasodilation in the 
cardiovascular system through a Ca2+-dependent pathway, play an important function in the 
immune and nervous systems as well as in cell death (Hseu et al., 2005; Sharma, Al-Omran, & 
Parvathy, 2007). It gives an anti-inflammatory effect under normal physiological conditions, 
is also involved in many pathological diseases in the body (Cirino, Distrutti, & Wallace, 2006; 
Joo et al., 2014). Reactive oxygen species (ROS) production play an important role in the 
modulation of inflammation. Major ROS produced within the cell are superoxide anion (O2-), 
hydrogen peroxide (H2O2), peroxide anion (O2 2-), hydroxyl ion (OH-) and hydroxyl radical 
(•OH). Nitric oxide is less reactive but can attack superoxide ion (O2-) to form peroxynitrite 
ONOO- (Castro et al., 2014). This peroxynitrite and several oxidative products can accumulate 
in the cells causing oxidative damages and increased cytotoxicity leading to tumor 
development, DNA damage and cell proliferation (Fangkrathok, Junlatat, & Sripanidkulchai, 
2013; Quang, Harinantenaina, et al., 2006). The inhibition of NO and other inflammatory 
mediator’s overproduction in cells may prevent the occurrence of inflammatory diseases and 
cancer.  
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Another class of important pro-inflammatory mediator is the tumor necrosis factor-α (TNF-α) 
secreted by activated macrophages, T-lymphocytes, mast cells, natural killer cells, monocytes 
and other defense cells (Habtemariam, 2013). TNF-α is one of the important pro-inflammatory 
mediators involved in the inflammatory process. When there is an immune stimulant, TNF-α 
attaches to some specific transmembrane receptors that tend to activate several signal 
transduction pathways responsible for the production of more TNF-α to the site of infection 
(Siqian Li & Shah, 2016). As TNF-α continues to accumulate, it causes a wide range of human 
diseases, apoptosis, excess pain, and cell damage. Regulation of the transcription factor NF-κB 
is the key component of TNF-α regulation (Habtemariam, 2013). The inhibition of TNF-α in 
LPS activated THP-1 monocytic cells, or RAW 264.7 macrophage cells, is generally used as 
in vitro models for evaluating the anti-inflammatory effects of various materials including 
mushroom extracts (S.-J. Wu, Lu, Lai, & Ng, 2013). Some of the studied mushrooms whose 
mechanism of action is the inhibition of TNF-α release are described in Table 2. 
NF-κB is a transcription factor that regulates the expression of several pro-inflammatory 
cytokines and enzymes such as IL-1β, TNF-α, iNOS, and COX-2 that play vital roles in 
apoptosis, immunity, and inflammation (Hseu, Huang, & Hsiang, 2010). When there is an 
immune stimulant (i.e lipopolysaccharide, viral proteins or cytokines), the NF-κB becomes 
activated (K. M. Kim et al., 2003). Toll-like receptors (TLRs) and tumor necrosis factor 
receptor (TNFr) localized in the macrophages membrane can detect these pathogen-associated 
molecular patterns (PAMPs) necessary for activation of several signaling cascade (Figure 12). 
After ligand binding, these receptors activate the myeloid differentiation protein 88 (MyD88) 
responsible for the activation of mitogen-activated protein kinase (MAPKs). This MAPKs 
further activate the IKK kinases (IKKα, IKKβ, IKKγ) leading to phosphorylation of the IκB 
proteins complex (Hasnat, Pervin, Cha, Kim, & Lim, 2015). Cytosolic IκB forms a complex 
with NF-κB and the IκB proteins become degraded allowing NF-κB to translocate to the 
nucleus where it triggers the transcription of several chemokines and cytokine genes involved 
in the innate and adaptive immune response (K. M. Kim et al., 2003). Some polyphenols have 
been known to inhibit specific steps in the pathway leading to NF-κB release (Ruiz & Haller, 
2006). These authors investigated the anti-inflammatory mechanism of flavonoids that were 
able to inhibit the phosphorylation of IκB preventing translocation of NF-κB to the nucleus. 
Hence, finding natural inhibitors of NF-κB for treatment and prevention of various 
inflammatory diseases have been the target of several scientists. 
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Figure 12. Schematic diagram of nuclear factor-κB (NF-κB) pathway. Macrophage cells express membrane 
receptors such as toll-like receptors (TLRs) and tumor necrosis factor receptors (TNFR). These receptors 
recognize pro-inflammatory stimuli such as lipopolysaccharides and viral proteins. Attachment of these pathogen-
associated molecular patterns (PAMPs) to membrane receptors activates the myeloid differentiation protein 88 
(MyD88). MyD88 activates specific protein kinases that are responsible for activation of IKK kinase (IKKα, 
IKKβ, IKKγ). This kinase further phosphorylates IκB-α complex leading to dissociation of the complex, and its 
proteasomal degradation, allowing NF-κB to translocate to the nucleus, where it binds to specific DNA sequences 
encoding the pro-inflammatory cytokines (e.g., IL-1, IL-2, IL-6, TNF-α as well as cyclooxygenase-2 (Cox-2) and 
inducible nitric oxide synthase (iNOS). 
 
The nonsteroidal anti-inflammatory drugs (NSAIDs) are a group of medications commonly 
administered to manage pain and inflammation (Moro et al., 2012). Most of them are available 
over the counter in the United States while the rest needs a prescription (Meek, van de Laar, & 
Vonkeman, 2010). Several side effects have been associated with frequent administration of 
NSAIDs particularly in the GIT where they cause bleeding, intestinal perforation and peptic 
ulcer. Other less pronounce side effects include renal dysfunction, high blood pressure and 
cardiovascular toxicity (Elsayed, El Enshasy, Wadaan, & Aziz, 2014). NSAIDs act by 
inhibiting the intracellular cyclo-oxygenase enzymes which have two isoforms (COX-1 and 
COX-2). Cyclooxygenases are enzymes involved in the process of inflammation. They catalyze 
the rate-limiting step in the biosynthesis of prostaglandins, prostacyclin’s, and thromboxane’s 
from arachidonic acid (Diyabalanage, Mulabagal, Mills, DeWitt, & Nair, 2008; Noreen, 
Ringbom, Perera, Danielson, & Bohlin, 1998; Stanikunaite, Khan, Trappe, & Ross, 2009). 
Prostaglandins (PG) are hormone-like chemicals in the body that perform ‘‘housekeeping’’ 
functions required for normal physiological activities. They are structurally related and have 
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regulatory roles as well as a pathological implication (Silveira et al., 2014). Cyclooxygenase 
enzymes catalyze the conversion of arachidonic acid to PGH2, which is converted to other 
prostanoid species including PGD2, PGE2, prostacyclin (PGI2), and thromboxane (TXA2) by 
the action of specific synthases (Figure 13) (M. Joo & Sadikot, 2012). COX-1 is primarily 
involved in the regulation of homeostatic functions and is constitutively expressed in a wide 
variety of cells, promoting physiological functions, such as gastric mucosal protection, control 
of renal blood flow, hemostasis, autoimmune responses, lungs, central nervous system, 
cardiovascular system and reproductive functions (Grosser, Fries, & FitzGerald, 2006). On the 
other hand, COX-2 is an inducible isoform of prostaglandin synthase in activated macrophages, 
fibroblasts, and endothelial cells that are responsible for inflammation. They are expressed 
significantly due to stimuli such as cytokines, endotoxins, viral proteins, and growth factors. 
COX-2 originates inducing prostaglandins, which contributes to the development of the four 
cardinal signs of inflammation: pain, heat, redness, and swelling, thus being considered as the 
main target for the anti-inflammatory action (FitzGerald, 2004). The search for selective 
inhibitors of COX-2 is considered important, based on the theory that the side effects, such as 
gastric lesions, that occurred from inhibition of COX-1 activity, were observed with some non-
selective nonsteroidal anti-inflammatory drugs (NSAIDs) such as dexamethasone, diclofenac, 
and indomethacin (Lu et al., 2013). Until now, very few compounds of natural origin have been 
reported to possess COX-2 inhibitory effects. (Yoshikawa et al., 2005) were the first to report 
the potential of lanostane triterpenoids and their glycosides as selective inhibitors of the COX-
2 enzyme. 
Usually, NSAIDs inhibit both isoforms of the cyclooxygenase enzyme but the recently 
discovered selective COX-2 inhibitors are specific for the COX-2 isoform, thus exerting the 
anti-inflammatory property of COX-2 inhibition while theoretically evading the adverse effect 
associated with COX-1 isoform inhibition (Nowak, 2012). Considerable resources have thus 
been invested in the pharmaceutical industries for development and design of drugs that act 
through selective inhibition of COX-2 to control inflammation with improved tolerability, less 
adverse effects, and without affecting normal metabolic processes. 
Background 
 
 
 
33 
 
Figure 13. Schematic diagram of the biosynthetic pathway of common prostaglandins. 
 
Numerous investigations have suggested that several mushroom species and their individual 
metabolites can exhibit anti-inflammatory potential based on their ability to reduce the 
production of inflammatory mediators. Antrodia camphorata (M. Zang & C.H. Su) Sheng H. 
Wu, Ryvarden & T.T. Chang also known as “Taiwanofungus camphoratus” is a well-known 
medicinal mushroom with a lot of pharmacological potentials (antioxidant, hepatoprotective, 
anti-inflammatory and immunomodulatory properties) (Geethangili & Tzeng, 2011). Hseu et 
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al., (2010) reported the anti-inflammatory effect of fermented culture broth of A. camphorata 
by measuring the level of pro-inflammatory cytokine IL-1β and TNF-α expression in different 
organs using ELISA kits. The extract was found to inhibit the LPS-induced production of 
cytokines and suppressed LPS-induced NF-κB activation in transgenic mice. The same 
researchers also studied fermentation culture of A. camphorata and examined its effect in LPS 
stimulated RAW 264.7 cells for NO, PGE2, iNOS and COX-2 protein expression. The results 
indicate inhibition of the production of TNF-α, IL-1β, NO and PGE2, as well as suppressing 
iNOS and COX-2 expression by blocking activation of NF-κB transcription factor. 
Gunawardena et al., (2014) studied the anti-inflammatory potential of five commercial 
mushroom species (A. bisporus, A. bisporus Portobello, F. velutipe, L. edodes, and P. 
ostreatus) in LPS activated RAW 264.7 macrophages cells for NO production and detection of 
TNF-α level using ELISA kit. Three mushroom species showed the highest activity with the 
result expressed in terms of IC50 for NO production and TNF-α release respectively: P. 
ostreatus (0.077 mg/mL and 0.035 mg/mL), L. edodes (0.027 mg/mL and 0.047 mg/mL) and 
F. velutipes (0.024 mg/mL and 0.099 mg/mL). Ethanolic extract of G. lucidum was studied for 
its anti-inflammatory potential by stimulating murine BV2 cell line with LPS, and the amount 
of NO, PGE2 and Cytokine (IL-1β and TNF-α) in culture supernatants quantified as reported 
by H. M. Yoon et al. (2013). Treatment of cell line with extract up to 1 mg/mL significantly 
repressed the production of NO due to the inhibition of iNOS mRNA protein expression. The 
amount of cytokine released was measured by ELISA and a significant reduction in the level 
of cytokines after treatment with extract was observed. Methanolic extract of G. lucidum was 
also evaluated by C. Chu, Ye, Wu, & Chiu, (2015), RAW 264.7 monocytic cells were 
stimulated with LPS and treated with extract at different concentrations. From the result, 100 
mg/mL of extract significantly inhibited NO production in the culture medium up to 85%.  
Moro et al. (2012) analysed six mushroom species from Spain (Boletus edulis, Cantharellus 
cibarius, Craterellus cornucopioides, Lactarius deliciosus, A. Bisporus and P. ostreatus) in 
what concerns the anti-inflammatory activity of their methanolic extracts through NO 
production in LPS stimulated RAW 264.7 cells. At 0.5 mg/mL, A. bisporus, Cratarellus 
cornucopioides, C. cibarius and L. deliciosus showed 35%, 65%, 80% and 40% of NO 
production inhibition, respectively. The release of TNF-α production was estimated by ELISA 
kits, but methanolic extracts showed no reduction of TNF-α production in the macrophages. 
Rao, Fang, & Tzeng, (2007), studied anti-inflammatory activity using methanolic extracts from 
the fruiting body of Cordyceps sinensis by stimulating macrophages cells with LPS and NO 
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production later quantified. The amount of TNF-α level and IL-12 were quantified by the 
ELISA test. From the results, 100 mg/mL of C. sinensis extract inhibited NO production by 
70%. E. S. Han, Oh, & Park, (2011) also studied the anti-inflammatory effect of hot water 
extract of Cordyceps militaris (L.) Fr. in vivo by inducing inflammation in mice. The extracts 
were known to inhibit inflammation as well as iNOS and TNF-α expression in colon tissue of 
Dextran sulfate sodium (DSS) induced colitis and in LPS-stimulated RAW 264.7 cells. K. M. 
Kim et al. (2003) also described the anti-inflammatory activity of another Cordyceps species. 
Methanolic extracts of Cordyceps pruinose (L.) Fr. were tested in vitro for inhibition of pro-
inflammatory cytokines production by using ELISA kit as well as NO production in LPS 
stimulated RAW 264.7 macrophages. The extracts suppressed gene expression of IL-1β, TNF-
α, iNOS, and COX-2.  
Silveira et al. (2014) isolated a 1,3 β-glucan from the fruiting body of Pleurotus sajor-caju and 
tested its anti-inflammatory effect in a monocytic cell line (THP-1) after LPS induction, for 
inhibition of proinflammatory genes production. Monocyte cells showed a significant decrease 
in TNF-α expression (61.8% inhibition) while IL-1β and COX-2 mRNAs were also 
significantly inhibited (37.0% and 63.6%, respectively). Silveira et al. (2015) isolated a 
mannogalactan from P. sajor-caju by submerged fermentation. The purified polysaccharide 
was chemically characterized, and its anti-inflammatory potential evaluated in vivo for 
reduction of carrageenan-induced paw edema in mice. The group treated with purified 
mannogalactan was able to reduce edema after 5-6 h of exposure to 1% carrageenan, with 69-
71% edema reduction observed and was quite as effective as dexamethasone used as a control. 
Therefore, mushroom polysaccharides have shown to be lead compounds for the development 
of anti-inflammatory agents. Andrea C. Ruthes et al.  (2013) isolated and purified a 
fucogalactan from A. bisporus fruiting bodies, and its anti-inflammatory effect was evaluated 
in vivo by formalin-induced pain in mice and detection of iNOS and COX-2 protein expression. 
Fucogalactan significantly decreased both iNOS and COX-2 expression by 53% and 54%, 
respectively, in relation to dexamethasone used as a control, which also affected both iNOS 
and COX-2 expression by 74.5% and 71.4%, respectively. The results showed significant 
inhibition of inflammatory pain and strongly confirm the anti-inflammatory potential of 
fucogalactan.  
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Mushroom species Pharmaceutical form Main Findings Reference 
Agaricus bisporus J.E.Lange Methanolic extract At 0.5 mg/mL, cell viability of RAW 264.7 macrophage cells was not inhibited and NO and TNF-α levels 
were reduced. 
(Moro et al., 2012) 
Fucogalactan Fucogalactan at 100 mg kg−1 decreased both iNOS and COX-2 expression by 53 and 54%, respectively. (Andrea C. Ruthes et 
al., 2013) 
2-amino-3H-phenoxazin-
3-one 
NO production was inhibited and iNOS protein expression suppressed at 1.5 µM while PGE2 production was 
inhibited at 0.27 µM. 
(Kohno et al., 2008) 
Extract Cell viability was not affected up to 2 mg/mL, NO and TNF-α production was inhibited at 0.032 mg/mL and 
1.88 mg/mL respectively. 
(Gunawardena et al., 
2014) 
A. bisporus Portobello J. E. Lange Extract Cell viability was not affected up to 2 mg/mL, NO production was inhibited at 0.063 mg/mL. (Gunawardena et al., 
2014) 
Agrocybe chaxingu Huaag β-Glucan Up to 100 µg/mL, RAW 264.7 macrophage cell viability was not affected and at 50 µg/mL, COX-2 and iNOS 
protein expression were inhibited. Topical application of β-Glucan to mice ears suppressed TPA-induced 
edema formation. 
(B. R. Lee et al., 
2009) 
Amanita muscaria (L.) Lam. Fucomannogalactan and β-
Glucan 
Formalin-induced inflammation was suppressed up to 91 ± 8% at a dose of 30 mg kg−1 and 88 ± 7% and 10 
mg kg−1 for β-Glucan and Fucomannogalactan respectively. 
(Andrea Caroline 
Ruthes et al., 2013) 
Albatrellus caeruleoporus (Peck) 
Pouzar 
Grifolin dervatives Grifolinones A and B, grifolin, and neogrifolin inhibited NO production with IC50 values of 23.4, 22.9, 29.0, 
and 23.3 µM, respectively. 
(Quang, Hashimoto, 
et al., 2006) 
Antrodia camphorata (M. Zang & 
C. H. Su) Sheng H. Wu, 
Ryvarden & T.T. Chang 
Eburicoic acid 
Dehydroeburicoic acid 
TNF-α, IL-1β and NO levels were significantly suppressed and at 10 mg/kg acetic acid and formalin-induced 
inflammation was significantly suppressed. 
(J. S. Deng et al., 
2013) 
Antrocamphin A 
(Benzenoids) 
After exposure of antrocamphin A (1, 5, 10, 20 µg/mL) to LPS induced Male rats, NO, COX-2 and PGE2 
production were significantly reduced.  
(Hsieh et al., 2010) 
Ergostatrien-3β-ol Acetic acid induced paw edema was significantly suppressed coupled with decreased IL-1β, NO and TNF-α 
levels. 
(G. J. Huang et al., 
2010) 
Table 2. Previous studies on anti-inflammatory activity of different mushroom extracts and their isolated metabolites 
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Antrocamphin A and its 
analogue 
At 20 mg/mL, cell viability of RAW 264.7 macrophage cells was maintained up to 99.71% while NO 
production was significantly inhibited up to 98.10%. 
(C.-L. Lee et al., 
2011) 
Zhankuic acid C At 12.5 100 µg/mL, TNF-α, IL-6, and IL-12 release were significantly inhibited in mouse bone marrow-
derived dendritic cells. 
(M. K. Lin et al., 
2015) 
Benzocamphorin Isolated benzocamphorin (8.6 ± 2.7 µM) suppressed LPS-induced NO production in murine microglial cells 
(BV2) cells. 
(Liao, Kuo, Liang, 
Shen, & Wu, 2012) 
Succinic and maleic 
derivatives 
Six compounds were found to suppress IL-1β and TNF-α release (10-25 µg/mL) in LPS-stimulated 
RAW264.7 cells. 
(S. C. Chien et al., 
2008) 
Antrodia cinnamomea Chang & 
Chou 
Maleimide and Maleic 
Anhydride 
Antrocinnamomins A, B, C and D extracted from the mycelium inhibited NO Production (IC50 12.5 - 21.8 
µM) with no decrease in cell viability. 
(M. Der Wu et al., 
2008) 
Maleimide Derivatives Four new maleimide derivatives, antrocinnamomins E, F, G and H extracted from the mycelium inhibited NO 
Production (IC50, 29 - 45 µM) and compounds did not cause cytotoxicity in RAW 264.7 macrophage cells. 
(M. Der Wu, Cheng, 
Yech, Yuan, & Chen, 
2013) 
Armillariella mellea (Vahl) P. 
Kumm 
Polysaccharides and 
sulfated polysaccharides 
At 500 µg/mL TNF-α and IL-6 were inhibited up to 31.17% and 62.74% with subsequent suppression of NF-
κB activation.  
(C. W. Chang, Lur, 
Lu, & Cheng, 2013) 
Phenolic compounds At 300 µg/mL, NO production was significantly suppressed and nuclear translocation of NF- κB/p65subunit 
was prevented. 
(Geng et al., 2017) 
Caripia montagnei (Berk.) Kuntze β-Glucan The β-glucans rich extract was found to show no reduction in cell viability of peripheral blood mononuclear 
cells and in vivo administration in male Swiss mice showed a significant reduction in NO, IL-10 and IFN-γ 
levels. 
(Queiroz et al., 2010) 
Cordyceps cicadae N6-(2-Hydroxyethyl) 
adenosine 
At 0.5-10µg/mL, cell viability of RAW264.7 macrophage cells was maintained, while NF-κB pathway was 
activated leading to decrease levels of IL-1β, TNF-α, and PGE2. 
(M. Y. Lu, et al. 
2015) 
Cordyceps militaris (L.) Fr. Cordycepin At 7.5 µg/mL, levels of NO, TNF-α and IL-12 levels were suppressed up to 50%. (Rao, Fang, Wu, & 
Tzeng, 2010) 
Cordycepin Up to 7.5 µg/mL, cell viability of murine BV2 cell line was maintained and there was a significant reduction 
in NO, PGE2, IL-1β and TNF-α levels. At 0.5-7.5µg/mL, NF-κB translocation was suppressed by blocking 
IkappaB-α (IκB-α). 
(Jeong et al., 2010) 
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Extract  Up to 500 µg/mL, aqueous extract suppressed NO, TNF-α and iNOS levels up to 50% in RAW264.7 
macrophages cells. 
(E. S. Han et al., 
2011) 
Cordyceps pruinosa (L.) Fr. Extract Methanolic extract between 10-100 µg/mL reduced IL-1, TNF-α, NO and PGE2 levels and suppressed NF- 
κB activation in LPS-stimulated RAW264.7 cells. 
(K. M. Kim et al., 
2003) 
Cordyceps sinensis (Berk.) Sacc. Extract  Methanolic extract between 25-100 µg/mL, TNF-α and IL-12 levels in murine peritoneal macrophages were 
significantly inhibited. 
(Rao et al., 2007) 
Coriolus versicolour (L.) Lloyd Extract  Hydroethanolic extract at 400 µg/mL reduced IL-2, IL-4, IL-6, IL-12, IL-18 and IFN- γ levels in murine 
splenic lymphocytes with no reduction in cell viability. 
(Ho et al., 2004) 
Cyathus africanus H. J. Brodie Diterpenoid Diterpene rich extract reduced NO level in RAW264.7 macrophage cells. (J. Han et al., 2013) 
Cyathus hookeri Berk. Cyathane diterpenoid Three diterpenes isolated from ethyl acetate extract suppressed NO level with IC50 between 15.5-52.3 µM. (Z. Xu et al., 2013) 
Daedalea gibbosa (Pers.) Extract  Ethyl acetate extract suppressed NO, TNF-α and PGE2 levels with significant suppression of iNOS promoter 
activity.  
(Nili Ruimi, et al., 
2010) 
Daedalea quercina (L.) Pers. Quercinol Isolated quercinol significantly suppressed COX-1 and COX-2 activity. (Gebhardt et al., 
2007) 
Daldinia childcare Ces. & De 
Not. 
Benzophenone derivatives Daldinals A, B, and C suppressed NO and iNOS activity in RAW 264.7 cells with IC50 values of 15.2, 4.6 and 
6.4 µM. 
(Quang, 
Harinantenaina, et al., 
2006) 
Elaphomyces granulatus Fr. Extract, syringaldehyde 
and syringic acid 
Ethanolic extract inhibited COX-2 activity up to 68% at 50 µg/mL, while isolated syringaldehyde and syringic 
acid reduced COX-2 activity with an IC50 of 3.5 and 0.4 µg/mL respectively.  
(Stanikunaite et al., 
2009) 
Flammulina velutipes (Curtis) 
Singer 
Extract Cell viability was not affected up to 2 mg/mL, NO and TNF-α production was inhibited at 0.024 mg/mL and 
0.099 mg/mL respectively. 
(Gunawardena et al., 
2014) 
Fomes fomentarius (L.) Fr. Methyl 9-Oxo-(10E,12E) 
octadecadienoate 
Isolated compound reduced NO PGE2, TNF-α, IL-6, iNOS and COX-2 levels in peritoneal macrophages. (Choe et al., 2015) 
Fomitella fraxinea (Bull.) 
Imazeki 
Exttracts, fomitellanols, 
cryptoporic acids, 
Ethyl acetate extract suppressed COX 1 and COX 2 activity at 10 µg/mL up to 96 and 59% respectively. 
Also, its four isolated fomitellanols suppressed COX 1 and COX 2 with inhibitory activity up to 90.5%. 
(Yoshikawa et al., 
2013) 
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Fomitopsis nigra (Berk.) Imaz. Pachymic acid The isolated compound (15 µM) maintained cell viability of Human dental pulp cells and significantly 
suppressed expression of ICAM-1, VCAM-1, iNOS, and COX-2.  
(Y. H. Lee et al., 
2013) 
Fomitopsis pinicola (Sw. Fr.) P. 
Karst. 
Lanostane triterpenoids, 
triterpene glycosides 
Isolated compounds, fomitopinic acid, formitoside E and Formitoside F showed significant Inhibition of 
COX-2 activity (IC50, 0.15-1.15 µM) corresponding to indomethacin (IC50, 0.60 µM). 
(Yoshikawa et al., 
2005) 
Ganoderma capense (Lloyd) 
Teng 
Glycopeptide At 100 µg/mL, NO production and iNOS expression were significantly suppressed in RAW264.7 mouse 
macrophage cell line. 
(Zhou, Chen, Ding, 
Yao, & Gao, 2014) 
Ganoderma lucidum (Curtis) P. 
Karst 
Lanostane triterpenes Twelve lanostane triterpenes were isolated and up to 50 µM cell viability of RAW264.7 cells were not 
affected and there was significant suppression of NO, TNF-α, and IL-6 levels. 
(S. Choi et al., 2014) 
Triterpene extract Up to 100 µg/mL, cell viability of RAW264.7 cells was maintained and between 3–50 µg/mL exposure to 
triterpene rich extract, NO, TNF-α and IL-6 levels were suppressed. 
(Dudhgaonkar, et al. 
2009) 
Triterpenic acids Nine lucidenic acids and four ganoderic acids were found to inhibit TPA-induced inflammation (1 µg/ear) in 
mice. 
(Akihisa et al., 2007) 
Triterpene butyl esters Isolated lanostane triterpenes suppressed NO levels and reduced iNOS and COX-2 protein expressions in 
RAW 264.7 cells with IC50 values between 4.3-9.4 µM. 
(Tung et al., 2013) 
Aqueous extract, 
Ganoderic acid C1 
(GAC1) 
At 100 µg/mL exposure to aqueous extract, cell viability of RAW 264.7 macrophage cells was maintained 
and TNF-α levels were suppressed with IC50 value 33.8, µg/mL. GAC1 suppressed TNF-α levels and ˂10 
µg/mL was sufficient to account for 50% inhibition. 
(C. Liu et al., 2015) 
Geastrum saccatum Fr. β-Glucan Isolated glucan suppressed croton oil-induced edema (60.4% at 10 mg/kg) comparable to diclofenac (89.2% 
at 5 mg/kg) or L-NAME (86.23% at 60 mg/kg). Expression of iNOS and COX were suppressed. 
(Guerra Dore et al., 
2007) 
Grifola frondosa (Dicks.) Gray Agaricoglycerides At 500 mg, the levels of IL-1β, TNF-α, NF-κB, ICAM-1, COX-2, and iNOS were significantly reduced. (C. Han & Cui, 2012) 
Fatty acid fraction, 
steroidal compounds 
The fatty acid fraction and isolated compounds up to 250 µg/mL displayed COX-1 and COX-2 enzyme 
inhibition 
(Y. Zhang, Mills, & 
Nair, 2002) 
Hericium erinaceum (Bull.) 
Persoon 
Hericirine (ergosterol) Up to 40µM, the isolated compound inhibits the expression of iNOS and COX-2, and reduced the levels of 
NO, PGE2, TNF-α, IL-6 and IL-1β in RAW264.7 cells. 
(W. Li et al., 2014) 
 Hericenone C, D, F, At 200 µg/mL, cell viability of RAW264.7 cells was maintained, and NO production was suppressed (D. G. Lee, Kang, et 
al., 2016) 
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Inonotus obliquus (Ach. ex Pers.) 
Pilát 
Extract fractions, steroidal 
compounds 
Ethanol extract, petroleum ether fraction, ethyl acetate fraction and n-butyl alcohol fraction showed 50% 
reduction in NO levels at 40 µg/mL.  Trametenolic acid and ergosterol peroxide suppressed NO levels by 
50.04% and 36.88% respectively.  
(Ma et al., 2013) 
Inonotus xeranticus (Berk.) 
Imazeki & Aoshima 
Davallialactone Cell viability of RAW264.7 cells was maintained between 3.12-50 µg/mL and NO and PGE2 release were 
suppressed. Following treatment with the isolated compound, the signaling cascade that activates NF-kB 
was blocked up to 40%. 
(Y. G. Lee et al., 
2008) 
Lactarius deliciosus (L. ex Fr.) 
S.F. Gray 
Extract At 0.5 mg/mL, cell viability of RAW 264.7 macrophage cells was not inhibited and NO and TNF-α levels 
were reduced. 
(Moro et al., 2012) 
Laetiporus sulphureus (Bull.) 
Murrill 
Acetyl Eburicoic Acid At 100 µg/mL, cell viability of RAW 264.7 cells were maintained and identified compound dose-
dependently inhibited the NO production and suppressed iNOS, COX-2, IL-1β, IL-6, and TNF-α expression. 
(Saba et al., 2015) 
Lentinus edodes (Berk.) Pegler β-Glucan At 200 µg/mL, NO and TNF-α levels were significantly reduced due to suppression of JNK1/2 and ERK1/2 
kinases. 
(X. Xu, Yasuda, et al. 
2012) 
Fucoidan and Lentinan At 500 µg/mL, both polysaccharides down-regulated IL-8 mRNA expression and suppressed TNF-α release 
from RAW264. 
(Mizuno, et al., 2009) 
Lentinus polychrous (L.) Fr. Mycelia extract At 100 µg/mL, cell viability of RAW 264.7 cells were not affected and expressions of iNOS, IL-1β, IL-6, 
TNF-α, and COX-2 were significantly suppressed. 
(Fangkrathok et al., 
2013) 
Lignosus rhinocerotis 
(Cooke) Ryvarden 
Extract fractions, Protein 
complexes 
Cold water extract, hot water extract, and methanol extract reduced carrageenan-induced edema. Its protein 
component inhibited of TNF-α production with an IC50 of 0.76 µg/mL. 
(S. S. Lee et al., 
2014) 
Neolentinus lepideus (Fr.) 
Redhead & Ginns 
Benzoquinone, cinnamic 
acid derivatives 
5-methoxyisobenzofuran- 4,7(1H,3H)-dione (6.2µM) one of the isolated compounds showed strong NO 
inhibitory activity even better than hydrocortisone (53.78µM) used as the positive control. 
(Yongxia Li et al., 
2013) 
Phellinus linteus (Berk. & M. A. 
Curtis) Teng 
Inotilone Cell Viability of RAW264.7 cells was maintained after exposure to inotilone (25µM), NO and iNOS 
expression were inhibited due to suppression of MAPK and NF-κB expressions. 
(G. J. Huang, Huang, 
& Deng, 2012) 
Hispolon Cell viability RAW264.7 cells was maintained after exposure to hispolon rich mycelial extract (50-400 
µg/mL) and levels of NO, iNOS, TNF-α, and NF-κB expressions were significantly decreased. 
(C. J. Lin et al., 2014) 
n-Butanol fraction At 0.1- 1 mg/mL, iNOS promoter activity were suppressed. (B. C. Kim et al., 
2006) 
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Piptoporus betulinus (Bull. ex 
Fr.) P. Karst. 
Lanostanoids, polyporenic 
acid C 
Both compounds inhibited COX-1 activity with IC50 values of 8.5µM and 4 µM even comparable to 
indomethacin (6.5 µM). 
(Wangun, et al., 
2004) 
Lanostane-type triterpene Polyporenic acids A, C, and its derivatives were found to suppress TPA (12-O-tetradecanoylphorbol-13-
acetate) induced edema up to 49-86% with a 400 nmol/ear application. 
(Kamo, et al., 2003) 
Pleurotus citrinopileatus Singer nonlectin glycoprotein Isolated compound up to 6.25 µg/mL, maintained cell viability and suppressed iNOS, COX-2, and NF-kB 
expressions in RAW264.7 cells. 
(J.-N. Chen, et al. 
2011) 
Pleurotus pulmonarius (Fr.) Quél. Mycelia extracts and β-
Glucan rich fraction 
TNF-α, IL-1β, and IL-10 mRNA expression were suppressed. (Lavi et al., 2010) 
Pleurotus sajor-caju (Fr.) Singer β-Glucan At 250 µg/mL, expression of TNF-α, IL-1β, and COX-2 were significantly suppressed. (Silveira et al., 2014) 
Poria cocos F.A. Wolf Triterpenes Five of the isolated compounds suppressed NO secretion in RAW264.7 cells with IC50 values between 16.8-
44.9 µM even comparable to L-NMMA (28.4 µM). 
(Cai & Cai, 2011) 
Scleroderma nitidum Berk. β-Glucan The polysaccharide reduced edema formation up to 73% at 50 mg/kg, NO, IFN-γ, IL-2, IL-10 levels were 
significantly suppressed. 
(Nascimento et al., 
2011) 
Termitomyces albuminosus 
(Berk.) R. Heim 
Crude polysaccharide, 
crude saponin extract 
Acetic acid-induced inflammation was reduced by 61.8%, 79.0% and 81.6% after treatment with crude 
saponin extract (200 mg/kg) and crude polysaccharide extract (200 mg/kg) respectively. 
(Y. Y. Lu et al., 
2008) 
Tremella fuciformis Berk Polysaccharide At 300 µg/mL, cell viability RAW264.7 cells were maintained, TNF-α and IL-6 expression were suppressed 
due to inactivation of NFκB. 
(Y. Ruan, Li, Pu, 
Shen, & Jin, 2018) 
Bioactive compounds  Type Main findings Reference 
3,4,5-Trihydroxycinnamic acid Commercial At 100 µM, it suppressed NO production up to 70% and reduced Iκβ degradation. (J. W. Lee et al., 
2013) 
Caffeic acid Commercial At 10–200 µg/mL, IL-8, IL-1β, IL-6, and TNF-α levels were suppressed, IκB-α degradation and p65 
phosphorylation inhibited. 
(M. Liu et al., 2014) 
Commercial At 10 µg/mL, it suppressed NO levels, blocked NF-κB translocation and prevented IκB-α degradation. (Búfalo et al., 2013) 
Caffeic acid phenethyl ester 
(CAPE) 
Commercial At 1 µM, COX-1 and IL-1β expression was suppressed. (Nagasaka et al., 
2007) 
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Caffeic acid derivatives (methyl, 
ethyl, butyl) 
Synthesized  At 21.4, 11.9 and 8.4 µM, the derivatives inhibited NO levels up to 50%. (da Cunha et al., 
2004) 
Chlorogenic acid Commercial 0.5–100 µmol/L of CGA suppressed the expression of NF-κB, p50, and IKKα/β. (L. Lou et al., 2016) 
Synthesized Intraperitoneally at 2.5–50 mg/kg, it suppressed TNF-α, IL-1β, and IL-6 release by inhibiting the TLR4-mediated 
NF-κB signalling pathway. 
(Ruifeng et al., 2014) 
Commercial At 20 µM, levels NO, IL-1β, TNF-α, and IL-6 were suppressed and the expression of COX-2 and iNOS reduced. (Hwang, Kim, Park, 
Lee, & Kim, 2014) 
Commercial At 20 µM, expression of IL-1β and COX-2 was significantly suppressed. (W.-P. Chen & Wu, 
2014) 
Cinnamic aid Commercial At 182 ± 1 µM, NO secretion was suppressed by 50% in RAW264.7 cells. (Taofiq et al., 2015) 
Cordycepin Commercial At 5 µM, NO production suppressed by 50% in RAW264.7 cells. (Imamura et al., 
2015) 
Ferulic acid Commercial FA topically and intraperitoneally inhibited the expression of TNF-α and IL-6. (Ambothi, Prasad, & 
Balupillai, 2015) 
p-Coumaric acid Commercial Suppressed TNF-α levels in vivo at 100 mg/kg body weight in arthritis-induced rats. (Pragasam & Rasool, 
2013) 
Commercial At 442 ± 33 µM, NO secretion was suppressed by 50% in RAW264.7 cells. (Taofiq et al., 2015) 
p-Hydroxybenzoic Commercial At 239 ± 29 µM, NO secretion was suppressed by 50% in RAW264.7 cells. (Taofiq et al., 2015) 
Rosmarinic acid Commercial At 2.75 µM, the expression of IL-6 and IL-8 were inhibited. (Lembo et al., 2014) 
Commercial At 1 µg/mL, TNF-α levels were reduced and iNOS expression suppressed. (Zdařilová et al., 
2009) 
Commercial TNF- α, IL-6 and IL-1β levels were suppressed after administration of 5, 10 and  
20 mg/kg of rosmarinic acid/mice weight. 
(X. Chu et al., 2012) 
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X. Xu, Yasuda, Nakamura-Tsuruta, Mizuno, & Ashida, (2012) isolated a β-glucan (lentinan) 
from the fruiting bodies of L. edodes and investigated its effects on NO and TNF-α production 
in LPS stimulated murine RAW 264.7 macrophages. Lentinan, at a concentration of 200 
mg/mL, was found to significantly inhibit NO production (70%) and was dose-dependent. 
Also, the amount of TNF-α released from RAW 264.7 cells was quantified and found to be 
suppressed up to 75% at 200 mg/mL. Furthermore, the protein expression of iNOS and the 
gene expression of iNOS mRNA and TNF-α mRNA were suppressed by lentinan suggesting 
its usefulness as an anti-inflammatory agent. 
S. Choi et al. (2014) isolated 12 triterpenes from the fruiting body of G. lucidum and the anti-
inflammatory activity was evaluated in LPS induced RAW 264.7 cells. Seven triterpenes; butyl 
lucidenate E2 (GT-1), butyl lucidenate D2 (GT-2), butyl lucidenate P (GT-3), butyl lucidenate 
Q (GT-4), Ganoderiol F (GT-5), methyl ganodenate J (GT-7) and butyl lucidenate N (GT-12), 
out of the studied twelve triterpenes, showed significant decrease in NO production. 20 mM of 
GT-2 showed up to 70% inhibition of NO production relative to the control. Dudhgaonkar, 
Thyagarajan, & Sliva (2009) also studied triterpene rich ethanolic extracts from G. lucidum in 
LPS stimulated RAW 264.7 macrophage cells. The extract at 10-50 mg/mL suppressed TNF-
α production in RAW 264.7 cells (IC50, 15.1 mg/mL), reduced IL-6 production (IC50 14.4 
mg/mL) and decreased the secretion of PGE2 and NO in a dose-dependent manner with IC50 
values of 28.2 mg/mL and 11.4 mg/mL, respectively. 
Cyathus africanus H. J. Brodie, also known as “bird nest fungi”, usually grows on animal 
dungs, woody debris, and soil rich in humus. J. Han et al. (2013) isolated diterpenes from its 
fruiting body and the anti-inflammatory activity was evaluated regarding NO production in 
LPS induced macrophages. Five diterpenes showed potent NO inhibition with IC50 values of 
2.57, 1.45, 12.06, 10.73, and 9.45 µM, compared to hydrocortisone 53.78 (µM) used as the 
control. Albatrellus caeruleoporus (Peck) Pouzar is an edible mushroom that grows on woody 
debris as well as on the ground, common in North America. Quang, Hashimoto, et al. (2006) 
chemically characterized its methanolic extracts in terms of phenolic acids and evaluated their 
anti-inflammatory potential in LPS induced RAW 264.7 cells regarding NO production. All 
four identified grifolin derivatives showed a significant reduction in NO production with IC50 
values of 23.4, 22.9, 29.0, and 23.3 µM compared to 88.4 µM of NG-methyl-L-arginine (L-
NMMA), a potent inhibitor of NO production used as the control.  
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Elaphomyces granulatus Fr. is an inedible mushroom known as “false truffle” in the United 
Kingdom and widely distributed in Europe and North America. Stanikunaite et al. (2009) 
studied the ethanolic extracts of E. granulatus and isolated syringaldehyde and syringic acid 
from its fruiting body. Extracts and phenolic acids were evaluated for their anti-inflammatory 
activity in RAW 264.7 macrophages cells by the COX-1 and COX-2-catalysed prostaglandin 
biosynthesis assay. The extracts caused a 68% inhibition of COX-2 activity at 50 mg/mL. 
Syringaldehyde and syringic acid moderately inhibited COX-2 activity with IC50 values of 3.5 
mg/mL and 0.4 mg/mL, respectively. NS-398, a specific inhibitor of COX-2, was used as a 
positive control and had IC50 0.2 mg/mL. 
P. linteus is a medicinal mushroom used for centuries in oriental countries to prevent several 
diseases (G. J. Huang et al., 2012; S. H. Kim et al., 2004). C. J. Lin et al., (2014) isolated 
hispolon from the fermentation broth of P. linteus and its anti-inflammatory activity was 
evaluated in LPS induced RAW 264.7 cells regarding inhibition of NO production. Hispolon 
at 10 mg/mL inhibited NO production by 72.1% and suppressed the expression levels of iNOS. 
Hence this compound has useful therapeutic potential, and additional research studies are 
needed to understand its mechanism of action. G. J. Huang et al. (2012) isolated inotilone, from 
the fruiting body of P. linteus and tested the anti-inflammatory effects in vivo in carrageenan-
induced hind mouse paw edema model as well as in vitro for inhibition of NO production and 
iNOS expression. Carrageenan-induced mouse paw edema volume was significantly decreased 
to 56.2%, NO production was inhibited up to 26.2-59.7%, TNF-α release was inhibited up to 
10.6-40.3%, while iNOS expression was significantly inhibited in a dose-dependent manner. 
Inhibition of NF-κB and MAPK activation was also observed. Ma, Chen, Dong, & Lu, (2013) 
isolated six main constituents from P. linteus fruiting body and their anti-inflammatory activity 
was evaluated for NO production in RAW 264.7 cell lines. Among the isolated compounds, 
ergosterol peroxide and trametenolic acid had the highest anti-inflammatory potential and 
significantly inhibited NO production by 36.88% and 50.04%, respectively. Other steroidal 
compounds isolated from mushrooms (e.g. lanosterol, 3b-hydroxy8, 24-dien-21-al, ergosterol, 
and inotodiol) had relatively low percentages of NO production inhibition. 
Liu et al. (2014) reported the anti-inflammatory activity of ethanolic extract from mycelia of 
P. tuber-regium produced by submerged fermentation broth in LPS induced murine 
macrophage cell line RAW 264.7. Two compounds, cerevisterol (CE) and ergosta-4, 6, 8(14), 
22-tetraen-3-one, were isolated, characterized and their anti-inflammatory activity evaluated. 
From the result, both compounds at 10 µM inhibited NO production in a dose-dependent 
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manner, very similar to the control. They also significantly inhibited TNF-α, IL-6, and PGE2 
release from the cell culture supernatant. The anti-inflammatory activity was reported to be due 
to down-regulation of iNOS and COX-2 mRNA protein expression. 
Fomes fomentarius is an inedible mushroom species common in Europe, Asia and North 
America, known for its large fruiting body and decomposing property. Its fruiting body was 
extracted with methanol and methyl 9-oxo-(10E, 12E)-octadecadienoate isolated (Choe et al., 
2015). The anti-inflammatory activity was evaluated in peritoneal macrophages for NO, PGE2 
production, TNF-α, and IL-6 release. At 20 mg/mL, the compound significantly inhibited NO 
and PGE2 by 65% and 50%, respectively, while TNF-α and IL-6 levels were inhibited up to 
35% and 13%, respectively. Finally, the mechanism of action of the compound was found to 
be due to inhibition of iNOS and COX-2 protein expression and due to a slight inhibition of 
phosphorylation of ERK1/2 kinase. 
Armillaria mellea P. Kumm., popularly referred to as honey fungus is a medicinal and edible 
mushroom widely distributed in North America, Europe, and Northern Asia. The anti-
inflammatory activity of its ethyl acetate extract showed maintenance of cell viability in BV-2 
mouse microglia cell line. At 300 µg/mL, NO production was significantly suppressed and 
nuclear translocation of NF- κB/p65subunit was prevented. The authors went on to identify the 
most import contributors to the anti-inflammatory activity as 5-hydroxymethylfurfural, 2-
furoic acid, 4-hydroxybenzoic acid, vanillic acid, syringate, daidzein, genistein (Geng et al., 
2017). 
The anti-inflammatory activity of a glycopeptide from Ganoderma capense (Lloyd) Teng was 
evaluated in RAW 264.7 cells for NO production and for iNOS enzyme activity (Zhou et al., 
2014). It was found that LPS-induced NO production and iNOS expression were significantly 
inhibited in a dose-dependent manner. Jeong et al. (2010) studied the anti-inflammatory 
activity of commercial cordycepin in LPS stimulated murine BV2 microglia cells for inhibition 
of NO production as well as PGE2, and pro-inflammatory cytokine release. Cordycepin at 7.5 
mg/mL, decreased levels of NO production up to 65%, while the PGE2 concentration measured 
using ELISA kit was also repressed up to 60%. This anti-inflammatory mechanism was found 
to be due to the inhibition of iNOS and COX-2 protein expression. Y. H. Choi, Kim, & Lee, 
(2014) also studied the anti-inflammatory potential of cordycepin in LPS stimulated RAW 
264.7 macrophage cell line for NO production, cytokine (TNF-α and IL-1β) levels, and PGE2 
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production. At 30 mg/mL exposure of induced cells to cordycepin, there was a significant 
decrease in NO, TNF-α, IL-1β and PGE2 levels. 
Several publications have reported the medicinal properties of Cordyceps mushroom, including 
the anti-inflammatory activity (E. S. Han et al., 2011; K. M. Kim et al., 2003; Rao et al., 2007, 
2010; Won & Park, 2005). This mushroom contains a lot of bioactive compounds and 
“Cordycepin” an adenosine analog is one of the most important one. Jeong et al. (2010) studied 
the anti-inflammatory activity of commercial cordycepin in LPS stimulated murine BV2 
microglia cells for inhibition of NO production as well as PGE2, and pro-inflammatory 
cytokine release. Cordycepin at 7.5 µg/mL, decreased levels of NO production up to 65% while 
the PGE2 concentration measured using ELISA kit was also repressed up to 60%. This anti-
inflammatory mechanism was found to be due to the inhibition of iNOS and COX-2 protein 
expression. The mechanism of inhibition was further confirmed by decreased levels of LPS-
induced NF-kB/p65 levels in the nucleus and inhibition of phosphorylation of IκB-α complex. 
Researchers have attempted to synthesize compounds with improved properties as drug 
candidates with the potential to inhibit production of NO and other inflammatory mediators 
such as interleukins (IL 1β, IL-6, IL-8), TNF-α and PGE2. Some synthesized and commercial 
compounds with positive anti-inflammatory potential have been reported (Table 2). Taofiq et 
al. (2015) studied the anti-inflammatory activity of commercial phenolic acids (p-
hydroxybenzoic and p-coumaric acids) and cinnamic acid, and of their synthesised metabolites 
(glucuronated p-coumaric acid, methylated p-coumaric acid, glucuronated cinnamic acid, 
methylated cinnamic acid, methylated p-hydroxybenzoic acid, glucuronated p-hydroxybenzoic 
acid)  (Heleno et al., 2014). All compounds were then tested for their potential to inhibit NO 
production in LPS stimulated RAW 264.7 cells. Cinnamic acid had the highest activity (IC50 
value 182 µM), followed by p-hydroxybenzoic (239 µM) and p-coumaric (442 µM) acids, in 
comparison with dexamethasone (40 µM) used as a control. Among the synthesized 
metabolites, CoA-GP (glucuronated derivative of p-coumaric acid) and CoA-M1 (methylated 
derivative with the methoxy group at the para position) presented strong anti-inflammatory 
activity with IC50 values of 58 µM and 35 µM respectively.  
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1.4.3. Anti-ageing and UV protective effects of mushroom extracts and their associated 
metabolites  
 
Several biological reactions, required for normal functioning of the organism, take place in 
body cells and tissues. These reactions often cause generation of species with unpaired 
electrons called free radicals. These free radicals include ROS, reactive nitrogen species (RNS) 
and reactive sulfur species (RSS) (Carocho & Ferreira, 2013a, H. Zhao et al., 2017). The body 
has mechanisms to balance ROS production and neutralization by means of its intrinsic 
antioxidant pool (glutathione peroxidase, catalase, and superoxide dismutase), but most of the 
times it can become depleted due to excessive ROS production allowing the body cells to suffer 
from oxidative stress (Carocho & Ferreira, 2013a). Subsequently, endogenous sources are 
needed to fulfill the antioxidant requirements and mushrooms, used as a dietary source, can 
help to surpass this lack since they contain high amounts of bioactive compounds displaying 
antioxidant activity (Hui et al., 2010). These dietary sources of antioxidants such as vitamin C 
(ascorbic acid), vitamin E (tocopherol), carotene, vitamin K, flavonoids, phenolic acids, 
selenium, and zinc tend to maintain a balance to control oxidative stress (Carocho & Ferreira, 
2013a). Skin exposure to high UV radiation causes ROS generation, which usually leads to a 
combined effect of DNA damage, skin inflammation, hyperpigmentation and stimulation of 
dermal fibroblast for expression of matrix metalloproteinase 1 (MMP-1). The results are 
collagen degradation and a decrease in collagen synthesis, thus resulting into a photo-aged skin 
(Masaki, 2010). The important role of antioxidants in skin health drives the continuous search 
for compounds of natural origin capable of scavenging ROS, inhibiting tyrosinase enzyme as 
well as suppressing MMP-1 expression. Ascorbic acid is usually used in skin care products but 
controversy in its efficacy has been raised due to its inability to penetrate the skin together with 
its poor stability in cosmetic formulations (Spagnol et al., 2016). α-Tocopherol is also an 
important antioxidant that is reported to downregulate MMP-1 expression by suppressing AP-
1 and also inhibiting tyrosinase enzyme, making it an important anti-wrinkle and 
hyperpigmentation correcting agent (Miyake et al., 2010). Several publications have reported 
the antioxidant activity of mushroom extracts mainly as radical scavengers (DPPH 2,2-
diphenyl-1-picrylhydrazyl; ABTS 2,20-azinobis 3- ethylbenzothiazoline-6-sulfonic acid; H2O2 
and O2 scavenging activity), reducing power (FRAP ferric reducing antioxidant power) and 
lipid peroxidation inhibitors (TBARS thiobarbituric acid reactive substances; Heme 
degradation of peroxides and FOX ferrous oxidation-xylenol) (Carocho & Ferreira, 2013a, Hui 
et al., 2010). 
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Antioxidant compounds are a key ingredient in preventing an ageing skin. These compounds 
act on several cell signal transduction pathways related to ageing, inflammation, 
hyperpigmentation and extracellular matrix degradation. As mentioned earlier, free radicals 
produced because of different cell functions are the most important contributors to an ageing 
skin and as such, compounds with antioxidant capacity have been described as the most 
important cosmetic and cosmeceutical ingredients against exogenous oxidative stress that 
occurs in our daily life. Some studies (Table 3) that have so far been reported on the anti-
ageing potential of mushroom extracts or their individual compounds will be discussed.  
A. bisporus is one of the most widely consumed mushrooms in the world. It contains high 
amount of dietary fibres, phenolic compounds and polysaccharides. Polysaccharide fraction 
obtained from A. bisporus  at the dose of 400 mg/kg was able to significantly decrease the 
activities of SOD, GSH-Px and CAT, in an ageing mice (Shangshang Li, Liu, Zhang, et al., 
2018). An exopolysaccharide was isolated from Grifola frondosa, the extract was submitted to 
cell viability assay in human dermal fibroblasts by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) method. The extracts (5-200 µg/mL) were found to significantly 
reduce expression of MMP-1 up to 61% and no reduction in cell viability was observed (J. T. 
Bae et al., 2005). Kim et al. (2007) also reported the contribution of both mycelia extract (GF-
M) and exopolysaccharide fraction (EPS) obtained from G. frondosa on the expression of 
MMP-1 and collagen synthesis. The samples were found not to cause any morphological 
change in human dermal fibroblast cell lines, while also reducing the expression of MMP-1 by 
20 and 40% for GF-M and EPS respectively. Another interesting finding regarding the 
contribution of a polysaccharide as an anti-ageing ingredient was reported by Hui et al. (2010), 
where mice were exposed to a polysaccharide-rich diet from H. erinaceum and the activities of 
SOD, CAT and GSH-Px were compared with a placebo group. The samples exposed to the 
bioactive fraction were found to have high MMP-1 and antioxidant enzyme activity and 
resulted in an enhanced collagen level. Polysaccharide-rich extract from Volvariella volvacea 
was also submitted to cell viability assessment (0.001-10 mg/mL) on human fibroblasts cell 
lines and up to 80% cell viability was achieved. The authors went further to report that the 
extract was able to stimulate collagen biosynthesis up to 146.77±13.20% (Ruksiriwanich, et 
al., 2014). Beside been able to act as anti-ageing ingredients, polysaccharides especially those 
from botanical and algae origin have been reported to have interesting skin hydrating and 
moisturizing effects because of their high water holding capacity (Z. S. Zhang, Wang, Han, 
Zhao, & Yin, 2012). Significant studies are still needed to be conducted to determine the 
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mechanism behind the anti-ageing potential of these class of compounds. Anti-ageing effects 
of exopolysaccharides (EPS) from Agrocybe cylindracea was conducted in mice and the 
authors reported an increase in serum activities of SOD, GSH-Px and total antioxidant capacity 
(H. Zhao et al., 2017). Similar studies were also reported for acidic-extractable polysaccharides 
from A. bisporus (Shangshang Li, Liu, Wang, et al., 2018), crude polysaccharides from 
Calocybe indica Purkay. & A. Chandra (Govindan et al., 2016), and acidic- and alkalic-
extractable mycelium polysaccharides from Agrocybe aegerita (Brig.) Sing (Jing et al., 2018). 
All extract fractions provided enhanced enzymatic (SOD, GSH-Px and CAT) and non-
enzymatic (MDA) free radical-scavenging defense. Polysaccharide fractions were prepared 
from the mycelium extract of G. frondosa and their cosmeceutical potential was evaluated in 
human dermal fibroblasts, showing no inhibition of cell growth and maintenance of cell 
viability. Also, biosynthesis of collagen was quantified and up to 80% was achieved at a 
concentration of 0.05% (w/v) (B. C. Lee et al., 2003). 
Besides the contribution of compounds that tend to elevate collagen synthesis, decrease the 
activities of intrinsic antioxidant enzymes and suppress collagen inhibitors, compounds that 
inhibit the activity of hyaluronidase have drawn increased attention in preventing an ageing 
skin (Meng et al., 2011). Hyaluronic acid is a glycosaminoglycan (GAG), a key component of 
the ECM that promotes dermal cell proliferation, suppresses cell differentiation and retains 
skin moisture, thereby preventing an ageing skin (Stern, 2004). To our best of knowledge, even 
though inhibitor of these molecules has been described in the past, very little is known or 
reported about them. Different extract fractions prepared from P. citrinopileatus were reported 
by Meng et al. (2011) to show antioxidant activity, and their potential to inhibit hyaluronidase 
was evaluated using hyaluronic acid potassium salt as substrate. The results showed that the n-
butanol, aqueous and methanol extract showed hyaluronidase inhibition up to 9.7%, 10.8%, 
and 25.4% respectively. Hyaluronidase inhibition activity was also reported for aqueous and 
acetonic extract prepared from Trametes lactinea and they were found to inhibit hyaluronidase 
activity by 88.6 ± 0.11% and 88.3 ± 0.14% respectively (Y. A. Yahaya & Don, 2012). To our 
best of knowledge, only these two reports are available on the hyaluronidase inhibition activity 
of mushroom extracts or their individual metabolite. Research studies in this area are still 
lacking. Commercial extracts prepared from the mycelium of Tricholoma matsutake was 
submitted to cytotoxicity assay in fibroblast cell lines and the anti-elastase was determined 
using the peptide N-Succinyl-tri-L-alanine 4-nitroanilide (STANA) as substrate. The extract at 
100 µg/mL did not cause any decrease in cell viability, while expression of MMP-3 was 
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significantly suppressed (Kim et al., 2014). Also, the extract at 100 µg/mL was found to inhibit 
elastase activity by 81.4 ± 3.92%. The authors suggested that the extract can be utilised as a 
potential anti-wrinkle agent. G. frondosa has interesting potential as a skin care ingredient. Its 
polysaccharide fraction isolated from its fruiting body was evaluated for cosmeceutical 
potential. At 100 µg/mL, it was found to suppress MMP-1 activity by 40% even more potent 
than trans-retinoic acid (tRA), a common MMP-1 inhibitor (S. W. Kim et al., 2007). The 
extracts were found to stimulate an increase of 53% in the biosynthesis of collagen without 
presenting any cytotoxicity. Finally, its polysaccharide fraction was found to present tyrosinase 
inhibition activity in B16 mouse melanoma cells up to 20%. These results showed that G. 
frondosa can be an efficient multifunctional cosmeceutical ingredient offering photoprotection 
and suppressing melanogenesis. 
Wound healing is a natural restorative response characterized by several complex cascades of 
cellular events associated with inflammation, fibroplasia, neovascularization, collagen 
deposition, epithelialization and wound contraction (Kimura, Hashimoto, Yamada, & 
Nishikawa, 2013). A β-glucan rich extract prepared from Sparassis crispa (Wulfen) Fr., an 
edible and medicinal mushroom commonly consumed in China and Japan, was investigated 
for its in vivo wound healing potential. The results showed histologically that there was an 
increased epithelialization and a rapid wound healing in the β-glucan treated wounds when 
compared to the placebo group. Also, collagen levels were elevated in normal adult human 
dermal fibroblasts (NHDF) exposed to β-glucan (100 µg/mL) fraction (Kwon, Qiu, Hashimoto, 
Yamamoto, & Kimura, 2009). More so, regarding S. crispa, orally and topically applied β-
glucan rich extract, improved wound healing in vivo (K. Yamamoto & Kimura, 2013), and oral 
administration also improved stratum corneum turn over and accelerated collagen synthesis 
(Kimura, Hashimoto, Yamada, & Nishikawa, 2013). 
A topical formulation containing 10% (w/w) of G. lucidum extract was compared with intrasite 
gel, an amorphous hydrogel which gently re-hydrates necrotic tissue, facilitating its healing. 
The former showed signs of dermal healing with the shortest re-epithelisation period (12.37 ± 
0.49 days). Intrasite-gel wound closure was 136.86 ± 22.8 mm2 (55%), while G. lucidum 
formulation was 242.08 ± 7.8 mm2 (97%). Serum activities of antioxidant enzymes were also 
enhanced in vivo (Cheng et al., 2013). Similarly, the wound healing potential of Antrodia 
camphorata was evaluated by Amin, Ali, Alshawsh, Darvish, & Abdulla, (2015). Cell viability 
of fibroblast cells was maintained at 100 !g/mL, and a topical formulation based on this 
mushroom was prepared. Wound closure was 33.67 ± 4.81mm2 (90.21%), comparable to 
Background 
 
 
 
51 
intrasite-gel (36.67 ± 7.45mm2; 89.29%). Aqueous extract from G. lucidum and Crinipellis 
schevczenkovi Bukhalo topically applied also showed wound healing activity (Krupodourova 
et al., 2015). The authors were not able to determine the mechanism behind the wound healing 
process and the most important bioactive compounds contributing to the observed effect. 
Agaricus blazei polysaccharides has an effective wound healing properties by suppressing IL-
1β release by macrophages (Sui et al., 2010). These findings showed that extracts and 
individual compounds from mushrooms have wound healing properties and can be explored as 
cosmeceutical ingredients to accelerate the wound healing process. 
The most widespread organic acids found in mushrooms include oxalic acid, quinic acid, malic 
acid, citric acid, and fumaric acid (Barros, Pereira, & Ferreira, 2013). These acids have been 
reported to normalize the rate of desquamation in the skin by increasing epidermal thickness, 
stimulate cellular renewal, increase dermal firmness and skin smoothness (Sams et al., 2001). 
They have been clinically proven to suppress photoageing, improve wrinkles, maintain skin 
elasticity, and promote skin hydration (Green, Yu, & Van Scott, 2009; Moghimipour, 2012). 
Alpha hydroxy acid (AHA) and beta hydroxy acid (BHA) are two main classes of hydroxy 
acids, both differing in the position of the hydroxyl group (Kornhauser et al., 2012). Citric acid, 
and its salts and esters are reported to have multifunctional properties in cosmetics as chelating 
agents, pH adjusters, skin-conditioning agents, fragrance ingredient and as plasticizers (Fiume 
et al., 2014). A 20% citric acid lotion, topically applied to photodamaged skin was found to 
increase skinfold thickness, viable epidermis thickness, and GAG content in a statistically 
significant manner (Bernstein et al., 1997). Both citric and malic acid presented photoprotective 
properties in UVB-irradiated keratinocytes (Tang & Yang, 2018). These organic acids can, 
therefore, enhance and improve the therapeutic effects of certain bioactive compounds, through 
a synergistic interaction that will result in the skin health improvement. Despite the 
multifunctional properties of these organic acids, caution should be exercised due to some 
adverse reactions associated with them. 
Ultraviolet (UV) radiation has been responsible for several skin damages, ranging from 
precancerous and cancerous skin lesions and accelerated skin ageing. Topical formulations 
containing sunscreen  and antioxidant resources have been utilised to absorb UV rays and 
reduce the risk of oxidative damages (Maske, Lokapure, Nimbalkar, Malavi, & D’souza, 2013; 
Saija et al., 1999). Phenolic compounds such as flavonoids, stilbenes, and hydroxycinnamic 
acid derivatives are the most utilised compounds as photoprotectors. Several studies have 
mentioned that polyphenolic rich extracts have high sun protection factor offering protection 
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to UV-irradiated cells (A. S. Fernandes et al., 2018, Tang & Yang, 2018). To our best of 
knowledge, Saija et al. (1999) were the first to report a potential UV protective effect for ferulic 
and caffeic acid. The authors mentioned that the compounds were able to suppress UV induced 
peroxidation. They conducted a skin permeation assay using human skin samples as membrane 
and ferulic acid (19.94%) was found to permeate more than caffeic acid (11.14%). These 
interesting findings let the authors to conduct further in vivo studies, to evaluate the potential 
of the studied compounds to reduce the severity of UVB-induced skin erythema. The level of 
erythema of volunteers was accessed by means of reflectance spectrophotometry, generating 
skin reflectance spectral values that can be utilised as reliable parameters to evaluate skin 
erythema. The results showed that both compounds were able to display significant protection 
to the skin against UVB-induced erythema (Saija et al., 2000). Pluemsamran et al. (2012) 
accessed the UV protective effect of caffeic and ferulic acid. The authors reported that exposure 
of human keratinocyte cell line (HaCaT) to UV radiation at a dose of 4 Jcm-2 significantly 
reduced cell viability up to 30%. After exposure of the compounds to the cells, cell viability 
was markedly enhanced in a concentration-dependent manner. Both compounds (3.75–30 µM) 
were found to also suppress MMP-1 activity. Another interesting method to suppress the 
severity of UV induced skin damages is the combination strategy where different compounds 
with antioxidant and UV protective capacity are formulated together in order to deliver the 
desired effect. Kwak et al. (2015) reported that ascorbic acid and p-coumaric acid were utilised 
to generate two hybrid compounds, Ascorbyl-3-p-coumarate, and Ascorbyl-2-p-coumarate (A-
3-p-C and A-2-p-C). The effects of these compounds on collagen synthesis were examined and 
at 100–300 µM, A-3-p-C and A-2-p-C promote collagen release up to 120–144% and 125–
191%, respectively. Both compounds were also found to decrease MMP-1 activity in a 
concentration-dependent manner. Phenolic compounds rich serum was applied topically in ten 
female volunteers, aged 38-52 years. There was a significant increase in epidermal and dermal 
thickness, increased fibroblast density and enhanced activity of antioxidant enzymes up to 32% 
(Freedman, 2009). Besides being able to protect the skin against UV induced damages, long 
term effects of these extracts and/or individual compounds have not yet been well reported 
clinically. Even though more progress has been made in the use of natural extracts as anti-
ageing ingredients, their safety and efficacy are not well regulated, and this challenge makes it 
difficult for consumers to know if these claims are true. 
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Mushroom Pharmaceutical form Main findings  Reference 
Agaricus bisporus J.E.Lange Polysaccharide fraction Superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) 
activity were effectively improved after oral exposure to extract fraction. 
(Shangshang Li, Liu, 
Zhang, et al., 2018) 
acidic-extractable polysaccharides Serum activities of SOD, GSH-Px and total antioxidant capacity were enhanced in vivo. (Shangshang Li, Liu, 
Wang, et al., 2018) 
Agrocybe aegerita (Brig.) Sing acidic- and alkalic-extractable 
mycelium polysaccharides 
Extract displayed enhanced enzymatic (SOD, GSH-Px and CAT) and non-enzymatic 
(Malondialdehyde) free radical-scavenging defense. 
(Jing et al., 2018) 
Agrocybe cylindracea (V. Brig.) Vizzini exopolysaccharides Serum activities of SOD, GSH-Px and total antioxidant capacity were enhanced in vivo. (H. Zhao et al., 2017) 
Calocybe indica Purkay. & A. Chandra crude polysaccharides Serum activities of SOD, GSH-Px and total antioxidant capacity were enhanced in vivo. (Govindan et al., 2016) 
Grifola frondosa (Dicks.) Gray Exopolysaccharide At 100µg/mL, cell viability of fibroblast cells was not inhibited and expression of 
MMP-1 mRNA was significantly suppressed up to 61.1%. 
(J. T. Bae et al., 2005) 
Mycelia extract (GF-M), 
Exopolysaccharide (EPS) 
At 100 µg/mL EPS and GF-M inhibit expression of MMP-1 by 20 and 40%, GF-M 
caused a 53% increase in collagen synthesis. 
(S. W. Kim et al., 2007) 
Hericium erinaceum (Bull.) Persoon Polysaccharides Bioactive fraction significantly enhanced skin antioxidant enzymes (SOD, CAT, GSH-
Px), MMP-1 activities and collagen protein levels in a dose-dependent manner. 
(Hui et al., 2010) 
Pleurotus citrinopileatus Singer Extract At 2.0, 1.1, and 4.1 mg/mL, extract inhibited hyaluronidase activity by 9.7%, 10.8%, 
and 25.4% respectively. 
(T. X. Meng et al., 2011) 
Tremella fuciformis Berk Polysaccharides Oral administration enhanced SOD, GSH-Px, and CAT activity after UV exposure. 
Collagen content in the UV-induced animal skin was enhanced up to 26%. 
(Wen et al., 2016) 
Polysaccharides After exposure to 400 µg/mL, H2O2-induced oxidative stress and apoptosis in human 
Dermal Fibroblast cells were significantly suppressed.  
(T. Shen et al., 2017) 
Trametes lactinea (Berk.) Sacc. Extract Aqueous and acetonic extract inhibited hyaluronidase activity by 88.6 ± 0.11% and 88.3 
± 0.14% inhibition for respectively. 
(Y. A. Yahaya & Don, 
2012) 
Table 3. Previous studies on anti-ageing and UV protective effects of different mushroom species. 
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Tricholoma matsutake (S. Ito & S. Imai) 
Singer 
Extract At 100 µg/mL, it decreased the expression of MMP-3 and inhibited elastase activity by 
81.4 ± 3.92%. 
(S. Y. Kim et al., 2014) 
Volvariella volvacea (Bulliard ex Fries) 
Singer 
Phenolic compounds and 
polysaccharide-rich extract 
Aqueous extracts stimulate collagen biosynthesis up to 146.77±13.20%. (Ruksiriwanich et al., 
2014) 
Individual   compounds  Type Main findings Reference 
Ascorbyl-3-p-coumarate, Ascorbyl-2-p-
coumarate 
Synthesized At 100–300 µM, A-3-p-C, and A-2-p-C promote collagen release by 120–144% and 
125–191%, respectively. 
(Kwak et al., 2015) 
Caffeic acid Commercial Cell viability of UV exposed HaCaT cell were maintained (3.75–30 µM) and MMP-1 
activity was enhanced up to 70% at 30 µM. Serum activities of SOD, GSH-Px and total 
antioxidant capacity were enhanced in vivo. 
(Pluemsamran et al., 
2012) 
Ellagic acid Commercial At 5µM suppressed the expression of MMP-1 and at 1-10µM up-regulated collagen 
levels. 
(J. Y. Bae et al., 2010) 
Ferulic acid 
 
Commercial  Cell viability of UV exposed HaCaT cell were maintained (3.75–30 µM) and MMP-1 
activity was enhanced up to 90% at 30 µM. Serum activities of SOD, GSH-Px and total 
antioxidant capacity were enhanced in vivo. 
(Pluemsamran et al., 
2012) 
Commercial FA applied topically at 0.01, 0.05–1 mg/site/mouse, significantly suppressed the expression 
of MMP-2 and MMP-9. 
(Staniforth, et al., 2012) 
Ferulic and caffeic acids Commercial Both compounds at 200 µL offered a protective activity to UVB-induced skin erythema. (Saija et al., 2000) 
Hispidin Commercial Expression of heme oxygenase-1 and catalase was enhanced. (D. E. Kim, et al., 2014) 
Lentinan Commercial Up to 6 µg/mL, lentinan protect H2O2-damaged Keratinocytes (HaCaT) cells and enhanced 
SOD activity. 
(Zi et al., 2018) 
p-Coumaric acid Commercial  At 30 µg/mL inhibited MMP-1 expression from dermal fibroblasts.  (Seok & Boo, 2015) 
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1.4.4. Antimicrobial activity of mushroom extracts and their associated metabolites  
 
The skin is constantly colonized by non-pathogenic microorganisms such as Staphylococcus 
aureus, Candida albicans and Streptococcus species. The distribution and density of the skin 
microflora depend on the individual’s age and environmental factors such as sebum secretion, 
temperature, and humidity (Elsner, 2006). The presence of these microorganisms is known to 
cause inflammatory skin diseases like atopic dermatitis, seborrheic dermatitis, cellulitis, 
erysipelas, impetigo, folliculitis, furuncle, carbuncle abscess and psoriasis (Alsterholm, 
Karami, & Faergemann, 2010). Among the common skin diseases mentioned above, atopic 
dermatitis and acne vulgaris have been known to be associated with increased colonization of 
the skin by microbes such as S. aureus and P. acne and these organisms tend to worsen the 
state of the diseases (Salah & Faergemann, 2015). Cosmetic industries are constantly searching 
for interesting bioactive compounds from natural origin to replace synthetic anti-microbial 
agents coupled with the fact that these microorganisms also develop resistance against 
conventional topical antimicrobials (Ribeiro, Estanqueiro, Oliveira, & Sousa Lobo, 2015). 
External application of medicinal plants in the form of paste and infusions for the treatment of 
skin inflammatory diseases has been practiced for many decades (Nesy & Mathew, 2014). 
Parabens are synthetic alkyl esters of p-hydroxybenzoic acid that are common preservatives in 
personal care products and pharmaceuticals, preventing the growth of bacteria, thanks to their 
broad-spectrum antimicrobial activity (Kerdudo et al 2016). However, some of their butyl and 
propyl esters have been discovered to cause reproductive defects (Heffernan et al., 2015). Their 
use is now facing some constraints, with the cosmetic industry starting to exclude this 
ingredient from their products (Velegraki, Hapeshi, Fatta-Kassinos, & Poulios, 2015). In this 
context, bioactive compounds from natural sources can become viable alternatives based on 
their antimicrobial activity. Phenolic acids, such as ferulic, caffeic acids and their derivatives, 
are known to cause disruption of bacterial and fungal cell membrane, allowing the leakage of 
the cytoplasmic membrane and, finally, cell death (Teodouro, Ellepola, Seneviratne, & Koga-
Ito, 2015). Numerous research studies have reported the anti-microbial potential of mushrooms 
as well as their bioactive compounds. Alves et al. (2012) reviewed the anti-microbial activity 
of mushroom extracts as well as their bioactive compounds and reported that both, edible and 
non-edible mushroom, displayed activity against pathogenic microorganisms. L. edodes was 
indicated to be the most interesting species against both gram-positive and gram-negative 
bacteria followed by species from the genera Boletus, Ganoderma, and Lepista. Phenolic 
compounds have been reported to display antibacterial activity by interfering with the cell 
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membrane and cell wall of invading pathogen and subsequently leading to the death of the 
pathogen (Ribeiro et al., 2015).  Alves et al., (2013) revealed that phenolic acids such as 2,4-
dihydroxybenzoic, protocatechuic, vanillic and p-coumaric acids showed higher antimicrobial 
potential against both Gram-positive and Gram-negative bacteria, while ferulic, caffeic, 
syringic, ellagic and chlorogenic acids also displayed interesting results. These authors went 
on to conclude that despite the recognized antimicrobial activity of some of the enumerated 
compounds, their mechanism of action needs to be fully understood and before the problem of 
the multiple resistance of bacteria to antibiotics is solved. Some interesting antimicrobial 
activity reported for some individual metabolites found in mushrooms is presented in Table 4.
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Compound Source Microorganisms Effect Reference 
2-Coumaric acid Synthesized Mycobacterium tuberculosis. MIC value of 122 µM (Guzman et al., 2014) 
3,4-Dialkoxy caffeic acids Synthesized Staphylococcus aureus, Corynebacterium diphtheria, Escherichia coli, Klebsiella pneumonia, 
Salmonella typhi. 
GI 100 µg/mL (Gangan et al., 2014) 
5-O-caffeoylquinic acid Commercial Escherichia coli, Staphylococcus aureus, Enterococcus faecium, Proteus vulgaris, Pseudomonas 
aeruginosa, Klebsiella pneumoniae and Candida albicans. 
MIC 5–10 mg/mL (Bajko, et al., 2016) 
Caffeic and cinnamic acid 
ester 
Synthesized Candida albicans biofilm. MIC 32 µg/mL (De Vita et al., 2014) 
Caffeic, chlorogenic,  
o-coumaric, p-coumaric acid 
Commercial E. coli, S. aureus, Salmonella typhimurium, Lactobacillus rhamnosus. MIC 125–1000 µg/mL (Parkar, Stevenson, & 
Skinner, 2008) 
Chlorogenic acid Synthesized S. aureus, Streptococcus pneumoniae, Bacillus subtilis, E. coli, Shigella dysenteriae  
Salmonella Typhimurium. 
MIC 20–80 µg/mL. (Z. Lou, Wang, Zhu, Ma, 
& Wang, 2011) 
Chlorogenic, rosmarinic, 
sinapic and ferulic acid 
Commercial Campylobacter jejuni, Campylobacter coli. MIC 4.9–313 µg/mL (Klančnik, Možina, & 
Zhang, 2012) 
Ferulic acid Commercial P. aeruginosa, E. coli, L. monocytogenes, S. aureus biofilm formation. MBC 500–5000 µg/mL (Borges, Saavedra, & 
Simões, 2012) 
Commercial Bacillus cereus and Pseudomonas fluorescens single- and dual-species biofilms. MIC 500 µg/mL (Lemos et al., 2014) 
Ferulic acid esters Synthesized Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus faecalis, Candida 
albicans, Candida krusei, Candida parapsilosis. 
MIC 8–1024 µg/mL (Ergün, Çoban, Onurdag, 
& Banoglu, 2011) 
Ferulic acid, p- coumaric acid Commercial Bacillus cereus, Micrococcus flavus, S. aureus, Listeria monocytogenes, E. coli, Enterobacter 
cloacae, P. aeruginosa, S. typhimurium, C. albicans. 
MIC 0.01–0.04 mg/mL (Šiler et al., 2014) 
o-Coumaric, m-coumaric, p-
coumaric acid 
Commercial C. albicans, Candida parapsilosis, Candida glabrata, Candida tropicalis, Candida krusei, 
Candida lusitaniae, Cryptococcus neoformans. 
GI 5.9%–99.9% (Faria et al., 2011) 
p-Coumaric acid Commercial S. aureus, Streptococcus pneumoniae, B. subtilis, E. coli, Shigella dysenteriae, S. typhimurium. MIC 10–80 µg/mL (Z. Lou et al., 2012) 
Table 4. Antimicrobial activity reported for some individual metabolites found in mushrooms. 
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p-Coumaric acid derivatives Synthesized S. aureus, B. subtilis, E. coli C. albicans, Aspergillus niger. MIC 0.68–1.93 µM/mL (Khatkar, Nanda, Kumar, 
& Narasimhan, 2017) 
Trans-cinnamaldehyde,  
p-coumaric, ferulic acid. 
Commercial E. coli biofilm. 0.25%–0.5% 
concentration 
(Kot, Wicha, Piechota, 
Wolska, & Grużewska, 
2015) 
GI: growth inhibitory activity, MBC: minimal bactericidal concentrations, MIC: minimum inhibitory concentration. 
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Some of the studies reported above have shown that mushrooms are important sources of 
natural bioactive compounds with the potential to be used as cosmetic ingredients to treat 
several disorders associated with the skin. Among the reviewed mushroom species, Pleurotus 
species seem to be the most reported even though the bioactive compounds responsible for 
some of the bioactive properties have not been identified yet. Other interesting mushrooms are 
Agaricus species, Inonotus species, Lentinula species, and Ganoderma species. Different 
classes of bioactive compounds were also reported to show promising cosmeceutical benefits. 
p-Coumaric acid seems to be a very interesting cosmetic ingredient because of its reported anti-
collagenase, anti-tyrosinase, and anti-inflammatory activity. Some mushroom species such as 
Lyophyllum decastes, were reported to combat atopic dermatitis by oral ingestion of their 
fruiting bodies, resulting in the disease improvement. The results suggest that oral ingestion of 
mushroom can also exert a positive appearance benefit (Ukawa et al., 2007). These studies 
have shown that cosmeceutical and nutricosmetics formulations developed with mushroom 
extracts or their individual metabolites have the potential to successfully protect and defend 
the skin against free radicals, reduce production of inflammatory mediators, inhibit 
collagenase, elastase, and tyrosinase associated with inflammatory diseases, wrinkle, ageing, 
and hyperpigmentation. However, studies regarding the safety, topical bioavailability and 
clinical studies on the potential of these mushroom extracts and their associated metabolites as 
a cosmetic material are still lacking. 
 
1.5. Commercially available cosmeceutical and nutricosmetic formulations with 
mushroom-based ingredients 
 
Mushroom extracts and their individual metabolites have been formulated either in the form of 
lotions and creams for topical application or as supplements for oral ingestion. Some of them 
are formulated either alone or in combination with other botanical extract and are commercially 
available, with the sole aim of maintaining skin health. Dr. Andrew weil for OriginsTM mega-
mushroom (www.origins.com/dr-weil-mega-mushroom) was among the first premium western 
brands to exploit fungi in skin care. Launched in 2006, the product is a skin relief face mask 
used to calm, soothe, and defend skin against visible signs of ageing. In its formulation, it 
includes Hypsizygus ulmarius mycelium, G. lucidum and Cordyceps sinensis extracts. Recently 
added by Dr. Weil for Origins product catalog is Plantidote mega-mushroom body cream, a 
moisturizing cream containing the three mushrooms complex as well as other ingredients like 
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ginger, turmeric and holy basil (Ocimum sanctum L.). Menard is a brand of cosmetic product 
with mushroom ingredients (www.menard-cosmetic.com). It employs the use of G. lucidum 
extract in its Embellir range, not only to give an appearance benefit but to eliminate toxins and 
help repair skin damage associated with overexposure to UV radiation and free radicals. Estée 
Lauder developed a formulation with G. lucidum, wolfberry and ginseng along with other 
antioxidants, moisturizers, some cell-communicating ingredients and mixtures of common skin 
ingredients in its new Re-Nutriv sun care product (www.esteelauder.com). This product claims 
to defend, revive the skin radiance, and help reduce the ageing effects of everyday exposure to 
UV radiation, including the formation of age spots, uneven skin tone, and other imperfections.  
Aveeno positively ageless is a moisturizing eye cream that contains natural shiitake complex, 
a clinically proven antioxidant that works with the skins natural renewal process 
(www.aveeno.com). This formula intends to brighten the appearance of the skin around the 
eyes and reduce the appearance of dark circles. Positively ageless collection launched in 
October 2007 has been developed to improve the appearance of skin and fight the signs of 
ageing. Dr. Patricia Wexler owns Wexler Dermatology in New York City. The Instant De-Puff 
Eye Gel was reformulated with A. bisporus and other important ingredients 
(www.wexlerdermatology.com). This anti-ageing product contains ingredients that improve 
the skin surface and boost elastin level in the skin necessary for preventing wrinkling. One 
Love Organics Vitamin D Moisture Mist (www.oneloveorganics.com), formulated with 
different botanical extract and L. edodes extract is used to tone, hydrate and protect the skin 
against environmental stress. Body Repair Lotion from CV Skinlabs (www.cvskinlabs.com), 
free from synthetic fragrances, parabens, and hydroquinone, formulated with G. lucidum 
extract and other botanical extracts (Aloe Barbadensis leaf juice, Calendula Officinalis flower 
extract, Curcuma Longa (Turmeric) root extract, Hypericum Perforatum flower/leaf/stem 
extract (St. John’s Wort) and Rosa Canina fruit oil (Rose Hip)), is used to accelerate wound 
healing and suppress skin inflammation. Osmia facial brightening serum is formulated with 
botanical extracts (broccoli, papaya, pumpkin seed oils), algae extract (Spirulina platensis) and 
mushroom extract (L. edodes) (https://osmiaorganics.com).  This serum facilitates healthy cell 
turnover and improves the elasticity of the skin resulting in a more luminous and more 
moisturized skin appearance. 
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1.6. Challenges associated with the use of mushroom extracts and their associated 
metabolites as cosmeceutical ingredients 
 
1.6.1. Extraction process 
 
The emergence of bioactive compounds as value-added ingredients with potential applications in 
the pharmaceutical, cosmeceutical and nutraceutical industries, has drawn significant attention over 
the last couple of years (Chanioti & Tzia, 2018; Heleno, Martins, et al., 2015; Santos et al., 2013). 
Considering all the health promoting benefits associated with these compounds, their recovery is 
becoming a very hot topic in the multidisciplinary area of applied chemistry, biology and 
technology. Among several techniques of extraction, the conventional extraction methods such as 
maceration and heat-assisted extraction in their simplest form basically involve mixing the matrix 
and the solvent allowing for interaction and subsequent release of bioactive compounds. These 
processes require long extraction times, high solvent and energy consumption with a resulting lower 
extraction yield. Bearing in mind these constraints, several non-conventional extraction techniques 
have been utilized to successfully maximize extraction of phenolic compounds such as microwave 
assisted (MAE), hydrostatic pressure (HPAE), pulsed electric field (PEF), supercritical fluid 
extraction (SFE) and ultrasound-assisted extraction (UAE), offering advantages of short extraction 
time, lower solvent consumption and maximum extraction yield (Albuquerque et al., 2016; Heleno, 
Prieto, et al., 2016).  
UAE is based on the principle of acoustic cavitation, which can disrupt the cell walls thereby 
allowing the release of bioactive compounds (Heleno et al., 2016; Medina-Torres et al., 2017). 
MAE, also an effective extraction method, maximizes extraction yield at shorter times, using 
moderate energy and a low solvent amount, while also offering protection to thermo-labile bioactive 
compounds. It is based on using microwave energy to heat up samples, causing reduction in the 
moisture present in the matrices, and further generates a high pressure on the cell wall, allowing the 
leaching out of the bioactive compounds (Heleno, Prieto, et al., 2016; Medina-Torres et al., 2017; 
Vieira et al., 2017). HPAE is a faster, effective, non-thermal and environment-friendly extraction 
process that operates under very high pressure. In this method, higher pressure favours solvent 
penetration into the solid cells increasing compounds release (Briones-Labarca, Giovagnoli-
Vicuña, & Cañas-Sarazúa, 2018; Chanioti & Tzia, 2018; Haining & Yongkun, 2017). SFE is a 
sustainable extraction process that utilises supercritical fluids such as CO2, ethane, butane, pentane, 
nitrous oxide, ammonia, trifluoromethane and water (Cong-cong, Bing, Yi-qiong, Jian-sheng, & 
Tong, 2017). This technique requires high capital investment but it is environment-friendly, safe, 
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non-toxic, non-carcinogenic and non-flammable (Ghafoor, AL-Juhaimi, & Choi, 2012; Santos, 
Villaverde, Silva, Neto, & Silvestre, 2012). PEF technology is an emerging non-thermal extraction 
technique that involves the exposure of solid samples to short duration electric field pulses of high 
intensity, causing a transmembrane potential difference across the cell membrane. When the 
potential difference reaches a critical value, the cell membrane starts to collapse allowing for 
increased intracellular metabolite extraction (Barba, Zhu, Koubaa, Sant’Ana, & Orlien, 2016; 
López-Giral et al., 2015; López, Puértolas, Condón, Álvarez, & Raso, 2008).  
Obtaining an enhanced compound rich extract from different matrices depends on the extraction 
method utilised as well as the range of the experimental domain used.  Different extraction variables 
such as solvent type and proportion, temperature, time, the molecular affinity between solvent and 
solute, liquid-to-solid ratio, and particle size have been reported to influence the extraction yield 
(Azmir et al., 2013, Heleno, Prieto, et al., 2016). Therefore, it is essential to define the main 
variables and relevant response criteria prior to the optimization process to determine the values 
corresponding to response maximization according to the defined objectives (e.g. using minimum 
time, energy and solvent to achieve a cost-effective and profitable extraction system). To effectively 
carry out an optimization, the influence of each defined variable should be independently assessed. 
Nevertheless, the application of mathematical models such as the response surface methodology 
(RSM) is gaining visibility among the scientific community. Through RSM design, the optimization 
of possible interactions between experimental variables is allowed simultaneously with the 
prediction of the most efficient conditions (Albuquerque et al., 2016; Heleno, Prieto, et al., 2016; 
Jiménez et al., 2018; Oludemi et al., 2018; Pinela, Prieto, Carvalho, et al., 2016; Vieira et al., 2017).  
 
1.6.2. Use of extract vs individual compound  
 
Extracts possess an array of structurally diverse bioactive compounds, with either similar, 
overlapping, different or complementary biological capacities. When these extracts are utilised, 
either as nutraceutical or cosmeceutical ingredients, the total biological capacity of the individual 
bioactive may be modified via synergistic, additive, or antagonistic interactions with other 
components, which may in turn change their physiological impacts (Phan, Paterson, Bucknall, & 
Arcot, 2018; S. Wang, Meckling, Marcone, Kakuda, & Tsao, 2011). In additive phytochemical 
interactions, the combined effect is equal to the sum of the individual effects of the biomolecules 
present in the mixture. In synergistic interaction, the combined effect produces a response greater 
than the arithmetical sum of their individual effects, while if an antagonistic interaction occurs, the 
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combined effect resulted to be less potent (Phan et al., 2018). Extracts are a combination of 
hydrophilic and lipophilic antioxidants, such as polyphenols, carotenoids, organic acids, and 
tocopherols. When these compounds coexist in a mixture, they present advantages, possibly leading 
to synergistic effects, but exerting health promoting benefits associated with the diverse array of 
bioactive molecules.  
When an individual compound with a target biological property is to be utilised, large doses are 
often needed. The possibility to use extracts may lower the required doses due to the cumulative 
effect of the individual compounds present in the extract. This helps to prevent some side effects 
associated with the use of large amounts of the individual compounds. Significant antioxidant 
synergism between β-carotene paired with puerarin, quercetin and rutin were reported with an 
increase antioxidant activity up to 50% (R. M. Han et al., 2011). Rosmarinic acid was shown to 
have a strong antioxidant capacity due to its synergistic interaction with α-tocopherol, which 
resulted in caffeic acid generation (Panya et al., 2012). These results showed that synergistic 
antioxidant response of extract combinations may not necessarily be due to the interaction among 
polyphenols but possibly from interactions with other bioactive molecules. A synergistic interaction 
between chlorogenic, gallic, protocatechuic and vanillic acid was also reported (Hugo et al., 2012). 
On the contrary, Pinelo et al. (2004) found an antagonistic effect when catechin, resveratrol, and 
quercetin interacted at three different temperatures using the DPPH method. Antagonistic 
interactions were also reported in myricetin/naringenin combinations in terms of Oxygen radical 
absorbance capacity (Freeman, Eggett, & Parker, 2010). The mechanisms underlying the combined 
biological effects of these phytochemicals are still unknown imposing further studies to assist the 
future design, standardization, and optimization of extract mixtures preparation based on their 
synergistic or antagonist interactions. However, despite all the mentioned benefits for extracts use, 
they may also present some limitations. These limitations are mostly resulting from the presence of 
several anti-nutritional or toxic compounds such as alkaloids, tannins, saponins and mycotoxins, 
which at higher amounts could result in numerous health-related implications in humans 
(Malongane, McGaw, & Mudau, 2017). These naturally occurring compounds, when ingested can 
affect nutrient utilisation in the human body, especially proteins, vitamins, and minerals, which 
reduce their absorption, inhibit enzyme activities and reduce their bioavailability in the 
gastrointestinal tract (Nikmaram et al., 2017). Based on the various interactive mechanisms among 
these bioactive compounds, and nutritional components affecting their bioavailability, further 
studies must be conducted to balance extract intake. This must be based on their content in 
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biomolecules to maximize the supplementation process to improve the nutritional quality and 
health-promoting benefits of the extract. 
 
1.6.3. Safety and Efficacy 
 
Cosmetic users often believe that cosmeceutical claims are valid and properly regulated. Even 
though cosmetics are regulated by the Federal Food, Drug, and Cosmetic Act (FD&C Act) and 
the Fair Packaging and Labelling Act (FPLA), the term cosmeceuticals still have no meaning 
under the FD&C Act because of the claims stated that they have "medical drug-like effects" 
(Newburger, 2009). The U.S. Food and Drug Administration, Centre for Food Safety and 
Applied Nutrition, Office of Cosmetics and Colours, however, says, “The FD&C Act does not 
recognize ‘cosmeceuticals’ and they reiterated that a product can be a drug, a cosmetic, or a 
combination of both, but the term ‘cosmeceutical’ has no meaning under the law” (Lintner, 
Mas-Chamberlin, Mondon, Peschard, & Lamy, 2009). Thus, cosmeceuticals are a category of 
cosmetic dermatology that is still undefined, unclassified, unregulated and is still in its early 
years of exploitation. Advertising claims made by cosmeceutical manufacturers are 
investigated for efficacy by the Federal Trade Commission (FTC) and the claims suggesting 
that the products have a positive effect on the structure or function of the human body must be 
substantiated by scientific evidence. These limitations faced by the cosmeceutical firms is 
based on the overestimation of the efficacy and safety claims of the products, which would 
remove them from the cosmetic category to place them into the drug category since they are 
stated to improve skin function (Draelos, 2009). Most of the products introduced in the market 
by cosmeceutical manufacturers undergo self-policing as no regulations for cosmeceutical are 
in place at present times. Some of these ingredients can cause several allergies, hence the need 
to set up approaches and regulations to identify allergens in some of these products (Draelos, 
2009). Some of the common unwanted skin irritation encountered with topical cosmeceuticals 
include contact dermatitis, photosensitivity, hair and nail damage, hyperpigmentation, 
hypopigmentation and systemic effects (Gao, Zhang, Wei, & Chen, 2008).  
The Scientific Committee on Cosmetic Products and Non-Food Products intended for 
consumers (SCCNFP) and its successor, the Scientific Committee on Consumer Products 
(SCCP) is the scientific advisory body to the European Commission in matters of consumer 
protection with respect to cosmetic ingredients and non-food products (Pauwels et al., 2009). 
Safety data leading to a positive opinion include characterisation and physicochemical 
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properties; acute oral toxicity; skin/eye irritation; skin sensitization; in vitro dermal absorption; 
oral toxicity; mutagenicity/genotoxicity and reproductive toxicity (Vinardell and Mitjans, 
2017). Over the years the body has also supported the development of alternative methods to 
replace animal testing. According to the Cosmetics Regulation, it is prohibited in the EU to 
market any cosmetic products and ingredients that have been tested on animals (Pauwels et al., 
2009). It is expected that more sophisticated formulations will be developed in the future and 
if regulations are not continuously adhered to, more bioactive molecules with no proper safety 
assessment will get into the market and this might result in health implications.  
Assessing the toxicological profile of cosmeceutical ingredients is a regulatory requirement 
and this evaluation should take the route of administration into consideration. Considering that 
cosmeceuticals are ingredients for topical use, studies need to be conducted in skin cell lines, 
in particular with keratinocytes and fibroblasts. The determination of cytotoxicity is crucial to 
identify toxic effects elicited by these cosmetic ingredients before they are available in the 
market, and over the years several in vitro assays have been developed to measure cell viability 
or toxicity (Rampersad, 2012). One of the most widely used methods is the assessment of cell 
membrane integrity by measuring lactate dehydrogenase (LDH) leakage. LDH is a cytosolic 
enzyme released into the extracellular medium when the cell membrane is compromised 
because of apoptosis or necrosis. Even though other cellular enzymes such as adenylate kinase 
and glucose-6-phosphate dehydrogenase are released during cell death, LDH is found to be 
stable with no significant loss of activity (Fotakis & Timbrell, 2006). Another common assay 
to determine cell cytotoxicity is the measurement of viable cells after exposure to an active 
ingredient. This is conducted by measuring the metabolic activity of the viable cells based on 
tetrazolium reduction (Rodrigues et al. 2013). 
Like challenges in the area of safety, it is also difficult to ascertain the efficacy of some of these 
cosmeceuticals since the required clinical studies have, ideally, to go through several steps. 
Cosmeceutical development involves several steps, like extraction to identify the chemical 
compounds, extract purification and fractionation to isolate compounds of interest, in vitro 
studies to assess bioactive properties, studies to understand the mechanism behind the 
upregulation or downregulation of key cellular bioactivities, formulation in a vehicle for topical 
delivery, clinical trials to determine if bioactive compounds show cosmeceutical claims, and 
finally patenting and licencing for the product to enter the market (Draelos, 2009). Most 
reputable cosmeceutical formulators tend to test only the active ingredient with very few testing 
on the final formulation. Even when in vivo trials are conducted, they are often few and rarely 
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subjected to peer review, making physicians and dermatologists question the benefits of these 
cosmeceutical products (Baumann, 2012). Presently, cosmetic scientists and researchers have 
conducted interesting studies regarding formulation development with bioactive ingredients 
and, certainly, some of these cosmeceutical formulations affect the function of the skin and as 
such the FDA, should put in strict amendment of laws to authorize evaluation of such 
cosmeceuticals claims from their safety, efficacy and labelling (Newburger, 2009).  
The debate whether to classify active cosmeceuticals as cosmetic or drugs is also down to the 
fact that the average time for drug development ranges from 7 to 15 years, because it must go 
through strict safety and efficacy studies (toxicology, pharmacokinetics, pharmacology, and 
drug-drug interaction) (Norman, 2016), while the time for cosmetic development with 
significant breakthrough technology can occur in less than 5 years (Newburger, 2009). Hence, 
time and financial resources, strict regulations and long efforts are the main reason why 
cosmeceutical manufacturers prefer to avoid drug classification. Although many trusted 
manufacturers have emerged in the cosmeceutical world, and some of the active ingredients 
and the final formulations have been subjected to clinical testing with proven efficacy, the lack 
of official oversight leaves room for doubt both from consumers, physicians, and 
dermatologists. 
 
1.6.4. Stability and Degradation  
 
Bioactive compounds from natural sources have interesting properties that can support the design 
of innovative cosmeceutical formulations. Despite these promising bioactive properties, the 
efficacy and usage of mushroom extract and their individual metabolites in topical formulations are 
still affected by their poor stability, increased oxidation, degradation and poor permeability across 
biological membranes (Casanova, Estevinho, & Santos, 2016). To overcome such constraints, new 
strategies have been developed in the form of nano- and micro- technologies that employ the use of 
coating material, either as pure compounds or a mixture of components (sugars, gums, proteins, 
natural and modified polysaccharides, lipids and synthetic polymers) to protect active principles, 
conferring protection, improving stability, and/or provide their gradual release over time, assuring 
therapeutic treatments at correct concentrations at the target sites (Carvalho, Estevinho, & Santos, 
2016; Dias, Ferreira, & Barreiro, 2015). The encapsulation process can be performed using different 
methods such as coacervation, extrusion-based processes, spray-based processes, emulsion-based 
processes, liposomes, supercritical fluid-based processes, ultrasound-based processes and fluid bed 
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coating among others (Dias et al., 2015). The choice of the encapsulation technique is driven by the 
desired application in the product, and selected methods should be capable to produce particles with 
homogeneous size distribution, with high encapsulation efficiency, high loading capacity, and be 
able to ensure a release (Vincekovi et al., 2017). Controlled release is one of the main goals of 
microencapsulation, i.e. release phenomenon can be modulated, including maintained during the 
time (sustained release) or suppressed until the right time or site (Aguiar, Estevinho, & Santos, 
2016). The mechanism behind the controlled release of the active ingredient is partly due to the 
physico-chemical properties of the wall materials and the type of active ingredient itself. Most 
release mechanisms comprise diffusion, dissolution, erosion, digestion, mechanical disruption, and 
triggered release due to environmental changes (i.e temperature, pH, pressure, and ionic force) 
(Vincekovi et al., 2017).  
To develop cosmeceutical formulations using microencapsulation processes, it is vital to utilise 
non-toxic and biodegradable raw materials and be in accordance with the legal regulations. 
Additionally, evaluating the performance of the microencapsulated ingredients, after 
incorporation on the final products, is of high relevance and can often range from months to 
even years. Attention is now focused on finding effective microencapsulation methods that will 
optimally encapsulate the bioactive materials ensuring their sustained release. Casanova et al. 
(2016) prepared microparticles containing rosmarinic acid (RA) using chitosan and modified 
chitosan as the encapsulating materials. RA has vital biological properties, being an interesting 
ingredient for cosmetic formulations, but its use is limited due to its poor stability, degradation, 
and slow transport across biological membranes. The authors employed a spray drying 
technique to produce the microcapsules, and their release profile was analysed in aqueous and 
coconut oil media. Encapsulation yield and particle sizes were 42.6% and 39.8% and 4.2 µm 
and 7.7 µm for chitosan and modified chitosan particles, respectively, and the results showed 
that the chitosan particles displayed a slower release in water, while those in oil were more 
sustained. On the other hand, Biswick, Park, & Choy, (2012), due to the poor stability of caffeic 
acid towards solar radiation and oxidation, prepared microcapsules using zinc hydroxide nitrate 
as a matrix to prevent degradation and ensure a sustainable release compatible with 
cosmeceutical applications. The prepared microparticles were able to withstand both UVA and 
UVB radiation, indicating that this technology can be applied in the design of sunscreen 
cosmetic formulations. Due to the unique properties exhibited by chitosan, it was selected by  
Lee, Woo, Ahn, & Je, (2014) for encapsulating hydroxycinnamic acids (caffeic acid, ferulic 
acid, and sinapic acid). The idea was to develop a conjugate made up of chitosan and the 
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phenolic acids to evaluate and compare their bioactive properties. The antioxidant activity was 
screened by DPPH and ABTS assays, and the results indicated that chitosan conjugated with 
hydroxycinnamic acids displayed higher radical-scavenging activity than the unmodified form. 
The results also showed that the conjugated chitosan inhibited bacterial growth, suggesting that 
this application can be useful in formulations preventing bacterial growth, thus, increasing shelf 
life. Candida, a common skin microflora, was studied by Panwar, Pemmaraju, Sharma, & 
Pruthi (2016), who reported the potential of encapsulated ferulic acid against C. albicans. 
Ferulic acid was encapsulated into chitosan with an encapsulation efficiency and particle size 
diameter of 56.45% ± 2.47% and 52.54 ± 0.22 nm, respectively. The stability and integrity of 
the phenolic acid after encapsulation were also studied; the nanoparticles showed activity 
against C. albicans biofilm formation, confirming the integrity of ferulic acid in the 
microencapsulated form. The results showed that microencapsulation procedures can be 
efficient in the development of cosmetic formulations against fungal infection. Several 
technologies can be used for the encapsulation of bioactive compounds (Dias et al., 2015). 
Ignatova et al., (2016) encapsulated caffeic acid using poly (3-hydroxybutyrate) (PHB) and 
polyethylene glycol (PEG). The nanoparticles prepared by electrospinning were evaluated for 
antibacterial activity against S. aureus and E. coli, as well as for their release profile. The results 
showed that after 24 h 95.4% and 97.0% of caffeic acid were released from PHB and PEG, 
respectively. Free and nanoencapsulated CA displayed antibactericidal activity against S. 
aureus after 24 h exposure at 1800 µg/mL. Ouimet, Faig, Yu and Uhrich (2015) showed that 
encapsulated ferulic acid presented a slow release over time, so it is necessary to work on 
alternative methods to ensure a quicker release adapted to topical delivery. These authors 
reported that the incorporation of ethylene glycol with the encapsulating material could allow 
a faster degradation of the polymeric matrix and, therefore, a faster release. Complete release 
of ferulic acid was achieved after a few days, and the antioxidant activity was also found to be 
higher. Furthermore, Vashisth, Kumar, Sharma and Pruthi (2015) isolated and characterized 
ferulic acid from the Parthenium hysterophorus L. plant, further nanoencapsulated by 
electrospinning. Polylactic-co-glycolic acid (PLGA) and polyethylene oxide (PEO) were 
employed as encapsulating materials at a PLGA:PEO ratio of 1:1 using 
dichloromethane/dimethylformamide (4:1, v/v) as the solubilizing medium. The free and 
encapsulated ferulic acid were evaluated for DPPH radical scavenging activity. The antioxidant 
activity of the encapsulated ferulic acid was found to be 59%, while the isolated compound 
gave 41%, thus suggesting that encapsulated ferulic acid preserved the antioxidant activity. 
Even though the active ingredient can be efficiently encapsulated, there is still a continuous 
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search for new methods to overcome some of the limitations associated with the process of 
microencapsulation (Casanova & Santos, 2016). Another major drawback in the use of the 
microencapsulation system in personal care products involves properly evaluating the release 
profile of the active ingredient from the encapsulating material, as well as skin permeation 
studies. Furthermore, the behaviour of the microparticles produced needs to be further studied 
to be able to understand the mechanism of diffusion and how the microparticles interact with 
the lipid component of the stratum corneum. Hence, conducting more studies will further allow 
for a better understanding of the choice of encapsulating system and the polymeric material. 
 
1.6.5. Skin permeation 
 
The barrier properties of the SC of the skin have made it difficult for transdermal penetration 
of some ingredient in the cosmetic formulation. The SC offers a barrier against the entry of 
foreign materials, pathogens and loss of moisture (Kubota, Shibata, & Yamaguchi, 2016). 
Physico-chemical parameters, such as the molecular weight and lipophilic/hydrophilic balance, 
have been reported to affect the permeability of compounds in cosmetic formulation through 
the skin (T. Uchida et al., 2015). Conducting in vitro permeation studies is important to fully 
understand the permeation profile of these topically-applied chemicals. However, using human 
samples is very expensive and is subject to ethical evaluation, and that has led to the increased 
search for alternative artificial skin diffusion apparatus (T. Uchida et al., 2015, 2016). Strat-
M™ (Merck Millipore, Billerica, MA, USA) is the most utilised to mimic the skin in a Franz-
type diffusion cell, while epidermal full thickness (EFT) human skin cultures (MatTek, 
Ashland, MA, USA) can also be used to validate the penetration through skin for various 
bioactive metabolites. The skin permeation studies of mushroom extracts and their individual 
metabolites have not been fully studied, but among the ones available in the literature, only 
ferulic acid seems to be the most widely reported. In vitro experiments were conducted by 
Thitilertdecha, Guy, & Rowan, (2014) using a pigskin model with a cosmetic formulation 
containing phenolic compounds, but none of the hydroxycinnamic acids were able to penetrate 
the skin in an amount that could be quantified after 3 h of exposure. The authors suggested that 
the use of a potential skin penetration enhancer, like propylene glycol, can increase skin 
penetration of these compounds, but the use of penetration enhancers is subject to controversies 
and still lacks regulatory approval (Mujica Ascencio et al., 2016). In vitro skin permeation 
studies of a gel containing coumaric, caffeic and ferulic acids were conducted by Žilius, 
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Ramanauskiene, & Briedis, (2013) using Bronaugh-type diffusion cells. The results showed 
that after 24h exposure of the gel to the skin cells, the epidermis was found to contain 5% 
coumaric and ferulic acids and 4% coumaric and 6% ferulic acid in the dermis, while no traces 
of caffeic acid were found. The authors report that the differences in penetration might be 
associated with the variation in the lipophilicity of the tested compounds, as well as the 
composition of the cosmetic vehicle used. After 8 h of in vitro skin permeation experiments, 
over 90% phenolic compounds were released from hydrophilic gel and only up to 5% and 22% 
of phenolic compounds were released from ointment and w/o cream respectively. Another 
author prepared an aqueous vehicle with ferulic acid (FA) and its skin permeation potential 
was evaluated using porcine skin because of its physiological similarity to human skin (L. W. 
Zhang, Al-Suwayeh, Hsieh, & Fang, 2010). Ferulic acid was found to permeate the skin with 
the flux; a term used to denote the amount of compound that traverses across a unit area of the 
skin per unit time reported to be between 0.48 ± 0.10 and 1.16 ± 0.30 nmol/cm2/h at pH 6 and 
pH 9, respectively. The result suggests that this compound exhibits penetration ability across 
the skin, and the pH of the vehicle does not significantly affect the penetration profile of this 
compound. The release of phenolic compounds from semisolid vehicles is influenced not only 
by the physiochemical properties of the bioactive ingredient but also by the properties of the 
vehicle and concentration of the bioactive in the formulation. L. W. Zhang et al. (2010) reported 
the potential of FA and its derivative ferulic acid ethyl ether (FAEE) to be utilised as an 
antioxidant to prevent damage from ultraviolet (UV) radiation and skin carcinogenesis. The 
above authors conducted a skin permeation analysis to determine transdermal bioavailability 
of the studied compounds using porcine skin. The results showed that FA and FAEE were able 
to permeate the skin and there was no significant difference in skin deposition between pH 6 
and 9.9 buffers. Further studies on the compounds were evaluated by transepidermal water loss 
(TEWL), erythema and pH value. The result showed that topical application of FA and related 
compounds for up to 24 h did not cause skin irritation. Cutaneous permeation of FA into the 
skin layers, from different cosmetic vehicles, an O/W emulsion (pH 6.0) and two gel-type 
formulations (A and B at pH 6.0 and 7.4, containing FA alone and with α-cyclodextrin 
respectively) were conducted by Monti et al. (2011). In vitro permeation studies were 
conducted using hairless rat excised skin. The results showed that FA fluxes were 8.48±2.31, 
8.38±0.89 and 5.72±0.50 µg/cm2 h, for O/W emulsion, gels A and B, respectively, suggesting 
that the pH significantly influenced FA permeation. Overall, ferulic acid seem to be one of the 
phenolic acids with the most in vitro permeation studies reported (Bai et al., 2014; Harwansh, 
Mukherjee, Bahadur, & Biswas, 2015; Monti et al., 2011; Nazaré et al., 2014; L. W. Zhang et 
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al., 2010). Hence, more studies need to be conducted on more mushroom extract and their 
individual metabolites. 
 
1.7. Objectives and Working Plan 
 
The cosmetic industry is constantly in search of ingredients from natural sources because of 
their competitive effectiveness and lower toxicity effects. Mushrooms, for years, have been an 
important part of our diet because of the essential biomolecules they contain. Nowadays it is 
perceived that they can be interesting sources of cosmeceutical or nutricosmetic ingredients. In 
the present thesis, five mushroom species Agaricus bisporus, Agaricus blazei, Ganoderma 
lucidum, Lentinula edodes, and Pleurotus ostreatus were selected to evaluate their potential to 
be used as ingredients in cosmeceutical and nutricosmetic formulations. The specific objectives 
of this work were: 
1. Extraction optimization to maximize the recovery of phenolic compounds and triterpenic 
acids from Ganoderma lucidum as well as ergosterol from A. blazei, using response surface 
methodology. Conventional techniques (Soxhlet and maceration) were compared with more 
sustainable methods (microwave and ultrasound assisted extraction). 
2. Chemical and nutritional characterization of the previously mentioned species, including 
macronutrients, energetic contribution, hydrophilic (sugars and organic acids) and lipophilic 
(tocopherols and fatty acids) components. Preliminary safety tests for nutraceutical 
applications were conducted. 
3. Preparation of ethanolic extracts from the previously mentioned species, but also from A. 
bisporus, Lentinula edodes and Pleurotus ostreatus using the Soxhlet extraction system, 
followed by chemical characterization in terms of phenolic acids and related compounds and 
ergosterol. Screening of the bioactivity of the extracts considering antioxidant, anti-tyrosinase, 
anti-inflammatory, antimicrobial and cytotoxic properties, and further incorporation into base 
cosmetic cream to provide cosmeceutical properties.  
4. Evaluation of the contribution of individual phenolic acids and their related compounds (p-
hydroxybenzoic, p-coumaric, protocatechuic and cinnamic acids), and ergosterol as 
cosmeceutical ingredients (anti-inflammatory, anti-tyrosinase and antimicrobial activity), 
followed by incorporation into base cosmetic creams to provide cosmeceutical properties. 
Background 
 
 
 
72 
5. Encapsulation of the bioactive ingredients (extracts and individual compounds) using the 
atomization/coagulation technique, to avoid loss of potency over time due to degradation or 
oxidation (confer protection). Characterization of the microparticles (morphology evaluation, 
particle size distribution and encapsulation efficiency), and incorporation into base cosmetic 
creams. Comparison of their performance in relation to free forms and physico-chemical 
evaluation (colour and pH) of the final formulations until 6 months of storage.  
6. In vitro safety evaluation of the most promising extracts and their corresponding 
formulations, using MTT and LDH assays in keratinocyte (HaCaT) and fibroblast (HFF-1) cell 
lines.  
7. Ex vivo skin permeation studies with the most promising extracts and their corresponding 
formulations, using a Franz diffusion apparatus with pig ear skin as permeation membrane.  
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CHAPTER 2: Material and Methods 
 
2.1. Standards and reagents 
 
For chemical analysis: Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of 
HPLC grade from Fisher Scientific (Lisbon, Portugal). Formic acid was purchased from 
Prolabo (VWR International, Fontenay-sous-Bois, France). Fatty acids methyl ester (FAME) 
reference standard mixture 37 (standard 47885-U), ergosterol (98%), ganoderic acid A, α and 
δ-tocopherols and sugar standards as well as phenolic standards (p-hydroxybenzoic, p-
coumaric, syringic acid, protocatechuic and cinnamic acids) were all purchased from Sigma 
(St. Louis, MO, USA). Tocol, β- and γ-tocopherols were purchased from Matreya (Pleasant 
Gap, PA, USA). Perchloric acid 70%, glacial acetic acid, and sulphuric acid were purchased 
from Fischer chemicals (Loughborough, UK). Vanillin from Labkem (Barcelona, Spain) and 
ursolic acid from Acros Organics (New Jersey, USA). Water was treated in a Milli-Q water 
purification system (TGI Pure Water Systems, Greenville, SC, USA).  
For antioxidant activity evaluation: 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained 
from Alfa Aesar (Ward Hill, MA, USA). Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid) was from Sigma (St. Louis, MO, USA). 
For cytotoxicity in human tumor and non-tumor cells: Ellipticine, phosphate buffered saline 
(PBS), acetic acid, sulforhodamine B (SRB), trichloroacetic acid (TCA) and Tris were 
purchased from Sigma (St. Louis, MO, USA). Foetal bovine serum (FBS), L-glutamine, 
Hank’s balanced salt solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic acid), 
nonessential amino acids solution (2 mM), penicillin/streptomycin solution (100 U/mL and 100 
mg/mL, respectively) and DMEM (Dulbecco's Modified Eagle Medium) were from Hyclone 
(Logan, Utah, USA).  
For anti-inflammatory activity: Griess reagent system (Promega), Dimethyl sulfoxide 
(DMSO) and lipopolysaccharide (LPS) were obtained from Sigma-Aldrich Co. (Saint Louis, 
MO, USA). 
For anti-tyrosinase activity: 3,4-dihydroxy-L-phenylalanine (L-DOPA) and tyrosinase 
enzyme were obtained from Sigma-Aldrich Co. (Saint Louis, MO, USA). 
For antimicrobial activity evaluation: The culture media Mueller Hinton broth (MHB) and 
tryptic soy broth (TSB) were from Biomerieux (Marcy l’Etoile, France). The dye p-
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iodonitrotetrazolium chloride (INT) was purchased from Sigma-Aldrich (St Louis, MO, USA) 
to be used as a microbial growth indicator. 
For MTT and LDH assays: Deionized water was obtained using the Mili-Q water purification 
system (TGI Pure Water Systems, Carrollton, TX). Dulbecco’s modified Eagle’s medium 
(DMEM) with GlutaMAX-I, fetal bovine serum (FBS), streptomycin, penicillin, and 
amphotericin B were from Invitrogen (Carlsbad, CA). 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT) assay kit (CellTiter 96 Aqueous One Solution Cell Proliferation 
Assay) was purchased from Promega (Madison, WI). Lactate dehydrogenase (LDH) 
colorimetric cytotoxicity assay kit (LDH Cytotoxicity Detection Kit) was purchased from 
Takara Bio Inc. (Shiga, Japan). Human immortalized non-tumorigenic keratinocyte cell line 
HaCaT (Ethnicity, Caucasian; age, 62 years; gender, male and tissue, skin) was supplied by 
CLS cell lines service, Germany. Human foreskin fibroblasts (HFF-1) were purchased from 
ATCC (ATCC Number: SCRC-1041; ATCC, Manassas, VA). Caco-2 cells were obtained from 
American Type Culture Collection (ATCC, USA) and HT29-MTX cell line was kindly 
provided by Dr. T. Lesuffleur (INSERMU178, Villejuif, France). Culture flasks were from 
OrangeScientific, (Belgium) and Triton X-100 was purchased from Boehringer, Mannheim. 
For Microencapsulation: Sodium alginate was provided by Fluka Chemie (USA), calcium 
chloride and Tween 80 by Panreac (Spain).  
For skin permeation assays: Franz cells assembly, 9 mm with 5 mL receptor volume 
(PermeGear, Inc. Pennsylvania USA) and pig ear skin obtained from a slaughterhouse (Porto). 
 
2.2. Mushroom Samples 
 
The fruiting bodies (basidiocarps) of A. blazei used in the present work were donated by a local 
producer in Maringá, Paraná, Brazil. They were dried in a circulation oven at 40 °C and milled 
to a fine powder (40 mesh). Finally, the samples were vacuum packed and stored at room 
temperature until analysis. Fresh samples of Pleurotus ostreatus, Agaricus bisporus and 
Lentinula edodes were purchased from a local supermarket in the Northeast of Portugal. The 
fruiting bodies were dried at 30 °C in an oven, reduced to a fine powder (20 mesh) and were 
stored at room temperature until analysis. The fruiting bodies of Ganoderma lucidum were 
provided by Bioreishi - Agricultura Biologica, Lda, Portugal (Reishi producers; Batalha, 
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Portugal) as dry material. The specimens were reduced to powder (20 mesh) and mixed to 
obtain homogeneous samples. 
 
2.3. Extraction methodologies  
 
2.3.1. Heat-assisted extraction (HAE) 
 
The samples of dry powdered mushroom (600 mg) were placed in a vial with 20 mL of solvent 
maintaining the solid/liquid ratio (S/L) at 30 g/L. The beaker was then placed in a thermostatic 
water bath under continuous electromagnetic stirring for the required time. The variables tested 
were: time (t, min), temperature (T, ºC) and solvent content (S, %). The powdered samples 
were extracted using different t, T, and S as defined by the RSM design. After extraction, 
samples are filtered, supernatant is carefully collected, and the dry weight obtained to deduce 
the extraction yield. 
2.3.2. Soxhlet extraction (SE) 
 
Soxhlet extraction is also an HAE. The powdered samples (3.0 g) were extracted with 100 mL 
of ethanol by refluxing in a Soxhlet apparatus. Finally, the solvent was evaporated under 
reduced pressure (rotary evaporator Büchi R-210, Flawil, Switzerland) to obtain the dried 
ethanolic extracts. To compare the efficiency of the extraction system, the number of cycles in 
the Soxhlet system was taken into consideration and up to seven cycles were analysed.  
2.3.3. Microwave-assisted extraction (MAE) 
 
The MAE process was performed with a Biotage Initiator Microwave (Biotage® Initiator+, 
Uppsala, Sweden) using closed vessels. The samples mushroom powder (300 mg) were 
extracted with 10 mL of solvent maintaining the solid/liquid ratio (S/L) at 30 g/L. The variables 
and ranges tested were: time (t, min) and temperature (T, ºC). During processing, the fixed 
hold-time and cooling options were “off”, samples were stirred at 600 rpm using a magnetic 
stirring bar, power variable was set to 400W as previous studies have shown that microwave 
power has nearly no influence on the extraction process (Pinela, Prieto, Carvalho, et al., 2016). 
After extraction, samples are filtered, supernatant is carefully collected, and the dry weight 
obtained to deduce the extraction yield. 
Material and Methods 
 
 
 
77 
2.3.4. Ultrasound-assisted extraction (UAE) 
 
The UAE was carried out using an ultrasonic probe device (QSonica sonicators, model CL-
334, Newtown, CT, USA). The dried mushroom powder (3 g) were extracted with 100 mL 
(solvent at different %) maintaining the solid/liquid ratio (S/L) at 30 g/L using different times 
(t, min) and ultrasound power ranges (P, W), while the temperature was constantly maintained 
at 30-35 ºC using an ice bath (Heleno, Diz, et al., 2016). The obtained extraction solutions were 
filtered through a Whatman paper nº 4 and then evaporated under reduced pressure to remove 
the solvent, and the dry weight obtained to deduce the extraction yield. 
 
2.4. Analysis of the chemical composition 
 
2.4.1. Total phenolics 
 
Total phenolics (Ph) in the mushroom extract was estimated based on the procedure reported 
previously (Heleno et al., 2012). In brief, the extract solution (0.5 mL, 1 mg/mL) was mixed 
with the Folin–Ciocalteu reagent (2.5 mL, previously diluted in water 1:10, v/v) and sodium 
carbonate (Na2CO3; 2 mL, 75 g/L). The tubes containing the solutions were then vortexed for 
15 s and allowed to stand for 30 min at 40 °C for colour development. The absorbance was 
then measured at 765 nm against a blank (methanol). Gallic acid (chosen as the standard) was 
used to obtain the calibration curve (0.0094–0.15 mg/mL), and the results were expressed as 
mg of gallic acid equivalents (mg equiv. GA). 
 
2.4.2. Total terpenoids 
 
Mushroom material (800 mg) was extracted with methanol (10 mL) for 1 h and subsequently 
filtered. Shortly, 1 mL of the supernatant was mixed with chloroform (0.4 mL) and sulphuric 
acid (0.6 mL). The sample solution absorbance was measured at 538 nm against a blank 
containing methanol, using a UV-visible-light spectrophotometer (UV-160A; Shimadzu 
Corporation, Kyoto, Japan). Linalool (0.1875–6 mg/mL in methanol) was used as a standard 
and results were expressed in mg of linalool per g of dw.  
 
 
Material and Methods 
 
 
 
78 
2.4.3. Total triterpenes 
The triterpene content was evaluated according to the protocol described by  Chang, Lin, & 
Lai, (2012). Shortly, 10 mg of the previously obtained mushroom extract was dissolved in 1 
mL methanol, 100 µL of this solution was mixed with a vanillin-glacial acetic acid solution 
(150 µL, 5% w/v) and perchloric acid solution (500 µL, 70%) in triplicate. Sample solutions 
are further heated for 45 min at 60 °C   and then cooled in an ice-water bath followed by 
addition of glacial acetic acid (2.25 mL). The absorbance of the sample solution was measured 
at 548 nm against a blank containing methanol, using a UV-visible-light spectrophotometer 
(UV-160A; Shimadzu Corporation, Kyoto, Japan). Ursolic acid (0.0078–0.5 mg/mL in 
methanol) was used as a standard. Results were expressed as milligram ursolic acid equivalent 
(mg ursolic acid equivalent/g extract).  
 
2.4.4. Individual phenolic acids  
 
Dried extracts were re-dissolved in a water/ethanol mixture (80:20, v/v) and filtered through a 
0.22 µm nylon disposable filter. The Shimadzu 20A series ultra-fast liquid chromatograph 
(UFLC, Shimadzu Corporation, Kyoto, Japan), operating at 0.5 mL/min and equipped with a 
Waters Spherisorb S3 ODS2 C18 column (3 µm, 150 × 4.6 mm) thermostatted at 35 °C, was 
used for phenolic acids identification and quantification. A binary solvent mixture consisting 
of 0.1 % formic acid in water (A) and acetonitrile (B) was used. The detection was performed 
using a photodiode array detector (PDA) at 280 nm as the preferred wavelength. The phenolic 
acids were quantified using calibration curves obtained from commercial standards, namely: 
protocatechuic acid (y = 164741x; R2 = 0.999), p-hydroxybenzoic acid (y = 113523x; R2 = 
0.999), p-coumaric acid (y = 433521x; R2 = 0.998), syringic acid (y = 376056x; R2 = 0.998) 
and cinnamic acid (y = 583527x; R2 = 0.998). The results were expressed as µg per g of extract. 
 
2.4.5. Individual triterpenes  
 
For the individual triterpenoid compounds characterization, the obtained extracts were 
dissolved in ethanol (5.5 mg/mL), filtered through a 0.22 mm nylon syringe filter and analysed 
by HPLC-DAD-ESI/MSn in a Dionex Ultimate 3000 UPLC system (ThermoScientific, San 
Jose, CA, USA). The equipment consisted of a diode array detector coupled to an electrospray 
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ionization mass detector, a quaternary pump, an auto-sampler (kept at 5˚C), a degasser and an 
automated thermostated column section (kept at 35 ˚C). Waters Spherisorb S3 ODS-2 C18 (3 
mm, 4.6 × 150 mm, Waters, Milford, MA, USA) column was used. The solvents used were 
(A) 0.1% formic acid in water and (B) acetonitrile. The gradient elution applied was: 15% B 
(0-5 min), 15% B to 20% B (5-10 min), 20-25% B (10-20 min), 25-35% B (20-30 min), 35-
50% B (30-40 min), the column was then re-equilibrated, using a flow rate of 0.5 mL/min. Data 
were collected simultaneously with DAD (280 nm) and in negative mode detection on a Linear 
Ion Trap LTQ XL mass spectrometer (ThermoScientific, San Jose, CA, USA), following a 
procedure previously described by Bessada, Barreira, Barros, Ferreira, & Oliveira, (2016). 
Xcalibur® data system (ThermoScientific, San Jose, CA, USA) was used in data acquisition. 
To perform quantitative analysis, the calibration curves of the available triterpenoid standards 
were constructed based on the UV signal (ganoderic acid A: y = 2539.7x, R2 = 0.999). 
Compounds with unavailable commercial standards were quantified using the calibration curve 
of the most similar available standard. The results were expressed as mg/g of extract. 
2.4.6. Ergosterol  
 
Each dried mushroom extract was re-dissolved in ethanol and filtered through a 0.22 µm nylon 
disposable filter. The ergosterol identification and quantification was performed in HPLC-UV 
equipment, an integrated system composed by a pump (Knauer, Smartline system 1000, Berlin, 
Germany), a degasser system (Smartline manager 5000), an auto-sampler (AS-2057 Jasco, 
Easton, MD, USA), and a UV detector (Knauer Smartline 2500) according to a procedure 
previously described by Barreira, Oliveira, & Ferreira, (2014). Chromatographic separation 
was achieved with an Inertsil 100A ODS-3 reversed-phase column (5 µm, 4.6 × 150 mm, BGB 
Analytik AG, Boeckten, Switzerland) operating at 35 °C (7971R Grace oven). The mobile 
phase was acetonitrile/methanol (70:30, v/v) and detection was performed at 280 nm. The 
results were expressed as mg per g of extract. 
 
2.5. Analysis of the nutritional composition  
 
2.5.1. Crude composition 
 
The samples were analysed for its crude composition (proteins, fat, carbohydrates and ash) 
using the standard AOAC procedures (Latimer 2016). The sample crude protein content (N 
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4.38) was estimated by the Kjeldahl method; the crude fat was determined using a Soxhlet 
apparatus by extracting a known weight of sample with petroleum ether; the ash content was 
determined by incineration at 600 ± 15 °C. The amount of available carbohydrate present in 
the given sample was determined by using Anthrone method. The total carbohydrates were 
calculated by difference and the energy content estimated using the following equation:  
 Energy (kcal) = 4 (g protein) + 4 (g carbohydrate) + 9 (g fat).  
 
2.5.2. Sugars 
 
Free sugars were identified and quantified using the high-performance liquid chromatography 
coupled to a refraction index detector (HPLC-RI) after an extraction procedure previously 
described by  Fernandes et al. (2016). The equipment consists of an integrated system with a 
pump (Knauer, Smartline system 1000, Berlin, Germany), a degasser system (Smartline 
manager 5000), an autosampler (AS-2057 Jasco) and an RI detector (Knauer Smartline 2300), 
operating at 30 °C (7971 R Grace oven). The chromatographic separation was achieved with a 
Eurospher 100-5 NH2 column (5 µm, 4.6 mm x 250 mm, Knauer). Quantification was achieved  
based on refraction signal response of each standard, using the internal standard (IS, raffinose) 
method and by using calibration curves obtained from commercial standards of each 
compound: fructose (y=0.864x; R2=0.999); glucose (y=0.909x; R2=0.999); mannitol 
(y=0.892x; R2=0.999) and trehalose (y=0.953x; R2=0.999). The results were recorded and 
processed using Clarity 2.4 software (DataApex, Prague, Czech Republic), Sugar contents of 
the samples were further expressed in g per 100 g of dw. 
 
2.5.3. Fatty acids 
 
Samples (1.5 g) were extracted using the Soxhlet apparatus with petroleum ether as recycling 
solvent. The samples undergo transesterification using a derivatization reagent in the presence 
of anhydrous sodium sulfate as a catalyst (Fernandes et al., 2016). The analysis was carried out 
using a gas chromatography equipment (DANI 1000, Contone, Switzerland), with a 
split/splitless injector and a flame ionization detector (FID at 260 °C). Separation was achieved 
with a Macherey-Nagel (Duren, Germany) column (50% cyanopropyl-methyl- 50% 
phenylmethyl polysiloxane, 30 m×0.32 mm ID×0.25 µm df). The oven temperature program 
was as follows: the initial temperature of the column was 50 ºC, held for 2 min, then a 30 
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ºC/min ramp to 125 ºC, 5 ºC/min ramp to 160 ºC, 20 ºC/ min ramp to 180 ºC, 3 ºC/min ramp 
to 200 ºC, 20 ºC/min ramp to 220 ºC and held for 15 min. The carrier gas (hydrogen) flow-rate 
was 4.0 mL/min (0.61 bar), measured at 50 ºC. Split injection (1:40) was carried out at 250 ºC. 
Fatty acids identification was made by comparing the relative retention times of FAME peaks 
from samples with standards. The results were recorded and processed using CSW 1.7 software 
(DataApex 1.7, Prague, Czech Republic), and expressed in relative percentage (%) of each 
fatty acid. 
 
2.5.4. Tocopherols 
 
Tocopherols were determined similarly to a procedure previously described by  Fernandes et 
al. (2016). Samples (500 mg) were extracted in the presence of BHT (butylhydroxytoluene) 
solution in hexane (10 mg/mL; 100 ml) and internal standard (IS) solution in hexane (tocol; 
2.0 mg/mL; 250 mL). The samples were homogenized with methanol (4 mL) by vortex mixing 
(1 min), followed by addition of hexane (4 mL), NaCl aqueous solution (2 mL) and 
homogenizing the mixture (1 min). The samples were centrifuged (Centurion K24OR-2003 
refrigerated centrifuge) 5 min and the clear upper layer were carefully transferred to a vial. The 
sample was re-extracted twice with hexane. The combined extracts were taken to dryness under 
a nitrogen stream, re-dissolved in 1 mL of hexane, dehydrated with anhydrous sodium sulfate, 
filtered through a 0.22 µm nylon disposable filter, transferred into a dark injection vial and 
analysed by HPLC coupled to a fluorescence detector (FP-2020; Jasco, Easton, MD, USA) 
programmed for excitation at 290 nm and emission at 330 nm. The chromatographic separation 
was achieved with a Polyamide II (5 µm, 250 mm x 4.6 mm) normal-phase column from YMC 
Waters (Dinslaken, Germany) operating at 30 °C. Quantification was based on calibration 
curves obtained from commercial standards of each compound: α-tocopherol (y=1.295x; 
R2=0.991); β-tocopherol (y=0.396x; R2=0.992); γ-tocopherol (y=0.567x; R2=0.991); δ-
tocopherol (y=0.678x; R2=0.992). The results were expressed in µg per 100 g of dw. 
 
2.5.5. Organic acids 
 
Organic acids were determined following a procedure previously optimized and described by 
the authors Barros, Pereira, & Ferreira, (2013). Samples (1.5 g) were extracted by stirring with 
25 mL of meta-phosphoric acid (25 °C at 150 rpm) for 45 min and subsequently filtered through 
Whatman no. 4 paper. The resulting solution was filtered through 0.2 µm nylon filters and 
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analysis was performed by ultra-fast liquid chromatograph (UFLC) coupled to photodiode 
array detector (PDA), using a Shimadzu 20A series UFLC (Shimadzu Cooperation). Detection 
was carried out in a PDA, using 215 and 245 nm as preferred wavelengths. The organic acids 
were quantified by comparison of the area of their peaks recorded at 215 nm with calibration 
curves obtained from commercial standards of each compound: oxalic acid, (y=9×106x; 
R2=0.99); malic acid (y=912441x; R2=0.99) and citric acid (y=1×106x; R2=0.99). The results 
were expressed in mg per 100 g of dry weight.  
 
2.6. Bioactive properties evaluation 
 
2.6.1. Antioxidant activity 
 
2.6.1.1. Reducing Power 
The extracts were dissolved in ethanol at 10 mg/mL and further diluted to achieve several 
concentration ranges (25 mg/mL to 0.078 mg/mL). The extract solutions (0.5 mL) were mixed 
with sodium phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% 
w/v, 0.5 mL). The mixture was incubated at 50 ˚C for 20 min and trichloroacetic acid (10% 
w/v, 0.5 mL) was added. Then, 0.8 mL of the mixture was transferred to a 48-well plate, 
followed by addition of deionized water (0.8 mL), ferric chloride (0.1% w/v, 0.16 mL) and the 
absorbance measured at 690 nm in the Microplate Reader (ELX800 Bio-Tek Instruments, Inc.). 
Trolox was used as a positive control. 
 
 2.6.1.2. DPPH scavenging activity 
The reaction mixture in each 96-wells consist of 30 µL of each different concentration of 
ethanolic extract solution and 270 µL of methanol containing DPPH radicals (6 × 10−5 mol/L). 
The mixture was allowed to stand in the dark for 1 h. The absorbance was measured at 515 nm 
in the Microplate Reader mentioned above. The radical scavenging activity (RSA) was 
calculated using the equation: %RSA = [(ADPPH − AS)/ADPPH] × 100, where AS is the 
absorbance of the sample solution with the sample and ADPPH is the absorbance of the DPPH 
solution. The concentrations responsible for 50% of RSA (EC50 values) were calculated from 
the graphs of RSA percentages versus extract concentrations.  
 
 
Material and Methods 
 
 
 
83 
2.6.2. Anti-tyrosinase activity 
 
Tyrosinase inhibition assay was performed using L-DOPA as substrate according to the 
procedure described by Yoon et al. (2011). The ethanolic extract was dissolved in 50% DMSO 
at 10 mg/mL and submitted to successive dilutions (10 to 0.10 mg/mL). The assays were carried 
out in a 96-well microplate with each well containing 40 µL of the sample, 80 µL of phosphate 
buffer (0.1 M, pH 6.8), 40 µL of tyrosinase enzyme (60 units/mL) and 40 µL of L-DOPA (3.5 
mM). The mixture was incubated for 10 min at 37 °C and the absorbance measured at 475 nm 
using a microplate reader (ELX800 Bio-Tek Instruments, Inc.). L-ascorbic acid was used as 
the positive control and the results were compared with a control comprising 50% DMSO 
instead of the sample. The percentage of tyrosinase inhibition was calculated as follows: 
[(Acontrol − Asample)/Acontrol] × 100. EC50 values were calculated from the calibration curve of 
tyrosinase inhibition percentage versus extract concentration. 
 
2.6.3. Anti-inflammatory activity 
 
The anti-inflammatory activity was carried out according to the procedure reported by Moro et 
al. (2012). The mouse macrophage-like cell line RAW 264.7 cultured in DMEM medium was 
supplemented with 10% heat-inactivated fetal bovine serum, glutamine and antibiotics at 37 
°C under 5% CO2, in humidified air. A cell density of 5 × 105 cells/mL was used followed by 
seeding cells in a 96-well plate at 150,000 cells/well and allowed to stand for attachment 
overnight. The cells were treated with different concentration of extract (400 to 50 µg/mL) in 
order to determine effective concentration necessary to evaluate the anti-inflammatory activity, 
followed by stimulation with LPS (1 µg/mL) for 18 h. The effect of all the tested samples in 
the absence of LPS was also evaluated, in order to observe if they induced changes in nitric 
oxide (NO) basal levels. In negative controls, no LPS was added. Both extracts and LPS were 
dissolved in supplemented DMEM.  Nitric oxide was evaluated using Griess Reagent System 
kit which contains sulphanilamide, N-(1-napthyl) ethylenediamine hydrochloride (NED) and 
nitrite solutions. A reference curve of the nitrite (sodium nitrite 100 µM to 1.6 µM; y = 0.0066x 
+ 0.1349; R2 = 0.9986) was prepared in a 96-well plate. The cell culture supernatant (100 µL) 
was transferred to the plate and mixed with sulphanilamide and NED solutions, 5–10 min each, 
at room temperature. The nitric oxide produced was determined by measuring the absorbance 
at 540 nm (microplate reader ELX800 Biotek), and by comparison with the standard calibration 
curve. 
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2.6.4. Antimicrobial activity 
 
The microbial strains used in the present work are clinical isolates obtained from patients 
hospitalized in various departments at the Hospital Centre of Trás-os-Montes and Alto Douro 
(Vila Real, Portugal). Six Gram-negative bacteria (Escherichia coli, E. coli ESBL, Klebsiella 
pneumoniae, K. Pneumoniae ESBL, Proteus mirabilis and Morganella morgani (all isolated 
from urine), Pseudomonas aeruginosa (isolated from expectoration)) as well as four Gram-
positive bacteria (Enterococcus faecalis (isolated from urine), methicillin-sensitive 
Staphylococcus aureus (MSSA) (isolated from wound exudate), Listeria  monocytogenes and 
methicillin-resistant Staphylococcus aureus (MRSA) (isolated from expectoration)), and  
Candida albicans (isolated from urine ) were tested . All microbial strains were cultured in the 
appropriate fresh medium for 24 h and kept in the oven at 37 ˚C before analysis in order to 
maintain the exponential growth phase. 
The minimal inhibitory concentration (MIC) was determined by the microdilution method 
using p-iodonitrotetrazolium chloride (INT) dye as a microbial growth indicator. Initially, 50 
µL of the extract solution at different concentrations were added to 450 µL of medium TSB or 
MHB, according to the bacteria requirements. Then, 190 µL of this extract solution was added 
to each well of the 96-well microplate and therefore submitted to successive dilutions over the 
wells containing 90 µL of MHB or TSB media, starting by taking 100 µL of the higher 
concentration to the right below one and thus repeating this procedure sequentially. Afterward, 
10 µL of inoculum (1.5 × 108 CFU/mL) was added to all the microplate wells. Three negative 
controls were prepared (one with MHB/TSB 5% DMSO, another one with the extract, and the 
third one with medium and antibiotic).  Colistin and vancomycin were used for Gram-negative 
and Gram-positive bacteria’s respectively. Positive control was also performed with 
MHB/TSB medium at 5% DMSO and the inoculum. The plates were then incubated at 37 ˚C, 
for 24 h, in an oven (Jouan, Berlin, Germany) and the MIC determined after adding INT (0.2 
mg/mL, 40 µL) and incubating at 37 ˚C for 30 min. Viable microorganisms reduced the yellow 
dye to a pink colour. MIC was defined as the extract concentration that prevented colour change 
thus showing complete inhibition of microbial growth (Kuete et al., 2011). 
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2.6.5. Cytotoxic activity 
 
2.6.5.1. Cytotoxicity in human tumor cell lines 
The antitumor potential of the extract was evaluated in four human tumor cell lines MCF-7 
(breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma) 
and HepG2 (hepatocellular carcinoma) according to the procedure previously reported by 
Abreu et al. (2011). Cells were routinely maintained as adherent cell cultures in RPMI-1640 
medium supplemented with 10% heat-inactivated FBS and 2 mM glutamine, at 37 °C, under 
5% CO2, in humidified air. Each cell line was plated at an appropriate density (7.5 × 103 
cells/well for MCF-7 and NCI-H460 or 1.0 × 104 cells/well for HeLa and HepG2) in 96-well 
plates. The sulforhodamine B assay was performed and ellipticine an antitumor agent was used 
as positive control. Extract concentrations (1.56–400 µg/mL) were added to the cells and 
incubated for 48 h. After that, prechilled trichloroacetic acid (TCA 10%, 100 µL) was added 
and incubated for 60 min at 4 °C to improve the adherence of the cells. The plates were washed 
with deionized water, dried and after the addition of a sulforhodamine B solution (SRB 0.1% 
in 1% acetic acid, 100 µL), the mixture was incubated for 30 min at room temperature. 
Subsequently, the plates were washed with acetic acid (1%) to remove the unbound SRB and 
dried. The bounded SRB was solubilized with Tris (10 mM, 200 µL) and the absorbance 
measured at 540 nm using an ELX800 microplate reader (Bio-Tek Instruments, Inc.; Winooski, 
VT, USA). The results were expressed as GI50 values in µg/mL which correspond to sample 
concentration that inhibited 50% of the net cell growth. 
 
2.6.5.2. Cytotoxicity in non-tumor liver cells primary culture 
Cell culture from a freshly harvested porcine liver obtained from a local slaughterhouse was 
prepared and designated as PLP2. The cell culture was constantly monitored every two to three 
days using a phase contrast microscope. Before confluence was reached, cells were sub-
cultured and plated in 96-well plates at a density of 1.0 × 104 cells/well in DMEM medium 
supplemented with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin. The results 
were expressed as GI50 values in µg/mL as described above. 
 
2.6.6. MTT assay 
 
MTT assay was used to assess cell integrity of the extract and the final cosmetic formulation 
by monitoring the uptake of the vital mitochondrial dye, 3–(4,5-dimethylthiazol-2-yl)-5-(3-
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carboxymethoxyphenyl)-2–(4-sulfophenyl)-2H-tetrazolium (MTT) by cell mitochondria. For 
the cell treatment, samples were dissolved in DMEM and subsequent dilutions were prepared 
from 1µg/mL to 10 mg/mL. HaCaT, HFF-1, Caco-2, and HT29-MTX cell lines were grown 
separately in tissue culture flasks (Orange Scientific, Belgium). Cell lines were grown in 
DMEM medium fortified with L-glutamine, 10% inactivated fetal calf serum (FBS), 
antibiotic–antimitotic mixture (final concentration of 100 U/mL penicillin, 100 µg/mL 
streptomycin and 0.25 µg/mL amphotericin B) maintained in 5% CO2 incubator (Cell Culture® 
CO2 Incubator, ESCO GB Ltd., UK). At 90–95% confluence, cells were trypsinized and plated 
in microtiter dishes. The viable cells were counted using trypan blue dye (Gibco) in a 
hemocytometer.  Cell viability was assessed using the (MTT) conversion assay. Cells were 
cultured in 96-well micro titter plate at a density of 25×103 cells per mL culture medium for 24 
h. Then, cells were incubated with 1 µg/mL–10 mg/mL of both extracts and its corresponding 
formulation, for 24 h at 37 ˚C. After the removal of samples from the wells, cells were washed 
in phosphate-buffered saline, followed by addition of fresh medium. The micro titer plates were 
then incubated in a humidified atmosphere of 5% CO2 at 37 ºC for 24 h. To evaluate the number 
of viable cells, 100 µL of MTT solution was added into each well and incubated for 4 h at 37 
˚C in the dark. Afterward, the medium was removed, the intracellular formazan crystals were 
solubilized and extracted with 100 µL dimethylsulfoxide (DMSO). After 15 min in continuous 
stirring at room temperature, the absorbance was measured at 490 nm with background 
subtraction at 630 nm in a Synergy HT Microplate Reader (BioTek Instruments, Inc., 
Winooski, VT) (Rodrigues et al., 2013).  
 
2.6.7. LDH assay 
 
To access cell integrity and cytotoxicity of the extracts and final cosmetic formulations leakage 
of the cytosolic enzyme, lactate dehydrogenase (LDH) into the cell medium (LDH assay) was 
measured. For the cell treatment, samples were dissolved in DMEM and subsequent dilutions 
were prepared from 1 µg/mL to 10 mg/mL. In both tests, triplicate wells were incubated with 
fresh medium in the absence or presence of samples. Briefly, cell lines were seeded in 96-well 
plates and cultured for 48 h. Ethanolic extract at different concentrations was prepared in the 
appropriate medium and added to the cells. After incubation (37 C/5% CO2), cells were washed 
twice with PBS (pH 7.4) and the kits were used according to the instructions of the 
manufacturers (Rodrigues et al., 2013). To determine maximum LDH release (high control), 
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some cells were solubilized with a final concentration of 1% (w/v) Triton X-100. Absorbance 
was measured at 490 nm with background subtraction at 690 nm in a Synergy HT Microplate 
Reader (BioTek Instruments, Inc., Winooski, VT). Each concentration was tested in triplicate 
in three independent experiments. 
 
2.7. Ex vivo skin permeation studies 
 
Skin model. Porcine ear skin was freshly obtained from a slaughterhouse in Porto, Portugal. 
Preparation of the porcine skin samples consisted of cleaning with water to remove debris and 
drying them with paper towels. The prepared skin was protected with aluminum foil and frozen 
at −20 ◦C until required. Before each test, the skin was placed in a 0.9 % NaCl solution at room 
temperature for rehydration. 
Franz diffusion cells. The Franz diffusion cell system was used to test the penetration of 
compounds present in the ethanolic extract of P. ostreatus and G. lucidum and their 
corresponding formulations. A Franz cell assembly (9 mm unjacketed Franz Diffusion Cell) 
comprising a 5-mL receptor volume and a diffusion area of 0.8 cm2 (PermeGear, Inc. 
Pennsylvania USA) was used. The skin cells were placed between the donor and the receptor 
phase with the stratum corneum side facing upward into the donor compartment. The donor 
medium consisted of 300 µL (500 µg/mL) in the case of ethanolic extracts and 100 mg of 
formulation accurately spread on the skin membrane with the help of a spatula. The receptor 
(5 mL) was filled with PBS buffer. The stirring rate and temperature of the receptor solution 
were, respectively, kept at 600 rpm and 37 ˚C. At appropriate intervals (15 min, 30 min, 45 
min, 1 h, 2 h, 4 h, 6 h and 8 h) 600 µL aliquots of the receptor medium were withdrawn with a 
syringe and immediately replaced with equal volumes of fresh receptor phase (Casiraghi et al., 
2017). The cumulative quantity of compounds was determined by HPLC. 
 
2.8. Microencapsulation procedure 
 
The atomization/coagulation technique was employed to microencapsulate mushroom extracts 
and individual metabolites, similarly to the protocol reported by Caleja et al. (2016) with slight 
modifications. Sodium alginate, in combination with calcium chloride (CaCl2), was used. The 
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microspheres were produced as follows: 100 mg in the case of extracts and 50 mg for individual 
compounds were suspended in 20 mL of distilled water in the presence of 100 mg of tween 80 
as a surfactant. The mixture was then homogenized for 20 min using a Unidrive X100 
homogenizer (Ingenieurbüro CAT, Germany). Afterward, 400 mg of sodium alginate was 
added to the suspension, keeping this mixture under stirring until complete dissolution of 
alginate. The produced solution was atomized in the NISCO Var J30 system (Zurich, 
Switzerland) at a flow rate of 0.3 mL/min and a nitrogen pressure of 100 mbar (Figure 14).  
 
 
Figure 14. Nisco Var J30 microencapsulation unit used for microparticles preparation. 
The atomized droplets were coagulated by contacting with the aqueous solution of CaCl2 (250 
mL, concentration of 4% (w/v)) over a time period of 4 h. The produced microspheres were 
then recovered by filtration under reduced pressure, washed twice with distilled water, and 
finally lyophilized and stored in the dark conditions at 4 °C.  
 
2.8.1. Microspheres characterization 
 
Microspheres were analysed by optical microscopy (OM) using a Nikon Eclipse 50i 
microscope (Tokyo, Japan) equipped with a Nikon Digital Sight camera and NIS Elements 
software for data acquisition. OM analysis was applied to assess the size and morphology of 
the microspheres after the atomization and coagulation stages.  
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2.8.2. Microparticle yield, loading and encapsulation efficiency 
 
Encapsulation efficiency (EE %) 
This parameter measures the ability of the encapsulating material to properly encapsulate the 
bioactive ingredient and can be achieved by analysing the amount of compounds presents in 
the coagulation solution and in the first washing solution by using the HPLC system. The 
encapsulation efficiency is calculated using the following expression:  
EE (%)= !"##	%&	'()"*#+,"-'.	/0%")-01'-%-",	!"##	%&	/0%")-01'	  × 100 
 
Encapsulation yield (EY %) 
This parameter compares the total mass of microcapsules obtained after encapsulation and the 
total mass of material before encapsulation. It is calculated using the following expression: 
EY (%)= !"##	%&	!0)2%*3'2'	*2%.+)'.!"##	%&	*%,4!'20)	!"-'20",5!"##	%&	/0%")-01'	0(62'.0'(-	 × 100 
 
Encapsulation load (EL %) 
This parameter measures the mass fraction of encapsulated bioactive ingredient per unit mass 
of the encapsulating material and is expressed using the relation:         
EL (%)= !"##	%&	'()"*#+,"-'.	/0%")-01'!"##	%&	!0)2%*3'2'	*2%.+)'.  × 100 
 
2.8.3. Particle size measurement 
 
The particle size distribution of the microspheres was analysed using a Malvern Mastersizer 
3000 laser diffraction equipment, equipped with a Hydro MV dispersion unit (Malvern, UK). 
Data were obtained and treated with Mastersizer software version 3.10. Water was used as a 
sample dispersion medium. Five measurements were made to ensure reproducibility, and the 
results were expressed in volume distributions, being the mean particle size results expressed 
as the percentiles of 10%, 50%, and 90%. All the residual values were less than 1%. The 
number distribution was calculated based on the volume distribution, and the corresponding 
Material and Methods 
 
 
 
90 
percentiles were also obtained. The span of the particle size distribution in terms of volume 
was also determined using the expression (Dv90-Dv10)/Dv50. 
 
2.9. Incorporation of the extracts in a base cosmetic cream  
 
In the present work, a base cosmetic cream Versatile™, with a light colour, free from 
fragrances, colourants, parabens, mineral oils, sodium lauryl sulfate (SLS), propylene glycol, 
and ethoxylates purchased from Fagron Iberica S.A.U. (Barcelona, Spain) was used. According 
to the supplied technical data available, this formulation has been certified to be safe by the US 
Food and Drug Administration (FDA), Regulation (EC) No 1907/2006—REACH and the 
National Health Surveillance Agency (ANVISA) of Brazil. Example of active pharmaceutical 
ingredients (APIs) and Dermaceutical ingredients (DIs) compatible with Versatile™ cream 
base is described in Table 5.  
To cover all the bioactive properties evaluated, the base cosmetic creams were incorporated 
with 2.5 times EC50 and MIC values which correspond to a scale of 25 mg of extract and 125 
mg of microspheres per gram of base cream. For the compounds, 7 mg of individual compound 
and 63 mg of microspheres were incorporated per gram of base cream. The formulations were 
continuously mixed until sample homogenization is fully achieved. The samples were stored 
at 5 °C for chemical characterization, evaluation of bioactive properties and its physico-
chemical properties.  The final cream formulations were extracted with methanol for 30 min, 
filtered, dried in a rotary evaporator, and re-dissolved in a water:methanol mixture (80:20, v/v) 
for phenolic acids analysis; in methanol for ergosterol analysis; in 50% DMSO for anti-
inflammatory activity evaluation; in 50% DMSO for anti-tyrosinase activity evaluation; in 
100% DMSO for antioxidant activity evaluation; and in 5% DMSO for antibacterial activity 
evaluation. 
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Ingredients Topical intervals Versatile™ 
Alpha-bisabolol 0.5-5 0.5-5 
Aloe vera 0.5-10 0.5-10 
Ascorbic, acid 5-15 5-15 
Azelaic, acid 10-20 10-20 
Sulfur 5-10 5-10 
Benzoyl peroxide 2.5-10 2.5-10 
Benzyl Benzoate 25 25 
Caffeine 1-2 1-2 
Ciclopirox olamine 1 1 
Clindamycin HCl 1-3 1-3 
Clotrimazole 1-2 1-2 
Coaltar saponinado 5-20 10 
Diclofenac sodium 3 3 
Glycerol 0.5-20 0.5-20 
Glycolic, acid 5-15 5-15 
Sodium hyaluronate 1 1 
Ketoconazole 2 2 
Lactic, acid 1-20 1-20 
Lidocaine HCl 0.5-10 0.5-10 
Shea butter 1-20 1-20 
Menthol 1-3 1-3 
Metronidazole 0.5-3 0.5-3 
Nicotinamide (Vit. B3) 2-5 2-5 
Salicylic, acid 0.5-20 10 
Tetracycline HCl 2-3 2-3 
Tocopherol alfa, acetate (vit. E) 0.5-20 0.5-20 
Urea 5-40 5-40 
Zinc oxide 1-40 10 
Zinc sulfate 1-10 1-10 
 
 
 
 
 
Table 5. List of active pharmaceutical ingredients (APIs) and Dermaceutical ingredients (DIs) usual intervals 
for dermatological application.  
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2.10. Physico-chemical parameters 
 
2.10.1. Colour measurement 
The colour of each cosmeceutical formulation was measured using a colourimeter (model CR-
400, Konica Minolta Sensing Inc., Tokyo, Japan) that has been calibrated against a standard 
white tile (Caleja, Barros, Antonio, Oliveira, & Ferreira, 2017). The colour was measured using 
the L*a*b* system where L* is a measure of the lightness, a* is a measure of the 
(greenness/redness) while b* is a measure of the (blueness/yellowness). The colour of each 
sample was measured in three different points, and the average considered the true colour 
value. Colour space values were registered using the data software “Spectra Magic Nx” 
(version CM-S100W 2.03.0006). 
 
2.10.2. pH measurement  
 
The pH of each cosmeceutical formulation was measured directly in triplicate with an HI 99161 
pH-meter (Hanna Instruments, Woonsocket, Rhode Island, USA).  
 
2.11. Statistical analysis 
 
For all the experiments three samples were analysed and all the assays were carried out in 
triplicate. The results are expressed as mean values ± standard deviation (SD). The differences 
between the different samples were analysed using one-way analysis of variance (ANOVA) 
followed by Tukey's honestly significant difference post hoc test with α = 0.05, coupled with 
Welch's statistic. This treatment was carried out using SPSS v. 23.0 program (IBM Corp., 
Armonk, New York, USA). 
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CHAPTER 3: Results and Discussion  
 
3.1. Optimization of bioactive compounds extraction  
 
Generally, solid-liquid extraction by conventional techniques such as Soxhlet extraction (SE) 
and heat-assisted extraction (HAE) require the consumption of large solvent amounts and are 
time-consuming processes. In this context, several non-conventional extraction techniques are 
being successively proposed and applied to maximally extract valuable compounds from 
natural matrices using much more amiable conditions. Among them, ultrasound-assisted 
extraction (UAE) and microwave-assisted extraction (MAE) are among the most widely used 
alternative extraction methods, offering the advantage of reaching interesting results using, for 
example, hydroalcoholic mixtures. Moreover, some other advantages over other conventional 
systems include the use of lower extraction times and lower solvent consumption (Chemat, 
Zill-E-Huma, & Khan, 2011; Garcia-Salas, Morales-Soto, Segura-Carretero, & Fernández-
Gutiérrez, 2010; L. Wang & Weller, 2006). 
Independently of the employed system, the extraction of target compounds is often influenced 
by several variables, which require individual analysis due to their intrinsic nature and stability. 
Therefore, it is essential to define the main variables and relevant responses prior to the 
optimization process in order to determine the values conducting to the response maximization 
according to the defined objectives (e.g. using minimum time, energy and solvent and achieve 
a cost-effective and profitable extraction system) (Dai & Mumper, 2010). To effectively carry 
out an optimization, the influence of each defined variable should be independently assessed. 
Nevertheless, the application of mathematical models such as the response surface 
methodology (RSM) is gaining visibility among the scientific community. Through RSM 
design the optimization of possible interactions between experimental variables is allowed 
simultaneously with the prediction of the most efficient conditions. This is achieved by using 
second order polynomial models with interactions able to describe and maximize the selected 
response criteria, based on the tested experimental range (Albuquerque et al., 2016). 
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3.1.1. Extraction of triterpenoids and phenolic compounds from Ganoderma lucidum: 
optimization study using the response surface methodology. 
 
The purpose of this part of the work was to optimize and compare the extraction of phenolic 
compounds and triterpenes from G. lucidum for food, pharmaceutical and cosmetic application 
by SE, HAE, and UAE. For that, the extraction yield and their content in triterpenes and total 
phenolics were maximized by RSM using as independent variables, ethanol solvent proportion 
(hydroethanolic mixtures), temperature and ultrasonic power (in the case of UAE). The extracts 
corresponding to the optimal conditions were fully characterized in terms of individual 
phenolic compounds and triterpenoids by HPLC-DAD-ESI/MS analysis. 
The influence of the various independent variables, defined for HAE and UAE techniques, was 
studied using one-factor-at-a-time to select the significant ones and to determine their 
preliminary range. Based on previous experimental results (data not shown), the variables X1 
(time in min), X2 (temperature in ºC or power in W) and X3 (ethanol content in %) were selected 
for the RSM design. Therefore, the combined effect of these three variables on the achieved 
extraction yield (Y1) and content on Tr and Ph present in G. lucidum (maximizing responses 
individually or globally), was studied using circumscribed central composite design (CCCD) 
as proposed formerly (Box & Hunter, 1957). The responses were solved using 20 independent 
combinations including 6 replicates at the centre of the experimental domain. In this design, 
the experimental points are generated on a sphere around the centre point. It is supposed that 
the centre point is close to an optimum position for the response, so it is repeated to maximize 
the prediction (Box, Hunter, & Hunter, 2005). 5 Levels of each factor were also necessary for 
this design. Experimental runs were randomized to minimize the effects of unexpected 
variability in the observed responses. A detailed description of the mathematical expressions 
used to calculate the design distribution and to decode and code the tested variable’s ranges 
can be found in Table 6. Once the optimal conditions (X1, X2, and X3) were found, the next step 
was to optimize the solid/liquid ratio (S/L or X4, expressed in g/L), in order to scale-up 
processes and maximize the extraction efficiency 
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Table 6. Experimental design and responses achieved. Variable values of the RSM experimental design applied in HAE and UAE are presented in coded and natural values. 
Extraction time (X1: t), temperature or power (X2: T or P); and solvent proportion (X3: S) are combined in five levels experimental design of 14 independent variable combinations 
and 6 replicates at the centre of the experimental domain (20 data points). Results of the response surface experimental plan for the HAE and UAE optimization process of 
independent variables comprising the following: 1) % extraction yield of the R; 2) Tr content in the format values Y1 and Y2; and Y3) Ph content in the format values Y1 and Y2. 
      
      
 EXPERIMENTAL DESIGN  HAE RESPONSES  UAE RESPONSES 
      
      
 CODED VALUES  HAE CONDITIONS  
UAE 
CONDITIONS  RESIDUE  
TRITERPENE 
CONTENT  
PHENOLIC 
CONTENT  RESIDUE  
TRITERPENE 
CONTENT  
PHENOLIC 
CONTENT 
                            
                            
 X1 X2 X3  X1: t X2: T X3: S  X1: t X2: P X3: S  Yield  Y1 Y2  Y1 Y2  Yield  Y1 Y2  Y1 Y2   min ºC %  min W %  %  mg/g dw mg/g R  mg/g dw mg/g R  %  mg/g dw mg/g R  mg/g dw mg/g R 
                            
                            
1 -1 -1 -1  40 35 20.3  13.5 180 20.3  3.83  3.60 93.81  2.54 66.17  4.30  7.02 163.25  3.02 70.25 
2 1 -1 -1  130 35 20.3  33.5 180 20.3  3.86  3.67 95.51  2.71 68.93  4.62  7.54 162.89  3.20 66.31 
3 -1 1 -1  40 75 20.3  13.5 420 20.3  6.99  3.51 50.27  3.61 56.10  3.64  6.12 167.79  2.96 85.32 
4 1 1 -1  130 75 20.3  33.5 420 20.3  3.35  3.46 103.56  3.17 90.08  4.56  6.89 152.82  4.46 102.08 
5 -1 -1 1  40 35 79.7  13.5 180 79.7  15.51  7.49 48.23  5.93 39.03  7.02  17.10 245.65  6.28 88.60 
6 1 -1 1  130 35 79.7  33.5 180 79.7  10.84  13.02 120.14  5.82 49.16  5.77  21.62 374.96  6.67 110.81 
7 -1 1 1  40 75 79.7  13.5 420 79.7  8.14  13.52 166.27  6.00 73.68  5.58  18.68 336.73  6.22 112.65 
8 1 1 1  130 75 79.7  33.5 420 79.7  11.64  12.91 112.18  5.79 52.18  5.10  16.00 314.30  6.13 123.25 
9 -1.68 0 0  9 55 50  6.7 300 50  5.11  11.07 219.19  5.41 105.77  8.55  13.06 152.92  7.56 93.81 
10 1.68 0 0  160 55 50  40.3 300 50  8.50  15.21 181.41  6.21 72.92  6.04  11.43 189.26  5.93 96.17 
11 0 -1.68 0  85 20 50  23.5 100 50  6.02  11.44 189.85  5.86 100.62  6.09  14.35 235.76  6.28 100.93 
12 0 1.68 0  85 90 50  23.5 500 50  4.50  14.66 325.37  7.38 160.39  8.48  10.92 128.66  6.80 84.99 
13 0 0 -1.68  85 55 0  23.5 300 0  4.97  4.67 94.41  3.27 78.27  7.19  4.75 65.07  3.43 48.74 
14 0 0 1.68  85 55 100  23.5 300 100  5.74  12.34 214.20  3.61 59.34  3.71  15.24 410.68  4.90 126.09 
15 0 0 0  85 55 50  23.5 300 50  5.52  12.29 222.66  5.28 100.74  6.59  11.01 166.99  6.04 100.37 
16 0 0 0  85 55 50  23.5 300 50  5.14  11.52 224.43  5.29 103.52  6.08  10.46 172.13  6.84 114.00 
17 0 0 0  85 55 50  23.5 300 50  4.84  11.73 242.70  5.36 110.75  6.42  10.94 170.70  6.44 97.82 
18 0 0 0  85 55 50  23.5 300 50  5.26  11.83 225.40  5.49 105.00  6.63  10.58 159.78  6.39 96.54 
19 0 0 0  85 55 50  23.5 300 50  4.74  10.77 228.07  5.04 104.53  6.54  10.01 153.68  6.44 99.14 
20 0 0 0  85 55 50  23.5 300 50  4.81  11.78 245.84  5.10 106.53  8.04  11.27 140.07  7.32 91.96 
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Mathematical model 
The response surface models were fitted by means of least-squares calculation using the 
following second-order polynomial equation: 
 (1) 
where Y is the dependent variable (response variable) to be modeled, Xi and Xj define the 
independent variables, b0 is the constant coefficient, bi is the coefficient of linear effect, bij is 
the coefficient of an interaction effect, bii the coefficients of quadratic effect and n is the number 
of variables. As dependent variables, for each extraction technique, the following responses 
were used: the extraction yield and the two format values (Y1 and Y2) defined for Tr and Ph, 
reflecting, respectively, the content of Tr or Ph in the dry material and in the extract (5 genuine 
responses for each extraction technique) were used. 
Procedure to optimize the variables to a maximum response 
A maximization process of the model produced responses was achieved, using a simple method 
tool to solve non-linear problems (Heleno, Diz, et al., 2016; Pinela, Prieto, Barreiro, et al., 
2016). Limitations were made to the variable coded values to avoid unnatural conditions (i.e., 
times lower than 0).  
Fitting procedures and statistical analysis 
The experimental results statistical analysis and fitting were built according to the equations 
for the responses obtained using a Microsoft Excel spreadsheet in three phases: 
1) Coefficients measurement was achieved using the nonlinear least-square (quasi-Newton) 
method provided by the macro ‘Solver’ in Microsoft Office Excel (Prieto, Vázquez, & Murado, 
2015), by minimization of the sum of quadratic differences between observed and model-
predicted values. 
2) Coefficients significance was obtained via ‘SolverAid’ macro in Microsoft Office Excel  
(Prieto, Curran, Gowen, & Vázquez, 2015) to determine the parametric confidence intervals. 
The terms that were not statistically significant (p-value > 0.05) were dropped to simplify the 
model. 
1
2
0
1 1 2 1
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3) Model reliability was confirmed by applying the following standards: a) the Fisher F-test 
(a=0.05) was used to determine the consistency of the constructed models to describe the 
obtained data (Pinela, Prieto, Antonio, et al., 2017); b) the ‘SolverStat’ macro in Microsoft 
Office Excel was used to make assessment of parameter and model prediction uncertainties 
(Comuzzi, Polese, Melchior, Portanova, & Tolazzi, 2003); c) R² was determined to explain the 
proportion variability of the dependent variable obtained by the model. 
Extraction efficiency by Soxhlet technique 
The used extraction conditions with SE technique were selected by applying 7 cycles that 
correspond to a total extraction time of 4 h. The used solvent was ethanol and the extraction 
was performed at its boiling point (80 ºC). However, depending on the compounds to be 
extracted, the number of time-cycles can influence the recovered quantity. For the studied 
target compounds (Tr and Ph) there are many scientific references suggesting a significant 
degradation rate at ethanol’s boiling point as the time-cycles are prolonged (Sathishkumar et 
al., 2013). Therefore, to optimize the number of cycles, and consequently measure the total 
content of Tr and Ph at its maximum, the time-cycle (note that each cycle account 
approximately for a 30-min period) of the SE for G. lucidum was monitored.  
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Figure 15. Results obtained for the cycles optimization of the conventional Soxhlet extraction using the responses 
extraction yield and the two format values (Y1 and Y2) of the Tr and Ph content. 
 
Figure 15 shows the effect of the time-cycles number on Tr (part A) and Ph (part B) contents. 
The results were performed in triplicate for each considered time-cycle and confidence 
intervals were calculated (α=0.05). For Tr content (Figure 15, part A), a positive linear 
dependency was achieved for the responses Y3 and Y1. At the final number of performed time-
cycles, the response Y1 shows an asymptotic-decreasing extraction stage (likely to be related to 
Tr maximum extraction level combined with Tr slight degradation). However, the increase in 
Y3 is more prominent than the one observed for Y1, suggesting that other compounds of the 
sample start to be extracted at higher rates than the Tr. This intensifies the decrease of Y2, 
causing a sharp decrease of Tr content in the R, which is reflected by the decreasing patterns 
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of Y2 (from 410 to 150 mg Equiv. UA/g R). Although the Tr content in the R is lower, the 
overall number of optimal time-cycles for Tr extraction was determined as 5-6 time-cycles in 
which ~14 mg Equiv. UA/g dw were obtained. These claims have been supported by other 
authors Y. Gao et al. (2011), who reported that the extraction of Tr from G. lucidum is largely 
influenced in the T range between 80 to 100 °C and if prolonged time-cycles of 2 h (~4 cycles) 
are used. 
In what concerns Ph from G. lucidum, a nearly identical pattern to the one described for Tr was 
observed. The Ph content expressed in terms of Y1 was found to increase significantly up to 5 
time-cycles (~5 mg Equiv. GA/g dw) reaching a maximum value before a gradual decrease 
starts to be observed (likely attributed to degradation rates of Ph). The Y3 response increases 
linearly with increasing number of cycles, presenting also a higher slope when compared with 
Y1 response, finishing with a sharp decrease in Ph content in the dry material. In terms of Ph 
content in the extract (Y2 format value) the number of time-cycle maximizing its value was 
achieved at the early stages of the process (1-3 time-cycles with ~160 mg Equiv. GA/g R), 
thereafter decreasing significantly as the extraction process is extended. This behaviour is 
similar to the one reported for flavonoids extraction from flowers of Tabernaemontana 
heyneana Wall (Sathishkumar et al., 2013). To the authors’ best knowledge, the effect of the 
applied time-cycles number on the extraction efficiency of Tr and Ph from G. lucidum, through 
SE, have not been previously reported. 
The extraction efficiency of HAE and UAE optimized by RSM 
Theoretical response surface models  
The selected variables for the techniques HAE (t, T and S variables) and UAE (t, P and S 
variables) of the applied CCCD experimental design (Table 6) were based on preliminary tests 
and information collected from bibliographic data (Albuquerque et al., 2016; Thabit et al., 
2014; Wei et al., 2015).  
The obtained results, according to the proposed RSM design (based in a CCCD), are shown in 
Table 6 for the optimization of HAE and UAE techniques using as responses the extraction 
yield (%) and Tr and Ph in the format values Y1 and Y2. Therefore, by using a non-linear least-
squares procedure to fit Eq. (1) to the response results, the estimated parametric values of the 
equation, the parametric confidence intervals (α=0.05) and relevant statistical values to assess 
the goodness of fit were presented in the first part of Table 7.    
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Those coefficients, which showed effects with coefficient interval values higher than the 
parameter value, were considered as non-significant (ns) and were not considered for the model 
development.  
Consequently, non-linear equations were built based in the second-order polynomial model of 
Eq. (1). Then, for HAE system: 
 (2) 
 (3) 
 (4) 
 (5) 
 (6) 
and for UAE process: 
 (7) 
 (8) 
 (9) 
 (10) 
 (11) 
These equations translate the patterns for individual measurement of the assessed response 
(Eqs. (2) to (6) for HAE and Eqs. (7) to (11) for UAE). Note that not all the parameters of Eq. 
(1) were used for building the model since some coefficients were rejected (Table 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 2
 1 5.3 0.16 0.01 1.2 0.05 1.1
HAE
YPh t T S T S= + + + + -
2 2
 1 11.6 2.1 0.5 3.7 0.28 1.7 0.11 1.3
HAE
YTr t T S t S tS TS= + + + - - - +
2 25.3 0.46 3.2 1.1 0.96 1.4HAEYield T S t S TS= - + + + -
2 2
 2 108.1 10.4 7.9 12.6 20.1
HAE
YPh T S t S= + - - -
2 2
 2 220.1 14.1 38.4 23.4 37.4 39.4 20.6
HAE
YTr t T t S tT TS= - + - - - +
2 2
 1 6.45 1.22 0.23 1.17 0.21 0.23 0.19
UAE
YPh S t S tP tS PS= + - - + - -
2 2
 1 11.2 0.62 4.41 0.55 0.54 0.58
UAE
YTr P S P S tS= - + + - -
26.64 0.35 0.73 1.4 0.27 0.41UAEYield t S S tS PS= - + - - -
2
 2 96.7 1.9 3.7 18.4 2.5 4.5 2.5
UAE
YPh t P S S tP PS= + + + - + -
2
 2 178.9 89.5 30.5 19.3
UAE
YTr S S tP= + + -
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TRITERPENE CONTENT  PHENOLIC CONTENT 
       
       
HAE  UAE  HAE  UAE 
       
       
 
 
 
 
 
 
 
       
Figure 16. Shows the graphical results in terms of the response surfaces of the format value of Y1 (mg/g dw) of Tr and 
Ph from the developed equations for the HAE and UAE system optimizations. Part A: Shows the joint graphical 3D 
analysis as a function of each of the variables involved. Each of the net surfaces represents the theoretical three-
dimensional response surface predicted with the second order polynomial Eq. (1) as a function of each one of the 
involved variables and described by Eqs. (2) and (3) for HAE and Eqs. (7) and (8) for UAE. The statistical design and 
results are described in Table 6. Estimated parametric values are shown in Table 7. The binary actions between 
variables are presented when the excluded variable is positioned at the centre of the experimental domain (Table 6). 
Part B: To illustrate the goodness of fit, two basic graphical statistic criteria are used. The first one, the ability to 
simulate the changes of the response between the predicted and observed data; and the second one, the residual 
distribution as a function of each of the variables. Note all the differences in the axes scales. 
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The profile patterns derived from the parametric values of these mathematical models on the 
assessed response criteria can also be depicted by graphical representation. Figure 16 and 
Figure 17 represent a 3D graphical analysis of the results concerning the extraction yield and 
Ph and Tr (expressed as Y1 and Y2) for the studied techniques (HAE and UAE).  
 
Regarding the interactive effects for HAE system in terms of Tr-Y1, there was no significant 
interaction between t & T but a positive correlation for the pairs t & S and T & S was observed. 
In terms of Tr-Y2, a negative correlation for t & T and a positive for t & S, and no interaction 
for T & S was detected. In the case of HAE system in terms of Ph-Y1 and Ph-Y2 no interaction 
was found between the variables t, T and S. For the UAE system in terms of Tr-Y1, there was 
no significant interaction between t & S, and P & S while a negative interaction for t & P was 
observed. In terms of Tr-Y2, a negative correlation for t & P, a positive for t & S, and no 
interaction for P & S was observed. Also, in the Ph-Y1, the correlation was negative for t & S, 
and P & S. No significant interaction was observed in terms of Ph-Y1 and Ph-Y2 between t & 
P, while for P & S it was negative for Ph-Y1 and not significant for Ph-Y2.  
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Figure 17. Shows the joint graphical 3D analysis as a function of each variable involved for HAE and UAE systems 
for the extraction yield and the response content of Tr and Ph in the format value of Y2 (mg/g R). Each of the net 
surfaces represents the theoretical three-dimensional response surface predicted with the second order polynomial Eq. 
(1) as a function of each one of the involved variables and described by Eqs. (4), (5) and (6) for HAE and Eqs. (9), 
(10) and (11) for UAE. The statistical design and results are described in Table 6. Estimated parametric values are 
shown in Table 7. The binary actions between variables are presented when the excluded variable is positioned at the 
centre of the experimental domain (Table 6). 
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Table 7. Estimated coefficient values obtained from the second-order polynomial model, parametric intervals and 
numerical statistical criteria for each parametric response criteria of the extractions systems tested (HAE and UAE). 
Response criteria comprise the following: 1) % extraction yield; 2) Tr content in the format values Y1 and Y2; and 3) 
Ph content in the format values Y1 and Y2. 
 
              
              
PARAMETERS 
RESIDUE  TRITERPENE CONTENT  PHENOLIC CONTENT 
      
      
Yield  Y1 Y2  Y1 Y2 
              
              
HEAT-ASSISTED EXTRACTION (HAE) 
              
              
Intercept b0 5.37 ±1.0  11.62 ±0.7 220.09 ±25.2  5.33 ±0.3 108.07 ±10.5 
Linear effect  
b1 ns ns  2.15 ±0.7 -14.12 ±12.6  0.16 ±0.0 ns ns 
b2 -0.46 ±0.3  0.51 ±0.7 38.37 ±18.7  0.01 ±0.0 10.44 ±7.7 
b3 3.24 ±0.7  3.67 ±0.7 ns  1.21 ±0.0 -7.99 ±7.7 
Quadratic effect 
 
b11 1.01 ±0.7  -0.28 ±0.1 -23.41 ±18.7  ns -12.63 ±7.9 
b22 ns  ns ns  0.05 ±0.0 ns 
b33 0.96 ±0.7  -1.73 ±0.7 -37.41 ±18.7  -1.07 ±0.0 -20.01 ±7.9 
Interactive effect 
b12 0.35 ±0.3  ns -39.42 ±18.7  ns ns 
b13 ns  -0.11 ±0.3 20.62 ±18.7  ns ns 
b23 -1.38 ±0.9  1.27 ±0.3 ns  ns ns 
              
              
Statistics (R²) 0.8948  0.8978 0.8136  0.9104 0.8210 
              
              
ULTRASOUND-ASSISTED EXTRACTION (UAE) 
              
              
Intercept b0 6.64 ±0.3  11.26 ±0.7 178.99 ±17.7  6.45 ±0.3 96.70 ±1.8 
Linear effect  
b1 -0.35 ±0.3  ns ns  ns 1.95 ±1.8 
b2 ns  -0.62 ±0.5 ns  ns 3.67 ±1.8 
b3 0.73 ±0.3  4.41 ±0.5 89.57 ±16.0  1.22 ±0.2 18.44 ±1.8 
Quadratic effect 
 
b11 ns  ns ns  -0.23 ±0.2 ns 
b22 ns  0.55 ±0.5 ns  ns ns 
b33 -1.36 ±0.3  -0.54 ±0.5 30.50 ±16.3  -1.17 ±0.2 -2.53 ±1.8 
Interactive effect 
b12 ns  ns -19.32 ±9.9  0.21 ±0.2 4.55 ±1.8 
b13 -0.27 ±0.3  -0.58 ±0.3 ns  -0.23 ±0.2 ns 
b23 -0.41 ±0.3  ns ns  -0.19 ±0.2 -2.55 ±1.8 
              
              
Statistics (R²) 0.9222  0.9349 0.9330  0.9223 0.9013 
              
              
 
 
The regression coefficients related with the interactive effects of the responses, presented in 
Table 7, suggest that the use of an RSM approach to optimize the extraction responses 
(extraction yield and Tr and Ph (expressed as Y1 and Y2)) for both systems (HAE and UAE) is 
correctly justified. If approaches based on one-variable at a time were applied, the high level 
of interactions showed between the variables will make the optimum values difficult to 
determine. As an illustrative example, Figure 16 shows the response of Tr in HAE representing 
the effect of T & S (at constant values of t), in which the related parameter shows a positive 
value b23 of 1.27±0.3 that causes an increase extraction of Tr as both variables increase (closely 
related with synergistic effects). However, by looking at their individual profile, at fixed values 
for the other, such interaction will be nearly impossible to predict without a large investment 
on experimental analysis.  
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In terms of the statistical analysis of the models fitting to the responses, the lack-of-fit test used 
to assess the competence of the models showed that the significant parameters in both RSM 
approaches (Table 7) were highly consistent (p < 0.01) and if any of them was suppressed, the 
reached solution would not be acceptable. This was also verified by the achieved high R2 value, 
indicating the percentage of the variability explained by the model (Table 7). In all cases, the 
R2 was higher than 0.8, with values over ~0.9 in almost all responses. The residuals distribution 
presented in Figure 16 was arbitrarily around zero and no group of values or autocorrelations 
were observed. Additionally, the agreement between the experimental and predicted values 
implies an acceptable explanation of the obtained results through the used independent 
variables. Therefore, the models developed in Eqs. (2) to (6) for HAE and Eqs. (7) to (11) for 
UAE, are completely functional and adequate to be used for prediction and process 
optimization.  
Overall effects of the process variables on the target responses 
Figure 16 shows the extraction results in terms of Ph-Y1 and Tr-Y1 (mg/g dw) for the HAE and 
UAE, respectively. Each subfigure of Figure 16 is divided into two subsections (A and B). 
Subsection A shows the combination of the predicted three-dimensional response surface plots 
with their respective second order polynomial Eq. (1) as a function of each one of the involved 
variables, as described by Eqs. (2) and (3) for HAE and Eqs. (7) and (8) for UAE. The binary 
action between variables is presented when the excluded variable is positioned at the centre of 
the experimental domain (see Table 6). Subsection B illustrates the capability to predict the 
obtained results and the residual distribution as a function of each one of the considered 
variables. The response surfaces of the different variable combinations displayed in Figure 16 
clearly shows the various trends observed when the interaction between the variables is 
compared. The shape of each plot indicates the significance of the interactions that occur in 
between the variables. The Tr-Y1 for HAE technique showed that S was the most significant 
variable with an approximately linear effect. The Tr-Y1 for the UAE technique showed a non-
linear interaction for P and t suggesting saturation effects of the responses as the variables 
increase. The Ph-Y1 for HAE and UAE technique showed a bell profile behaviour indicating 
that its extraction increases as the considered variables (t, T, P, and S) increase up to an 
optimum point and, then, start to decrease. Thus, the analysis of these response surface curves 
indicates the optimum level necessary for each variable to optimize the extraction of the 
compound of interest. In general terms, the information provided in Figure 16 shows that Tr-
Y1 increases to an optimum value, meanwhile the Ph-Y1 increases to an optimum value and then 
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decreases. Therefore, in almost all combinations the optimum can be found at one single point 
along the response, allowing computing the conditions that lead to the absolute or relative 
maximum. 
Figure 17 shows an illustrative 3D analysis representing the effect of each one of the involved 
variables in HAE and UAE systems on the extraction yield (%) and Tr-Y2 and Ph-Y2 (mg/g R). 
Each one of the net surfaces represents the response predicted by the second-order polynomial 
Eqs. (4), (5) and (6) for HAE and Eqs. (9), (10) and (11) for UAE. The actions between the two 
considered variables are presented when the excluded variable is positioned at the centre of the 
experimental domain (Table 6). The Ph-Y2 for HAE and UAE showed a bell-shaped profile 
indicating that an increase in t and S increases the content of Ph to a certain point, followed by 
a significant decrease. These patterns are also found in the Tr-Y2 for HAE and UAE but in a 
lesser extent. As in SE, this behaviour is likely to be related due to the joint action of the two 
process. The extraction yield increases at higher rates than the Tr and Ph contents, suggesting 
that other compounds start to be extracted from the G. lucidum sample, which causes a decrease 
in both Tr and Ph contents since a maximum extraction level is achieved. In addition, 
degradation of these compounds may also occur justifying the strongest decrease visualized in 
the produced surfaces.   
Numerical individual and global optimal conditions that maximize the extraction, statistical 
analysis and experimental verification of predictive models 
The response optimization by RSM, for the HAE and UAE techniques, provides a strong 
solution by minimizing errors using a short number of experimental trials, as it was 
demonstrated elsewhere (Roselló-Soto et al., 2015; Wong et al., 2015). The multivariable 
fitting decreases the needed number of parameters to analyse the response leading to better 
estimations, reducing their interval of confidence and allowing to predict the response 
behaviour. In addition, by applying a simple procedure (considering constraints to the 
experimental ranges) the individual optimal conditions can be found, as well as the maximal 
response values (first part of Table 8). Relative (marked with * when the optimal value may 
be outside of the studied experimental range) or absolute optimal conditions were found for all 
the responses as follows: 
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- For the extraction yield, the HAE was the best solution; 21.3±1.7 % was achieved at 
*160.0 min, *20.0 ºC and 100.0 % ethanol.  
- For the Tr-Y1, the UAE was the best solution; 21.3±4.1 mg Equiv. UA/g dw was 
achieved at *7 min, *100.0 W and *100.0 % ethanol. 
- For the Tr-Y2, the UAE was the best solution; 470.5±41.7 mg Equiv. UA/g extract was 
achieved at *40 min, *100.0 W and *100.0 % ethanol. 
- For the Ph-Y1, the UAE technique was the best solution; 6.7±0.7 mg Equiv. GA/g dw 
was achieved at 29.4 min, *100.0 W and 59.7 % ethanol. 
- For the Ph-Y2, the HAE was the best solution; 125.9±12.7 mg Equiv. GA/g extract was 
achieved at 81.3 min, *90.0 ºC and 49.1 % ethanol.  
 
Comparing both techniques in terms of extraction efficiency, UAE conducted to 
significantly higher values than HAE, probably due to compound’s degradation as 
described previously by other authors (Jacotet-Navarro et al., 2016; Ying Li, Fabiano-
Tixier, Tomao, Cravotto, & Chemat, 2013). Regarding the extraction time, UAE was the 
fastest extraction method for almost all responses. In the second part of Table 8, the global 
optimal conditions are found, as well as the relative response values: 
- For the HAE, the global conditions that maximize the responses were 78.9 min, *90.0 
ºC and 62.5 % of ethanol conducting to an extraction yield of 5.2±0.6 %, Tr content in 
the dry material and in the extract of 14.6±1.9 mg Equiv. UA/g dw and 285.7±31.2 mg 
Equiv. UA/g R, respectively; and Ph content in the dry material and in the extract of 
5.8±1.2 mg Equiv. GA/g dw and 116.3±13.2 mg Equiv. GA/g R, respectively. 
- For the UAE the global conditions that maximize the responses were *40 min, *100.0 
W and 89.5 % of ethanol conducting to an extraction yield of 4.9±0.6 %, Tr content in 
the dry material and in the extract of 17.4±2.9 mg Equiv. UA/g dw and 435.6±41.2 mg 
- Equiv.UA/g R, respectively; and Ph content in the dry material and in the extract of 
4.6±0.2 mg Equiv. GA/g dw and 106.6±16.2 mg Equiv. GA/g extract, respectively. 
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Finally, Figure 18 shows the summarized individual 2D responses as a function of the defined 
variables for HAE and UAE techniques guiding the selection of the most favourable conditions. 
The line represents the variable response pattern when the other responses are located at the 
optimal values presented in Table 8. The dots () presented alongside the line highlight the 
location of the optimal value. For all techniques and responses, the conditions that lead to the 
optimal values were re-checked to ensure the accuracy of the presented results. The interest in 
scale-up processes to obtain bioactives of interest, such as the ones proposed in the present 
work (triterpenes and phenolic compounds) can take advantages from the data reported in 
Figure 18. The data was organized in a simple format to allow an easy interpretation of the 
responses.  
 
       
       
Table 8. Operating conditions that maximize the extracted residue and the content of Tr and Ph compounds from G. lucidum.  
       
       
 
OPTIMAL EXTRACTION CONDITIONS   OPTIMUM RESPONSE 
     
 
     
X1: t (min) X2: T (ºC) or P(W) X3: Et (%)   
         
        
INDIVIDUAL OPTIMAL RESPONSES 
         
         
Heat-Assisted Extraction (HAE) 
         
         
    Yield * 160.0 * 20.0 * 100.0   21.3 ±1.7 % 
    Tr (Y1) * 160.0 * 90.0 * 100.0   22.1 ±2.9 mg Equiv. UA/g dw 
    Tr (Y2) * 10.0 * 90.0 35.4   362.1 ±33.1 mg Equiv. UA/g R 
    Ph (Y1) * 160.0 * 20.0 65.7   6.3 ±0.7 mg Equiv. GA/g dw 
    Ph (Y2) 81.3 * 90.0 49.1   125.9 ±12.7 mg Equiv. GA/g R 
         
         
Ultrasound-Assisted Extraction (UAE) 
         
         
    Yield * 7.0 * 100.0 70.6   7.8 ±0.9 % 
    Tr (Y1) * 7.0 * 100.0 * 100.0   21.3 ±4.1 mg Equiv. UA/g dw 
    Tr (Y2) * 40.0 * 100.0 * 100.0   470.5 ±41.7 mg Equiv. UA/g R 
    Ph (Y1) 29.4 * 500.0 59.7   6.7 ±0.7 mg Equiv. GA/g dw 
    Ph (Y2) * 40.0 * 500.0 * 100.0   135.65 ±15.7 mg Equiv. GA/g R 
         
        
GLOBAL OPTIMAL RESPONSES 
         
         
Heat-Assisted Extraction (HAE) 
         
         
    Yield 
78.9 * 90.0 62.5  
 5.2 ±0.6 % 
    Tr (Y1)  14.6 ±1.9 mg Equiv. UA/g dw 
    Tr (Y2)  285.7 ±31.2 mg Equiv. UA/g R 
    Ph (Y1)  5.8 ±1.2 mg Equiv. GA/g dw 
    Ph (Y2)  116.9 ±13.2 mg Equiv. GA/g R 
         
         
Ultrasound-Assisted Extraction (UAE) 
         
         
    Yield 
* 40 * 100.0 89.5  
 4.9 ±0.6 % 
    Tr (Y1)  17.4 ±2.9 mg Equiv. UA/g dw 
    Tr (Y2)  435.6 ±21.1 mg Equiv. UA/g R 
    Ph (Y1)  4.6 ±0.2 mg Equiv. GA/g dw 
    Ph (Y2)  106.6 ±16.2 mg Equiv. GA/g R 
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Figure 18. Shows an illustration that summarizes the effects of all variables assessed for HAE and MAE systems. 
Part A: Shows the individual 2D responses of all studied responses as a function of all the variables assessed. The 
variables in each of the 2D graphs were positioned at the optimal values of the others (Table 8). The dots () presented 
alongside each line highlights the location of the optimum value. Lines and dots are generated by the theoretical 
second order polynomial models of Eqs. (2) to (6) for ME and Eqs. (7) to (11). Part B: Shows the dose response of 
S/L ratio at the optimal values of the other three variables optimized by RSM. Points (l for HAE and for UAE) 
represent the obtained experimental results, meanwhile the line shows the predicted pattern by a simple linear relation. 
The limit value (80 g/L) shows the maximum achievable experimental concentration until the sample cannot be 
physically stirred at laboratory scale. 
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Dose-response analysis of the solid-to-liquid effect at the optimum conditions 
The S/L studies for the HAE and UAE techniques, performed at the optimal global conditions 
predicted by the polynomial Eqs. (4) to (11), are presented in the third part of Table 8. For 
HAE the conditions were: 78.9 min, 90.0ºC and 62.5% of ethanol, whereas for UAE the 
conditions were: 40.0 min, 100.0 W and 89.5% of ethanol. Preliminary obtained results showed 
that the experimental limit value at lab-scale was proximal to 80 g/L. Therefore, in both 
techniques an experimental dose-response test was designed to verify the S/L behaviour 
between 10 g/L to 80 g/L. In all cases, the S/L effect can be described by a simple non-linear 
relationship with an intercept, and in almost all cases, the linear relationship shows a decreasing 
pattern as the S/L ratio increases. The S/L increase leads to a decrease in the solvent extraction 
ability and the observed decreasing patterns are expected due to the saturation effects. 
Consequently, the dose-response is explained by means of the linear parametric values of the 
slope (m) and the intercept (b). The effects of the S/L dose-response for the HAE and UAE 
techniques are presented in Figure 18. In all cases, the obtained responses through the HAE 
and UAE systems are consistent with the previous results obtained using a S/L ratio of 30 g/L. 
Figure 18 shows the experimental results (dots: l for HAE and  for UAE) and model 
predictions of the linear relationship (lines) obtained for each technique. The results derived 
from the linear fitting analysis are summarized as follows: 
- For the extraction yield, the HAE technique conducted to a predicted intercept of 
b=4.2±0.4% of R and a slope with positive values (m=0.069±0.008%), which can 
indicate an extract increase with the S/L. This was the only case that presented increased 
patterns as a function of the rise of the S/L. The reasons behind may be the high values 
of T applied (90.0 ºC), which may help to dissolve other substances even at high values 
of S/L. Meanwhile, for the UAE technique b=3.5±0.2 % of R and m=-0.005±0.004% of 
R per g/L. 
- For the Tr-Y1 response for HAE and UAE techniques the b values obtained were 
16.4±0.6 and 18.9±0.5 mg Equiv. UA/g dw, respectively. Regarding the decreasing m 
effect caused by the S/L increase were -0.066±0.012 and -0.091±0.011 mg Equiv. UA/g 
dw per g/L, respectively. 
- For the Tr-Y2 response for HAE and UAE techniques, the b values obtained were 
325.6±12.7 and 547.7 ±15.3 mg Equiv. UA/g R, respectively. Regarding the decreasing 
m effect caused by the S/L increase were -2.80±0.25 and -2.12±0.31 mg Equiv. UA/g 
R per g/L, respectively. 
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- For the Ph-Y1 response for HAE and UAE techniqmodelues, the b values obtained were 
6.3±0.2 and 4.9±0.2 mg Equiv. GA/g dw, respectively. Regarding the decreasing m 
effect caused by the S/L increase were -0.023±0.003 and -0.019±0.004  mg Equiv. GA/g 
dw per g/L, respectively. 
- For the Ph-Y2 response for HAE and UAE techniques the b values obtained were 
140.6±5.4 and 153.6±3.7 mg Equiv. GA/g R, respectively. Regarding the decreasing m 
effect caused by the S/L increase were -1.299±0.107 and -0.710±0.073 mg Equiv. GA/g 
R per g/L, respectively. 
Consequently, the dose-response in terms of all response criteria can be explained by the 
parametric results derived from the linear relationships and this trend was visually interpreted 
in Figure 18, for comparison purposes, in which the modelling predictions obtained for each 
technique are represented jointly up to determine the experimental limit value of 80 g/L. 
Characterization of the optimized extract in terms of individual triterpenoids and phenolic 
compounds by HPLC-DAD-ESI/MSn 
The global optimum conditions for Tr and Ph extraction by HAE and UAE techniques are 
presented in Table 8. These conditions were used to obtain extracts that were further 
characterized by using HPLC-DAD-ESI/MSn. The HPLC profiles (l= 280 nm) derived from 
G. lucidum regarding the content of phenolic and triterpenoid compounds at the optimal global 
conditions of UAE is shown in Figure 19. 
 
Identification and quantification of phenolic compounds 
The composition of G. lucidum extracts in terms of phenolic compounds is presented in Table 
9 (section A). Only phenolic acids, such as protocatechuic, p-hydroxybenzoic and syringic 
acids were identified in the SE extract, being p-hydroxybenzoic acid the most abundant 
compound. Different G. lucidum extracts have shown the presence of the above mentioned 
phenolic acid with slight dissimilarity, which could be attributed to differences in the extraction 
technique, origin, and variation in environmental conditions necessary for mushrooms 
maturation (Heleno et al., 2012). Composition in phenolic compounds of the extracts obtained 
using UAE and HAE systems showed the presence of syringic acid, while p-hydroxybenzoic 
acid was additionally present in the UAE ethanolic extract. Under the optimum conditions, the 
corresponding predicted response values for the Ph content in the SE, HAE and UAE samples 
(based on a spectrophotometric assay) were confirmed by HPLC-DAD-ESI/MSn. As expected, 
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the results showed that the predicted concentrations were slightly different from the 
experimental ones. The UV-Vis spectrophotometric determination of total phenolics by the 
Folin Ciocalteu’s method is one of the most widely used methods due to its simplicity and low 
cost, when compared to chromatographic assays, that are highly sensitive and accurate. This 
methodology is known to have interferences reacting also with non-phenolic reducing 
compounds, which can lead to an overvaluation of the phenolic content. Therefore, there are a 
lot of controversies regarding the comparison of results obtained from both methods and 
several scientific publications have revealed conflicting results (Marques et al., 2013; Popova 
et al., 2004). Due to the high diversity of chemical compounds in G. lucidum, the 
spectrophotometric method is often unable to accurately quantify the phenolic compounds 
present in the sample, however, it can be used to conduct optimization studies because of its 
operational advantages. 
 
Identification and quantification of triterpenoids  
An HPLC-DAD-ESI/MSn approach was used in the present work and it has proven to be 
successful in screening triterpene mixtures in ethanol extracts of G. lucidum, using two 
detectors, DAD and ESI-MS, to obtain the UV absorbance and the molecular weights 
respectively, to ensure easy and accurate identification. ESI-MS spectra in negative modes 
were used in the present study and all Tr gave [M – H]– and [2M – H]– ions. Under the optimum 
conditions, the corresponding predicted response values for the triterpene content in the SE, 
HAE and UAE samples were chromatographically confirmed to validate the model. Even 
though not all compounds could be recognised because they share the same mass and showed 
similar retention times, a total of 24, 26 and 28 Tr were correctly identified in HAE, UAE and 
SE, respectively (section B of Table 9). Seven ganoderic acid derivative compounds (peaks 8, 
12, 15, 18, 20, 25 and 28) were detected in all extraction techniques. The Tr identified in the 
present work resulted from a comparison with literature data, regarding the UV spectra, 
retention time and MS fragmentation pattern. The Tr profile in G. lucidum often depends on 
the extraction method employed and the geographical origin of the strain. However, most 
studies have reported good repeatability in the Tr profile of G. lucidum (Guo et al., 2012; 
Hadda, Djamel, & Akila, 2015; Hennicke et al., 2016; Yang et al., 2007). In all three extraction 
techniques evaluated, ganoderic acid A (peak 22) and ganoderic acid H (peak 23) were the 
most abundant Tr present. The experimental results obtained at the optimum conditions were 
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found not to be significantly different from what was predicted by the model, thus indicating 
the suitability of the model employed and the success of RSM in optimizing the extraction 
conditions for obtaining triterpenes from G. lucidum. The extraction efficiency for recovery of 
Tr compounds per extraction technique has been established as shown in Table 9. SE provided 
the highest results regarding the phenolic compounds; however, the SE technique requires high 
solvent consumption, long extraction time, and intensive manpower which often contradicts 
the “green chemistry” and “environmentally friendly” concept. Alternatively, the UAE 
technique has shown to overcome the challenges in the traditional method, because of its fast 
and environmentally friendly approach. 
 
 
 
Figure 19. Example of the HPLC profiles (l= 280 nm) derived from G. lucidum regarding the content of phenolic 
and triterpenoid compounds. A representative case at the optimal global conditions of UAE presented in Table 
8). Compounds identification numbers are described in detail in Table 9. 
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Table 9. Identification and quantification of phenolic compounds and triterpenoids in G. lucidum extracts produced at the determined optimal conditions of HAE, UAE and SE. 
        
        
Peak Rt 
UV 
lmax 
[M-H]-& [2M-
H] MS
2 Tentative identification Quantification (mg/g R) 
(min) (nm) (m/z) (m/z) HAE UAE SE 
        
        
A: Characterization of phenolic compounds  
        
        
1 7 259,293sh 153 109(100) Protocatequic acid  - - 1.80± 0.01 
2 10.8 257 137 93(100) p-Hydroxybenzoic acid - 0.364±0.01 2.98±0.01 
3 15 280 197 121(100) Syringic acid 0.250±0.001 0.260±0.001 1.51±0.01 
     Total phenolic acids 0.250±0.001 0.620±0.001 6.30±0.01 
        
        
B: Characterization of triterpenes  
 
        
        
4 29.06 259 533/1067 515(5),497(12),404(100),303(12) 
12-3,7,15-Trihydroxy-4-
(hydroxymethyl)-11,23-dioxo-
lanost-8-en-26-oic acid 
3.77±0.03 7.18 ±0.05 14.21±0.02 
5 30.8 256 533/1067 515(5),497(21),453(16),423(11),319(5),303(8) 12-Hydroxyganoderic acid C2 5.01±0.03 1.43±0.04 4.51±0.06 
6 31.27 252 529/1059 511(10),467(100),449(11),434(5),431(15),419(8),312(8), 285(5),263(11) 20-hydroxy-ganoderic acid AM1 - 5.41±0.06 11.40±0.01 
7 31.73 251 529/1059 511(13),499(100),481(6),465(18),438(28),419(18),367(11),287(11) 12-deacetylganoderic acid H 2.28±0.04 3.62±0.06 6.1±0.14 
8 32.28 255 547/1095 529(50),511(41),485(3),467(100),449(24),431(26),304(11),265(7) Ganoderic acid derivative 3.78±0.03 5.27±0.04 7.3±0.1 
9 33.94 258 531/1063 513(13),451(3),401(100),385(5),304(19),301(45),286(3),249(27) Ganoderic acid ɳ 5.50±0.03 14.13±0.08 25.41±0.04 
10 34.48 254 511/1023 493(23),449(100),431(5),413(15),405(3) Ganoderic acid F 5.34±0.03 12.46±0.05 17.97±0.02 
11 35.37 265 529/1059 511(5),467(100),449(20),437(29),317(10),301(5),263(5) 12-hydroxyganoderic acid D 4.15±0.04 7.78±0.05 6.86±0.07 
12 35.95 251 515/1031 497(100),453(31),437(8),303(19),287(5),235(3) Ganoderic acid derivative 11.03±0.06 21.61±0.06 21.20±0.08 
13 36.84 256 517/1035 499(100) 481(48),456(17),438(52),407(8),304(6),287(35) Ganoderic acid C2 17.92±0.03 28.09±0.08 38.70±0.15 
14 37.51 257 529/1059 511(5),481(7),467(100),451(14),438(38),424(3),319(5),303(3),301(5) Ganoderic acid C6 10.50±0.04 21.11±0.04 29.10±0.08 
15 38.16 256 529/1059 511(58),493(5),449(10),399(100),301(3) Ganoderic acid derivative 5.22±0.06 11.07±0.06 12.77±0.01 
16 38.46 256 531/1063 513(11),498(15),469(100),454(29),452(24),437(6),304(5),302(6),290(20),266(7) Ganoderic acid G 8.04±0.02 14.31±0.29 16.84±0.07 
17 38.75 248 513/1027 495(10),480(16),451(100),437(14),433(22),407(17),331(5),315(3),303(5),287(5) Ganoderenic acid B 13.12±0.01 23.05±0.50 10.66±0.09 
18 39.01 259 527/1055 509(26),465(6),397(100),355(4) Elfvingic acid derivative - - 10.41±0.09 
19 39.35 254 515/1031 497(10),453(100),439(5),409(5),304(21),287(12),263(3),250(14) Ganoderic acid B 18.86±0.07 35.72±0.02 23.99±0.09 
20 39.46 250 513/1027 495(100),479(27),462(12),451(30),433(31),381(25),301(15) Ganoderic acid derivative 25.64±0.03 44.70±0.16 22.44±0.10 
21 39.66 261 513/1027 495(21),480(5),451(100),433(24),381(6),301(6),247(3) Ganoderic acid AM1 - 11.56±0.03 15.82±0.01 
22 40.29 254 515/1031 497(100),480(5),454(6),436(10),302(8),301(4),285(3) Ganoderic acid A 28.79±0.05 43.46±0.20 36.77±0.04 
23 40.66 261 571/1143 553(100),511(8),481(3),468(8),437(3),423(2) Ganoderic acid H 27.32±0.19 58.13±0.03 41.05±0.39 
24 40.87 252 527/1055 509(20),479(13),465(100),435(3),421(3),317(3),301(3) Elfvingic acid A - - 9.83±0.01 
25 41.34 254 529/1059 511(10),496(22),493(21),467(100),449(61),434(4),319(6),317(8),301(16),300(11),299(12) Ganoderic acid derivative 6.12±0.07 13.98±0.05 11.56± 0.04 
26 41.93 246 511/1023 493(12),478(20),449(100),435(15),431(4),405(4),329(3),301(4),285(5),283(3),261(4) Ganoderenic acid D 12.38±0.04 23.06±0.04 10.27±0.07 
27 42.55 255 513/1027 495(16),451(100),437(6),433(3),407(4),301(23),286(3),284(11),247(8) Ganoderic acid D 15.17±0.09 17.61±0.12 11.31±0.01 
28 42.74 245 509/1019 491(100),476(18),461(34),447(15),429(3),417(3),300(5),299(4) Ganoderic acid derivative 13.37±0.13 28.36±0.04 12.81±0.08 
29 43.15 256 511/1023 493(100),449(65),435(3),300(5),247(4) Ganoderic acid E 12.84±0.03 31.53±0.08 10.81±0.07 
30 43.95 255 569/1139 551(100),509(35),508(21),466(8) 12-acetoxyganoderic acid F 15.91±0.03 32.59±0.12 12.08±0.07 
31      44.92 272 513/1027 451(100),437(8),433(3),422(3),301(5) Ganoderic acid J 8.41±0.16 14.05±0.42 2.92±0.05 
     Total triterpenoids 280.46±0.11 531.26±0.24 455.01±1.47 
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Extraction efficiencies assessment between HAE and UAE  
Extraction of bioactive compounds from natural matrices using solid-liquid extraction systems 
constitutes an important step to obtain ingredients to produce phytochemical-rich products. 
This is in accordance with current trends where a raising interest is devoted to the use of 
natural-derived ingredients in different industrial fields. Over the years, conventional 
extraction systems were predominantly applied (Azwanida, 2015; Joana Gil-Chávez et al., 
2013). Traditional methods such as SE and HAE, have been used everywhere for many 
different purposes. They are often time-consuming and require large quantities of polluting 
solvents in comparison to other emerging technologies. However, in terms of efficiency 
(extraction yield and purity), the SE is described as the standard chemical extraction process at 
laboratory scale. Nonetheless, by itself, it is an optimized extraction system and in addition, 
literature offers a high number of practical examples that report the favourable conditions 
(Azmir et al., 2013). Additionally, its sister in industrial applications, the repeated-heated-
extraction, has been used by food processing industries and researchers with the purpose of 
extracting more efficiently major and minor compounds.  
However, to maximally recover compounds of interest from natural sources, while also taking 
into consideration environmental factors, financial feasibility, time and extraction quality, non-
conventional technologies have been applied (such as UAE as well as pulsed electric field, 
enzyme digestion, extrusion, microwave assisted extraction, supercritical fluid extraction, etc.). 
New extraction techniques are continuously developed and/or modified to properly identify the 
most suitable technique that maximally increases the recovery of bioactive compounds. 
Even though there are reports on the optimization of Tr extraction from natural matrices (Wei 
et al., 2015), only Ruan et al., (2014) have been able to report the effects of different extraction 
variables on the extraction efficiency of Tr from G. lucidum. The above authors reported that 
Tr yield was 13.23 mg/g dw when the extraction conditions were 100% ethanol, 60.2 ˚C, and 
6 h. Wei et al., (2015) reported an increase in Tr extraction using the UAE system as the solvent 
proportion increased from 50 to 75% by 14.39 to 19.51 mg/g dw, respectively. Also, as the 
time increased from 10 to 40 min, the extraction yield increased from 12.50 to 18.93 mg/g dw, 
respectively. The above authors reported an optimum yield of 26.7±0.2 mg/g dw at 70% 
ethanol, 50 min, and 100 W, values that are consistent with Tr-Y1 content reported in the present 
work of 28.4±4.1 mg/g dw at the optimal individual conditions (Table 8, 100% of ethanol, 40 
min and 100 W). Studies conducted by Gao et al., (2011) revealed that an optimal extraction 
yield of 1.09% for the HAE system at 90% ethanol, 120 mins and 80 °C while 5.0± 0.6% were 
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obtained in the present work (Table 8). The dissimilarity in the above response could be due 
to the influence of the application of mathematical and statistic techniques to maximize the 
recovery. To the authors’ best knowledge, no previous studies have been conducted on the 
optimization of Ph compound extraction from G. lucidum using the UAE and HAE system. 
However, Lin, Yu, & Weng, (2012) conducted an optimization using the supercritical fluid 
extraction technique, obtaining optimum extraction values at lower temperatures. 
SE, HAE, and UAE extraction techniques have been examined, optimized and compared 
concerning the recovery of bioactive compounds from G. lucidum. The results showed that the 
main variables involved in those processes have significant effects on the extraction yield. The 
UAE system was found to be the most effective and faster method for Tr extraction, capable 
of yielding 17.4±2.9 mg Equiv. UA/g dw and producing a 4.9% R (49 mg R/g dw) with a purity 
of 435.6±21.1 mg Equiv. UA/g R at its optimal extraction conditions. Meanwhile, HAE was 
found to offer a better result for the Ph extraction showing 5.8±1.2 mg Equiv. GA/g dw and 
producing a 5.2% R (52 mg R/g dw) with a purity of 116.9±13.2 mg Equiv. GA/g R at its 
optimal extraction conditions. In global terms, applying the RSM conditions by UAE technique 
lead to higher amounts of compounds but also higher extraction yields than those found in HAE 
and SE, but the costs involving the use of this technique at industrial scale may not cover the 
investment needed. This work offers an overview through environmentally compatible 
extraction processes, in which G. lucidum is submitted to 'clean' technologies able to integrate 
a potential industrial sector in a sustainable approach. The obtained results indicate the viability 
of using G. lucidum as a productive source of an enriched extract with bioactive compounds. 
Under the optimum conditions, an HPLC-DAD-ESI/MSn confirmed the validity of the model 
with a total of 24, 26 and 28 Tr correctly identified in HAE, UAE and SE extracts, respectively. 
Protocatechuic, p-hydroxybenzoic and syringic acids were identified in the SE ethanolic 
extract. The HAE system showed the presence of only syringic acid while p-hydroxybenzoic 
acid was additionally present in the UAE extract. In addition, the present work can reinforce 
the potential of G. lucidum to serve as a source of bioactive compounds to be used as natural 
additives in functional foods, as cosmeceutical ingredients and as novel compounds with 
pharmaceutical potentials. Because of the widespread presence of Tr and Ph compounds in G. 
lucidum, further studies should be conducted using the optimal extraction conditions 
determined in the present work. 
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3.1.2. Optimization of ergosterol extraction from Agaricus blazei Murrill using 
response surface methodology: A comparative study between modern and conventional 
techniques 
 
The RSM was applied to optimize the HAE, MAE, and UAE techniques with the purpose of 
finding the most favourable conditions that maximizes the recovery from ergosterol and the 
results were expressed according to three response (Y) format values: Y1, the % of extracted 
material (R), which was used to evaluate the total extraction yield; Y2, in mg of ergosterol per 
g of extract residue (mg E/g R), which was used to evaluate the ergosterol purity in the extract; 
and Y3, in mg of ergosterol per 100 g of dry mushroom A. blazei (mg E/100 g M dw), which 
was used to analyse the extraction yield expressed in ergosterol. Studies previously conducted 
were taken into consideration to screen the appropriate variables to determine the experimental 
domain for an appropriate RSM design. Independent variables, which include t and T for HAE 
and MAE, and t and P for UAE, were preliminarily tested. 
Experimental design 
Trials were conducted based on one-at-the-time analysis of each one of the variables and each 
one of the selected techniques. The variables that caused significant changes, and the relevant 
ranges of action, were selected for each one of the studied extraction methodologies (Table 
10). The variables were coded according to the needs of the experimental design. For each 
technique, the combined effect of the two relevant variables was studied using a circumscribed 
central composite design (CCCD) using five levels for each one with 16 response combinations 
(three replicates per condition). Experimental runs were randomized, to minimize the effects 
of unexpected variability in the observed responses. 
 
         
CODED VALUES 
NATURAL VALUES 
        
        
HAE  UAE  MAE 
        
        
t (min) T (ºC)  t (min) P (W)  t (min) T (ºC) 
         
         
-1.41 10.00 30.00  5.00 100.00  2.00 60.00 
-1 30.50 34.10  8.66 118.31  5.37 73.18 
0 80.00 60.00  17.50 250.00  13.50 105.00 
+1 129.50 85.90  26.34 381.69  21.63 136.82 
+1.41 150.00 90.00  30.00 400.00  25.00 150.00 
         
         
 
Table 10. Experimental domain and codification of independent variables in the CCCD factorial design with 5 
range levels and 2 factors. 
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Response surface models were fitted by means of least-squares calculation using the 
following second order polynomial equation, 
 [12] 
where Y is the dependent variable (response variable) to be modelled, Xi and Xj define the 
defined independent variables, b0 is the constant coefficient, bi is the coefficient of linear effect, 
bij is the coefficient of the interaction effect, bii the coefficients of quadratic effect and n is the 
number of variables. The variables X1 and X2 were t and T or P (for HAE and MAE t and T 
were used, whereas for UAE t and P were chosen). Regarding the responses, three different 
response formats were used as the dependent variables: Y1, response format value in %, to 
analyse the total extraction yield; Y2, the response format value in mg/g of extract to analyse 
the ergosterol purity in the extract and Y3 the response format value in mg/100 g M dw to 
analyse the extraction yield in ergosterol. 
Procedure to optimize the variables to a maximum response 
A simple method was used to optimize the predictive model by solving nonlinear problems in 
order to maximize the responses (Y1, Y2, and Y3) individually or globally (Vieira et al., 2017). 
Certain limitations were imposed (i.e. t cannot be lower than 0) to avoid variables with 
unnatural and unrealistic physical conditions.  
Dose-response analysis of the solid-to-liquid ratio  
Once the optimal conditions (X1 and X2) were found by RSM, the following natural 
optimization step was to describe the pattern of the solid-to-liquid ratio (S/L or X3, expressed 
in g/L) aiming at achieving a more productive process for industrial applications. To depict the 
response effect as a function of the S/L variation, the Weibull (W) equation (Prieto, Curran, 
Gowen, & Vázquez, 2015) for increasing (↑) and decreasing (↓) responses were used with some 
parametric modifications to fit the searched purposes: 
   or     [13] 
where K is the maximum extraction value (response criteria units, i.e., if Y2 units would be 
mg/g R), a is a shape parameter related to the maximum slope of the response, n is any desired 
level between 0 to 100% of the response (Y1, Y2, and Y3) that would be achieved, and mn would 
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be the S/L value (X3) for such a response level of n selected (m10, m25, m75, m95, etc.). For 
example, if 99% was select for the n value, the mn parameter will display de needed S/L needed 
to achieve 99% of the assessed response (m99%). When the response shows increasing patterns 
(↑), the Weibull equation that will be used to describe the response will present an mn parameter 
with n=99%. When the response shows decreasing patterns (↓), an mn parameter with n=50% 
will be used. These different levels of the response as a function of the increasing or decreasing 
patterns of the response are logical relations of the intrinsic solutions for industrial purposes. 
When the response increases, it seems to be logical to know the maximum S/L value needed to 
achieve 99% of the assessed response (m99%), as it is the case for Y2 and Y3 responses. However, 
when the response decreases, the value of m99% will be approximately zero. Therefore, it seems 
to be logical to search for values that do not decrease our response more than the half of the 
maximum value (such as m50%), as it is the case for Y1 response. If other mn are required, Eq. 
[13] can be modified to produce any other desired result. However, the selected parameter 
values for K and mn provide key information related to the pattern of the response to assess the 
S/L trend.  
Numerical methods and statistical analysis 
Fitting procedures, coefficient estimates, and statistical calculations were performed as 
previously described by Pinela et al. (2016). In brief, a) the coefficient measurement was 
carried out using the nonlinear least-square (quasi-Newton) method provided by the macro 
“Solver” in Microsoft Excel, which allows minimizing the sum of the quadratic differences 
between the observed and model-predicted values; b) the coefficient significance was evaluated 
using the ‘SolverAid’ to determine the parametric confidence intervals. The non-statistically 
significant terms (p-value > 0.05) were dropped to simplify the model; and c) the model 
reliability was verified using the following statistical assessment criteria: i) the Fisher F-test 
(a=0.05) was used to determine whether the constructed models were adequate to describe the 
observed data; ii) the ‘SolverStat’ macro was used for the assessment of parameter and model 
prediction uncertainties; iii) the R² and R2adj were interpreted as the proportion of variability , 
of the dependent variable explained by the model; and iv) bias and accuracy factors of all 
equations were calculated to evaluate the fittings of the experimental data, such as the mean 
squared error (MSE), the root mean square of the errors (RMSE), the mean absolute percentage 
error (MAPE) and the Durbin-Watson coefficient (DW). 
RSM is a proficient tool to evaluate the effects of numerous variables and their interactions on 
one or more responses. The CCCD is a popular form of RSM and has been applied by a number 
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of researchers for optimization of various food processing methods (Bezerra et al., 2008). 
Figure 20 shows a comprehensive summary of the different steps carried out in the 
optimization of ergosterol extraction from the fruiting bodies (basidiocarps) of A. blazei. RSM 
was applied to study the level of significance of each independent variable, for each one of the 
carried extraction methods, on their respective responses to be able to fully describe the 
interactive effects among the numerous factors. 
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Figure 20. Diagram of the different steps carried out for optimizing the conditions that maximize the extraction 
responses (Y2 in mg E/g R and Y3 in mg E/100 g M dw) of the ergosterol compound and the total extracted residue 
(Y1 in %). 
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Theoretical mathematical models derived from the RSM analysis  
In the present study, a total of 16 experimental runs were needed to optimize the extraction and 
produce the parametric values for model development in HAE, UAE, and MAE with responses 
defined as Y1, Y2 and Y3. Table 10 shows the experimental conditions; the responses according 
to the statistical CCCD experimental design are presented in Table 11, for each one of the 
computed extraction techniques.  
 
              
              
Table 11. Experimental RSM results for the optimization of the two main variables involved (X1 and X2) in the HAE, 
UAE, and MAE for the three response value formats assessed (Y1, yield in %; Y2, mg E/g R; and Y3 mg E/100 g M dw). 
Variables, natural values, and ranges in Table 10. Three replicates were performed for each condition for each technique. 
              
              
CODED VALUES 
 EXPERIMENTAL RESPONSES 
            
            
 HEAT-ASSISTED EXTRACTION (HAE)  
ULTRASOUND-ASSISTED 
EXTRACTION (UAE)  
MICROWAVE-ASSSISTED 
EXTRACTION (MAE) 
              
              
X1 X2  Y1 Y2 Y3  Y1 Y2 Y3  Y1 Y2 Y3 
              
              
-1 -1  3.33 1.14 3.80  1.55 1.21 1.88  13.18 0.48 6.33 
-1 1  15.32 1.05 16.15  8.08 2.11 17.02  22.70 0.95 21.51 
1 -1  4.25 1.66 7.07  1.87 1.23 2.31  12.05 1.52 18.39 
1 1  19.20 0.67 12.87  9.24 2.13 19.74  18.59 0.70 12.99 
-1.41 0  6.70 1.06 7.20  4.18 1.93 8.06  15.90 1.03 16.32 
1.41 0  10.63 1.65 17.54  8.81 1.60 14.10  18.58 1.34 24.93 
0 -1.41  3.51 0.50 1.75  1.70 1.14 1.94  7.49 1.15 8.60 
0 1.41  14.30 1.39 19.91  11.77 1.59 18.72  24.30 1.07 26.14 
-1.41 -1.41  3.34 0.79 2.66  1.89 0.71 2.74  6.91 0.98 6.81 
-1.41 1.41  16.63 0.91 15.21  7.43 1.64 5.85  22.32 0.90 20.04 
1.41 -1.41  4.40 1.42 6.23  1.81 1.20 2.18  8.85 1.59 14.11 
1.41 1.41  20.45 1.01 20.56  9.82 2.08 20.43  23.84 0.99 23.78 
0 0  8.91 1.84 16.43  6.63 1.64 10.90  19.03 1.15 21.91 
0 0  9.15 1.67 15.27  6.67 1.84 12.28  18.73 1.02 19.03 
0 0  9.63 1.54 14.92  6.16 2.54 15.63  18.76 1.10 20.62 
0 0  9.70 1.49 14.45  6.29 2.20 13.82  19.33 1.03 19.97 
              
              
 
By fitting the second-order polynomial model of Eq. [12] to the obtained responses, using 
nonlinear least-squares estimations, the parametric values are obtained and presented in Table 
12 Part A. 
The coefficients showing confidence interval values (a=0.05) higher than the parameter value, 
considered as non-significant (ns) and were not accounted for in the model development. In 
statistical terms, the ns parameters of the RSM approaches do not improve the reached solution 
of the models, but increase the uncertainties of all significant parameters and, in addition, the 
ns parameters distort the predicted solutions in untested conditions. This has already been 
described in the literature (Ranic et al., 2014), and suggested as a mandatory step to avoid 
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irregularities in the mathematical analysis, such as response overfitting and inaccurate 
predictions of the results of untested operating conditions. Therefore, based on the results 
presented in Table 12 A, the final resulting models for each one of the assessed extraction 
techniques were the following: 
For the response format Y1 (yield of the extracted R material, %): 
for HAE:  [14] 
for UAE:  [15] 
for MAE:  [16] 
For the response format Y2 (mg E/g R): 
for HAE:  [17] 
for UAE:  [18] 
for MAE:  [19] 
For the response format Y3 (mg E/100 g M dw): 
for HAE:  [20] 
for UAE:  [21] 
for MAE:  [22] 
1 9.90 0.86 5.23 0.42YHAEY t T tT= + + +
1 21.49 0.09 0.26 0.10YUAEY t P tP= + - +
1 213.40 1.26 5.12 1.50YMAEY t T T= + + -
2 2 26.47 0.71 2.96 0.36 0.24 0.29YHAEY t T t T tT= + + - - +
2 21.80 0.03 0.29 0.21 0.03YUAEY t P P tP= + + - -
2 2 213.15 1.97 5.41 1.15 1.53 1.63YMAEY t T t T tT= + + - - +
3 2 218.57 5.18 0.46 1.21 0.19YHAEY T t T tT= + - - -
3 1.09 0.10 0.12 0.09YUAEY t P tP= + - -
3 219.83 2.50 4.92 1.69 0.80YMAEY t T T tT= + + - -
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Table 12. Parametric results of the second-order polynomial equation of Eq. [1] for the HAE, UAE and MAE extracting techniques assessed and in terms of the extraction behaviour 
of the three response value formats (Y1, yield in %; Y2, mg E/g R; and Y3 mg E/100 g M dw), according to the experimental design. Analysis of significance of the parameters 
(a=0.05) are presented in coded values. Additionally, the statistical information of the fitting procedure to the model is presented. 
                
                
COEFFICIENTS 
PARAMETRIC RESPONSES TO THE CENTRAL COMPOSITE DESIGNS FOR EACH TECHNIQUE  
              
              
HEAT-ASSITED EXTRACTION 
 (HAE)  
ULTRASOUND-ASSISTED EXTRACTION 
 (UAE)  
MICROWAVE-ASSISTED EXTRACTION 
 (MAE) 
              
              
Y1 Y2 Y3  Y1 Y2 Y3  Y1 Y2 Y3 
                
                
Fitting coefficients obtained 
                
                
Intercept b0 9.90 ±0.63 1.49 ±0.17 13.40 ±1.58  6.47 ±0.48 1.80 ±0.07 13.15 ±0.56  18.57 ±0.88 1.09 ±0.05 19.83 ±1.42 
Linear effect b1 0.86 ±0.64 0.09 ±0.11 1.26 ±1.05  0.71 ±0.28 0.03 ±0.02 1.97 ±0.32  ns 0.10 ±0.05 2.50 ±0.87 b2 5.23 ±0.63 ns 5.12 ±1.03  2.96 ±0.28 0.29 ±0.04 5.41 ±0.32  5.18 ±0.51 -0.12 ±0.05 4.92 ±0.85 
Quadratic effect b11 ns ns ns  -0.36 ±0.22 ns -1.15 ±0.39  -0.46 ±0.28 ns ns b22 ns -0.26 ±0.13 -1.50 ±1.19  -0.24 ±0.18 -0.21 ±0.05 -1.53 ±0.39  -1.21 ±0.64 ns -1.69 ±1.04 
Interactive effect b12 0.42 ±0.16 -0.10 ±0.09 ns  0.29 ±0.15 -0.03 ±0.03 1.63 ±0.29  -0.19 ±0.13 -0.09 ±0.04 -0.80 ±0.76 
                
                
Statistical information of the fitting analysis 
                
                
Obs 48 48 48  48 48 48  48 48 48 
R² 0.9179 0.8234 0.8153  0.9158 0.8123 0.8767  0.9463 0.8354 0.8849 
R²adj 0.9326 0.9533 0.8034  0.9003 0.8006 0.8795  0.8912 0.8156 0.8773 
MEC 280.1 960.3 0.008  602.7 1363.9 0.016  158.0 2397.5 0.003 
RMSE 16.73 30.99 0.088  24.55 36.93 0.126  12.57 48.96 0.050 
MAPE 12.15 11.46 8.32  12.78 11.05 6.55  12.41 15.23 5.07 
DW 2.228 2.071 2.101  1.321 2.043 2.047  2.179 1.659 2.093 
                
                
ns: non-significant coefficient; Obs: Number of observations; R²: Coefficient of determination; R²adj: The adjusted determination coefficient for the model; MSE: The Mean Square of 
the Error; RMSE: The Root Mean Square of the Errors; MAPE: The Mean Absolute Percentage Error; and DW: The Durbin-Watson statistic. 
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The variable models of Eqs. [14] to [22] derived from Eq. [12], where X1 (t, min) and X2 (T, ºC 
or P, W); Y is the response, with the sub-indices indicating the applied technique and the super-
indices the three used response criteria (Y1 in %, Y2 in mg E/g R and Y3 in mg E/100 g M dw). 
The parametric information presented in Table 12 or Eqs. [14] to [22], provides a complete 
summary of the effects caused by each one of the variables defined for each extraction system. 
These equations translate the response patterns, showing a relatively high complexity (higher 
than 5 parameters) of the possible sceneries for the Y1 and Y2 value formats and relatively 
simple solutions for the Y3 response value format (less than 4 parameters). 
Since the experimental plan is based on coded values of the variables, the obtained model 
coefficients are empirical and cannot be associated with physical or chemical parameters. 
However, their numerical values can be used for direct comparisons. In fact, the higher the 
absolute value of the coefficients is, the more important will be the weight of the corresponding 
variables. Correspondingly, when a factor has a positive effect, the response increases as the 
value of the involved variable increase, and when the factor has a negative effect, the response 
decreases. 
Graphical illustrations and general analysis of the results 
Figure 21, 22 and 23 show the fitting analysis, graphical descriptions of the responses as a 
function of each defined variable, statistical analysis and optimal conditions that maximize the 
assessed response format value (Y1, Y2, and Y3) of each variable for the HAE, UAE and MAE 
techniques. In each of these figures (Figure 21, 22 and 23), the illustration is divided in four 
sections: 
- Part A shows the surface plots in 3D response surface predicted with the second order 
polynomial Eq. [12] as a function of each one of the involved variables.  
- Part B shows the 2D contour plots of the simulations achieved with the models of Eqs. 
[14] to [22] after fitting the experimental results to Eq. [12].  
- Part C shows an illustration of the statistical robustness of the performed mathematical 
analysis. Two basic graphical criteria were used: the ability to simulate the changes of 
the response using the correlation between experimental and predicted values and the 
residual distribution as a function of each of the variables. 
- Part D shows the summarized individual 2D responses as a function of the defined 
variables for the HAE, UAE and MAE extraction systems to guide the selection of the 
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most favourable conditions. The line represents the variable response pattern when the 
others are located at the optimal values. The dots () presented alongside the line 
highlight the location of the optimal value. 
Observing the response surface plots for the extraction yield in the HAE system in Figure 21, 
it is possible to verify that the amount of extracted material increases up to a maximum value 
as t and T increase. On the other hand, in the UAE system the amount of extracted material 
increases to an optimum value and then starts to decrease as a function of t and P. In the MAE 
technique, a higher T favours a faster diffusion, thus achieving a higher content in Y1 due to an 
increase in the solubility and diffusion coefficient from the solid to the liquid matrix. Despite 
this positive effect on the extraction yield, increasing T may also affect the stability of the 
compound of interest. Hence, a combination of lower t and moderate T resulted in a better 
extraction yield. Observing the predicted surfaces for Y2 response format value (mg E/g R) in 
Figure 22, it is possible to draw the following conclusions: in MAE, a negative interactive 
effect between variables was observed (positive for t and negative for T), which indicates that 
higher t might be beneficial to improve exudation of active constituents from the ruptured cell 
walls, but prolonged exposure may cause compound deterioration, thus reducing the ergosterol 
purity in the extract. In the UAE system, the variable P was found to have a positive effect on 
Y2. The 2D response contour plot of Figure 22 (Part B), shows mutual interactions between the 
variables, whereas the circular contour plot reveals less interaction between the corresponding 
variables, and the elliptical contour plot shows the most significant interactions between the 
variables. The 2D plot for the UAE technique shows the most significant interactions, meaning 
that a moderate value of t and a higher P value generated the highest yield in ergosterol (mg 
E/g R). Observing Figure 23 and comparing the results among all the techniques, it allows 
concluding that MAE gave significantly higher values at a shorter t. The results with the UAE 
technique indicate that Y3 increased as a function of P and t increase, while an opposite effect 
was observed for HAE.
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Figure 21. Graphical results in terms of response value format Y1 (%) using HAE, UAE, and MAE extraction techniques. Part A: Points () represent the obtained experimental 
results (Table 11) and the net surface represents the theoretical 3D response surface predicted with the second order polynomial Eq. [12] as a function of each of the variables 
involved. Estimated parametric values are shown in Table 12. Part B: Two-dimensional representation of the fitting results of Eq. [12]. The binary actions between variables 
are presented when the excluded variable is positioned at the optimum of the experimental domain (Table 13). Part C: To illustrate the statistical description, two basic graphical 
criteria are used: the ability to simulate the changes of the response and the residual distribution as a function of each of the variables. Part D: The dots () presented alongside 
each line highlight the location of the optimum value. Lines are generated by Eq. [12]
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Figure 22. Graphical results in terms of response value format Y2 (mg E/g R) using HAE, UAE, and MAE extraction techniques. Part A: Points () represent the obtained 
experimental results (Table 11) and the net surface represents the theoretical 3D response surface predicted with the second order polynomial Eq. [12] as a function of each of 
the variables involved. Estimated parametric values are shown in Table 12. Part B: Two-dimensional representation of the fitting results of Eq. [12]. The binary actions between 
variables are presented when the excluded variable is positioned at the optimum of the experimental domain (Table 13). Part C: To illustrate the statistical description, two 
basic graphical criteria are used: the ability to simulate the changes of the response and the residual distribution as a function of each of the variables. Part D: The dots () 
presented alongside each line highlight the location of the optimum value. Lines are generated by Eq. [12]. 
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Figure 23. Graphical results in terms of response value format Y3 (mg E/100 g M dw) using HAE, UAE, and MAE extraction techniques.  
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Statistical and experimental verification of predictive models 
To assess the competence of the obtained models of Eqs. [14] to [22], several statistical tests 
were used, and the results are presented in Table 12. In general, for all the developed models, 
the statistical tests merge into the same conclusions: the models are practical and can be applied 
effectively in subsequent prediction stages. In fact, the most common statistical criteria 
presented in Table 12, coefficients R2 and R2adj, in all cases, displayed values higher than 0.8, 
which indicates a good agreement between the experimental and predicted values. The 
distribution of the experimental and predicted values can be visualized in part C of Figure 21 
to 23. Indeed, it suggests that more than 80% of variability was successfully explained by the 
model, thus indicating the suitability of the model and a high level of correlation between the 
observed and predicted values. For all extraction methodologies, all experimental points were 
found to be close to the line of perfect fit, suggesting an accurate correlation between the 
predicted and experimental values, what further confirms the suitability of the employed 
model. Additionally, the residuals distribution presented in Part C of Figure 21 to 23 was in 
all cases arbitrarily distributed around zero, and no group of values or autocorrelations were 
observed. This implies that the variation of the experimental results can be explained by the 
independent processing variables by using the specific parametric values presented in Table 
12, which validates the models of Eqs. [14] to [22], and allows the determination of the optimal 
conditions that will maximize the responses. 
Numerical optimal conditions that maximize the extraction and experimental verification of 
predictive models 
By applying a simple method to solve nonlinear problems, the optimum individual condition 
maximizing the recovery of ergosterol were determined for the three possible response format 
values. In addition, the global optimum conditions can also be determined. Both individual and 
global optimal conditions are presented in Table 13. The best results of the found optimal 
individual values, for each of the responses, are as follows: 
- For the extraction yield, response value Y1, the MAE was the best solution: 23.50±4.3% 
was achieved at 11.1±1.2 min and 150±10.2 ºC. 
- For the ergosterol purity in the extract, response value Y2, the UAE was the best 
solution: 1.92±0.2 mg/100 g E, was achieved at 30.0±1.5 min and 311.7±31.2 W  
- For the response yield in ergosterol, response value Y3, the MAE was the best solution; 
25.50±3.5 mg/100 g M dw was achieved at 25.0±3.4 min and 140.7±12.1 ºC. 
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The global optimal conditions found are as follow: 
- For the response value Y1, the MAE was the best solution: 21.16±2.3% was achieved 
at 25.0±2.6 min and 134.6±10.9 ºC.  
- For the response value Y2, the UAE was the best solution: 1.77±0.6 mg/100 g E, was 
achieved at 30.0±4.3 min and 400.0±18.7 W  
- For the response value Y3, the MAE was the best solution: 25.44±5.1 mg/100 g M dw 
was achieved at 25.0±2.6 min and 134.6±10.9 ºC. 
 
      
CRITERIA 
OPTIMAL VARIABLE CONDITIONS  OPTIMUM RESPONSE 
  
   
 X1: t (min) X2: T (ºC) or P(W)  
      
      
A) Individual optimal variable conditions: 
      
      
Maceration 
(ME) 
Y1 150.0±5.3 90.0±6.4  19.37±1.2 % 
Y2 150.0±6.2 54.3±7.1  1.64±0.2 mg E/g R 
Y3 150.0±4.9 90.0±8.6  19.43±3.1 mg E/100 g M dw 
      
      
Ultrasound  
(UAE) 
Y1 30.0±7.9 400.0±15.2  11.03±0.9 % 
Y2 30.0±1.5 311.7±31.2  1.92±0.2 mg E/g R 
Y3 30.0±6.2 400.0±51.1  21.49±1.9 mg E/100 g M dw 
      
      
Microwave  
(MAE) 
Y1 11.1±1.2 150.0±10.2  23.50±4.3 % 
Y2 25.0±4.2 60.0±11.5  1.59±0.4 mg E/g R 
Y3 25.0±3.4 140.7±12.1  25.50±3.5 mg E/100 g M dw 
      
      
B) Global optimal variable conditions:  
      
      
Maceration 
(ME) 
Y1 
150.0±6.1 81.6±2.6 
 17.05±1.9 % 
Y2  1.21±0.1 mg E/g R 
Y3  18.84±2.3 mg E/100 g M dw 
      
      
Ultrasound  
(UAE) 
Y1 
30.0±4.3 400.0±18.7 
 11.03±3.1 % 
Y2  1.77±0.6 mg E/g R 
Y3  21.49±0.9 mg E/100 g M dw 
      
      
Microwave  
(MAE) 
Y1 
25.0±2.6 134.6±10.9 
 21.16±2.3 % 
Y2  1.01±0.1 mg E/g R 
Y3  25.44±5.1 mg E/100 g M dw 
       
       
 
Considering both the individual and global values, the higher extract yield was obtained using 
the MAE technique. HAE also conducted to high extraction yields but requiring higher 
extraction times. In terms of Y2, UAE reached maximum results by consuming less energy and 
time, while providing higher ergosterol purity in the extract, which is aligned with the 
requirements of green technology. The results herein obtained are in accordance with 
Table 13. Variable conditions in natural values that lead to optimal response values for RSM according to the 
experimental design (Table 10) for each of the extracting techniques assessed (HAE, UAE and MAE), for the 
three individual response value formats (Y1, yield in %; Y2, mg E/g R; and Y3 mg E/100 g M dw) and for the 
global optimal conditions. 
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conclusions previously reported (Chemat et al., 2017; Montesano et al., 2008; Zhu et al., 2016). 
UAE is an eco-friendly alternative to conventional techniques. The main benefits are the time 
and energy reduction, and type of applied solvents, consequently minimizing industrial 
emissions (Chemat et al., 2017), which is an objective of the sustainable ‘‘green” chemistry. 
The extraction processes are completed in minutes with high reproducibility, simplifying 
manipulation and work conditions, giving products with higher purity and eliminating further 
treatment as it occurs in conventional extraction methods such as Soxhlet extraction or 
maceration (Chemat et al., 2017).  
Optimization of solid-liquid extraction using HAE, MAE and UAE technique 
As already described elsewhere, the ideal S/L should be one that allows the solvent to penetrate 
the structure of the solid matrix (Pinela et al., 2017), allowing also the solvent to dissolve all 
the target compounds (Albuquerque et al., 2016). Therefore, a study aiming to evaluate the S/L 
effect was conducted at the global optimal conditions predicted by the polynomial models 
obtained for HAE, UAE, and MAE techniques (Table 13, part B). Preliminary experiments 
indicated a limit value of S/L near to 120 g/L. Therefore, the dose-response analysis process 
was designed to analyse the S/L from 5 to 120 g/L.  
The dose-response results to the study of the S/L effects for the three response value formats 
(Y1, Y2, and Y3), and each one of the used three techniques was evaluated by fitting the Weibull 
model of Eq. [13] (in its increasing or decreasing form) to the obtained responses using 
nonlinear least-squares estimations. The obtained parametric values are presented in Table 14.  
The effects caused by the increase of the S/L on the response value formats are graphically 
shown in Figure 24 for the three studied techniques. Figure 24 part A shows the experimental 
dose-response results (in which: Y1 , Y2 £ and Y3) at the global optimal values of the two 
variables defined for each of the three assessed techniques (HAE, UAE and MAE), and their 
respective predictions made by the mathematical model of Eq. [13] (lines). In general, a non-
linear effect can be observed for all responses as the S/L dose-response increases, causing a 
saturated-decreasing effect (↓) for the Y1 (%) value format and saturated-increasing effects (↑) 
for the Y2 (mg E/g R) and Y3 (mg E/100 g M dw) value formats. Figure 24, part B shows, 
jointly, the dose-response simulation trends for HAE, UAE and MAE for comparison purposes. 
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 PARAMETRIC VALUES  STATISTICS 
      
      
 K m50% or m99% A  R2 
  
  
Y1 (%)  
  
  
HAE 33.43 ±2.19 41.14 ±4.51 0.79 ±0.08  0.9848 
UAE 22.00 ±3.65 53.85 ±6.28 0.65 ±0.17  0.8604 
MAE 26.98 ±3.51 82.76 ±8.58 1.60 ±0.19  0.9030 
  
  
Y2 (mg E/g R)  
  
  
HAE 2.57 ±0.63 155.46 ±12.61 1.22 ±0.09  0.9916 
UAE 2.92 ±0.33 102.44 ±17.96 1.17 ±0.11  0.9750 
MAE 1.01 ±0.19 12.70 ±2.11 7.40 ±0.87  0.9363 
  
  
Y3 (mg E/100 g M dw)  
  
  
HAE 22.60 ±3.45 25.34 ±2.17 2.32 ±0.26  0.9430 
UAE 25.07 ±4.12 36.35 ±2.25 1.38 ±0.18  0.8955 
MAE 28.01 ±3.76 26.57 ±3.85 1.71 ±0.37  0.9895 
  
  
 
The analysis of the results can be interpreted by means of the two main parameters K and mn 
(at 50% or 99% of the response). The parameter K shows the maximum extraction value that 
can be obtained as a function of the S/L dose-response. Thus, the lower the mn values are, the 
higher are the extraction levels reached in a shorter dose-response, which would limit the 
possibility of reducing the amount of needed solvent for industrial purposes. Given these 
considerations, both values are important to understanding the trends of the S/L dose-response 
effect. In a more detailed analysis, the following aspects can be observed: 
Table 14. Parametric results of the second-order polynomial equation of Eq. [13] or the HAE, UAE, and MAE 
techniques assessed in terms of the variation of the S/L. 
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Figure 24. Graphical illustration of the effects caused by the S/L on the response value formats for the three 
studied techniques. Part A shows the fitting analysis of the experimental dose-response results (in which: Y1 , 
Y2 £ and Y3 ) at the global optimal values of the two other variables for each of the three techniques assessed 
(HAE, UAE and MAE) and their respective predictions made by the mathematical model of Eq. [13] (lines). 
Meanwhile, part B shows the dose-response simulation trends for HAE, UAE, and MAE jointly for comparison 
purposes. 
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- For Y1 values, a response that translates the extraction yield: a saturated-decreasing 
dose-response pattern was found, which means that Y2 initially decreases to zero as S/L 
increases. For HAE, UAE, and MAE the m50% values obtained were 41.14±4.51, 
53.85±6.28, and 82.76±8.58 g/L, respectively, with a maximum extraction yield 
(parametric value of K) of 33.43±2.19, 22.00±3.65 and 26.98±3.51%, for all the 
assessed techniques. The R2 values obtained for the fitting results of the experimental 
values to Eq [13] in its saturated-decreasing form (↓) were 0.9848, 0.8604 and 0.9030 
for HAE, UAE, and MAE, respectively. 
- For Y2 values, a response that gives the ergosterol purity in the extracted: a saturated-
increasing (↑) dose-response pattern was observed, which means that Y1 initially 
increases as the S/L increases, but when certain S/L levels are reached the ergosterol 
purity in the extract remains constant. For HAE, the response increases until S/L reaches 
values close to 155.46±12.61 g/L (parametric value m99% from Eq. [13], Table 14), 
allowing a content of 2.57±0.63 mg E/g R (parametric value K from Eq. [13], Table 
14, positive). For UAE, the m99% value was 102.44±17.96 g/L, with a K value of 
2.92±0.33 mg E/g R, and for MAE, 12.70±2.11 g/L was obtained as m99%, with K giving 
1.01±0.19 mg E/g R. In HAE and MAE, the achieved increased levels of ergosterol 
purity by varying the S/L are not as pronounced as those observed with UAE, a fact that 
may be related to instrumental limitations. The R2 values obtained for the fitting results 
of the experimental values of Eq [13] in its saturated-decreasing form (↓) were 0.9916, 
0.9750 and 0.9363 for HAE, UAE, and MAE, respectively. 
- For Y3 values, a response that reflects the yield in ergosterol: a saturated-increasing (↑) 
dose-response pattern was noticed, which means that Y2 initially increases as the S/L 
values increase. For HAE, UAE, and MAE the m99% the obtained values were 
25.34±2.17, 36.35±2.25, and 26.57±3.85 g/L, respectively, presenting K values of 
22.60±3.45, 25.07±4.12 and 28.01±3.76 E/100 g M dw, respectively. These results may 
reflect the total ergosterol content available in the mushroom fruiting body, once the 
maximum concentration is achieved. In the non-conventional techniques (UAE and 
MAE) the decreasing effect is less noticeable, comparatively with the used 
conventional extraction method (HAE). In fact, for UAE and MAE, the S/L effect 
remains almost constant until ~120 g/L. 
In conclusion, UAE was the best extraction technique, closely followed by MAE. The less 
effective extraction system was HAE. These results prove that alternative solid-liquid 
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extraction methods are more suitable than the conventional ones for the extraction of ergosterol 
from ABM fruiting bodies. The findings of this work are in accordance with the ones of Tomšik 
et al. (2016), which stated that UAE enhances the extraction process by increasing the mass 
transfer between the solvent and the plant material.  The collapse of cavitation bubbles leads 
to a better cell disruption facilitating the release of extractable compounds, allowing greater 
penetration of solvent into the sample matrix, thus increasing the contact surface area between 
the solid and liquid phase (Chemat et al., 2017; Tomšik et al., 2016). 
Comparison of the efficiency of ergosterol extraction by conventional and non-conventional 
techniques 
Chemical synthesis of ergosterol and other valuable sterols can be carried out by chemical 
esterification and lipase-catalysed esterification that requires several energy and material 
consuming steps (He et al., 2014). Production of these valuable ingredients using these routes 
presents disadvantages, making alternative processes, such as extraction from ergosterol-rich 
matrices, attractive methods for ergosterol obtainment. Several authors have reported the 
extraction of ergosterol from mushrooms using the Soxhlet system (Barreira et al., 2014; 
Heleno, Diz, et al., 2016; Taofiq, Heleno, et al., 2016). A. bisporus and other edible or 
medicinal mushrooms belonging to the Agaricus genus have been reported to be novel sources 
of ergosterol (Table 15). A. bisporus presented the higher content of ergosterol (J. Deng et al., 
2017), when compared to other species, however, A. blazei can be valorised as a viable source 
of ergosterol, considering the surplus amount of its fruiting bodies that are discarded in the 
production/processing chain. From previous studies also reported in Table 15, extraction of 
ergosterol has been carried out using conventional techniques, as well as non-conventional 
methods, with the latter requiring milder conditions. Most of the methods reported in Table 15 
were conducted using one variable at a time, what in most cases does not guarantee 
maximization of the ergosterol recovery. Hence, carrying out RSM using a series of 
experimental domains, and possible combination of independent variables, presents advantages 
(Heleno, Diz, et al., 2016; Heleno, Prieto, et al., 2016).
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TECHNIQUE 
MUSHROOM MATERIAL SOLVENT  
CONDITIONS 
CONTENT REFERENCE 
Source Used parts Type Proportion (%) (mg E/100 g) 
HAE Agaricus bisporus Mycelium Methanol 100 25˚C, 1hr, non-saponified 17.49 ± 1.45 (Cardoso et al., 2017) 
HAE Agaricus bisporus Fruiting bodies Ethanol 95 1M NaOH, 80˚C, 1hr saponified 33.54 ± 6.34 (Shao et al., 2010) 
HAE Agaricus bisporus P Fruiting bodies Ethanol 95 1M NaOH, 80˚C, 1hr saponified 48.24± 3.12 (Shao et al., 2010) 
HAE Agaricus bisporus Fruiting bodies Ethanol 95 80˚C, 1hr, saponified 43.22±5.11 (N. K. Lee & Aan, 2016) 
HAE Agaricus arvensis Fruiting bodies Methanol 100 2M NaOH, saponified 26.83 ± 8.71 (Gąsecka et al., 2017) 
HAE Agaricus bisporus P Fruiting bodies Methanol 100 2M NaOH, saponified 26.46± 1.52 (Gąsecka et al., 2017) 
HAE Agaricus bisporus Fruiting bodies Methanol 100 2M NaOH, saponified 1.15 ± 36.16 (Gąsecka et al., 2017) 
HAE Agaricus bitorquis Fruiting bodies Methanol 100 2M NaOH, saponified 35.35 ± 0.55 (Gąsecka et al., 2017) 
HAE Agaricus brasiliensis Fruiting bodies Methanol 100 2M NaOH, saponified 6.01 ± 0.32 (Gąsecka et al., 2017) 
HAE Agaricus campestris Fruiting bodies Methanol 100 2M NaOH, saponified 42.34± 0.48 (Gąsecka et al., 2017) 
HAE Agaricus silvaticus Fruiting bodies Methanol 100 2M NaOH, saponified 45.82 ± 2.11 (Gąsecka et al., 2017) 
PLE Agaricus bisporus Fruiting bodies Ethanol -- 10.68 MPa, 50˚C 93.06 ± 4.21 (Gil-Ramírez et al., 2013) 
CAE Agaricus bisporus Fruiting bodies Hexane -- 4000 rpm,10 min 612.65 ± 9.45 (Guan et al., 2016) 
CAE Agaricus bisporus P Fruiting bodies Hexane -- 4000 rpm,10 min 759.34 ± 13.56 (Guan et al., 2016) 
CAE Agaricus brazilienses Mycelium Ethanol 95 4000 rpm, 20 min 74.67 ± 4.87 (H. Gao & Gu, 2007) 
MAE Agaricus bisporus Fruiting bodies Ethanol -- 19.4 min, 132.8˚C 555.3 ± 23.6 (Heleno, Prieto, et al., 2016) 
SFAE Agaricus bisporus Fruiting bodies Ethanol 10 9-30 MPa, 40 °C, 532.45 ± 4.85 (Gil-Ramírez et al., 2013) 
UAE Agaricus bisporus Fruiting bodies Ethanol 100 15 min, 375W 19.49 ± 0.74 (C. R. L. Francisco et al., 2018) 
UAE Agaricus bisporus Fruiting bodies Hexane  15 min, 375W 152.22 ± 6.53 (Heleno, Diz, et al., 2016) 
UAE Agaricus bisporus Fruiting bodies Ethanol 100 15 min, 375W 671.53 ± 10.51 (Heleno, Diz, et al., 2016) 
UAE Agaricus bisporus Fruiting bodies Limonene -- 15 min, 375W 372.02 ± 0.17 (Heleno, Diz, et al., 2016) 
UAE Agaricus bisporus Fruiting bodies Ethanol 100 15 mins, 375W 36.72 ± 0.01 (Heleno et al., 2017) 
SE Agaricus bisporus P Fruiting bodies Hexane 100 2hr 77.34 ± 1.45 (Barreira et al., 2014) 
SE Agaricus bisporus Fruiting bodies Hexane 100 2hr 352.32 ± 1.64 (Barreira et al., 2014) 
SE Agaricus bisporus Fruiting bodies Hexane 100 4hr, 12 cycles 186.11 ± 0.33 (Heleno, Diz, et al., 2016) 
SE Agaricus bisporus Fruiting bodies Ethanol 100 4hr, 12 cycles 676.12 ± 31.23 (Heleno, Diz, et al., 2016) 
SE Agaricus bisporus Fruiting bodies Limonene 100 4hr, 12 cycles 261.86 ± 11.75 (Heleno, Diz, et al., 2016) 
HAE-Heat assisted extraction; PLE-Pressurized liquid extraction; CAE-Centrifuge assisted extraction; MAE--Microwave assisted extraction; SFAE-Supercritical fluid assisted 
extraction; UAE-Ultrasound assisted extraction, SE- Soxhlet extraction.
Table 15. Ergosterol content reported in some Agaricus genus. 
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Conventional techniques such as SE and HAE have been used for decades requiring large 
solvent consumption and being high time-consuming processes, leading often to the 
degradation of compounds with health-related risks (Heleno, Diz, et al., 2016). However, non-
conventional extraction techniques such as the UAE and the MAE are being applied to 
maximize the extraction of several valuable compounds from natural matrices using shorter 
times and with high reproducibility (Rezende, Nogueira, & Narain, 2017). The MAE optimum 
conditions provided the highest extraction yield, while the UAE under the optimum achieved 
conditions conducted to the highest ergosterol purity in the extract.  The simplicity of using 
conventional extraction methodologies (HAE or maceration) vs the advantages of using non-
conventional technologies (microwave, ultrasound) to recover bioactive compounds from 
natural matrices, from an environmental and economic point of view, has received special 
attention in the last decades. In the present study, the optimum conditions of (t, T, and P; 
depending on the chosen technique), to recover ergosterol from A. blazei using HAE, MAE 
and UAE were established using RSM. The used response criteria account with the extraction 
yield, ergosterol purity in the extract, and yield in ergosterol. The results showed that the 
optimum conditions to maximize responses lie in the selected experimental domains that were 
selected. The values predicted by the models are in close agreement with the experimental 
observations, proving the validity of the model and the utility of the predictions for a future 
scale-up of the studied process, production of ABM-based ergosterol-rich extracts. The UAE 
technology, at the optimum conditions, was identified as the most appropriate to obtain high 
content ergosterol-rich extracts, followed by MAE and HAE. The obtained ergosterol-rich 
extracts can be applied as bioactive ingredients for food, pharmaceutical, cosmeceutical and 
nutraceutical purposes. 
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3.2. The bioactive and chemical composition of mushroom extracts towards the 
development of mushroom-based cosmeceutical formulation. 
 
The cosmeceutical potential of A. bisporus, L. edodes, and P. ostreatus ethanolic extracts was 
establish through the assessment of their anti-inflammatory, antimicrobial, antioxidant, and 
anti-tyrosinase activities, and further incorporation in a cosmetic base cosmetic cream. The 
bioactive properties of the final formulations were confirmed and related to the chemical 
ingredients present in the extracts, namely phenolic acids and ergosterol. 
 
3.2.1. The chemical composition of mushroom ethanolic extracts  
 
The chemical composition of the mushroom extracts is presented in Table 16. P. ostreatus 
showed the highest content in phenolic acids and cinnamic acid (a related compound), followed 
by L. edodes and, finally, A. bisporus. The highest content in P. ostreatus is due to the 
contribution of cinnamic and p-hydroxybenzoic acids, found in much higher amounts in this 
species, followed by p-coumaric acid. Protocatechuic acid was only identified in L. edodes, 
while A. bisporus only revealed the presence of cinnamic acid. The results are consistent with 
the ones published by Taofiq et al. (2015) that reported the presence of all those three phenolic 
acids in P. ostreatus ethanolic extract obtained by maceration and only cinnamic acid in A. 
bisporus. Carneiro et al. (2013) described the presence of vanillic and p-coumaric acids in 
methanol/water (80:20, v/v) extract of L. edodes from Brazil. The differences between the used 
extraction procedures and mushroom origin can justify the dissimilarity observed in the 
achieved phenolic acids profile. In the present study, the magnitude of the ergosterol content 
was: P. ostreatus > A. bisporus > L. edodes, even though Barreira et al. (2014) reported a 
different order, namely A. bisporus > L. edodes > P. ostreatus, but these authors used Soxhlet 
extraction with a different solvent (n-hexane). 
 
3.2.2. Bioactive properties of the mushroom ethanolic extracts  
 
The anti-inflammatory effects of the ethanolic extracts were assessed upon stimulation of RAW 
264.7 macrophages with lipopolysaccharide for the production of the inflammatory mediator 
(NO). The most efficient species were A. bisporus and L. edodes, presenting the lowest EC50 
values, followed by P. ostreatus (Table 17). The high activity exhibited by L. edodes extract 
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may be related to its high content of protocatechuic acid, but without discarding the presence 
of other metabolites from different chemical classes such as terpenes, polysaccharide and lipid 
metabolites that have also been reported as important contributors to the anti-inflammatory 
activity of mushroom extracts (Elsayed et al., 2014). A. bisporus displayed the highest anti-
tyrosinase activity among the studied mushroom species (Table 17). P. ostreatus and L. edodes 
exhibited very similar activities. To the author’s best knowledge, there are no reports on the 
anti-tyrosinase activity of A. bisporus. The activity displayed by the studied mushroom extracts 
were related with the identified phenolic acids and ergosterol and the studied mushroom 
extracts can be considered good candidates to be further explored as inhibitors of tyrosinase. 
A. bisporus and P. ostreatus showed the highest radical scavenging activity and reducing power 
(Table 17). The obtained results are consistent with the ones reported by Reis, Martins, Barros, 
& Ferreira, (2012), where A. bisporus methanolic extracts obtained by maceration gave the 
highest DPPH radical scavenging activity. Heleno, Ferreira, et al., (2015) reported that the 
reducing power of L. edodes methanolic extracts obtained by maceration revealed an EC50 of 
3.19±0.03 mg/mL, like the one reported in the present study. All the mushroom extracts 
showed antibacterial potential against MSSA and MRSA (Table 18). Regarding the Gram-
positive bacteria strains, in general, L. edodes showed the highest activity against the tested 
bacteria by presenting the lowest MIC values, while A. bisporus revealed the weakest activity 
presenting the highest MIC values against MSSA and MRSA and no activity against E. 
faecalis. P. ostreatus and L. edodes showed antibacterial activity against E. faecalis. None of 
the extracts was able to inhibit the growth of Gram-negative bacteria strains, even at the highest 
tested concentration (20 mg/mL). These results are in agreement with the ones reported by 
Barros, Cruz, Baptista, Estevinho, & Ferreira (2008) that described the absence of antibacterial 
activity in A. bisporus methanolic extracts against P. aeruginosa.  Alves et al. (2013) also 
reported no activity for A. bisporus against resistant P. aeruginosa and E. coli. However, 
Stojković et al. (2014a) reported antibacterial activity of this mushroom (methanolic and 
ethanolic extracts) against E. coli and P. aeruginosa, but this may be due to the fact that these 
authors used ATCC bacteria whereas in the present work all the bacteria strains were clinical 
isolates with an antibiotics resistance profile (Annex). The normal microflora of the skin 
includes S. epidermis, S. aureus and P. aeruginosa, among others (Rodrigues et al., 2013). 
Taking into account that these microorganisms are opportunistic and have high resistance 
profiles, they are a threat when skin lesions occur, causing severe localized infections even 
with systemic invasion (Russo et al., 2016). Thus, finding extracts/compounds with high 
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cosmeceutical formulations. The mechanism of phenolic compound’s antibacterial activity has 
been attributed to its ability to interfere with the bacteria membrane causing their disruption 
and subsequent DNA damage (Martins, Barros, Henriques, Silva, & Ferreira, 2015). 
 
3.2.3. Chemical profile and bioactivity of the final cosmeceutical formulations 
 
In the base cosmetic creams incorporated with the extracts, the presence of phenolic acids, 
including cinnamic acid, and ergosterol were monitored by HPLC-PDA and HPLC-UV. By 
analysing Table 16 it can be concluded that all the target compounds were stable when 
incorporated in the base cosmetic cream matrix. In fact, they were detected at almost the same 
amount as firstly found in the extracts. It was possible to quantify in the final cosmeceutical 
formulations up to 85% of the content quantified in the extracts before incorporation.  
The anti-inflammatory, anti-tyrosinase, antioxidant and antibacterial activities of the final 
cosmeceutical formulations were also evaluated, and the results are given in Table 17. The 
final formulations incorporated with A. bisporus and L. edodes showed the highest anti-
inflammatory activity like it was observed with the individual ethanolic extracts; while P. 
ostreatus presented the lowest anti-inflammatory potential. The cosmeceutical formulation 
incorporated with A. bisporus extract revealed the highest anti-tyrosinase, while P. ostreatus 
and L. edodes revealed the lowest one, also in agreement with the individual activity of the 
extracts before incorporation. A. bisporus and P. ostreatus cream formulations showed the 
highest antioxidant activity, while L. edodes presented the lowest DPPH scavenging activity 
and reducing power. All the cosmeceutical formulations showed inhibition against MSSA and 
MRSA (Table 18). A. bisporus cream formulation revealed the lowest activity for MSSA and 
MRSA and did not present activity against E. faecalis. L. edodes cream formulation showed 
the highest activity against E. faecalis, MSSA and MRSA. The cosmeceutical formulations 
displayed antibacterial activity against the same bacteria species that were inhibited by the 
extracts. All the bioactivities were affected when extracts were incorporated into the base 
cosmetic cream formulations, increasing the EC50 values to higher concentrations, but still 
displaying all the bioactivities evaluated and maintaining the levels of the analysed bioactive 
compounds. This increase in the EC50 values can be due to some interferences of the base 
cosmetic cream that may affect the extract availability to exert the same bioactivity. 
Considering the antioxidant and the antibacterial activities exhibited by the final cream 
formulations, mushroom extracts can also act as preservatives in the final formulations.
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 Mushroom extracts Cosmeceutical formulations 
Phenolic acids (µg/g) A. bisporus P. ostreatus L. edodes A. bisporus cream P. ostreatus cream L. edodes cream 
Cinnamic acid 90.06± 0.74b 362.7 ± 1.28a 7.31± 0.14c 87.73 ± 1.63b 317.43±1.32a 6.10 ± 0.56c 
p-Hydroxybenzoic acid nd 157.78 ± 4.13 83.05± 2.15 nd 138.88 ± 2.30 73.67 ± 1.56 
p-Coumaric acid nd 63.74 ± 0.15 nd nd 53.16 ± 2.94 nd 
Protocatechuic acid nd nd 52.45±0.38 nd nd 39.85±1.53 
Total (µg/g) 90.06± 0.74c 584.24 ± 3.01a 142.81 ± 2.39b 87.73 ± 1.63c 509.47 ± 3.93a 119.61± 2.54b 
Ergosterol (mg/g) 44.79 ± 0.37b 78.20 ± 0.54a 8.94± 0.04c 41.43±1.38b 71.62±0.29a 8.60±0.25c 
nd- not detected. In each row and within each group of samples (mushroom extracts and final cosmeceutical formulations), different letters mean significant statistical differences 
(p<0.05).  
 
Bioactivities 
Mushroom extracts Cosmeceutical formulations 
A. bisporus P. ostreatus L. edodes A. bisporus cream P. ostreatus cream L. edodes cream 
Anti-inflammatory (EC50 value, mg/mL) 0.18 ± 0.01b 0.29 ±0.03a 0.16 ±0.01b 2.52±0.23b 3.81±0.23a 2.59±0.23b 
Anti-tyrosinase (EC50 value, mg/mL) 0.16 ± 0.01b 0.86 ± 0.07a 0.82 ± 0.08a 3.22±0.37b 11.01±0.35a 11.89±0.85a 
Antioxidant (EC50 value, mg/mL)       
DPPH radical-scavenging activity 7.04 ± 0.32b 7.69 ± 0.20b 23.36 ± 1.11a 234.3±10.9b 239.5±10.4b 321.8±16.4a 
Reducing power 2.34 ± 0.05b 2.36 ± 0.08b 3.03 ± 0.04a 35.91±0.31b 32.18±2.73c 48.90±0.64a 
Dexamethasone was used as a positive control for anti-inflammatory activity (EC50=0.016 mg/mL). Ascorbic acid was used as positive control for anti-tyrosinase activity 
(EC50=0.031 mg/mL). Trolox was used as a positive control for antioxidant activity (EC50=0.041 mg/mL for reducing power and 0.042 mg/mL for DPPH scavenging activity. 
In each row and within each group of samples (mushrooms extract and final cosmeceutical formulations), different letters mean significant statistical differences (p<0.05).  
Table 16. Phenolic acids and ergosterol content in the mushrooms ethanolic extract and in the cosmeceutical formulations. 
Table 17. Anti-inflammatory, anti-tyrosinase, and antioxidant activities of the mushroom ethanolic extracts and of the cosmeceutical formulations. 
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Bacteria strains 
Mushroom extracts Cosmeceutical formulations 
A. bisporus P. ostrearus L. edodes A. bisporus cream P. ostreatus cream L. edodes cream 
Gram-positive       
Enterococcus faecalis  >20 10 5 >200 200 100 
Methicillin sensitive Staphylococcus aureus  10 2.5 2.5 200 50 50 
Methicillin resistant Staphylococcus aureus 10 2.5 2.5 200 50 50 
Gram-negative       
Escherichia coli >20 >20 >20 >200 >200 >200 
Pseudomonas aeruginosa >20 >20 >20 >200 >200 >200 
MIC- Minimum Inhibitory concentration
Table 18. Antimicrobial activity (MIC, mg/mL) of mushroom extracts and prepared formulations. 
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Based on the above findings, it can be concluded that ethanolic extracts of A. bisporus, P. 
ostreatus, and L. edodes own antioxidant activity which suggests that they have the ability to 
cope with oxidative stress promoting ROS generation and acting as skin anti-ageing 
ingredients. The extracts revealed antibacterial activity against MSSA and MRSA, which are 
microorganisms found to colonize the skin during injury and inflammation. After incorporating 
the extracts into the base cosmetic cream, the mushroom cosmetic formulations still display 
antioxidant and anti-inflammatory activity by inhibition of NO production and by suppression 
of tyrosinase activity. Furthermore, the final cosmeceutical formulations containing the 
mushroom extracts were found to inhibit important bacterial strains responsible for skin 
damage. These diverse functions displayed by the mushroom extracts before and after 
incorporation in the base cosmetic cream formulations suggest that the studied mushrooms 
contain bioactive compounds that can be the basis of cosmeceutical formulations capable to 
tackle skin ageing, inflammation, and hyperpigmentation. Hence, studies in dermal and 
epidermal cells should be conducted to clarify the role of the compounds responsible for the 
assessed bioactive properties. Further studies are currently being conducted regarding the 
evaluation of the stability of the cosmeceutical formulations. 
 
3.3. The potential of Ganoderma lucidum extracts as bioactive ingredients in topical 
formulations, beyond its nutritional benefits 
 
Herein, the fruiting bodies of G. lucidum were studied: i) in terms of nutritional and chemical 
composition to highlight its potential to be consumed as functional foods; ii) as a source of 
bioactive compounds, namely, triterpenic and phenolic acids which show antioxidant, anti-
inflammatory, anti-tyrosinase, antitumor and antimicrobial activities, for cosmeceutical 
purposes. This last concept was studied by incorporating G. lucidum ethanolic extracts in a 
base cosmetic cream, which was further characterized in terms of physico-chemical and 
bioactive parameters. 
 
 3.3.1. The nutritional and chemical composition of G. lucidum fruiting bodies 
 
The results for the nutritional composition of G. lucidum are presented in Table 19. 
Carbohydrates were the most abundant compounds, followed by proteins, fat, ash and salt. The 
results are fairly consistent with the ones reported by Stojković et al. (2014b) even though the 
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origin of the samples was different (Serbia). Regarding the free sugars, fructose was the only 
one identified in G. lucidum. Concerning the fatty acids (Table 20), polyunsaturated fatty acids 
(PUFA) were the most abundant ones due to the high contribution of linoleic acid followed by 
saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA). These results suggest G. 
lucidum as an important dietary source of PUFAs, which have been reported as effective agents 
in the support of the general body well-being by preventing several chronic diseases (J. Wang, 
Luo, Li, & Zhao, 2012). Concerning the tocopherols, the alpha and delta isoforms were found 
in G. lucidum, being δ-tocopherol the most abundant one (Table 19). This molecule has 
received special attention due to its reported health-promoting benefits and potent antioxidant 
properties, being highly used in clinical dermatology, as photoprotective skin agents against 
UV radiation (Thiele & Ekanayake-Mudiyanselage, 2007).  
 
Component Mean ± SD 
Nutritional value (g/100 g)  
Lipids  2.50±0.02 
Proteins  6.72±0.04 
Ash  2.4±0.2 
Available carbohydrates 38.0±0.7 
Total carbohydrate  88.4±0.2 
Energy (kcal/100 g) 201±3 
Free sugars (g/100 g)  
Fructose  2.15±0.04 
Tocopherols (µg/100 g)  
alpha-Tocopherol  18.1±0.2 
delta-Tocopherol  123±7 
Total content of biomolecules  
Terpenoids (mg linalool/g) 27.2±0.7 
Triterpenoids (mg ursolic acid/g) 5.6±0.5 
Values are expressed in dry weight basis. 
 
 
 
 
Table 19. The nutritional and chemical composition of G. lucidum fruiting bodies 
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A very common trend in the pharmaceutical and cosmetic industries involve the use of 
nutritional supplements to manage health conditions; including a popular term used among 
dermatologist and cosmetic formulators referred to as ʺbeauty pillsʺ. They involve the use of 
compounds such as vitamins, lycopene, retinol, essential fatty acids and other compounds with 
antioxidant properties to improve skin appearance (Draelos, 2010).  
G. lucidum is therefore considered a complete “package” of healthy food, being an excellent 
source of nutritional components, as well as, of other non-nutritional compounds and as such 
when orally ingested, it can improve body function and wellbeing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SFA- Saturated Fatty Acids; MUFA- Monounsaturated Fatty Acids; PUFA- Polyunsaturated Fatty Acids. Caproic acid (C6:0); 
Caprylic acid (C8:0); Capric acid (C10:0); ; Lauric acid (C12:0);  Myristic acid (C14:0);  Pentadecanoic acid (C15:0);  Palmitic 
acid (C16:0); Palmitoleic acid (C16:1); Heptadecanoic acid (C17:0); Stearic acid (C18:0); Oleic acid (C18:1n-9c); Linoleic 
acid (C18:2n-6c); a-Linolenic acid (C18:3n-3); ; Arachidic acid (C20:0); cis-11-Eicosenoic acid (C20:1); cis-11,14-
Eicosadienoic acid (C20:2); Eicosapentaenoic acid (C20:5n-3); Behenic acid (C22:0); Erucic acid (C22:1n-9); Lignoceric acid 
(C24:0) 
 
The Total terpenoids and triterpenoids were determined, and the results are shown in Table 19. 
The triterpene content reported in the present work was consistent with the one recently 
described by Liu et al. (2017), where the triterpene amount of G. lucidum was about 5.90 mg 
ursolic acid equiv/g dw. Commercially, there are already available nutraceutical products 
Table 20. Fatty acids (relative percentage) of G. lucidum.  
Fatty acids 
 
Amount (%) 
C6:0 0.57±0.04 
C8:0 0.37±0.02 
C10:0 0.24±0.01 
C12:0 0.283±0.007 
C14:0 1.16±0.02 
C15:0 2.84±0.06 
C16:0 21.32±0.34 
C16:1 0.46±0.04 
C17:0 1.88±0.11 
C18:0 5.79±0.17 
C18:1n9 12.68±0.10 
C18:2n6 42.42±0.13 
C18:3n3 1.35±0.05 
C20:0 0.71±0.04 
C20:1 0.141±0.006 
C20:2 0.27±0.02 
C20:5n3 0.86±0.03 
C22:0 2.88±0.13 
C22:1n9 1.05±0.09 
C22:6n3 1.48±0.10 
C24:0 1.28±0.07 
SFA (%) 39.30±0.35 
MUFA (%) 14.33±0.13 
PUFA (%) 46.37±0.26 
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containing G. lucidum extract, either alone or in combination with other mushroom species. 
Some of them include Organic Rare Red ReishiTM (100% G. lucidum); Organic ReiShi-Gen 
(50% G. lucidum and 50% L. edodes); Organic Trimyco-GenTM (33% Cordyceps sinensis 33% 
G. lucidum 33% L. Edodes). These products are either formulated in pills or capsules, rich in 
triterpenes and β-glucans, and have been recently reported by Rathore et al. (2017) to protect 
the body against oxidative stress and support the immune system.  
 
3.3.2. G. lucidum ethanolic extracts as relevant bioactive extracts 
 
The ethanolic extracts of G. lucidum were analysed by HPLC-DAD-ESI/MS and the obtained 
profiles included phenolic acids and triterpenic acids. Data regarding retention time, maximum 
wavelengths, pseudo-molecular ion and main fragment ions observed in MS2, compounds 
identification, and individual quantification are presented in Table 21. A total of three phenolic 
acids (peaks 1-3), identified by comparing their UV spectra, retention time and MS 
fragmentation pattern with the ones of commercial standards, were found in the G. lucidum 
extract, with p-hydroxybenzoic acid being the most abundant. Concerning published data, 
protocatechuic and p-hydroxybenzoic acids are the most widely reported phenolic acids in G. 
lucidum. Nevertheless, Yildiz et al. (2015) have also detected the presence of syringic acid in 
the methanolic extracts from this matrix, which is consistent with results achieved in this work. 
Heleno et al. (2012) and Stojković et al. (2014b) also reported the presence of p-coumaric and  
cinnamic acids in the fruiting body of G. lucidum, but differences in the extraction procedure 
and used environment for mushroom maturation can justify the dissimilarity found in the 
achieved phenolic composition and other secondary metabolites profiles. 
A total of 26 triterpenoids (peaks 4-7, 9-27 and 29-31) were identified (Table 21), being six of 
them identified as ganoderic acid derivatives. In fact, an ESI-MS spectrum in negative mode 
was used in the present study and all triterpenoids gave [M - H]- and [2M - H]- ions in their 
negative ion mass spectra. The triterpenoids identified in the present work resulted from a 
comparison with literature data, regarding the UV spectra, retention time and MS 
fragmentation pattern, namely with the one reported for triterpenoids in the works of Guo et al. 
(2012); Liu et al. (2014); Pecić et al. (2015); Qi et al. (2012) &Yang et al. (2007 ), which also 
studied G. lucidum samples. 
Ganoderic acid H, followed by ganoderic acid C2 and ganoderic acid A were the most abundant 
triterpenoids acids present. Yang et al. (2007) and Hadda et al. (2015) reported the presence of 
ganoderenic acid K in chloroform extracts of G. lucidum from China and Algeria, suggesting 
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that the triterpenoids profile might depends on the extraction method employed (namely used 
solvent and extraction conditions) and the geographical origin of the strain. However, most 
studies have reported good repeatability in the triterpenoids profile of G. lucidum (Hadda et 
al., 2015; Hennicke et al., 2016; Yang et al., 2007). 
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Table 21. Identification and quantification of phenolic compounds and triterpenoids in G. lucidum extracts produced using the SE. 
        
        
Peak Rt UV lmax [M-H]
-& [2M-H] MS2 Tentative identification 
Quantification 
(mg/g R) 
(min) (nm) (m/z) (m/z)  
       
       
Phenolic acid 
Phe       
       
1 5.23 259,293sh 153 109(100) Protocatequic acid  1.80± 0.01 
2 8.39 257 137 93(100) p-Hydroxybenzoic acid 2.98±0.01 
3 11.51 280 197 121(100) Syringic acid 1.51±0.01 
     Total phenolic acids 6.30±0.01 
       
       
Triterpenes 
 
       
       
4 29.06 259 533/1067 515(5),497(12),404(100),303(12) 
12-3,7,15-Trihydroxy-4-
(hydroxymethyl)-11,23-dioxo-lanost-8-
en-26-oic acid 
14.21±0.02 
5 30.8 256 533/1067 515(5),497(21),453(16),423(11),319(5),303(8) 12-Hydroxyganoderic acid C2 4.51±0.06 
6 31.27 252 529/1059 511(10),467(100),449(11),434(5),431(15),419(8),312(8), 285(5),263(11) 20-hydroxy-ganoderic acid AM1 11.40±0.01 
7 31.73 251 529/1059 511(13),499(100),481(6),465(18),438(28),419(18),367(11),287(11) 12-deacetylganoderic acid H 6.1±0.14 
8 32.28 255 547/1095 529(50),511(41),485(3),467(100),449(24),431(26),304(11),265(7) Ganoderic acid derivative 7.3±0.1 
9 33.94 258 531/1063 513(13),451(3),401(100),385(5),304(19),301(45),286(3),249(27) Ganoderic acid ɳ 25.41±0.04 
10 34.48 254 511/1023 493(23),449(100),431(5),413(15),405(3) Ganoderic acid F 17.97±0.02 
11 35.37 265 529/1059 511(5),467(100),449(20),437(29),317(10),301(5),263(5) 12-hydroxyganoderic acid D 6.86±0.07 
12 35.95 251 515/1031 497(100),453(31),437(8),303(19),287(5),235(3) Ganoderic acid derivative 21.20±0.08 
13 36.84 256 517/1035 499(100) 481(48),456(17),438(52),407(8),304(6),287(35) Ganoderic acid C2 38.70±0.15 
14 37.51 257 529/1059 511(5),481(7),467(100),451(14),438(38),424(3),319(5),303(3),301(5) Ganoderic acid C6 29.10±0.08 
15 38.16 256 529/1059 511(58),493(5),449(10),399(100),301(3) Ganoderic acid derivative 12.77±0.01 
16 38.46 256 531/1063 513(11),498(15),469(100),454(29),452(24),437(6),304(5),302(6),290(20),266(7) Ganoderic acid G 16.84±0.07 
17 38.75 248 513/1027 495(10),480(16),451(100),437(14),433(22),407(17),331(5),315(3),303(5),287(5) Ganoderenic acid B 10.66±0.09 
18 39.01 259 527/1055 509(26),465(6),397(100),355(4) Elfvingic acid derivative 10.41±0.09 
19 39.35 254 515/1031 497(10),453(100),439(5),409(5),304(21),287(12),263(3),250(14) Ganoderic acid B 23.99±0.09 
20 39.46 250 513/1027 495(100),479(27),462(12),451(30),433(31),381(25),301(15) Ganoderic acid derivative 22.44±0.10 
21 39.66 261 513/1027 495(21),480(5),451(100),433(24),381(6),301(6),247(3) Ganoderic acid AM1 15.82±0.01 
22 40.29 254 515/1031 497(100),480(5),454(6),436(10),302(8),301(4),285(3) Ganoderic acid A 36.77±0.04 
23 40.66 261 571/1143 553(100),511(8),481(3),468(8),437(3),423(2) Ganoderic acid H 41.05±0.39 
24 40.87 252 527/1055 509(20),479(13),465(100),435(3),421(3),317(3),301(3) Elfvingic acid A 9.83±0.01 
25 41.34 254 529/1059 511(10),496(22),493(21),467(100),449(61),434(4),319(6),317(8),301(16),300(11),299(12) Ganoderic acid derivative 11.56± 0.04 
26 41.93 246 511/1023 493(12),478(20),449(100),435(15),431(4),405(4),329(3),301(4),285(5),283(3),261(4) Ganoderenic acid D 10.27±0.07 
27 42.55 255 513/1027 495(16),451(100),437(6),433(3),407(4),301(23),286(3),284(11),247(8) Ganoderic acid D 11.31±0.01 
28 42.74 245 509/1019 491(100),476(18),461(34),447(15),429(3),417(3),300(5),299(4) Ganoderic acid derivative 12.81±0.08 
29 43.15 256 511/1023 493(100),449(65),435(3),300(5),247(4) Ganoderic acid E 10.81±0.07 
30 43.95 255 569/1139 551(100),509(35),508(21),466(8) 12-acetoxyganoderic acid F 12.08±0.07 
31      44.92 272 513/1027 451(100),437(8),433(3),422(3),301(5) Ganoderic acid J 2.92±0.05 
     Total triterpenoids 455.01±1.47 
        
Results and Discussion 
 
 
 
151 
The results regarding the bioactivity of G. lucidum extracts are presented in Table 22. The 
antioxidant results obtained are very similar to the ones reported by Heleno et al. (2012) for 
DPPH radical scavenging and reducing power, even though the authors performed a different 
extraction procedure (maceration in methanol:water mixture (80:20, v/v)). These authors also 
conducted studies concerning phenolic and polysaccharide extracts of G. lucidum, being the 
antioxidant activity slightly lower in the latter, suggesting that phenolic compounds play a more 
prominent role in the free radical scavenging activity.  
G. lucidum ethanolic extract also revealed tyrosinase inhibition activity. To the authors best 
knowledge only Chien et al. (2008) have reported the tyrosinase inhibition activity for ethanolic 
extract of G. lucidum from Taiwan with a reported EC50 reaching 0.32 mg/mL, lower than the 
one obtained herein, possibly justified by the used slightly different procedures. Kim et al. 
(2016) were able to identify a bioactive compound, ganodermanondiol, which suppressed the 
expression of the tyrosinase-related protein (TRP-1, TRP-2) and microphthalmia-associated 
transcription factor (MITF) thereby inhibiting the synthesis of melanin. Tyrosinase inhibitors 
have shown to be effective ingredients towards skin lightening, and among the bioactive 
compounds found in mushrooms, phenolics have been reported as the ones that contribute most 
significantly to their anti-tyrosinase activity (Taofiq, González-Paramás, et al., 2016). 
Therefore, the ethanolic extract studied in the present work can be further exploited as a 
tyrosinase inhibitor to reduce the severity of hyperpigmentation and decrease melanin 
biosynthesis, partly due to the registered amount on phenolic acids and triterpenoids. Regarding 
the anti-inflammatory activity, aqueous, methanolic and ethanolic extracts of G. lucidum 
presented activity mainly by inhibiting NO, PGE2, TNF-α IL1-β production (Taofiq, Martins, 
et al., 2016). In the present study, the ethanolic extract of G. lucidum revealed anti-
inflammatory activity by inhibiting NO production. Even though the phenolic compounds of 
mushrooms have been identified as the most important contributors to their anti-inflammatory 
activity (Taofiq et al., 2015), triterpenic acids such as ganoderic acid C1 and lanostane in G. 
lucidum, have also contributed significantly to its anti-inflammatory activity (Taofiq, Martins, 
et al., 2016). 
The numerous secondary metabolites contained in this mushroom have attracted huge interest 
and one of the most complete reported studies is the one on its cytotoxic effect (Amen et al., 
2016; Li et al., 2013). In the present work, no toxicity was observed in non-tumor porcine liver 
cells (PLP2) at the maximum tested concentration (400 µg/mL). However, the extract was able 
to inhibit all human tumor cell lines evaluated; with breast carcinoma cells showing to be the 
most susceptible cells, followed by non-small cell lung, hepatocellular and cervical carcinoma 
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cells. Our results against cervical carcinoma cells were mostly in line with the ones reported 
by Ćilerdžić et al. (2014)  with a growth inhibitory effect of 61.17 ± 0.75 µg/mL, even though 
mushroom origin (Serbia) and applied extraction procedure (maceration) were different. The 
results also correlated well with the statements reported by Reis et al. (2015) for methanolic 
extract, namely a similar trend on the registered activity was observed (MCF-7 > NCI-H460).  
Overall, a lot of studies have been able to identify the triterpenes as the most prominent class 
of compounds contributing to the shown cytotoxic effect (Amen et al., 2016; S. Y. Chen, 
Chang, Chen, Chang, & Lin, 2016; P. Li et al., 2013). The mechanism of antitumor effect of 
this mushroom has been associated with inducing autophagy (Reis et al., 2015), leading to 
apoptosis, inhibition of tumor invasion and metastasis (Patel & Goyal, 2012). 
Finally, among the analysed bacterial strains, G. lucidum extract showed the highest 
antibacterial activity against MSSA and MRSA with corresponding lowest minimum inhibitory 
concentrations (Table 22). Regarding the Gram-positive bacteria strains, Listeria 
monocytogenes was the least inhibited followed by Enteroccocus faecalis. For Gram-negative 
bacteria, the extract was not able to inhibit the growth of Morganella morganii and 
Pseudomonas aeruginosa even at the highest tested concentration, while the two E. coli and 
the two Klebsiella strains were inhibited. In brief, the extract was able to inhibit both Gram-
negative and Gram-positive bacteria. The antimicrobial activity of G. lucidum has been widely 
studied, and according to the review conducted by Alves et al. (2013), extracts of G. lucidum 
revealed antimicrobial activity against B. subtilis, S. aureus, E. coli, K. pneumoniae, P. 
aeruginosa, S. typhi, and S. Typhimurium. The phenolic acids present in this mushroom have 
been identified as the most important contributors to this activity (Heleno et al., 2013). These 
authors went further to evaluate the antimicrobial activity of these phenolic acid derivatives 
(glucuronated and methylated) to confirm if they reveal activity in their in vivo form after 
undergoing metabolism. In the review conducted by Ferreira et al., (2015), the polysaccharide 
fractions was also described to contribute significantly to the antimicrobial activity of this 
mushroom. Thus, further studies need to be conducted with this extract by testing other 
bacterial and fungal strains to confirm if it presents broad spectrum antimicrobial activity.  




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 G. lucidum ethanolic extract 
Antioxidant activity (EC50 values, mg/mL)  
DPPH scavenging activity  0.73 ± 0.01 
Reducing power  0.15 ± 0.01 
Cytotoxic activity (GI50 values, µg/mL)  
MCF-7 (breast carcinoma) 61 ± 4 
NCI-H460 (non-small cell lung carcinoma) 64 ± 3 
HeLa (cervical carcinoma) 73 ± 3 
HepG2 (hepatocellular carcinoma) 68.44 ± 0.08 
PLP2 (non-tumour primary liver porcine cells) > 400 
Anti-inflammatory activity (EC50, µg/mL)  
NO Inhibition 112 ± 1 
Anti-tyrosinase activity (EC50 values, mg/mL)  
L-DOPA assay 2.81 ± 0.01 
Antimicrobial activity (MIC, mg/mL)  
Gram-positive  
Enterococcus faecalis 10 
Listeria monocytogenes 20 
MSSA 5 
MRSA 5 
Gram-negative  
Eschericia coli 10 
Eschericia coli ESBL 10 
Klebsiella pneumoniae 20 
Klebsiella pneumoniae ESBL 20 
Morganella morganii >20 
Pseudomonas aeruginosa >20 
Proteus mirabilis 20 
Candida albicans >20 
The antioxidant activity was expressed as EC50 values, where lower values correspond to higher antioxidant potential. Trolox (positive control) 
EC50 values: 41 µg/mL (reducing power), 42 µg/mL (DPPH scavenging activity). Anti-inflammatory activity is expressed as EC50 values 
corresponding to 50% of inhibition of the NO production in comparison with the negative control (100% of NO production). Dexamethasone 
(positive control) EC50 values: 16 µg/mL. Anti-tyrosinase activity is expressed as EC50 values corresponding to 50% of inhibition of tyrosinase. 
Ascorbic acid (positive control) EC50 values: 31 µg/mL. Cytotoxicity results are expressed as GI50 values corresponding to the sample 
concentration responsible for 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2. Ellipticine (positive control) 
GI50 values: 1.21 µg/mL (MCF-7), 1.03 µg/mL (NCI-H460), 0.91 µg/mL (HeLa), 1.10 µg/mL (HepG2) and 2.29 (PLP2). Minimum Inhibitory 
concentration-MIC, MRSA- Methicillin-resistant Staphylococcus aureus; MSSA methicillin-susceptible S. aureus; ESBL- spectrum extended 
producer of β – lactamase. 
 
 
 
Table 22. Bioactive properties of G. lucidum ethanolic extract. 
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3.3.3. G. lucidum ethanolic extracts in cosmeceutical formulations 
 
The use of bioactive products such as vitamins, peptides, phenolic compounds, polyhydroxy 
acids, obtained from plant, mushroom and other natural matrices, as cosmeceutical ingredients, 
has received increased attention because of their multifunctional benefits on skin (e.g. 
antioxidant, anti-tyrosinase, anti-hyaluronidase, anti-collagenase, anti-elastase, 
photoprotective, antimicrobial and anti-inflammatory activities) (Hyde et al., 2010; Y. Wu et 
al., 2016). 
In the present study, the results of antioxidant, antimicrobial and anti-tyrosinase activities for 
the produced cosmeceutical formulation are presented in Table 23. The cosmeceutical 
formulations maintain the bioactivities exhibited by the extract. This achievement is quite 
interesting regarding the concern of cosmetic industry in reducing the presence of synthetic 
ingredients, and its gradual replacement by natural counterparts, due to the increased awareness 
on the negative effects reported for some artificial antimicrobial agents. In fact, natural 
bioactive compounds with a broad spectrum of antimicrobial properties are being slowly 
introduced in this industrial field, also justified by their multifunctional properties (Kerdudo et 
al., 2016). The formulations incorporated with G. lucidum extract were able to significantly 
inhibit the growth of MSSA and MRSA by presenting a low minimum inhibitory concentration. 
Also, this work demonstrates that extracts of G. lucidum have interesting biological properties 
that can be exploited in the design of cosmeceutical formulations either as tyrosinase inhibitors, 
anti-inflammatory agents or as preservatives to prolong the shelf life of the formulated product. 
The compounds earlier identified in the ethanolic extract were monitored by HPLC-DAD-
ESI/MS and found to be present in the produced cosmeceutical formulation. 
The relevance of G. lucidum properties is evident from the number of commercial 
cosmeceutical products in the market formulated from their extracts, either alone or in 
combination with other natural ingredients. Examples include Body Repair Lotion (G. lucidum 
extract and medicinal plant), Dr. Andrew Weil for OriginsTM Mega-Mushroom Skin Relief 
Face Mask (G. lucidum, C. sinensis and medicinal plants) and Menard Embellir Refresh 
Massage cream (G. lucidum and G. sinense). These products have all been used to suppress the 
severity of hyperpigmentation, to brighten skin appearance, prevent ageing effects, and to 
protect skin against UV radiation (Taofiq, González-Paramás, et al., 2016). 
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Table 23. Physico-chemical and bioactive properties of G. lucidum cosmeceutical formulation 
 G. lucidum cosmeceutical formulation 
Physico-chemical properties  
Colour  
L* 70.3 ± 0.7 
a* 12.1 ± 0.5 
b* 32.9 ± 0.9 
pH  4.61 ± 0.03 
Bioactive properties  
Antioxidant activity (EC50 values, mg/mL)  
DPPH scavenging activity  34 ± 1 
Reducing power  13.60 ± 0.09 
Anti-tyrosinase activity (EC50 values, mg/mL)  
L-DOPA assay 23.80 ± 0.03 
Antimicrobial activity (MIC, mg/mL)  
Enterococcus faecalis 200 
Listeria monocytogenes 400 
MSSA 100 
MRSA 100 
Eschericia coli 200 
Eschericia coli ESBL 200 
Klebsiella pneumoniae 400 
Klebsiella pneumoniae ESBL 400 
Morganella morganii >400 
Pseudomonas aeruginosa >400 
Proteus mirabilis 400 
Candida albicans >400 
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Even though the individual contribution of their constituents needs to be established, there are 
reports claiming that terpenes such as monoterpenes and sesquiterpenes have potential to 
enhance compound penetration across the skin by decreasing skin barrier resistance of the 
stratum corneum (Lane, 2013). Thus, the content of terpenoids determined for G. lucidum can 
play an important role by enhancing the topical availability of other constituents in 
cosmeceutical formulations.  
In today’s cosmetic market a wide variety of choices is offered to consumers, being colour 
attributes an important characteristic for their acceptance. Hence, companies have paid lots of 
attention to managing colour display during product design and formulation. In the present 
work, the colour attributes of the produced cosmeceutical formulation showed a light-yellow 
colouration. The rate of dermal absorption of topical formulations such as lotions and creams 
are often influenced by the pH of the product. The pH of skin external surface is around 5.5, 
and at this condition, the skin micro-flora, barrier homeostasis, and stratum corneum are 
maintained (Ali & Yosipovitch, 2013; Martínez-Pla, Martín-Biosca, Sagrado, Villanueva-
Camañas, & Medina-Hernández, 2004).  Most reports have suggested that a pH between 4 and 
6.5 can be considered as adequate for cosmetic formulations since most pathogenic bacteria 
(e.g. S. aureus),  thrive best at neutral pH levels (Ali & Yosipovitch, 2013). In the present work, 
the cosmeceutical formulation presented a pH 4.6, which is considered within the favourable 
pH range.
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3.4. Agaricus blazei Murrill: an ingredient for nutraceutical and cosmeceutical 
applications 
 
The fruiting bodies (basidiocarps) of Agaricus blazei Murrill (ABM) were donated by a local 
producer in Maringá, Paraná, Brazil (23°24′S 51°55′W). ABM fruiting bodies that are 
considered off-market and grouped as an agro-industrial residue, were used in the present work.  
The nutraceutical and cosmeceutical potential of this residue was studied herein by evaluating 
its nutritional and chemical composition. Ethanolic extracts, obtained by Soxhlet extraction, 
were evaluated regarding the effects on cell viability and death in Caco-2 and HT29-MTX cells 
lines (MTT and LDH assays; preliminary safety tests for nutraceutical applications). To 
evaluate the dermatological potential, the extract was incorporated into a semi-solid base 
formulation that, together with the ethanolic extract itself, were studied for the effects on cell 
viability of a keratinocyte cell line (preliminary safety tests for cosmeceutical applications). 
 
3.4.1. The nutritional and chemical composition of ABM 
 
Studies on the chemical and bioactive composition of mushrooms have been reported over 
years, aiming at identifying species with relevant biological properties and high nutritional 
value  (Heleno, Ferreira, et al., 2015; Stojković et al., 2014b; Taofiq, Heleno, et al., 2017). The 
proximate composition of the studied ABM bio-residues, expressed on a dry weight (dw) basis, 
are presented in Table 24. Its components include carbohydrates (48±2 g/100 g dw), crude 
protein (31.6±0.5 g/100 g dw), ash (6.2±0.5 g/100 g dw), and total fat (0.66±0.08 g/100 g dw). 
Carbohydrates were the major constituents, followed by proteins and ash; the fat content was 
low. The energy contribution was 325.3 ± 0.5 kcal/100 g dw, mainly attributed to the high 
carbohydrate content. Comparatively, with a commercial A. blazei supplement obtained from 
Brazil, there were no significant differences in the nutritional profile (ash, 7.47 ± 0.04 g/100 g 
dw; proteins, 31 ± 2 g/100 g dw; fat, 1.82 ± 0.03 g/100 g dw) (Carneiro et al., 2013). Regarding 
free sugars, mannitol and trehalose were the only ones detected, and found in similar amounts 
to the ones reported by Stojković et al. (2014a).  
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Table 24. Nutritional and chemical composition of ABM bio-residues. 
Component Mean ± SD 
Nutritional value (g/100 g)  
Lipids  0.66±0.08 
Proteins  31.6±0.5 
Ash  6.2±0.5 
Available carbohydrate 48±2 
Total Carbohydrates 61.5±2 
Energy (kcal/100 g) 325.3±0.5 
Free sugars (g/100 g)  
Mannitol  34.4±0.2 
Trehalose 5.1±0.2 
Total Sugars 39.5±0.4 
Tocopherols (µg/100 g)  
α-Tocopherol  17±0.6 
Organic acids (g/100 g)  
Oxalic acid 0.98±0.01 
 
In what concerns organic acids, oxalic acid was the unique detected compound, even though  
Stojković et al. (2014a) reported the presence of fumaric acid in A. blazei samples obtained 
from the Netherlands. Regarding the fatty acids profile, twenty-two molecules were identified 
(Table 25), with polyunsaturated fatty acids (PUFA) predominating (a high contribution of 
linoleic acid was identified), followed by saturated fatty acids (SFA) and monounsaturated 
fatty acids (MUFA). The distribution of fatty acids in the studied dried powder mushroom was 
similar to the ones reported by Carneiro et al. (2013). 
Most of the literature reports refer to intact fruiting bodies of ABM, while the present results 
show that discarded bio-residues are still promising sources of interesting biomolecules. To the 
author’s best knowledge, only Corrêa et al. (2018) have reported the re-utilisation of ABM bio-
residues to produce an ergosterol rich fraction with antioxidant and antimicrobial properties. 
Those authors went further by fortifying a commercial yoghurt with the obtained ergosterol 
rich extract, and the final formulation was found to present an enhanced antioxidant activity. 
ABM bio-residues studied in the present work is therefore considered a useful source of 
nutritional components as well as non-nutritional compounds, which can be utilised as food 
supplements.  
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The results are presented as mean ± SD. Caproic acid (C6:0); caprylic acid (C8:0); capric acid (C10:0); lauric acid (C12:0); myristic acid 
(C14:0); pentadecanoic acid (C15:0); cis-10-pentadecenoic acid (C15:1); palmitic acid (C16:0); palmitoleic acid (C16:1); heptadecanoic acid 
(C17:0) stearic acid (C18:0); oleic acid (C18:1n9); linoleic acid (C18:2n6); Gamma linolenic acid (C18:3n6); arachidic acid (C20:0); cis-11-
eicosenoic acid (C20:1); cis-11,14 - eicosadienoic acid (C20:2); heneicosanoic acid (C21:0); behenic acid (C22:0); erucic acid (C22:1); 
tricosanoic acid (C23:0); lignoceric acid (C24:0); SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA – polyunsaturated 
fatty acids.  
 
3.4.2. Preliminary safety tests with the ABM ethanolic extract for nutraceutical 
ingredients 
 
To fully confirm the nutraceutical potential of the obtained ABM ethanolic extracts, the major 
challenge still lies on the access of their safety throughout the GIT since the intestinal 
epithelium is the major area for the absorption of bioactive molecules allowing them to reach 
systemic circulation. Hence, in vitro models were used to mimic intestinal epithelium and 
access the safety of the bioactive extracts (Pan, Han, Zhang, Yu, & Liu, 2015). In the present 
work, the cell viability effect of the ethanolic extract prepared from ABM bio-residues was 
evaluated on Caco-2 and HT29-MTX cells following a concentration-dependent manner (1-
10000 µg/mL). Caco-2 cells are similar to enterocytes in the gut epithelium, while HT29-MTX 
cells are like the mucus-producing goblet cells. Both cell lines have been widely used as 
intestinal models to evaluate the safety of novel nutraceutical ingredients (de Francisco et al., 
Table 25. Fatty acids (relative percentage, %) in ABM bio-residues. 
Fatty acids  Amount (%) 
C6:0 0.225±0.006 
C8:0 0.459±0.009 
C10:0 0.319±0.003 
C12:0 2.36±0.01 
C14:0 1.36±0.02 
C15:0 1.22±0.01 
C15:1 0.056±0.001 
C16:0 20.6±0.1 
C16:1 0.170±0.005 
C17:0 1.34±0.01 
C18:0 5.58±0.02 
C18:1n9 2.66±0.02 
C18:2n6 51.04±0.05 
C18:3n6 1.47±0.02 
C20:0 1.88±0.02 
C20:1 0.046±0.002 
C20:2 0.201±0.007 
C21:0 0.572±0.001 
C22:0 4.36±0.07 
C22:1 2.1±0.1 
C23:0 0.516±0.004 
C24:0 1.52±0.04 
SFA 42.2±0.1 
MUFA 5.0±0.1 
PUFA 52.71±0.02 
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2018). Concerning Caco-2 cells, at 100 µg/mL, cell viability was not influenced up to 80% 
(Figure 25). Regarding HT29-MTX cells, up to 80% cell viability was maintained at 1 mg/mL, 
while the highest tested concentration (10 mg/mL) was found to significantly reduce the cell 
viability (Figure 26).  
 
Figure 25.  Cell viability effects of the ABM ethanolic extract at different concentrations on Caco-2 cells as 
measured by the MTT assay (n = 4). 
 
The LDH assay has been utilised as a good marker to ascertain cytotoxicity of bioactive 
ingredients. The mechanism behind it involves the measurement of lactate dehydrogenase 
(LDH), an enzyme found in the surroundings of compromised cell membranes. In the present 
work, both Caco-2 and HT29-MTX cells were found to have no significant effect on LDH 
leakage up to 100 µg/mL (Figure 27). However, the LDH level was significantly detected in 
Caco-2 at 1 mg/mL and 10 mg/mL, while LDH was only detected at 10 mg/mL for HT29-
MTX cells. From the obtained results, the cell viability studies in the MTT assay were 
complementary with what was observed in the LDH assay. 
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Figure 26. Cell viability effects of the ABM ethanolic extract at different concentrations on HT29-MTX as 
measured by the MTT assay (n = 4). 
 
 
Figure 27. Cytotoxicity effects of the ABM ethanolic extract on HT29-MTX and Caco-2 cells at different 
concentrations as measured by LDH assay (n = 4). 
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3.4.3. Preliminary safety tests with the ABM ethanolic extract and final cream 
formulation for cosmeceutical applications 
 
The global cosmetic industry has been a successful industrial sector over the years. Due to the 
increased awareness, coupled with the higher demand for safer and natural-based cosmetic 
products, innovative natural ingredients able to exert multifunctional benefits to the skin are an 
utmost of this industrial sector (Kerdudo et al., 2016; F. Rodrigues et al., 2015; Taofiq, 
González-Paramás, et al., 2016). In this context, mushroom-based cosmeceutical ingredients 
are gaining increased importance, even though they are still exploited at modest levels. 
Moreover, some of the bioactive properties displayed by mushroom extracts and/or their 
individual metabolites have lead dermatologists and researchers linked to the cosmetic field to 
become optimistic considering the future of mushrooms and their compounds in this sector. 
In the present work, the incorporation of the ethanolic extract into a base cosmetic cream 
resulted in a formulation with a lower level of lightness (L*) when compared with the former 
base cosmetic cream (control). The following colour attributes, using the L*a*b* scale, were 
obtained (74.30 ± 0.8, 9.16 ± 0.31, 19.31 ± 0.48). The final pH of the mushroom-based 
formulation was 4.31 ± 0.03, while for the control was 4.84 ± 0.02. Some studies have reported 
that formulations with pH between 3.5 and 6.0 can be considered favourable as most 
pathogenic bacteria thrive best at neutral pH levels and, at these conditions, the skin micro-
flora and barrier homeostasis are maintained (Ali & Yosipovitch, 2013; Martínez-Pla et al., 
2004). Additionally, some of the biomolecules identified and quantified in the studied ABM 
bio-residues, namely tocopherols, fatty acids, organic acids and sugars, can play major roles 
on skin antioxidant defence, protection against photoageing, regulation of collagen synthesis, 
suppression of inflammatory response, normalization of epidermal lipid profiles and 
improvement of skin hydration and elasticity (De Vaugelade et al., 2017; Hyde et al., 2010; 
Kayashima, 2002; Rhimi et al., 2018; Shapiro & Saliou, 2001; Taieb, Gay, Sebban, & Secnazi, 
2012). Noteworthy is the detected high content of mannitol in the analysed ABM bioresidues 
(Table 25). Mannitol is largely used in cosmetics as a humectant to preserve the product from 
dehydration, and as a moisturising agent to prevent the dryness of the skin. In the last years, 
mannitol has been considered as the ideal excipient to be used with hyaluronic acid (HA) fillers, 
thanks to its hydrating and antioxidant properties (André & Villain, 2017). Thus, the action of 
these molecules incorporated in the final formulation prepared herein can contribute to a better 
skin function. 
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Figure 28. Cell viability effects of the ABM ethanolic extract at different concentrations on keratinocytes 
(HaCaT) cell line as measured by the MTT assay (n = 4).  
 
Even though progress have been made in what concerns the use of natural extracts as 
cosmeceutical ingredients, their safety and efficacy lack appropriate reporting and 
dissemination. This constraint makes consumer’s acceptance difficult, since they may not 
perceive that bioactive claims are true. In addition, the safety evaluation of ingredients for 
cosmeceutical applications is a critical step as some of these natural extracts contain different 
compounds and biomolecules that may be irritant to skin cells. In the present work, the effects 
of the obtained ethanolic extract on keratinocyte (HaCaT) cells viability was evaluated using 
MTT and LDH assays, as this cell line was previously documented as a reliable in vitro model 
to access the safety of cosmeceutical ingredients (Rodrigues et al., 2013). 
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Figure 29. Cell viability effects of the final cream formulation with the ABM ethanolic extract at different 
concentrations on keratinocytes (HaCaT) cell line as measured by the MTT assay (n = 4).  
 
From the results shown in Figure 28 for the MTT assay, ABM ethanolic extract did not show 
cytotoxicity on HaCaT cell line up to 100 µg/mL. However, at 1 mg/mL, there was a reduction 
in the cell viability up to 30%, while a significant decrease was observed at the highest tested 
concentration (10 mg/mL). These results showed that higher concentrations of the extract can 
be deleterious for skin cells. It can also be seen that the obtained cell viability results for the 
corresponding formulation, showed maintenance of 50% cell viability at 1 mg/mL (Figure 29). 
Cytotoxicity of A. blazei extracts and their individual metabolites in different cell lines have 
been reported, (Cardozo et al., 2013; C. F. Kim, Jiang, Leung, Fung, & Lau, 2009; K. A. 
Yamamoto et al., 2013) and in the case of  Shahirah et al. (2014) the in vitro cytotoxicity effect 
of ABM using the MTT assay in a fibroblast cell line (V79-4), was determined. According to 
the authors, the extracts displayed cytotoxicity effects above 1 mg/mL, which is consistent with 
the results achieved in the present work.  
The present study is the first report evaluating the potential of re-utilisation of A. blazei by-
products, based on its nutritional and chemical composition, for nutraceutical and 
cosmeceutical applications. Also, the dermatological potential of an ethanolic extract was 
accessed through cell viability effects in a skin cell line. The presence of essential nutrients 
-20
0
20
40
60
80
100
120
140
1 10 100 1000 10000
C
el
l v
ia
bi
lit
y 
(%
)
Concentration (µg/mL)
Control ABM Formulation
Results and Discussion 
 
 
 
165 
such as carbohydrates, proteins, and fatty acids was demonstrated. The ethanolic extract 
maintained the cell viability on Caco-2 and HT29-MTX cells at 100 µg/mL. The richness in 
sugars, α-tocopherol, and organic acids make A. blazei by-residues a potential ingredient for 
developing nutraceutical ingredients and/or functional foods, which may contribute to better 
nutrition and health improvement. It is also important to note that the oral administration of 
extracts rich in compounds with antioxidant capacity can be used to prevent the effects of 
cutaneous sun damage, but the efficacy of these extracts as nutricosmetics still needs to pass 
proper long-term clinical trials. To further confirm the cosmeceutical potential of ABM, skin 
permeation studies using Franz diffusion cells to determine topical bioavailability of the active 
ingredients are needed, as well as dermal and ocular irritability tests to ascertain safety. The 
results presented herein support the sustainable re-use of mushroom wastes, here demonstrated 
with ABM, which are generated in significant quantities during their production chain. This is 
highly meaningful since global mushrooms’ cultivation has been predicted to increase 
significantly in the coming years. 
 
3.5. Mushrooms as cosmeceutical ingredients: stability and use of microencapsulation 
techniques to ensure a controlled release 
 
Following studies conducted in section 3.2, where ethanolic extracts of A. bisporus, L. edodes 
and P. ostreatus demonstrated cosmeceutical potential, A. bisporus and P. ostreatus, due to 
their highest bioactivity, was selected to be used in the present section. Thus, ethanolic extracts 
obtained from these mushroom species were prepared and further microencapsulated by the 
atomization/coagulation method with sodium alginate as the polymeric matrix. The produced 
microspheres were fully characterised and thereafter incorporated in a base cosmetic cream. 
The bioactive and physico-chemical properties imparted by these microencapsulated extracts, 
comparatively with the use of the respective free forms, were evaluated over a 6 months’time 
period. These studies were performed to ascertain the stability of the prepared formulations, 
compare microencapsulated versus free forms, and monitor the in vitro release profile of 
selected bioactive compounds (phenolic acids and ergosterol) in the developed cosmeceutical 
formulations. 
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3.5.1. Microencapsulation of the extracts 
 
Table 26 summarizes the results obtained for the encapsulation efficiency, yield, and load. The 
concentration of the phenolic acids and related compounds in the coagulation and washing 
solutions was determined using the HPLC to calculate the EE (%), conducting to values of 72.8 
and 99.6% for A and P, respectively, corroborating the successful encapsulation of the extracts. 
The EY (%), which represent the effectiveness of the process, conducted to values of 60.2 and 
55.0 % for A and P, which might be considered satisfactory considering that the technique was 
applied at a laboratory scale. The EL%, which depicts the content of bioactive in the 
microparticles was 14.6% and 19.9% for A and P, respectively. It allows to determine the 
quantity of microspheres needed to be incorporated in the base cosmetic cream. 
 
Samples EE (%) EL (%) EY (%) 
A 72.8 14.6 60.2 
P 99.6 19.9 55.0 
E na na 60.2 
na-not applied; A, P and E represent samples prepared with A. bisporus, P. ostreatus and empty microparticles 
respectively. 
 
The surface morphology of the prepared microparticles, immediately after production, was 
visualized by optical microscopy and the respective images (acquired at magnifications of 40x, 
100x and 400x) are shown in Figure 30. It is possible to observe a consistent spherical 
morphology with few particles displaying crumpled shapes of various sizes (consistent with a 
polydisperse sample), and no agglomeration. The lyophilized microspheres were rehydrated in 
distilled water and analysed again (magnification of 100x). The final shape of the rehydrated 
microspheres was quite irregular, but despite their deformation, the final size was close to that 
obtained immediately after encapsulation. 
Table 26. Comparison of encapsulation efficiency, load, and yield of the microparticles prepared using alginate 
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Figure 30. Optical Microscopy analysis with magnifications of 40, 100 and 400x of the microspheres after 4 h of coagulation under stirring. with A, and P representing samples 
prepared with A. bisporus and P. ostreatus respectively
A 
P 
40x 100x (lyophylized) 100x 400x 
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Figure 31. Microparticles size distributions expressed as mean number distribution, with A, P and E representing 
samples prepared with A. bisporus, P. ostreatus and empty microparticles respectively. 
 
The results for the particle size distributions, in number and volume, represented in terms of 
percentiles (D10, D50, and D90) are presented in Table 27. The respective average particle size 
(in number and volume) are also presented in Table 27. The achieved average sizes in volume 
for A, P and E were 122, 110 and 102 µm respectively.  
 
 
 
Table 27. Comparison of particle size distribution in terms of number and volume, encapsulation efficiency, 
load and yield of the microparticles prepared using alginate. 
Samples Particle size distribution Mean particle size (µm) 
Volume distribution Number distribution  
Volume 
 
Number D10 D50 D90 Span D10 D50 D90 
A 27.1 100 254 2.27 0.72 0.94 2.05 122 1.14 
P 27.7 94.7 240 2.24 0.72 0.92 1.96 110 1.11 
E 19.5 79.2 235 2.72 0.82 1.15 2.83 102 1.50 
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Figure 32. Microparticles size distributions expressed as mean volume distribution, with A, P and E representing 
samples prepared with A. bisporus, P. ostreatus and empty microparticles respectively. 
 
From the analysis of the particle size distributions shown in Figure 31 and 32, distributions in 
number (Figure 31) were unimodal (or proximately unimodal), whereas distributions in 
volume showed a bimodal pattern (Figure 32). Considering the span (dispersity) parameter 
which reveals how homogenous the particle’s size is (Table 27), there is no significant 
dissimilarity among all three produced types of microparticles. 
 
3.5.2. Bioactivity of mushroom-based cosmeceutical formulations – use of free forms 
 
In the present work, the cosmeceutical potential of each prepared formulation was investigated 
based on their ability to display antioxidant, anti-tyrosinase and antimicrobial activities. The in 
vitro antioxidant activity of the cosmeceutical formulations prepared with the ethanolic extracts 
are presented in Table 29. The formulations revealed both DPPH scavenging activity and 
reducing power. The antioxidant activity decreased over time, which can be partly attributed 
to the oxidation of the extracts. A similar study was reported by Gezina et al. (2015) in which 
the authors prepared semi-solid formulations containing two species of Honeybush (Cyclopia 
maculata Vent and Cyclopia genistoides Vent). The active bioflavonoids present in their 
hydromethanolic extracts were found to lack sufficient stability in semi-solid formulations to 
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sustain the antioxidant activity. The phenolic acids, and related compounds composing the 
ethanolic extracts of P. ostreatus and A. bisporus have been previously described (section 3.2; 
Taofiq, Heleno, et al., 2016). These compounds have been reported to contribute significantly 
to the antioxidant activity (Heleno, Martins, et al., 2015). The quantification of these 
compounds in the corresponding semisolid formulations are presented in Table 28. For the 
cosmeceutical formulations prepared with A. bisporus extract (BCAb), and P. ostreatus extract 
(BCPo), phenolic acids, related compounds and ergosterol revealed no significant changes in 
their content over the storage time (6 months). Considering that there was no significant loss 
of bioactive compounds under the used storage temperature (4 ˚C), further studies are needed 
to be conducted at different environmental conditions (temperature and relative humidity) to 
confirm this observation. 
 
Samples Ergosterol, Phenolic acids and Related Compounds in each cosmeceutical formulation 
 Cinnamic acid 
(µg) 
p-Hydroxybenzoic acid 
(µg) 
p-Coumaric acid 
(µg) 
Ergosterol (mg) 
BCAbT0 2.20±0.07a nd nd 1.11±0.01ª 
BCAbT3 2.19±0.07a nd nd 1.10±0.01ª 
BCAbT6 2.18±0.03a nd nd 1.08±0.01ª 
BCPoT0 8.84±0.02ª 3.87±0.02a 1.52±0.02a 1.93±0.01ª 
BCPoT3 8.82±0.14ª 3.84±0.06a 1.51±0.07a 1.92±0.03ª 
BCPoT6 8.80±0.03ª 3.80±0.07a 1.50±0.02a 1.89±0.03ª 
In each column, different letters mean significant differences in bioactive compounds content between formulations (p<0.05). 
 
Table 28. Phenolic acids and ergosterol content in the developed cosmeceutical formulations. 
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In each row, different letters mean significant differences between formulations (p<0.05). When only two samples were present a Student´s t-test was used to determine the 
significant difference between two different samples, with α = 0.05. *Means a significant difference between the samples (p>0.001). 
 
 
 
 
 
 
 
Table 29. Bioactive properties of the developed cosmeceutical formulations 
Creams Anti-tyrosinase activity 
EC50 values (mg/mL) 
 
Antioxidant activity 
EC50 values (mg/mL) 
DPPH Reducing power 
 Time 0 Time 3 Time 6 Time 0 Time 3 Time 6 Time 0 Time 3 Time 6 
BCAb 25.1±0.5* 89±8* >100 347± 1b 380±2a 385±13a 69±1b 69±5b 74±1a 
BCPo 23±2c 40±3b 56±1a 339±2c 355±2b 378 ±6a 51±1c 57.8±0.6b 62±2a 
BCMAb >100 31±1* 69±3* >400 >400 >400 >400 >400 >400 
BCMPo >100 46±4 46±1 >400 >400 >400 >400 >400 >400 
BCEM >100 >100 >100 >400 >400 >400 >400 >400 >400 
BC >100 >100 >100 >400 >400 >400 >400 >400 >400 
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MIC (mg/mL) 
 Enterococcus faecalis MSSA MRSA E. coli  Proteus mirabilis Candida albicans 
 T0 T3 T6 T0 T3 T6 T0 T3 T6 T0 T3 T6 T0 T3 T6 T0 T3 T6 
BCAb >400 >400 > 400 400 400 > 400 400 400 > 400 >400 >400 >400 200 200 > 400 400 400 > 400 
BCPo 400 400 >400 200 200 400 200 200 400 > 400 > 400 > 400 400 400 > 400 400 400 > 400 
BCMAb >400 >400 > 400 >400 >400 400 > 400 > 400 400 > 400 > 400 > 400 > 400 > 400 > 400 > 400 > 400 > 400 
BCMPo >400 >400 400 >400 >400 400 > 400 > 400 400 > 400 > 400 > 400 > 400 > 400 400 > 400 > 400 400 
BCEM >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 
BC >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 
 
 
Sample 
Colour T0 Colour T3 Colour T6  
pH T0 
 
pH T3 
 
pH T6 l* a* b* l* a* b* l* a* b* 
BCAb 85.8±0.7a 0.8±0.3a 18.9±0.6a 81.42± 2b 0.597±0.03b 18.5±0.1ab 79.4±0.5b 0.26 ±0.02c 18.400±0.03b 3.88 ± 0.01b 3.88 ± 0.04b 4.12±0.01a 
BCPo 88.3±0.5a 0.21±0.02c 19.0±0.4b 87.3±0.4b 0.37±0.02a 22.6±0.1a 78.4±0.5c 0.28 ±0.03b 19.2±0.1b 3.42 ± 0.02b 3.46 ± 0.02b 3.69±0.01a 
BCMAb 75.7±0.7a -0.65±0.05a 5.3±0.2c 72.4±0.3b -1.29 ±0.02c 6.0±0.2b 69.7±0.3c -1.08±0.01b 7.0±0.2a 3.82 ± 0.03b 3.75 ± 0.03b 4±0.01a 
BCMPo 72.0±0.3a -0.71±0.05a 5.9±0.3c 71.02±0.05b -1.24 ±0.01c 6.23±0.02b 68.02±0.07c -0.91 ±0.01b 7.23±0.02a 3.67 ± 0.02b 3.7 ± 0.01b       3.96±0.01a 
BCEM 85.6± 0.8a -0.63±0.05a 7.9±0.3a 81.8± 0.2b -1.55±0.04c 6.18±0.05b 77.5± 0.4c -1.26±0.02b 6.35±0.06b 3.64±0.03b 3.75±0.05b 3.92±0.01a 
BC 92.2± 0.4a -0.99±0.07b 3.65±0.07b 89.4± 0.3b -1.15±0.04c 4.8±0.2a 85.6± 0.4c -0.86±0.04a 3.04±0.09c 4.78±0.01b 4.83±0.03ab 4.84±0.02a 
In each row and between each colour parameter during the different times, different letters mean significant differences between formulations (p<0.05). T0-immediately after 
formulation preparation, T3-3 months and T6-6 months. 
Table 30. Antimicrobial activity of the developed cosmeceutical formulations. 
Table 31. Physico-chemical properties of the semi-solid cosmeceutical formulations. 
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Another interesting potential of bioactive ingredients in cosmeceuticals is their tyrosinase 
inhibition potential, making them suppressors of melanin that largely contribute to 
hyperpigmentation and photoageing (Taofiq, González-Paramás, et al., 2016). The search for 
tyrosinase inhibitors has also intensified in the last decade due to the negative consequences 
associated with the use of synthetic ingredients that present several negative effects on the skin 
(Taofiq, González-paramás, et al., 2017). In the present study, the results for the tyrosinase 
inhibition activity of the developed formulations are presented in Table 29. For the 
formulations prepared with mushroom extracts (BCAb and BCPo), an anti-tyrosinase activity 
was observed and the results show that both formulations contain compounds that can inhibit 
tyrosinase, thus indicating their potential to be used in hyperpigmentation correction 
formulations. Like what was observed with the antioxidant activity; a gradual loss of tyrosinase 
inhibition activity from time 0 to 6 months in the formulations prepared with mushroom 
ethanolic extracts, was observed. This can be attributed to possible interactions with the 
different ingredients present in the base formulation along time. 
The life span of cosmetic and personal care products has been extended using synthetic 
preservatives due to their broad spectrum of antimicrobial activity, low price and to the fact 
that these compounds do not origin degradation products that affect physico-chemical 
properties (colour, pH, viscosity) (Kerdudo et al., 2016). Over the years some of these synthetic 
preservatives have become more controversial because of some negative effects associated 
with their use. Bearing in mind these challenges, cosmetic companies are now in search of non-
harmful alternatives for consumers, and bioactive compounds with multifunctional properties 
are slowly been used for this purpose (Taofiq, González-paramás, et al., 2017). In the present 
study, the antimicrobial activity of each cosmeceutical formulation against Gram-negative, 
Gram-positive and yeast strains is presented in Table 30.  
In all cases, the prepared formulations were found to be effective against Gram-negative, 
Gram-positive bacteria and Candida albicans. However, at the effective minimum inhibitory 
concentration, the antimicrobial activity failed to be maintained, highlighting a loss of 
bioactivity of the extracts. However, the results suggest that the compounds present in the 
studied extracts have the potential to be used as preservatives, capable of preventing microbial 
contamination in cosmeceutical formulations, but need strategies to increase effectiveness 
maintenance along storage time. 
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3.5.3. Bioactivity of mushroom-based cosmeceutical formulations – use of 
microencapsulated forms 
 
Real-time in vitro release of bioactive compounds from polymeric microspheres is typically 
done to evaluate control release at appropriate environmental and physiological conditions. 
This process may, sometimes, take weeks, months, or even years (Andhariya et al., 2017). The 
real-time in vitro release of the mushroom extracts loaded in the prepared microparticles was 
performed under controlled temperature during a 6-month period. The microparticles prepared 
in the present work showed high encapsulation efficiencies and the manifestation of bioactivity, 
due to compounds release from the microparticles, was evaluated on the base cosmetic cream 
added with microencapsulated extracts. From the obtained results, it can be seen that the 
formulations prepared with BCMAb and BCMPo particles, respectively, did not display 
significant antioxidant and antimicrobial effects up to month 3, which can be due to a very slow 
release of the encapsulated bioactives, whose concentration is not enough to exert a bioactive 
effect. The slow release makes the process suitable to be used in the design of cosmeceutical 
formulations, whose shelf life span varies from months to even years.  
Therefore, the gradual release ensures continuous effectiveness against microbial growth. 
However, and from the point of view of skin beneficial effects, their slow release can be 
disadvantageous as the formulated product may not release the bioactive compounds at the 
required levels for the intended effect. Nevertheless, it is expected that the application process 
of the cream favour mechanical disruption of the capsules, and thus the prompt release of the 
protected bioactive compounds on the skin surface. About the anti-tyrosinase activity, the 
released compounds were sufficient to cause activity manifestation of the formulations at the 
3rd month of storage, as shown in Table 29. From the anti-tyrosinase bioactivity evolution 
profile presented in Figure 33, it can be observed that both formulations, BCMAb and BCMPo, 
showed comparable patterns until the 3rd month of storage time (no bioactivity). After this time-
period, they start to reveal significant activity (31 ± 1 and 46 ± 4 mg/mL, for BCMAb and 
BCMPo respectively) but with a decreasing profile until the 6 months. In particular, BCMPo 
was able to maintain a more sustained release (no significant decrease was observed), 
comparatively with BCMAb that showed an important decrease up to the 6th month. As 
expected BCEM did not show any contribution to the tested bioactivities. Most studies on 
bioactive compounds release, consider various conditions such as temperature, solvent, pH, 
presence of enzymes or even stirring rate (J. Shen & Burgess, 2012).  
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Figure 33. Extrapolated real-time in vitro release profile of formulations designed with microparticles (BCMAb- 
base cosmetic cream with microparticles of A. bisporus extract, BCMPo- base cosmetic cream with microparticles 
of P. ostreatus extract and BCEM- base cosmetic cream with empty microparticles (control)). 
 
However, some of these conditions do not mimic the real environment, or the mechanism 
behind the release, making the real-time release evaluation, such as the assays done in the 
present work, an important contribute despite the long time required. In what concerns release 
profiles evaluation, Acosta et al. (2015) reported that the release of polyphenols from olive 
extract microencapsulated with chitosan was pH dependent, and the release rate at pH 7.4 
doubled the one obtained at pH 5.5. Hence, more studies need to be conducted to find the best 
conditions that might promote the degradation of the polymeric material allowing for faster 
delivery of the bioactive compounds, when applied. 
 
3.5.4. Physico-chemical parameters 
 
During product development, especially when bioactive ingredients are added either to 
improve products shelf life or to functionalise the formulations, several procedures need to be 
conducted to ascertain the safety and efficacy of the product. Some of the preliminary tests 
include pH, viscosity, colour and odour evaluation. Table 31 summarizes the pH values of 
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each formulation and the behaviour in terms of colour changes. Over the course of incubation, 
no significant colour changes were observed suggesting that the compounds present in the 
extracts were stable and their possible degradation did not lead to products imparting colour 
changes. From data on Table 31, it is possible to conclude that the formulations incorporated 
with the mushroom ethanolic extracts (BCAb and BCPo) presented a lower level of lightness 
(l*) as the storage time increase and this may be due to oxidation of the incorporated extracts. 
The colour coordinates for the formulations prepared with microparticles revealed a deeper red 
(greater a* value) mainly due to the contribution of alginate. Overall, the initial colour were 
maintained and without significant variations over the course of storage, and these are crucial 
parameters during preliminary stability testing analysis. 
In the present work, all the cosmeceutical formulations presented a pH between 3.4 and 5.0 
suggesting that these formulations have a large pH range, that was maintained even after 
months under storage. Samples were stored at 4˚C and the lack of significant pH variations is 
a clear indication of formulation stability. However, because most of the products exhibit 
excellent stability at this temperature, temperature variation studies are necessary at 50˚C, 25˚C 
and -10˚C in order to fulfill the cycle stability tests and to evaluate the behaviour of the 
developed formulations under temperature stress (Moraes, 2018). 
The above findings reveal that ethanolic extracts of A. bisporus and P. ostreatus, display strong 
antioxidant, antimicrobial and anti-tyrosinase activities, mainly due to the contribution of their 
bioactive components, being suitable as multifunctional cosmeceutical ingredients. The 
atomization/coagulation technique was successfully applied to encapsulate the bioactives. 
After incorporating the extracts into the base cosmetic cream, they displayed bioactivity; even 
with a decreasing pattern along the 6 months, for the free extracts. For the microencapsulated 
extracts, no demonstration of significant antioxidant and antimicrobial activity was observed, 
with anti-tyrosinase bioactivity being displayed after 3 months. Key findings in the present 
study revealed that it is important to study the release profile of the bioactive compounds from 
the microspheres, under different environmental conditions, in order to promote a faster release 
of the active ingredient, which might be interesting for certain applications. Results presented 
in the present work reveal the promising potential of mushroom extracts in what concerns 
bioactivity and stability. 
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3.6. Individual bioactive compounds as cosmeceutical ingredients: stabilization by 
microencapsulation to ensure a controlled release 
 
The present section intends to evaluate the anti-inflammatory, antimicrobial and anti-tyrosinase 
activities of p-hydroxybenzoic, p-coumaric, protocatechuic and cinnamic acids, and ergosterol. 
Based on the exhibited bioactivity, and interest to be used in cosmeceuticals formulations, these 
compounds were microencapsulated using the atomization/coagulation method with calcium 
alginate as the matrix material. The produced microspheres were fully characterised and tested 
against the use of the non-encapsulated forms (free compounds) in a base cosmetic (semi-solid 
formulation). Each produced formulation was submitted to bioactivity evaluation over a period 
of 6 months to ascertain stability and monitor the in vitro release of compounds responsible for 
the effect. Additionally, target compounds (phenolic acids, cinnamic acid, and ergosterol), 
incorporated in its free form were monitored using the HPLC. 
 
3.6.1. Bioactive properties of the individual compounds 
 
In the present work, the potential of the studied compounds to suppress NO production was 
evaluated (Table 32). Regarding the results, p-coumaric acid showed the highest potential 
presenting the lowest EC50 values (152.17 ± 6.22 µg/mL), followed by cinnamic (180.12 ± 
14.18 µg/mL), protocatechuic (182.16 ± 9.76 µg/mL) and p-hydroxybenzoic acids (195.21 ± 
8.70 µg/mL). These results are in agreement with the ones reported previously by our research 
group for cinnamic and p-hydroxybenzoic acids (Taofiq et al., 2015). On the other hand, 
ergosterol showed lower activity (338 ± 23 µg/mL), possibly due to its low solubility in the 
culture medium. To our best knowledge, only Kuo et al. (2011) have reported an anti-
inflammatory potential for commercial ergosterol at 10 µg/mL by inhibiting NO production in 
RAW. 7 macrophage cells. 
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Anti-inflammatory activity is expressed as EC50 values corresponding to 50% of inhibition of the NO production in comparison with the 
negative control (100% of NO production). Dexamethasone (positive control) EC50 values: 16 µg/mL. Anti-tyrosinase activity is expressed as 
EC50 values corresponding to 50% of inhibition of tyrosinase. Ascorbic acid (positive control) EC50 values: 31 µg/mL. In the column different 
letters mean significant differences (p < 0.05). *Statistically different values, Student´s t-test p-value <0.001. 
 
 
Concerning the anti-tyrosinase activity (Table 32), cinnamic acid displayed the strongest 
activity exhibiting the lowest EC50 value (0.31 ± 0.05 mg/mL). The other tested compounds, 
showing EC50 values above the highest tested concentration of 2.0 mg/mL, presented limited 
activity. To the author’s best knowledge, no studies have been previously reported for the 
tyrosinase inhibitory activity of protocatechuic, p-hydroxybenzoic and cinnamic acids; 
however, some other phenolic acids such as caffeic acid (43.09±2.3 µM), ferulic acid 
(51.85±1.7µM) and gallic acid (18.30 µM) have been reported as significantly suppress 
tyrosinase activity (Kumar et al., 2013; Thangboonjit et al., 2014). Although in the present 
study it was not possible to report anti-tyrosinase activity for p-coumaric acid, studies 
conducted by An et al. (2010) related that p-coumaric acid at 10 µg/mL showed activity at 
levels comparable to kojic acid, whereas Jun et al., (2012) confirmed that the anti-tyrosinase 
activity mechanism of p-coumaric acid was due to its ability to reduce MITF and tyrosinase 
mRNA expression by 73 and 82 %, respectively. The results show that these compounds 
display a promising potential to be used, either alone or in combination with other bioactive 
ingredients, to provide protection against hyperpigmentation. 
The results for the antimicrobial activity expressed as MIC values are shown in Table 33 for 
the studied compounds. All the individual compounds showed considerable antimicrobial 
capacity against gram-positive, gram negative bacteria and Candida, with cinnamic acid and 
ergosterol exhibiting a similar antimicrobial pattern. Interestingly, p-coumaric and 
protocatechuic acids presented the highest activity against methicillin-sensitive Staphylococcus 
aureus (SA), similarly to what was reported by Parkar et al. (2008). All the compounds showed 
Table 32. Anti-inflammatory and anti-tyrosinase activities of the individual compounds.  
Individual compounds Anti-inflammatory activity  
(EC50 values, µg/mL) 
Anti-tyrosinase activity  
(EC50 values, mg/mL) 
Cinnamic acid 180 ± 14c 0.31 ± 0.05* 
Protocatechuic acid 182 ± 10c >2.0 
p-Hydroxybenzoic acid 195 ± 9b 1.86 ± 0.01* 
p-Coumaric acid 152 ± 6d >2.0 
Ergosterol 338 ± 23a >2.0 
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inhibitory activity against E. coli in accordance with the results reported by Cueva et al. (2010). 
Due to the well-known constraints associated with the use of synthetic antimicrobial agents, 
this study highlights the potential of the studied polyphenols and sterols as viable alternatives.  
 
 
 
    MIC-Minimum Inhibitory concentration 
 
Phenolic acids such as ferulic and caffeic acid have been reported to be interesting anti-
wrinkling and photoprotective ingredients for skin care products, as reported by Pluemsamran 
et al. (2012), while Seok and Boo (2015) have reported anti-ageing potential for p-coumaric 
acid in dermal fibroblasts cell lines. However, most of the cosmeceutical properties were only 
evaluated for the individual compounds, and the compounds seldom incorporated in base 
cosmetic creams to evaluate if the bioactive properties are maintained. 
 
3.6.2. Morphology and characteristics of the developed microspheres 
 
The surface morphology images of the prepared microspheres, immediately visualised by 
optical microscopy after preparation, and at magnifications of 40x, 100x and 400x, are shown 
in Figure 34. It is possible to observe a consistent spherical morphology with particles of 
various sizes showing no agglomeration.  
 
 
 
Table 33. Antimicrobial activity of the individual compounds. 
  MIC (mg/mL) 
 Bacterial 
strains 
cinnamic 
acid 
p-hydroxybenzoic 
acid 
p-coumaric 
acid  
protocatechuic 
acid Ergosterol 
Gram 
+ MRSA 1 1 0.5 2.5 1 
 MSSA 1 1 0.5 2.5 1 
 E. faecalis 1 1 1 1 1 
Gram 
- E. coli 1 1 2.5 0.25 1 
 P. mirabilis 1 2.5 2.5 2.5 1 
 Yeast strain       
 C. albicans 2.5 2.5 2.5 2.5 2.5 
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Figure 34. Optical Microscopy analysis with magnifications of 40, 100 and 400x of the microspheres after 4 h of 
coagulation under stirring. 
 
Figure 35. Microparticles size distribution in number. 
 
The results for the particle size distribution, in terms of number and volume, represented as 
percentiles (D10, D50, and D90), are presented in Table 34. From the analysis of particle size 
distribution, the distributions in number (Figure 35) were unimodal whereas the distributions 
in volume were bimodal (Figure 36). Another important parameter to consider is the Span 
(dispersity) which indicates the width of the particle size distribution and gives an indication 
of particle size homogeneity. The lyophilized microspheres were rehydrated in distilled water 
and analysed using the optical microscope at a magnification of 100x. The final shape of the 
rehydrated microspheres was quite irregular but close to what was observed with microspheres 
right after the encapsulation process. 
 
40x 100x 400x 100x lyophylised 
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Figure 36. Microparticles size distribution in volume. 
Samples 
Particle size distribution (µm) Mean particle size (µm) 
Volume distribution Number distribution 
Number Volume 
D10 D50 D90 Span D10 D50 D90 
A 19.5 79.2 235 2.72 0.82 1.15 2.83 1.50 102 
B 20.5 74.6 206 2.28 0.72 0.93 2.10 1.63 95.1 
C 25.4 90.7 208 2.01 0.71 0.91 1.84 1.07 104 
D 36.1 115 261 1.95 0.72 0.91 1.95 1.10 132 
E 21.3 71.0 186 2.31 0.72 0.95 2.05 1.15 90.1 
F 36.3 108 273 2.19 0.63 0.77 1.26 0.86 132 
A - empty microparticles B - p-hydroxybenzoic acid, C - p-coumaric acid, D - cinnamic acid, E - protocatechuic acid, F - Ergosterol. 
 
 
From the obtained data, there is no significant dissimilarity among the particles incorporating 
the various bioactive ingredients. Table 35 summarizes the results obtained for the 
encapsulation yield, loading, and efficiency of the produced alginate microspheres. To 
determine EE %, the concentration of the analysed compounds was determined both in the 
coagulation and washing solutions using the HPLC and the amount effectively encapsulated 
obtained by difference.  
The results showed that the compounds were successfully encapsulated with EE % greater than 
50% for all the studied cases. The EY %, which represents the weight of dry microspheres, 
Table 34. Particle size distribution in number and volume (D10, D50 and D90 and mean particle size) of the 
prepared microspheres. 
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recovered after encapsulation process, relatively to the weight of raw-materials initially used, 
was found to be over 45% in all the samples. These values are quite satisfactory considering 
that the applied technique was conducted at a laboratory scale. Some authors reported the 
encapsulation of phenolic acids such as caffeic, chlorogenic and rosmarinic acids, using similar 
scales, with a EY (%) only over 37%, for all the studied cases (Aguiar, Costa, Rocha, 
Estevinho, & Santos, 2017). The EL (%,) representing the compound content per gram of 
microspheres, allows the determination of the microsphere’s amount needed to be incorporated 
in the base cosmetic creams. By analysing the results listed in Table 35, the EL (%) was above 
5% in all the cases. 
 
 
 
 
 
 
 
 
                       
                      na- not applied 
 
3.6.3. Bioactive properties of cosmeceutical formulations  
 
In the present work, the cosmeceutical potential of each prepared formulation was investigated 
based on their ability to display anti-inflammatory, anti-tyrosinase and antimicrobial activities. 
The results for the in vitro anti-tyrosinase activity of the prepared cosmeceutical formulations 
containing the individual compounds are presented in Table 36. From the results, all the 
developed formulations (CFHA, CFCoA, CFCA, CFPA) were able to inhibit tyrosinase 
activity over 6 months under storage. On the other hand, the formulation prepared with 
ergosterol (CFE) was also able to inhibit the tyrosinase activity, however, a significant loss was 
observed as the storage time increased, which can be attributed to the interaction between 
ergosterol and other ingredients present in the base cosmetic cream (Table 36). Several studies 
have reported that phenolic acids and related compounds are the most significant contributors 
to anti-tyrosinase activity, but most of these studies only investigated pure compounds without 
Table 35. Encapsulation efficiency, load and yield of the prepared microspheres. 
Samples EE (%) EY (%) EL (%) 
A na 60.2 na 
B 88.3 57.8 9.80 
C 73.7 55.7 8.19 
D 98.4 58.9 10.9 
E 50.3 62.2 5.59 
F 63.2 45.5 7.02 
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performing their incorporation in topical semi-solid formulations (T. S. Chang, 2009; Taofiq, 
González-paramás, et al., 2017). An exception was the work of Seo et al. (2011), who 
conducted clinical trials by exposing the forearms of 21 persons after topical application of a 
p-coumaric acid-based cream twice daily. The results showed that there was a significant 
improvement in the hyperpigmentation formation. 
For the anti-inflammatory activity, all the developed formulations containing the individual 
phenolic acids, cinnamic acid and ergosterol were able to inhibit NO production (Table 36). 
As observed for the other bioactive properties there was a gradual loss of bioactivity as the 
storage time increased, with the ergosterol-based formulation (CFE) showing the lower anti-
inflammatory activity. The formulation prepared with p-coumaric acid (CFCoA) was the most 
promising one, as determined based on the observations made with the individual compounds.  
The antimicrobial activity of the developed cosmeceutical formulations, against Gram-
negative, Gram-positive and yeast microbial strains, are presented in Table 37. In all the cases, 
the prepared formulations were found to be effective against Gram-negative, Gram-positive 
bacteria, and C. albicans. The antimicrobial activity of the formulations incorporated with the 
free individual agents decreased along the storage time, probably due to the interaction with 
the ingredients present in the base cosmetic cream. Our findings suggest that these bioactive 
compounds have the potential to be used as preservatives capable of preventing microbial 
contamination in cosmeceutical formulations. 
The identification and quantification of the individual compounds present in the prepared 
formulations, determined by HPLC, are presented in Table 36. It can be concluded that all the 
target compounds were stable and where identified in their corresponding formulation. The 
validation of an extraction protocol for phenolic acids extraction from semi-solid formulation 
still poses some challenges. However, it was possible to effectively identify and quantify the 
amount of phenolic acids and related compounds present in each prepared cosmeceutical 
formulation over the storage time. The results showed that there was no significant loss of 
phenolic compounds, or ergosterol, over the course of the incubation period for all the 
considered semi-solid formulations.  
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3.6.4. Physico-chemical parameters 
 
Although it is possible to find in the market, a wide range of cosmetic colours, the majority of 
consumers still prefer products with a basic white colour. Hence, the cosmetic industry has 
paid attention to colour management during the design of new products. Responding to this 
requisite, the physico-chemical evaluation of the prepared semisolid formulations in terms of 
colour, and pH, was carried out during the storage period at time 0, 3 and 6 months (Table 38). 
Over the course of the six-month incubation period, no significant colour changes were 
observed, suggesting that the individual compounds are stable, and their degradation does not 
lead to end products causing significant colour changes. It was possible to observe that the 
formulations presented lower levels of lightness (l*) as the storage time increase, which may 
be derived from the oxidation of the incorporated compounds. Lower l* values and higher 
yellowness (b*) was observed for the formulations prepared with the individual compounds, 
whereas the colour coordinates for the formulations prepared with the microspheres revealed a 
deeper red (greater a* value), mainly due to the contribution of alginate. Overall, the initial 
odour (qualitative evaluation) and colour were maintained, i.e. they were not significantly 
different over the course of the storage time, which are crucial parameters for the preliminary 
analysis of stability. In this work, all the developed cosmeceutical formulations presented a pH 
in the range 3.4 – 6.0, suggesting that they have a favourable pH along the storage time. The 
samples, stored at 4 ˚C in darkness, presented no significant pH variation, which is a clear 
indication of their stability. Also, most of the products exhibited excellent stability under this 
temperature.
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Creams Anti-tyrosinase activity  
(EC50 values, mg/mL) 
 
Anti-inflammatory activity 
(EC50 values, mg/mL) 
 
Bioactive compounds profile 
(mg/g) 
 Time 0 Time 3 Time 6 Time 0 Time 3 Time 6 Time 0 Time 3 Time 6 
CFHA 54±4b 55.3±0.1 b 59.9±0.5a 30.66±1c 41.92±2.17 b 54.13±0.93a 6.80± 0.07a 6.83± 0.04a 6.39± 0.02b 
CFCoA 37.6±0.9b 41±7 b 51±6a 22.64±0.76c 33.04±1.51 b 45.29±1.63a 6.67± 0.03a 6.52± 0.08 b 6.48± 0.07b 
CFCA 32.3±0.2b 36±5ab 40±3a 33.47±0.46c 40.03±1.09 b 47.05±1.01a 6.50± 0.01a 6.4± 0.2a 6.39± 0.02a 
CFPA 40±3b 43±2b 61±7a 36.28±1.62* 47.59±0.55* >60 6.64± 0.08a 6.5± 0.1b 6.42± 0.01b 
CFE 24±2c 51±5 b 98.2±0.7a 53.35±1.62 >60 >60 6.9±0.01a 6.81±0.01b 6.78±0.02b 
CFEM >100 >100 >100 >60 >60 >60 nd nd nd 
CFMHA >100 >100 48±12 >60 50.56±0.57* 42.66±0.94* nd nd nd 
CFMCoA >100 73±1* 45±4* >60 42.34±1.02* 34.57±0.43* nd nd nd 
CFMCA >100 80.8±0.7* 43.0±0.8* >60 48.440.5±* 40.33±1.13* nd nd nd 
CFMPA >100 >100 49±8 >60 46.99±1.43* 40.07±0.17* nd nd nd 
CFME >100 47±4* 32.6±0.6* >60 >60 >60 nd nd nd 
BA >100 >100 >100 >60 >60 >60 nd nd nd 
nd-not determined, for easy identification of the samples, each formulation was labelled as follows: i) Cosmeceutical formulations incorporated with free Individual compounds:  CFHA- p-hydroxybenzoic acid, CFCoA- 
p-coumaric acid, CFCA- cinnamic acid, CFPA- protocatechuic acid, CFE- ergosterol; ii) Cosmeceutical formulations incorporated with microencapsulated compounds: CFEM- empty microspheres (control), CFMHA- 
microspheres with p-hydroxybenzoic acid, CFMCoA- microspheres with p-coumaric acid, CFMCA- microspheres with cinnamic acid, CFMPA- microspheres with protocatechuic acid, CFME- microspheres with 
ergosterol. For all the assays a negative control was analysed with base cosmetic cream (BA). In each row different letters mean significant differences (p < 0.05). *Statistically different values, Student´s t-test p-value 
<0.001. 
Table 36. Bioactive properties of the individual compounds developed cosmeceutical formulations and compounds monitoring over the storage time.  
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Mic (mg/mL)    
Bacterial strains Yeast 
Samples 
E. faecalis 
 
MSSA 
 
MRSA 
 
E. coli 
 
P. mirabilis 
 
C. albicans 
 
 T0 T3 T6 T0 T3 T6 T0 T3 T6 T0 T3 T6 T0 T3 T6 T0 T3 T6 
BA >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 
CFHA 200 200 400 200 200 400 200 200 400 200 200 400 400 400 400 400 400 400 
CFCoA 200 200 400 100 100 200 100 100 200 400 400 400 200 200 400 400 400 400 
CFCA 200 200 400 200 200 400 200 200 400 200 200 400 200 200 400 400 400 400 
CFPA 200 200 400 100 100 200 100 100 200 400 400 400 400 400 400 400 400 400 
CFE 200 200 400 200 200 400 200 200 400 200 200 400 200 200 400 400 400 400 
CFEM >400 > 400 >400 >400 400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 >400 > 400 >400 
CFMHA >400 400 200 >400 400 200 >400 400 200 >400 400 200 >400 >400 400 >400 > 400 400 
CFMCoA >400 400 200 >400 200 >400 >400 200 100 >400 >400 400 >400 >400 200 >400 > 400 >400 
CFMCA >400 400 200 >400 400 200 >400 400 200 >400 >400 400 >400 >400 400 >400 > 400 >400 
CFMPA >400 400 200 >400 200 100 >400 200 100 >400 >400 400 >400 >400 400 >400 > 400 >400 
CFME >400 400 200 >400 400 200 >400 400 200 >400 >400 400 >400 >400 400 >400 > 400 400 
 
 
 
 
Table 37. Antimicrobial activity of the final cosmeceutical formulations.  
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Sample 
Colour T0 Colour T3 Colour T6  
pH T0 
 
pH T3 
 
pH T6 L* a* b* L* a* b* L* a* b* 
CFHA 93.0±0.3ª -0.85±0.07ª 4.31±0.08a 86.35±0.2b -0.88±0.02a 3.71±0.04b 81± 1c -0.9±0.2a 3.4±0.3b 5.43±0.02ab 5.49±0.05a 5.4±0.02b 
CFCoA 93.0±0.4a -0.79±0.05a 4.6±0.1a 85.06±0.5b -0.80±0.02a 3.48±0.08b 80.4± 0.3c -0.82±0.02ª 2.9±0.3c 4.37±0.02a 4.41±0.04a 4.4±0.04a 
CFCA 93.1±0.2a -0.98±0.07c 4.21±0.07a 84.29±0.5b -0.64±0.01a 2.82±0.02c 81.0± 0.1c -0.74±0.01b 3.0±0.1b 4.35±0.01c 4.4±0.02b 4.47±0.02a 
CFPA 92.7±0.4a -1.01±0.02c 3.68±0.06a 84.70±0.2b -0.94±0.01b 3.23±0.04b 80.7± 0.2c -0.84±0.01ª 3.1±0.1c 3.75±0.01c 3.8±0.01b 3.89±0.01a 
CFE 92.8±0.4a -1.05±0.09b 4.6±0.2a 83.53±0.03b -0.72±0.04a 3.10±0.01c 81.3± 0.2c -0.78±0.03ª 3.58±0.01b 4.57±0.04b 4.61±0.02a 4.65±0.02a 
CFEM 85.6±0.8a -0.63±0.05a 7.9±0.3a 81.8±0.2b -1.55±0.04c 6.18±0.05b 77.5± 0.4c -1.26±0.02b 6.35±0.06b 3.64±0.03c 3.75±0.05b 3.92±0.01a 
CFMHA 77.9±0.5a -0.09±0.03a 6.3±0.1a 77.3± 0.5a -0.64±0.01b 6.11±0.03ab 76.8± 0.3a -0.84±0.02c 5.9±0.3b 4.54±0.01b 4.55±0.05b 4.68±0.02a 
CFMCoA 81.7±0.6a -0.81±0.06a 5.1±0.2a 79.4±0.3b -0.81±0.06a 4.96±0.02ab 78.7± 0.3b -0.83±0.04ª 4.7±0.2b 4.07±0.02b 4.1±0.02b 4.22±0.01a 
CFMCA 65.1±0.9a -0.89±0.03c -0.5±0.1a 64.25±0.04a -0.58±0.02a -0.38±0.03ª 64.3± 0.3a -0.63±0.05ª -0.46±0.04b 4.39±0.01b 4.33±0.01c 4.47±0.01a 
CFMPA 79.7±0.5a -0.59±0.06a 4.6±0.2a 79.7±0.1a -0.74±0.03b 4.61±0.02ª 78.7± 0.1a -0.81±0.03b 4.64±0.02ª 3.92±0.01c 3.98±0.02b 4.1±0.01a 
CFME 80.8±0.4a -0.84±0.07a 5.5±0.4a 78.2± 0.3b -1.25±0.08c 5.4±0.2ab 77.3± 0.3c -1.02±0.02b 4.8±0.2b 3.81±0.01b 3.83±0.03b 4.00±0.01ª 
BA 92.2±0.4ª -0.99±0.07b 3.65±0.07b 89.4±0.3b -1.15±0.04c 4.8±0.2ª 85.6± 0.4c -0.86±0.04ª 3.04±0.09c 4.78±0.01b 4.83±0.03ab 4.84±0.02ª 
In each row and between each colour parameter (L, a and b) during the different times, different letters mean significant differences between samples (p<0.05)
Table 38. Physico-chemical properties of the developed cosmeceutical formulations.  
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3.6.5. Real-time in vitro release  
 
The real-time in vitro release of the microencapsulated bioactive agents was performed under 
controlled temperature medium. Their release was evaluated based on their potential to increase 
the bioactive properties of the corresponding formulations. From the obtained data, 
microspheres showed a very slow release of the encapsulated bioactives up to the 6th month 
under storage. Throughout the process of microencapsulation, the anti-tyrosinase, anti-
inflammatory, and antimicrobial activities were not compromised since the bioactivity was 
kept in almost all cases, highlighting the potential of alginate particles as effective delivery 
vehicles. Regarding the anti-tyrosinase activity, a fast release, sufficient to cause activity, was 
achieved for the formulations at the 3rd month of storage as shown by the data of Table 36. It 
was also observed that both formulations CFMCoA and CFMCA showed similar profile 
relative to the anti-tyrosinase and anti-inflammatory activity. The release in both cases was 
able to sustain the bioactivities up to the 6th month. As expected BCEM did not show any 
contribution to the tested bioactivities. CFMPA and CFMHA were able to maintain an anti-
tyrosinase activity lower than the one obtained for CFMCoA and CFMCA, regardless they 
showed the best anti-inflammatory activity. BCE was able to sustain the anti-tyrosinase 
activity, however, no anti-inflammatory activity was perceived. The slow release supports the 
suitability of the microencapsulation process to be used in the design of cosmeceutical 
formulations, whose shelf life span from months to even years, making the gradual release 
adequate to ensure the continued effectiveness against microbial growth. It is also interesting 
to note that the compounds not released during the evaluated storage time can be further 
released in the skin during the application of the cosmeceutical formulation. In fact, due to the 
applied pressure, capsules breakage will occur with the subsequent release of the encapsulated 
compounds, which will result in skin benefits derived from the fraction of preserved bioactives. 
From the obtained results, the alginate microcapsules showed potential to ensure the controlled 
release of the bioactive agents, which will add in the cosmetic preservation during storage and 
will provide benefits for the skin upon application (preserved fraction). 
Some relevant reports have been presented on the use of microencapsulation techniques to 
protect bioactive compounds for cosmeceutical purposes. Biswick et al. (2012) 
microencapsulated caffeic acid, with the produced microparticles able to withstand both UVA 
and UVB radiation, indicating their suitability to be used in the design of sunscreen cosmetic 
formulations. Ouimet et al. (2015) microencapsulated ferulic acid, whose slow release was 
reported as acting for days, but able to achieve antioxidant activity. Different factors such as 
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polymer nature and molecular weight and microparticle’s size have been reported by Sharma 
et al. (2016), as influencing the release rate making these issues worthy of further investigation. 
The studies performed under the context of the present work is a valuable strategy to access 
the long-lasting effect of the encapsulated bioactive compounds. The overall results show that 
microencapsulation can provide efficient tools to support the development of cosmetic 
formulations promoting the preservation of the cosmeceutical ingredients, and the sustained 
release of the compounds (i.e. bioactivity maintenance). 
The findings achieved in this work reveal that the studied compounds (p-hydroxybenzoic, p-
coumaric, protocatechuic and cinnamic acids, and ergosterol) displayed anti-tyrosinase, 
antimicrobial and anti-inflammatory activities making them suitable to be explored as 
multifunctional cosmeceutical ingredients. The atomization/coagulation technique was 
successfully applied to encapsulate the bioactive agents, conducting to EE% values above 50% 
for all the tested compounds. After incorporating the individual compounds in the cosmetic 
formulations, bioactive properties were only partially maintained while their 
microencapsulated formulations have shown a sustained release able to better preserve 
bioactivity. Moreover, over the course of storage time, no significant changes were observed 
in the tested stability parameters, namely colour, and pH.  By the obtained results, the analysed 
bioactive agents revealed promising bioactivity and stability.  
 
3.7. Safety and topical bioavailability of mushroom extracts as cosmeceutical ingredients 
 
Following studies conducted in section 3.2 and 3.3 where interesting cosmeceutical potential 
was displayed for ethanolic extracts of P. ostreatus and G. lucidum, both extracts were selected 
for further studies. Both extracts, obtained by Soxhlet extraction, and their corresponding final 
cosmetic formulations, prepared from a selected base cosmetic cream, were tested regarding 
cell viability and cytotoxic effects using MTT and LDH assays in keratinocytes (HaCaT) and 
fibroblasts (HFF-1). Additionally, the extracts and the final formulations were submitted to 
skin permeation assays using the Franz diffusion cell with pig ear skin as the permeation 
membrane.  
Natural extracts, or their individual metabolites, offer many advantages as cosmeceutical 
ingredients and are being increasingly used nowadays. They assume an importance not just 
because of the bioactive potential but also due to the commercial and market appeal, making 
them positively recognized and accepted by consumers. Ethanolic extracts obtained from G. 
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lucidum and P. ostreatus (E1 and E2, respectively) were incorporated into base cosmetic 
creams and the generated formulations designated as F1 and F2 for G. lucidum and P. ostreatus, 
respectively. The incorporated extracts may have a positive effect on the skin when applied 
topically due to their content in different bioactive molecules (e.g triterpenoids, phenolic acids 
and related compounds), as well as the bioactive properties previously reported (Taofiq, 
Heleno, et al., 2017, 2016; Taofiq et al., 2018). The colour attributes of the produced 
formulations in the L*a*b* system were 70.3±0.7, 12.1±0.5, 32.9±0.9 and 88.3±0.5, 
0.21±0.02, 19.01±0.4 for F1 and F2, respectively. Both formulations present pH between 3.4 - 
4.7 and can be considered adequate for topical application.  
 
3.7.1. Safety of ethanolic extracts as cosmeceutical ingredients  
 
Most products introduced into the market by cosmeceutical manufacturers undergo self-
policing since no dedicated regulation for safety is available. Some of these ingredients can 
cause several allergies; hence, setting up approaches and methods to identify allergens and 
evaluate the potential toxicity of some of these products is of huge importance (Draelos, 2009). 
The presence of a diversity of chemical compounds in bioactive extracts may trigger some 
unwanted skin irritations, contact dermatitis, photosensitivity, hair and nail damage, 
hyperpigmentation, hypopigmentation and systemic effects (X. H. Gao et al., 2008). Since 
these ingredients are going to be in contact with the skin, it is vital to evaluate their safety and 
potential toxicity against skin cells. Over the years, in vitro models were developed to mimic 
skin cells and assess the safety and potential toxicity of bioactive extracts intended for 
dermatological use (Rodrigues et al., 2013). In the present work, the cell viability effect of the 
ethanolic extracts prepared from G. lucidum and P. ostreatus was evaluated on HaCaT 
(keratinocytes) and HFF-1 (fibroblast) cells, following a concentration-dependent manner (1-
10000 µg/mL). Keratinocytes are a biologically relevant target for skin irritants because they 
are the first living cells that contact topically with the applied compounds. Also, HaCaT cells 
present several morphological and functional features typical of normal epidermal 
keratinocytes, making them a good model for skin toxicity tests (Abruzzo et al., 2017). The 
chemical profile of the ethanolic extracts from G. lucidum and P. ostreatus (Tables 16 and 21) 
correspond to a mixture of different bioactive compounds, which could potentiate the 
development of reactions (allergic or irritant) when applied for dermatologic purposes, 
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imposing the need to perform cytotoxicity evaluation and access the minimum concentration 
reducing the viability of the tested cell lines. 
 
  
Figure 37. Effect of ethanolic extracts of G. lucidum (E1) and P. ostreatus (E2) exposure on the viability of 
HaCaT cells at different concentrations, as measured by the MTT assay. Values are expressed as means ± SD (n 
= 3). In each extract, different letters mean significant differences between the concentrations (p<0.05). 
 
Regarding HaCaT cells after exposure to both extracts (Figure 37), up to 90% cell viability 
was maintained at 100 µg/mL, while the highest tested concentration (10 mg/mL) was found 
to significantly inhibit cell viability. Concerning HFF-1 cells, the cell viability was maintained 
up to 60% at 100 µg/mL for E1, and up to 90% when the same concentration was used with 
E2. Above 100 µg/mL, both extracts were found to significantly affect the viability of HFF-1 
cells as shown in Figure 38. This result can be used to compare the potential toxicity of the 
studied mushroom ethanolic extracts, based on which further experiments can be conducted. 
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Figure 38. Effect of ethanolic extracts of G. lucidum (E1) and P. ostreatus (E2) exposure on the viability of HFF-
1 cells at different concentrations, as measured by the MTT assay. Values are expressed as means ± SD (n = 3). 
In each extract, different letters mean significant differences between the concentrations (p<0.05). 
 
The LDH assay has been utilised as a good marker to ascertain cytotoxicity of bioactive 
ingredients. The mechanism behind it involves the measurement of lactate dehydrogenase 
(LDH), an enzyme found in the surroundings of compromised cell membranes. As shown in 
Figure 39, E2 did not show any potential to cause LDH leakage after exposure to HaCaT cells. 
This low toxicity was achieved at 100 µg/mL, more than 50% toxicity was found above 1 
mg/mL. In what concerns E1, a lower level of toxicity was found in the range of 4-100 µg/mL, 
while increased cellular LDH efflux was found above 100 µg/mL. Similarly, Figure 40 showed 
that both extracts present low toxicity to HFF-1cells between 1-10 µg/mL, but increased LDH 
level was observed between 100-10000 µg/mL for both extracts, comparable to Triton X-100 
(negative control). The results indicate that the fibroblasts cells were more sensitive when 
compared to the keratinocytes after exposure to different concentrations of the extracts. These 
results are in agreement with those obtained for hydroalcoholic extract obtained from the leaves 
of six species of Medicago (Rodrigues et al., 2013). The authors observed that the keratinocytes 
were more resistant than fibroblasts when exposed to different concentrations of the extract. 
Based on the achieved results described, the extract concentration that was able to maintain 
cell viability up to 50% can be selected for further experiments or applications. 
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Figure 39. Cytotoxicity (%) of LDH in HaCaT cells after exposure to extracts E1 and E2.  Values are expressed 
as means ± SD (n = 3). In each extract, different letters mean significant differences between the concentrations 
(p<0.05). 
 
 
Figure 40. Cytotoxicity (%) of LDH in HFF-1 cells after exposure to extracts E1 and E2.  Values are expressed 
as means ± SD (n = 3). In each extract, different letters mean significant differences between the concentrations 
(p<0.05). 
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The final cosmeceutical creams formulated with the extracts were also submitted to studies 
evaluating their cell viability and cytotoxicity effect on fibroblasts and keratinocyte cell lines. 
Data of Figure 41 indicates that the cell viability of HaCaT cell lines, after exposure to F1, 
undergo, up to 60%, maintenance of cell viability at 1 mg/mL. 
 
 
Figure 41. Effect of formulations (F1 and F2) exposure on the viability of HaCaT cells at different concentrations, 
as measured by the MTT assay. Values are expressed as means ± SD (n = 3). In each extract, different letters 
mean significant differences between the concentrations (p<0.05). 
 
The effect of F2 on cell viability of HFF-1 (Figure 42) showed a cell survival rate of ~60% for 
all concentrations below 100 µg/mL, while 1 mg/mL and 10 mg/mL were found to be 
deleterious to the cells as compared to Triton X-100 (negative control). In fact, it is difficult to 
deduce the cytotoxic contribution of each component present in the base cosmetic cream, as 
well as the contribution of the individual compounds identified in the extracts.  
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Figure 42. Effect of formulations (F1 and F2) exposure on the viability of HFF-1 cells at different concentrations, 
as measured by the MTT assay. Values are expressed as means ± SD (n = 3). In each extract, different letters 
mean significant differences between the concentrations (p<0.05). 
 
3.7.2. Ex vivo Skin permeation studies 
 
To identify which of the naturally occurring compounds of the prepared ethanolic extracts from 
G. lucidum and P. ostreatus were able to penetrate through the skin, and to evaluate their 
permeability, ex vivo experiments were conducted using a pigskin model. From the results 
described in Table 39, in what concerns skin penetration profile of E1, significant amounts of 
compounds were found to penetrate the skin, but these compounds were not detected in the 
receptor compartment. The results showed that a significant percentage of the compounds 
earlier detected in the extract were retained in the skin layers. It will be of utmost significance 
if these compounds retained in the skin layers can elicit a local cosmeceutical effect.  
Bioactive ingredients present in cosmeceutical formulations must be released from the carrier 
(base cosmetic cream) and be able to penetrate the stratum corneum of the skin in order to 
deliver a cosmeceutical effect (Rodrigues et al., 2016). Because of the ban on the use of in vivo 
assays for testing cosmetics ingredients, in the cosmetic directive 76/768/EEC there is a 
demand for novel in vitro methods to determine the bioavailability of topically applied 
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chemicals (Gerstel et al., 2016). Skin permeation studies have been conducted in the past using 
human skin as a membrane, but these experiments are expensive and sometimes limited due to 
ethical issues. Penetration studies with human and pig skin have been conducted and the results 
have shown that both skin cells demonstrate positive correlation and bioavailability distribution 
in the different skin layers with comparable and reproducible results (Barbero & Frasch, 2009). 
Histologically, many similarities are observed such as the tissue turnover time, the SC 
thickness, the hair-follicle density and the characteristics of their keratinous proteins. However, 
dissimilarities exist in the level of vascularization, fat component of the SC organized in a 
hexagonal lattice in pigs and orthorhombic lattice in human (Praça et al., 2018). The goal is the 
permeation of active ingredients in stratum corneum, which is popularly referred to as the rate-
limiting barrier before successfully permeating through the epidermis (Haq, Goodyear, Ameen, 
Joshi, & Michniak-Kohn, 2018).
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Each value represents the mean ± SD 
 
 
 
        
        
Table 39. Identification and quantification of phenolic compounds and triterpenoids during ex vivo permeation study. 
        
        
 
Rt UV lmax [M-H]-& [2M-H] MS2 and MS3 Tentative 
identification 
Quantification  
(min) (nm) (m/z) (m/z) Initial    Final Expected  penetration 
        
        
Phenolic compounds                                                                                                                                                                                                                 µg/g  
        
        
 5.31 259,293sh 153 109(100) Protocatequic acid   377±7 tr  377±7 
 8.5 257 137 93(100) p-Hydroxybenzoic acid 285±7 tr 285±7 
 11.45 280 197 121(100) Syringic acid 612±8 tr 612±8 
     Total phenolic acids 1275±22  1275±22 
        
        
Triterpenes                                                                                                                                                                                                                               mg/g                                                                                                                                                                                        
 
        
        
 35.5 265 529/1059 511(5),467(100),449(20),437(29),317(10),301(5),263(5) 12-Hydroxyganoderic acid D 3.37±0.06 1.12±0.07 2.25±0.01 
 36.8 251 515/1031 497(100),453(31),437(8),303(19),287(5),235(3) Ganoderic acid derivative 7.0±0.1 2.166±0.003 4.8±0.1 
 36.9 256 517/1035 499(100) 481(48),456(17),438(52),407(8),304(6),287(35) Ganoderic acid C2 12.57±0.07 5.8±0.4 6.8±0.3 
 37.5 257 529/1059 511(5),481(7),467(100),451(14),438(38),424(3),319(5),303(3),301(5) Ganoderic acid C6 6.6±0.1 tr 6.6±0.1 
 38.2 256 529/1059 511(58),493(5),449(10),399(100),301(3) Ganoderic acid derivative 1.65±0.04 tr 1.65±0.04 
 38.5 256 531/1063 513(11),498(15),469(100),454(29),452(24),437(6),304(5),302(6),290(20),266(7) Ganoderic acid G 12.0±0.4 tr 12.0±0.4 
 38.8 248 513/1027 495(10),480(16),451(100),437(14),433(22),407(17),331(5),315(3),303(5),287(5) Ganoderenic acid B 5.83±0.07 3.5±0.1 2.3±0.2 
 39.4 254 515/1031 497(10),453(100),439(5),409(5),304(21),287(12),263(3),250(14) Ganoderic acid B 24.4±0.4 21.0±0.1 3.4±0.5 
 40.4 254 515/1031 497(100),480(5),454(6),436(10),302(8),301(4),285(3) Ganoderic acid A 14.8±0.6 9.0±0.2 5.8±0.4 
 40.7 261 571/1143 553(100),511(8),481(3),468(8),437(3),423(2) Ganoderic acid H 9.24±0.02 tr 9.24±0.02 
 40.9 252 527/1055 509(20),479(13),465(100),435(3),421(3),317(3),301(3) Elfvingic acid A 11.9±0.5 6.92±0.09 5.0±0.4 
 41.9 246 511/1023 493(12),478(20),449(100),435(15),431(4),405(4),329(3),301(4),285(5),283(3),261(4) Ganoderenic acid D 8.47±0.05 6.7±0.2 1.8±0.02 
 42.6 255 513/1027 495(16),451(100),437(6),433(3),407(4),301(23),286(3),284(11),247(8) Ganoderic acid D 14.3±0.3 9.7±0.2 4.6±0.1 
 42.8 245 509/1019 491(100),476(18),461(34),447(15),429(3),417(3),300(5),299(4) Ganoderic acid derivative 10.7±0.3 3.34±0.01 7.4±0.3 
 43.2 256 511/1023 493(100),449(65),435(3),300(5),247(4) Ganoderic acid E 8.9±0.5 7.5±0.1 1.4±0.1 
 44.0 255 569/1139 551(100),509(35),508(21),466(8) 12-Acetoxyganoderic acid F 7.26±0.02 2.38±0.03 4.88±0.02 
      45.1 272 513/1027 451(100),437(8),433(3),422(3),301(5) Ganoderic acid J 4.7±0.2 tr 4.7±0.2 
     Total triterpenoids 163±4 79±1 85±3 
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Different factors such as higher molecular weight, lipophilicity, and aqueous solubility have 
been reported to be the most important determining factors that explain the tendency of 
compounds to permeate or to be retained on the skin surface (Žilius et al., 2013). Protocatechuic 
and syringic acids were the unique compounds that permeated from the E1 extract suspension 
through the skin in an amount that could be quantified between 1 - 8 h, as shown in Table 40.  
 
 
Time Compounds Amount detected in the receptor compartment  
(µg/g) 
15 min - - 
30 min - - 
45 min - - 
1 h Protocatechuic acid 51.5±0.4 
2 h Protocatechuic acid 35.3±0.2 
4 h Protocatechuic acid 11.5±0.1 
Syringic acid 37.2±0.4 
6 h Protocatechuic acid 
Syringic acid 
12.1±0.1 
tr  
8hr Protocatechuic acid 
Syringic acid 
tr 
tr 
 
Each value represents the mean ± SD 
 
Both compounds were also detected in the receptor compartment of formulation F1 test. 
Phenolic acids and related compounds identified in the E2 extract are cinnamic, p-
hydroxybenzoic and p-coumaric acids, and none of these compounds were detected in the 
receptor fluid, up to 8 h of assayed time. This finding was an indication of the low skin 
permeation of compounds found in extracts prepared from P. ostreatus. Similarly, the 
penetration and permeation of compounds in formulation F2 were very low and no compounds 
were detected in the receptor compartment. The results showed that the penetration ability of 
the phenolic acids identified in the receptor compartment of the assays with sample E1 and F1 
might be due to the enhanced contribution of the high size triterpenes of E1 and corresponding 
formulation. Studies have identified triterpenes, terpenes, and sesquiterpenes as promising non-
toxic, highly advanced, non-irritating transdermal penetration enhancers, which were classified 
as generally regarded as safe (GRAS) by the Food and Drug Administration (Aqil, Ahad, 
Sultana, & Ali, 2007). The results of E1 and F1 samples showed that the amounts of compounds 
penetrating in the F1 case were higher than the ones of E1 extract suspension (Figure 43). 
These results are in agreement with the ones reported by Tachaprutinun et al. (2014) in which 
Table 40. Skin permeation profile of the extract E1 (Ganoderma lucidum). 
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the authors confirmed that the properties of the base cosmetic cream (vehicle) have a significant 
impact on the penetration of the active ingredients. 
 
Figure 43. Permeation profile of compounds in E1 and F1. 
 
Various types of bioactivities have been reported for triterpenes and phenolic acids, such as 
antimicrobial, anti-inflammatory and antioxidant properties (M. J. Alves et al., 2013; Heleno, 
Martins, et al., 2015; Taofiq et al., 2015). In vitro studies have shown that syringic acid present 
anti-inflammatory activity due to the ability to suppress iNOS and COX-2 activity (M. H. Lee 
et al., 2013; Stanikunaite et al., 2009). On the other hand, protocatechuic acid presents 
hyperpigmentation potential due to its ability to inhibit the tyrosinase enzyme (Sahin, 2018). 
Hence, when applied to the skin, F1 will be able to deliver these health promoting potentials 
namely antioxidants and anti-inflammatory effects. Abla and Banga (2013) have reported the 
permeation of catechin and resveratrol using porcine ear skin, which was favoured due to the 
use of propylene glycol that acts as a penetration enhancer. A more significant amount of 
catechin was retained in the stratum corneum whereas only 10% was able to be quantified in 
the underlying skin. Other authors suggested that the release of phenolic compounds from 
semisolid vehicles is influenced, not only by the physiochemical properties of the bioactive 
ingredient but also by the properties of the used vehicle, as well as by the concentration of the 
bioactive in the formulation. 
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The above phenomena were reported by Žilius et al. (2013) after 8h of ex vivo skin permeation 
experiments, where over 90% of the phenolic compounds were released from a hydrophilic 
gel, and only up to 5% and 22% of phenolic compounds were released from ointment and 
water-in-oil (w/o) cream, respectively. These results demonstrated that the E1 ethanolic extract 
can be utilised as an ingredient for cosmeceutical application due to the beneficial biological 
properties of its individual compounds (protocatechuic and syringic acids). After topical 
application, they penetrate the skin, offering advantages as antioxidative support to the skin, 
suppressing oxidative stress and protecting the skin against photoageing.
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Conclusions and Future Perspectives 
 
Mushrooms are a source of biologically active metabolites that present an interesting potential 
to be utilised as cosmeceutical and nutricosmetic ingredients. The present study was aimed to 
strengthen the knowledge of mushrooms and their individual metabolites as potential 
ingredients for cosmetic application. Optimization studies were successfully conducted to 
obtain extracts from G. lucidum and A. blazei, rich in bioactive compounds, by comparing 
conventional and more sustainable non-conventional approaches. Regarding G. lucidum, in 
global terms at the optimum conditions predicted by the RSM model, the UAE led to the 
obtainment of extracts richer in triterpenes than those obtained by HAE and SE, mainly due to 
the higher amounts of ganoderic acid C2, A and H. Regarding A. blazei, the MAE, at the 
optimum conditions, was identified as the most appropriate to obtain higher extraction yield 
and ergosterol content, followed by UAE and HAE. The values predicted by the models were 
in close agreement with the experimental observations, proving the validity of the model and 
the utility of the predictions for future scale-up towards the production of an ergosterol-rich 
extract from A. blazei. 
The ethanolic extracts of A. bisporus, P. ostreatus, L. edodes and G. lucidum displayed strong 
antioxidant activity which suggests that they can prevent/minimize the oxidative stress related 
to ROS generation, thus acting as skin anti-ageing ingredients.  The magnitudes of the other 
bioactive properties were as follows: anti-tyrosinase: A. bisporus ˃ L. edodes ˃ P. ostreatus, 
L. edodes ˃ A. blazei ˃ G. lucidum; anti-inflammatory: G. lucidum ˃ L. edodes ˃ A. bisporus 
˃ P. ostreatus ˃ A. blazei; antimicrobial: G. lucidum ˃ L. edodes ˃ A. bisporus ˃ P. ostreatus. 
G. lucidum was found to present the highest amount of phenolic acids and related compounds, 
due to the contribution of protocatechuic, p-hydroxybenzoic and syringic acids, closely 
followed by P. ostreatus which presented p-hydroxybenzoic, protocatechuic and cinnamic 
acids. After incorporating the extracts into the base cosmetic cream, the mushroom cosmetic 
formulations still preserved some of its bioactivities, which highlights that mushrooms contain 
sustainable bioactive compounds that can be utilised as cosmeceutical ingredients. 
After incorporating the extracts into the base cosmetic creams, they displayed bioactivity; even 
with a decreasing pattern along the 6 months, for the free extracts. Microparticles were then 
developed to ensure topical delivery of A. bisporus and P. ostreatus ethanolic extracts. The 
release profile after incorporating microparticles in semi-solid base formulation showed no 
demonstration of significant antioxidant and antimicrobial activities, but with the anti-
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tyrosinase activity being displayed even after 3 months.  The produced microparticles 
effectively offered protection, and when compared to the free forms they were able to allow 
for a sustained release of the bioactive compounds.  
In the study related to the cosmeceutical potential of the individual compounds, the magnitude 
of the bioactivities displayed were as follows: anti-tyrosinase activity: cinnamic acid ˃ p-
hydroxybenzoic acid; antimicrobial activity: p-coumaric acid ˃ cinnamic acid ˃ ergosterol ˃ 
p-hydroxybenzoic acid ˃ protocatechuic acid; anti-inflammatory activity: p-coumaric acid ˃ 
cinnamic acid ˃  protocatechuic acid ˃  p-hydroxybenzoic acid ˃  ergosterol. The multifunctional 
properties displayed by these compounds make them suitable candidates to be explored as 
cosmeceutical ingredients. The atomization/coagulation technique was successfully applied to 
encapsulate the bioactive agents, conducting to encapsulation efficiency percentages above 
50% for all the tested compounds. After incorporating the individual compounds in the 
cosmetic formulations, bioactive properties were only partially maintained while their 
microencapsulated formulations have shown a sustained release able to better preserve 
bioactivity. Moreover, over the course of storage time, no significant changes were observed 
in the tested stability parameters, namely colour and pH.  By the obtained results, the analysed 
bioactive agents revealed promising bioactivity and stability.  
Besides the interesting biological properties displayed by G. lucidum and A. blazei ethanolic 
extracts, these mushroom species also showed high nutritional contribution. α-Tocopherol, 
oxalic acid, and twenty-one fatty acids (mainly polyunsaturated fatty acids) were quantified in 
A. blazei. In G. lucidum, a similar fatty acid profile was observed with the presence of α-
tocopherol and δ-tocopherol. Comparatively, A. blazei was found to present lower fat content, 
but a higher energy contribution. The cell viability effect of the extract prepared from A. blazei 
on Caco-2 and HT29-MTX cells were found to be maintained in a concentration-dependent 
manner. It is interesting to note that the oral administration of extracts rich in compounds with 
antioxidant capacity can be utilised to prevent damages caused by cutaneous sun damage 
resulting in better and healthy skin, but the efficacy of these extracts as nutricosmetics is still 
subjected to proper long-term clinical trials. 
Following previous results, G. lucidum and P. ostreatus demonstrated the best cosmeceutical 
potential, due to their highest bioactivity; both extracts and their corresponding formulations 
were selected for further studies. Regarding HaCaT cells, after exposure to the extracts, up to 
90% cell viability was maintained after the MTT assay, while HFF-1 cells were found to be 
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more sensitive to G. lucidum extract. In the LDH assay, P. ostreatus extract did not show any 
potential to cause LDH leakage after exposure to HFF-cell. This low toxicity was achieved at 
100 µg/mL, while up to ˃ 50% toxicity was found above 1 mg/mL. The results showed the 
absence of toxicity for keratinocytes and fibroblasts in a concentration-dependent manner, 
which is indicative of the safety of these extracts for cosmeceutical ingredients’ purposes. 
Protocatechuic and syringic acids were the only compounds permeating from G. lucidum 
extract, while very low detection was observed for compounds from the P. ostreatus extract. 
These results pointed out for the suitability of using mushroom extracts as skin care ingredients. 
The studies conducted here successfully optimized extraction techniques to maximize the 
recovery of different compounds from mushrooms; highlighted the biological properties of 
mushroom extracts; and were validated in final applications in cosmetic matrices. Furthermore, 
the nutritional and chemical composition of the mushroom fruiting bodies were also 
determined, and the microencapsulation with polymeric materials were applied to modulate the 
release of bioactive compounds and provide protection against degradation factors. The 
absence of toxicity of the extracts and their final formulations was confirmed, and skin 
permeation studies were conducted to evaluate the topical availability of the bioactive 
compounds. Overall, it can be concluded that the studied mushrooms represent an important 
source of bioactives with multifunctional biological properties, which can be used as 
ingredients to formulate cosmetic creams or lotions.  
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Future perspectives 
1. From a sustainable point of view, focus should be placed on residues generated during 
mushrooms’ production processes to suppress the negative impact of these wastes on the 
environment, while contributing effectively as sources of biologically active cosmeceutical 
ingredients; 
2. Mushroom extract and individual compounds revealed intereting biological properties and 
as such determine the biochemical mechanism behind each bioactive property by testing the 
levels of expression of the respective protein markers by western blot analysis can be further 
carried out; 
3. Comprehensive safety and toxicity assessment of the extracts and the individual compounds 
can also be conducted using validated cell-based in vitro models as proposed by the European 
Centre for the Validation of Alternative Methods (ECVAM) to predict carcinogenicity, repeat 
dose toxicity and reproductive toxicity; 
4. Because of the limitations on testing cosmetic ingredients on animals, technological 
advancements have led to the development of 3D models, either as epidermal models 
(containing keratinocytes) or full thickness models (containing keratinocytes and fibroblasts) 
such as EpiSkinTM, EpiDermTM, StrataTestTM, SkinEthicTM, Epiderm FTTM, and epiCSTM. 
Therefore, evaluation of the permeability and topical availability of the bioactive metabolites 
in the studied extracts and individual compounds in these models will further strengthen the 
knowledge on their use as cosmeceutical ingredients;  
5.  Studies related to the in vivo effects of the extracts and their corresponding cosmeceutical 
formulations should be conducted. Volunteers can be asked about their perception of the 
formulation based on properties such as skin hydration, wrinkles depth, skin roughness and 
transepidermal water loss. 
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Annexes 
 
 
 
 
Resistance profile of Gram- negative bacteria to different antibiotics; MIC values (µg/mL). 
 
 
Amoxicillin/ 
Clavulanic Acid 
Ampicillin Gentamicin Cefuroxime Ciprofloxacin Fosfomycin Nitrofurantoin Norfloxacin 
Gram negative         
E. coli 
>8/4 >16 ≤2 ≤4 >2 ≤16 ≤32 >8 
S R R S R S S R 
P. mirabilis 
≤ 8/4 ≤8 na ≤4 >2 na >64 na 
S S  S R  R  
S- Susceptible; R- Resistant: this classification was made according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute (CLSI) and 
European Committee on Antimicrobial Susceptibility Testing (EUCAST); na- not applicable. 
 
Resistance profile of Gram-positive bacteria and C. albicans to different antibiotics; MIC values (µg/mL; mg/mL, respectivelly). 
 Ampicilin Clindamycin Erythromycin Gentamicin Levofloxacin Linezolide Oxacilin Trimethoprim/ sulfamethoxazole Vancomicin 
Gram positive          
MRSA na ≥ 8 ≥ 8 ≥16 4 2 ≥4 ≤10 2 
  R R R R S R S S 
MSSA na <0,25 <0,25 ≤1 na 2 <0,25 ≤1/19 ≤1 
  S S S  S S S S 
E. faecalis ≤1 na na na na na na na na 
 S         
Yeast  Fluconazol        
C. albicans  0.06 mg/mL        
MSSA - methicillin-sensitive Staphylococcus aureus; MRSA - methicillin-resistant Staphylococcus aureus; S- Susceptible; I- Intermediate; R- Resistant: this classification was 
made according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility 
Testing (EUCAST); na- not applicable. 
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